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Abstract 
Microglia have neurotoxic and neuroprotective effects. The aim of the current 
project was to investigate the effects of perineuronal microglial activation on 
axonal regeneration in adult rats and the effects of prolonged neuroinflammation 
on foetal mouse brain. 
In contrast to the PNS, the CNS only displays limited axonal regeneration after 
injury and little perineuronal inflammation. Inflammation around the cell bodies of 
axotomised neurons has been demonstrated to promote CNS regeneration.  
Polyinosinic:polycytidylic acid (Poly I:C) is an inflammatory agent. Following 
delivery of Poly I:C into the motor cortex and a concomitant C4 dorsal 
corticospinal tract (CST) injury, rats exhibited more CST axons in the cervical 
spinal cord and less retraction from the injury site than controls. Following facial 
nerve axotomy, Poly I:C injections adjacent to the facial nucleus accelerated 
functional recovery. 
Viral vectors carrying Granulocyte Macrophage Colony Stimulating Factor (GM-
CSF) were injected into motor cortex. GM-CSF virus reduced retraction of 
corticospinal axons from a spinal cord injury site. Behavioural studies of forelimb 
movements showed that C4 injury had a greater impact on fine distal movements, 
particularly reaching and grasping, which are known to be controlled by the CST. 
Treating rats with GM-CSF virus showed a trend towards improved forelimb sub-
movements and significantly aided the reaching function recovery. 
Perinatal activation of periventricular phagocytes has been suggested to result in 
white matter damage, causing persistent motor disabilities. Transuterine 
injections of control or GM-CSF virus targeting the lateral ventricles of mice at 
gestational day 14, resulted in a widespread virally-transduced cells. Greater 
numbers of phagocytic and activated microglia were present in the areas of viral 
transduction. There was increased inflammation in the periventricular white 
matter. Although, the level of transduction remained relatively constant with 
increasing time, inflammation decreased, suggesting that GM-CSF toxicity is high 
before or around birth. 
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CHAPTER ONE 
INTRODUCTION 
Axons in the central nervous system (CNS), which include those of the spinal 
cord, normally fail to regenerate after injury. However, it is well documented that 
peripheral nervous system (PNS) axonal regeneration is vigorous and is often 
associated with structural and functional recovery (Cajal, 1928). There are three 
main theories that seek to explain this dichotomy: first, presence of inhibitory 
molecules in the CNS; second, lack of neurotrophic support in the CNS 
environment; and third, intrinsic inability of CNS neurons to mount an appropriate 
cell body response to axotomy. 
Peripheral Nerve Regeneration after Injury 
Cell body response 
Morphological changes 
The neuronal cell body undergoes a range of morphological changes following 
axonal injury. The Nissl bodies, which are large accumulations of granular 
endoplasmic reticulum and free ribosomal rosettes (Lieberman, 1971), disperse 
in the cytoplasm (chromatolysis), the nucleus is displaced from the centre of the 
neuron to the periphery, the nucleolus is enlarged, the cell body swells, and the 
synaptic terminals retract from the cell body (Lieberman, 1971). In addition there 
is an increase in the number of organelles such as ribosomes and mitochondria 
(Lieberman, 1971). The cell body response reflects the switch in metabolic priority 
from making neurotransmitters to the synthesis of materials that are necessary 
for axonal repair and growth (Grafstein, 1975). 
Molecular Changes 
Following peripheral nerve injury, axotomised neurons undergo a molecular 
response which drives axonal regeneration. They increase the expression of 
growth-associated proteins including adhesion molecules, axonal transport 
molecules, cytoskeletal components, secreted growth factors and cytokines. 
There is also an increase in energy, amino acid, iron and lipid metabolism 
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(Holtmaat et al., 1998; Lieberman, 1971; Raivich and Makwana, 2007), and 
changes in the expression of ion channels and transporters, particularly those for 
calcium (Arteaga et al., 2004; Hudmon et al., 2008; Wu et al., 2008). This 
molecular response is initiated by signals from the injury site that act on 
intracellular pathways which ultimately influence gene expression. 
INJURY SIGNALS 
Axonal injury generates three types of signals that exert effects on neurons. First, 
injury transiently opens the axonal membrane permitting the influx of ions (Yoo 
et al., 2003), which cause depolarisation and transmission of injury mediated 
action potentials. Second, axotomy produces a discontinuation in the axonal 
transport which normally brings neurotrophic signals to the neuronal cell body 
(Raivich et al., 1991b). Third, injury exposes the axon to neurotrophic intracellular 
contents of adjacent cells (Elde et al., 1991; Kirsch et al., 2003; Sendtner et al., 
1997) and other molecules from the inflamed neural environment (Lindholm et 
al., 1987); these can be retrogradely transported to the neuronal cell body (Hanz 
et al., 2003). 
MAPK AND OTHER EARLY SIGNAL ENZYMES 
Intracellular signalling enzymes are involved in propagating the signals derived 
from injury site within the injured neuron. In vitro studies have demonstrated that 
neurite outgrowth is influence by signalling involving mitogen activated protein 
(MAPK), Jun-N-terminal (JNK), and extracellular signal regulator (ERK), abl, AKT 
and p38 protein kinases, as well as cAMP, and cAMP-dependent protein kinase 
A (PKA) (Lindwall and Kanje, 2005; Perlson et al., 2005). 
In vivo, JNKs become activated rapidly after peripheral nerve injury and are 
retrogradely transported with their upstream kinases (Lindwall and Kanje, 2005). 
Deletion of JNK1 and JNK2 genes mildly delays functional recovery after facial 
nerve injury (Ruff et al., 2012). 
Mammalian sterile 20-like kinase-3b (Mst3b) is a protein kinase activated by PKA 
(Zhou et al., 2000). In vitro, Mst3b is essential for neurotrophin-stimulated axon 
outgrowth (Irwin et al., 2006). In vivo, removal of Mst3b abolishes neurite 
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outgrowth by retinal ganglion cells and reduces axonal regeneration after 
peripheral nerve injury (Lorber et al., 2009). 
Peripheral axotomy causes a decrease in the activated form of Ras, a small 
GTPase involved in the activation of mitogen activated proteins (Makwana et al., 
2009). Neuronal overexpression of active Ras in vivo increases central sprouting 
emanating from the injured motor neurons (Makwana et al., 2009). 
Phosphatidyl-Inositide-3 kinase (PI3K) expression (Ito et al., 1996) and activation 
of Akt, its main target protein kinase, is induced by axotomy (Murashov et al., 
2001; Owada et al., 1997). In vivo, deletion of the p110 delta catalytic component 
of PI3K reduces Akt activation, slows down axonal regeneration and mildly delays 
functional recovery (Eickholt et al., 2007). 
TRANSCRIPTION FACTORS 
The cytoplasmic signalling cascades brought about by axonal injury are followed 
by an increased nuclear localisation and activation of proteins involved in gene 
transcription. Numerous axotomy-induced transcription factors have been 
identified. These include: c-Jun, Jun-D, activating transcription factor 3 (ATF3), 
P311, Sox11, several members of the CEBP family and STAT3 (de Heredia and 
Magoulas, 2013; Fujitani et al., 2004; Jankowski et al., 2009; Mason et al., 2003; 
Nadeau et al., 2005; Schwaiger et al., 2000). In contrast, the expression of other 
transcription factors can be reduced, including islet-1 (Hol et al., 1999), Fra-2 and 
ATF-2 (Herdegen et al., 1997; Robinson, 1996). 
AP-1 
c-Jun is  consistently upregulated in all models of successful regeneration 
(Herdegen et al., 1991; Jenkins and Hunt, 1991; Lindwall and Kanje, 2005; 
Mason et al., 2003; Raivich et al., 2004). Neuronal injury increases JNK-mediated 
c-Jun phosphorylation (Herdegen et al., 1998; Kenney and Kocsis, 1998). 
Application of JNK inhibitor to explanted injured dorsal root ganglions (DRG) 
reduces neurite outgrowth (Lindwall et al., 2004). However, in vivo removal of 
phosphorylation sites in the c-Jun protein does not affect peripheral nerve 
regeneration (Ruff et al., 2012). Nonetheless, neuronal deletion of c-Jun 
dramatically reduces the expression of regeneration-associated genes, the 
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speed of target reinnervation and the recovery of motor function (Raivich et al., 
2004). In addition, deletion of c-Jun blocks post-axotomy perineural sprouting 
(Makwana et al., 2010), reduces neuronal cell death and inhibits the activation of 
neighbouring microglia and recruitment of lymphocytes (Raivich et al., 2004). 
ATF3 is axonally transported from the injured distal stump (Lindwall and Kanje, 
2005) and may act as a retrograde injury signal similar to STAT3 (Lee et al., 
2004a). In vitro, ATF3 encourages neurite outgrowth. In vivo, the overexpression 
of ATF3 leads to increased expression of regeneration-related genes and an 
earlier onset of axonal regeneration (Seijffers et al., 2006). ATF3 is highly 
localised in the neuronal nucleus after axotomy but is cytoplasmic in the absence 
of injury (Bontioti et al., 2006; Campbell et al., 2005) Interestingly, nuclear 
localisation of ATF3 after axotomy appears to depend on the presence of c-Jun 
(Raivich, 2011). 
STAT3 
Early after peripheral nerve injury there is a transient increase in STAT3 
expression, activation and nuclear translocation (Schwaiger et al., 2000) in the 
cell bodies of the injured neurons. STATs can be activated by signalling pathways 
induced by several cytokines and growth factors including IL-6, LIF, CNTF, G-
CSF, G-CSFR, EPO, EGF, IGF-1, and BDNF, as well as NGF withdrawal and the 
presence of free radicals, excitatory neurotransmitters and other inflammatory 
mediators released after injury (Dziennis and Alkayed, 2008). STAT3 is 
phosphorylated at the proximal stump of the injured axon and retrogradely 
transported to the neuronal cell nucleus (Lee et al., 2004a). Conditional mutant 
mice lacking STAT3 specifically in their neurons have a profound reduction in 
expression of other neuronal regeneration-associated genes, speed of axonal 
regeneration, functional recovery and target reinnervation (Patodia and Raivich, 
2012a). 
C/EBP 
C/EBPβ is upregulated and phosphorylated after neuronal injury and has an 
important role on the expression of regeneration-associated genes (Nadeau et 
al., 2005). In vitro, c/EBP delta-deficient primary sensory neurons demonstrate 
impaired axonal growth, and a reduced response to a conditioning lesion (de 
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Heredia and Magoulas, 2013). In vivo, c/EBP delta also appears to have a role in 
the response to facial nerve axotomy (Patodia and Raivich, 2012a). Other 
signalling pathways involved in axonal injury such as the JAK/STAT pathway may 
also converge on the c/EBP family (Jiang and Zarnegar, 1997). 
SOX11 
SRY-box containing gene 11 can drive expression of neurite growth associated 
genes (Bergsland et al., 2006; Jankowski et al., 2006). In vivo, SOX11 is 
upregulated after axotomy (Boeshore et al., 2004; Jankowski et al., 2006; 
Jankowski et al., 2009).In vitro, inhibition of SOX11 decreased DRG regeneration 
following axotomy (Jankowski et al., 2006). In vivo, knocking down SOX11 
reduces the number of regenerating DRG axons and diminishes the injury 
induced ATF3 levels by half (Jankowski et al., 2009). 
P53 
p53 is a regulator of the expression of growth cone guidance molecules and their 
receptors (Arakawa, 2005). Overexpression of dominant negative p53 leads to 
growth cone collapse in primary cortical neurons and a decrease in neurite 
outgrowth, together with reduced expression of growth cone-associated genes 
(Di Giovanni et al., 2006; Tedeschi et al., 2009). In contrast, over-expression of 
wild type p53 leads to increased growth cone size (Qin et al., 2009). In vivo, p53 
knock out mice show decreased target muscle reinnervation after nerve injury (Di 
Giovanni et al., 2006). 
NUCLEAR FACTOR KAPPA LIGHT CHAIN ENHANCER OF ACTIVATED B 
CELLS 
High levels of NF-kappa B can be observed in the injured neuron after peripheral 
nerve injury (Ma and Bisby, 1998; Pollock et al., 2005). Like STAT3 and ATF3, it 
responds to stimuli in neurites and travels retrogradely to affect gene 
transcription. NF-kappa-B can enhance or inhibit neurite growth depending on its 
phosphorylation status. Phosphorylation of NF-kappa B by the IκBα subunit IKK-
β results in reduced neurite growth, whilst neurons lacking IKK β activity show 
increased neurite growth (Gutierrez et al., 2008). 
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DOWNSTREAM EFFECTOR MOLECULES 
Changes in intracellular signalling and the regulation of transcription after 
peripheral nerve injury lead to the expression of molecules which encourage 
successful axonal regeneration. These include adhesion molecules, 
neuropeptides and cytoskeletal adaptors (Patodia and Raivich, 2012b). 
ADHESION MOLECULES 
Adhesion molecules enable the axon to interact with the bands of Büngner as the 
axon elongates (Grumet, 1991; Shapiro et al., 2007). Among the numerous 
adhesion molecules up-regulated by axons following injury, α7β1 (Raivich et al., 
2004; Werner et al., 2000) and CD44 (Lin and Chan, 2003; Nagy et al., 1998) 
have been identified as the in vivo downstream targets of regeneration-
associated transcription factors. Deletion of neuronal c-Jun or STAT3 is 
associated with a reduction in the expression of α7β1 integrin (Patodia and 
Raivich, 2012b; Raivich et al., 2004; Ruff et al., 2012). There are significant 
delays in axonal regeneration following facial nerve crush injury in mice in which 
the α7 subunit is globally deleted (Jones et al., 2000). In addition, preliminary data 
suggests that the deletion of β1 integrin is associated with a reduction in axonal 
regeneration speed, similar to that seen in α7 knockout mice (Patodia and 
Raivich, 2012b). Following facial nerve axotomy, CD44 expression is abolished 
in mice lacking neuronal c-Jun (Ruff et al., 2012) and STAT3 (Patodia and 
Raivich, 2012b). Inhibition of CD44 reduces axon outgrowth from noradrenergic 
neurons grafted into the anterior chamber of the eye (Nagy et al., 1998) and 
produces significant defects in routing of retinal axons through the optic chiasm 
(Lin and Chan, 2003) 
NEUROPEPTIDES 
Axonal injury leads to an increase in the expression of neuropeptides, molecules 
involved in cell signalling via their action on G-coupled receptors. The expression 
of the neuropeptides calcitonin gene-related peptide (CGRP) and galanin is 
regulated by transcription factors c-Jun and STAT3. Mice deficient in neuronal c-
Jun and STAT3 fail to upregulate CGRP and galanin following facial nerve 
axotomy (Patodia and Raivich, 2012b; Raivich et al., 2004; Ruff et al., 2012). The 
absence of galanin reduces the rate of sciatic nerve regeneration following a 
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crush injury and was associated with long-term functional deficits in the injured 
animals. In addition, cultured DRG from galanin deficient mice show deficits in 
neurite number and length (Holmes et al., 2000). Knocking down CGRP 
expression, by delivery of siRNAs to the sciatic nerve injury site, was also 
associated with significant disruption to axonal growth (Toth et al., 2009). 
CYTOSKELETAL ADAPTORS 
Cytoskeletal adaptors are present in growth cones and are involved in 
cytoskeletal remodelling (Baas and Ahmad, 2001). Increased expression of the 
adaptor molecules, GAP-43 and CAP-23, is induced by nerve injury and 
regulated by regeneration-associated transcription factors (Bomze et al., 2001; 
Goslin and Banker, 1990). Following nerve injury, GAP-43 and CAP-23 mRNA 
are upregulated in axotomised neurons (Mason et al., 2002). Mice deficient of 
c/EBPβ show reduced upregulation of GAP-43 following injury (Nadeau et al., 
2005). Similarly, axotomy-induced expression of CAP-23 is reduced in mice 
lacking c-Jun (Patodia and Raivich, 2012b). Functionally, global deletion of GAP-
43 results in defective neuronal pathfinding during development, leading to a 
grossly abnormal adult CNS in mice (Strittmatter et al., 1995). Similarly, CAP-23 
knock out mice fail to produce stimulus-induced nerve sprouting at the adult 
neuromuscular junction (Frey et al., 2000), and show reduced axonal 
regeneration following facial nerve axotomy (Anderson et al., 2006). 
Axonal Response 
Distal end 
Following peripheral nerve injury the portion of nerve distal to the injury site 
undergoes Wallerian degeneration. This process is already noticeable around 24 
hours after nerve lesion (Perry and Brown, 1992; Stoll and Muller, 1999) . There 
is rapid breakdown of the axoplasm, with granular disintegration of the axonal 
cytoskeleton (Bignami and Ralston, 1969; Trojanowski et al., 1984). The myelin 
sheath becomes fragmented and breaks down into fatty spheroids (Lassmann et 
al., 1978). Schwann cells detach from myelin sheaths and begin to clear myelin 
and axonal debris (Hirata et al., 2002; Perry and Brown, 1992). However, this 
process is predominantly taken over by infiltrating macrophages (Tanaka et al., 
1992), which are recruited by Schwann cells through the release of cytokines 
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(Tofaris et al., 2002). Debris clearance eliminates some factors associated with 
myelin (e.g. MAG) which might otherwise inhibit axonal growth. This begins the 
process of turning the distal nerve into an environment that promotes 
regeneration. 
Schwann cells proliferate as they lose axonal contact and are stimulated by 
macrophages secreted cytokines (Karanth et al., 2006). They then line up within 
the hollowed endoneurial tubes forming the bands Büngner, pathways that will 
later support regenerating axons (Bungner, 1891) by secreting neurotrophic 
factors (Funakoshi et al., 1993; Lindholm et al., 1987; Meyer et al., 1992), and 
expressing adhesion molecules and their receptors (Fawcett and Keynes, 1990; 
Martini and Schachner, 1988). 
Proximal end 
At the proximal nerve stump, injury also causes axonal degeneration with 
macrophage invasion and myelin breakdown but this is limited to the area most 
proximal to the lesion site (Grafstein, 1975; Lieberman, 1971). 
Injury transiently opens the membranes of cells within the nerve, exposing the 
injured axonal tip to the intracellular contents of other axons and Schwann cells 
(Kirsch et al., 2003; Sendtner et al., 1997). With the arrival of axoplasm containing 
cytoskeletal components and organelles, the proximal end of the axon seals and 
forms a bulbous swelling at the tip (Meller, 1987; Vallee and Bloom, 1991).These 
axonal swellings eventually give rise to some of the axonal sprouts which are 
tipped by growth cones (Cajal, 1928). 
Growth cones are highly dynamic sensory structures at the tip of sprouts (Spira 
et al., 2003). The growth cone looks like a webbed foot; it has a swollen central 
area from which processes called lamellipodia and filopodia extend (Fawcett and 
Keynes, 1990). Growth cones grow towards their target tissues aided by the 
mechanical and chemical guidance from the bands of Büngner (Ide, 1996). 
SPROUTING 
In addition to the sprouting observed at the tips of regenerating axons, growth 
cones can arise more proximally: at the nodes of Ranvier (Cajal, 1928), distal part 
of dendrites (Fenrich et al., 2007) and sometimes even at the level of the injured 
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neuronal cell body (Linda et al., 1985; Makwana et al., 2010). Nerve injury can 
also promote sprouting from adjacent uninjured axons (Nurse et al., 1984); 
(Nguyen et al., 2002; Tanigawa et al., 2005). Sprouts which arise closest to the 
injury site can enter the distal nerve stump along with those arising directly from 
the injured axonal tip (Mackinnon et al., 1991; Morris et al., 1972). 
Successful axonal regeneration leads to the reinnervation of target synapses 
(Magill et al., 2007). In motor axon regeneration, this process appears to occur in 
a step wise manner. The fastest regenerating axons reach the muscle and sprout, 
a single regenerating axon forming synapses on many denervated 
neuromuscular junctions. Subsequent arrival and sprouting of more axons, 
results in many NMJs receiving axonal endplates from more than one 
regenerating axon. This phenomenon has been termed NMJ polyinnervation. 
Ultimately, pruning abolishes polyinnervation and each NMJ is innervated by a 
single axon (Magill et al., 2007). Mono-innervation of NMJs is associated with 
good functional recovery (Magill et al., 2007). 
Upon reinnervation of targets, Schwann cells remyelinate the regenerated axon 
providing them with the property of saltatory nerve conduction (Ide, 1996). 
However, the diameter of regenerated axons, their conduction velocity and 
excitability remain below normal levels for a long time following regeneration 
(Fields and Ellisman, 1986). Figure 1 summarises the changes that occur 
following injury to peripheral neurons. 
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The rate of nerve regeneration and functional recovery 
In the first 2 to 7 days following nerve injury, there is a delay in axonal 
regeneration, which is associated with the initial retrograde degeneration of 
proximal axon and slow axonal growth through the nerve injury scar (Forman and 
Berenberg, 1978; Gutmann et al., 1942; Sunderland, 1947). Having crossed the 
scar, axonal fibres grow at a rate between 1 to 4 mm per day (Bisby and Keen, 
1985; Forman and Berenberg, 1978; Gutmann et al., 1942). Estimates of the rate 
of axonal regeneration depend on the method used for its measurement (Raivich 
and Makwana, 2007). 
Complete anatomical target reinnervation following sciatic nerve transection 
occurs after 6 weeks in mice (Magill et al., 2007) and after 10 weeks in rats (Sinis 
et al., 2009). At these times, functional recovery is robust and almost complete in 
mice (Magill et al., 2007) but minimal in rats (Sinis et al., 2009). In fact, functional 
recovery in the rat is minimal even up to 16 weeks after peripheral nerve 
transection (Bendella et al., 2011; Hadlock et al., 2010; Knox et al., 2013). 
Figure 1: Summary of cellular mechanisms involved in successful regeneration: injury-induced 
signalling (A); cell body response involved in axonal growth (B); and molecular mechanisms of 
neurite outgrowth at the growth cone (C). (A) Axonal trauma induces a cessation of normal trophic 
retrograde transport (blue arrows), a rapid influx of cations resulting in an antidromal train of action 
potentials (red), and exposure to injury signals transported retrogradely via proteins containing 
nuclear localization signals (green), that may act in synergy to induce the biochemical activation 
in the neuronal cell body. This regeneration programme includes enzymes regulating mRNA 
metabolism—ODC, TGT, intracellular cascades such as MAP kinases and PI3K-Akt, and 
complemented by enhanced nuclear localization and phosphorylation or other forms of activation 
(*) for a host of transcription factors (TF) including c-Jun, etc., as well as numerous molecules 
that regulate cell death, including death domain carrying membrane proteins (p75, TNFR, fas) as 
well as cytoplasmic caspases and bcl-2 family members. At the cut axon, the rapid influx of Ca2+ 
causes calpain activation and cytoskeletal remodelling that results in structured accumulation of 
anterogradely transported vesicles and cytoskeletal components, transforming the axon tip into 
an extension-competent growth cone. (B) Regenerating neurons undergo transcription factor-
dependent changes in mRNA and protein synthesis that result in the production and anterograde 
transport of vesicles and proteins (cell adhesion molecules, cytoskeleton, growth-associated 
proteins such as the GMC family members GAP43, CAP23 and MARCKS), that are needed for 
interacting with the local cell adhesion and guidance molecules (L1, NCAM, N-cadherin, laminin 
etc.) and extending the axonal growth cone along the Schwann cells and the basal membrane 
substrate of the peripheral neural tubes. (C) A brief overview of signals regulating neurite 
outgrowth at the axonal growth cone. This can involve a variety of interactions via preferentially 
homophilic (L1, NCAM) or heterophilic cell adhesion ligands (laminin, alpha7 beta1 integrin, 
ninjurin/gicerin), a variety of growth factors and their receptors such as FGF and FLTR3, and the 
phosphoinositol-4,5-diphosphates – PI(4,5)P2 – that associate with the GMC family of 
calcium/calmodulin ligands and Protein Kinase C (PKC) and regulate actin cytoskeleton 
polymerization, organization and disassembly. The anterograde axonal transport of vesicles, 
signalling molecules, cytoskeletal proteins and their mRNA plays a critical role in providing 
structural and regulatory components for axonal elongation. From Raivich and Makwana (2007). 
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The overall rate of axonal regeneration after peripheral nerve injury can be 
accelerated by the use of conditioning lesions (McQuarrie et al., 1977) and 
electrical stimulation of the proximal stump of severed peripheral nerves (Al-
Majed et al., 2000a; Brushart et al., 2002). However, these procedures only 
marginally increase functional recovery in the rats after peripheral nerve 
transection, despite increasing the speed of anatomical regeneration (Hadlock et 
al., 2010; Zhang et al., 2013).  
The poor functional recovery in rats despite robust axonal regeneration has been 
explained by inaccurate target reinnervation. Collateral axonal sprouting at the 
nerve transection site (Ito and Kudo, 1994) results in highly branched axons 
innervating multiple inappropriate targets (Bendella et al., 2011; Dohm et al., 
2000; Sinis et al., 2009). In addition, terminal motor axon sprouting at the 
neuromuscular junctions leads to poly-innervation of NMJs rather than normal 
mono-innervation (Guntinas-Lichius et al., 2000; Sinis et al., 2009).  
Polyinnervation of NMJs and collateral sprouting remain up to 16 weeks post 
nerve transection in rats and are associated with poor functional recovery 
(Bendella et al., 2011). Interestingly, when rat peripheral nerve is crushed instead 
of transected, robust functional recovery is achieved (Zhang et al., 2013) and no 
NMJ polyinnervation or inappropriate multiple target innervation by axons is 
observed (Magill et al., 2007). 
Changes following CNS axonal injury 
Although some functional recovery occurs following partial spinal cord injury, 
tracts which are damaged almost invariably fail to demonstrate successful 
regeneration. This failure has been most commonly explained by the fact that the 
environment presented to an injured CNS projecting axon is highly inhibitory to 
regeneration and lacks the neurotrophic support that is characteristic of the 
injured PNS 
Axonal die back 
After spinal cord injury axons are known to undergo a series of changes. Like in 
the PNS, distal CNS axon ends undergo Wallerian degeneration (Cajal, 1928). 
However, the ends of the axons in the proximal stump die back and fail to 
regenerate. The distance that axons die back increases as time passes: at week 
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one the mean die back distance that CST axons die back is 1.4mm and at 16 
weeks it is approximately 4.1mm. However, the majority of axons stop dying back 
after 4 weeks, at approximately 2.5mm from the injury site. Nonetheless, a 
minority of axons continue to die back for much longer distances (Seif et al., 
2007).  
The proximal endings of severed spinal axons develop into spherical swellings 
known as terminal bulbs (or retraction bulbs), which are clearly seen within one 
day after injury and persist for many months (Fishman and Kelly, 1984b; Pallini 
et al., 1988; Pasquale-Styles et al., 2003). Terminal bulbs contain dense 
accumulations of axoplasmic organelles (Borgens et al., 1986; Fishman, 1987; 
Hill et al., 2001). The formation of axonal retraction bulbs may involve the 
increase in axoplasmic flow in axons following trauma. The constant pushing 
force produced by this flow is thought to be a contributor to the end bulb swelling, 
and subsequent rupture that is characteristic of axon tips as they undergo die 
back (Jacob and McQuarrie, 1996; Kao et al., 1977; Kreutzberg, 1995). 
Small axonal swellings (varicosities) are also present sporadically along the 
length of the injured and adjacent uninjured axons. They are filled with 
axoplasmic organelles including mitochondria. They normally occur at least every 
3-10 um along the axon (Shepherd and Harris, 1998) and can be distinguished 
from end bulb by their size. Axonal swellings greater than 6 um2 can be identified 
as a terminal bulb, while those smaller being varicosities (Seif et al., 2007). 
Axonal Sprouting 
Axons undergoing die-back do engage in regenerative attempts in the form of 
axonal sprouting but these attempts are transient and rarely lead to axonal 
elongation (Hill et al., 2001; Li et al., 1994). About 30% of injured corticospinal 
axons mount an initial growth response, some between 6 to 24 hours after lesion. 
During this early growth phase axons seem to grow in two different modes: 
elongation in which the axons advance fast and straight, and branching in which 
numerous small lateral outgrowths form. Branching seems to be initiated when 
elongation stalls or when it is quenched from the beginning. It allows the axon to 
navigate outside pre-established axon pathways (Bareyre et al., 2004; 
Kerschensteiner et al., 2005). Neither mode of growth, however, allows axons to 
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advance substantially closer to their original targets. Figure 2 summarises the 
changes that CNS axons undergo following injury. 
 
 
Figure 2: Axonal changes following spinal cord after injury. A: Diagram shows a longitudinal 
section through the rodent dorsal corticospinal tract after cervical spinal cord injury. B: Diagram 
depicts the axonal response following injury. Descending axons are interrupted by injury. Some 
axons form new circuits with motor neurons via interneurons. Axonal branching and elongation is 
also evident. However, axons do not grow for long distances. Axons that fail to regenerate die 
back. Edited from Thuret et al., (2006). 
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The injury site 
Following spinal cord injury in the rat, microglia take on an activated phenotype 
(Anderson et al., 1982), they upregulate molecules including the MHCI and II, 
complement receptor C3, and the macrophage activation marker ED1 (Flaris et 
al., 1993) and they later take on a phagocytic morphology (Andersson et al., 
1991). Microglial activation starts in the epicentre of injury and spreads 
moderately into the spinal grey matter and white matter (Dusart and Schwab, 
1994). 
Astrocytes become hypertrophic, they proliferate and show a pronounced 
increase in expression of GFAP (Obrien et al., 1994). After one week post injury, 
GFAP-positive astrocytes accumulate at the margins of the lesion to form a scar 
between the intact tissue and wound (Reier and Houle, 1988). At longer time 
points post injury, astrocytes build a very dense network of processes (Reier and 
Houle, 1988). 
Infiltration of a number of different cells proceeds in waves (Blight, 1985; Dusart 
and Schwab, 1994). The first consists of the influx of polymorphonuclear 
granulocytes. The granulocyte entry to the lesion site and adjacent tissue is seen 
within the first few hours, is highest at 24 hours and disappears by 3 days post 
injury in the rat (Dusart and Schwab, 1994). Invading neutrophils are involved in 
the production of oxygen radicals undergoing oxidative burst (McCord, 1987) and 
neurophagia (Means et al., 1978). The second involves the infiltration of 
predominantly monocytes/macrophages (Blight, 1985; Bunge et al., 1994). Their 
primary role is to phagocytose cell  debris (Perry et al., 1993). Relatively few 
lymphocytes appear at spinal cord injury sites (Popovich et al., 1993). There is 
also infiltration of Schwann cells, meningeal cells and fibroblasts into the injury 
site (Blakemore, 1975). Schwann cells have been implicated in the remyelination 
of axons (Blight and Young, 1989) and produce neurotrophic factors (Brown et 
al., 1991) , which may promote axonal regeneration. Meningeal cells may play a 
role in establishing a glial limitans at the boundary of the scar (Carbonell and 
Boya, 1988). Fibroblasts originating from the meninges (Maxwell et al., 1990) or 
overlying connective tissue also invade the lesion site to some degree (Krikorian 
et al., 1981).  
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In the later stages of spinal cord injury in rats, phagocytic macrophages disappear 
from the lesion site and leave behind a cerebrospinal fluid-filled cyst surrounded 
by scar tissue (Madsen et al., 1994). At this later stage, GFAP-positive 
hypertrophic astrocytes surround the margin of the lesion, with their end feet 
forming multi-layered stacks at the border between intact tissue and the wound 
(Reier and Houle, 1988). A summary of the different cells found in the injury site 
is found in figure 3.  
Molecules inhibitory to axonal growth 
Numerous molecules have been found to inhibit axonal regeneration or repel 
regenerating axons in the CNS. Molecules with the most significant role in axonal 
regeneration generally fall into three categories: those associated with the 
meningeal/glial scar, (chondroitin sulphate proteoglycans -CSPGs), axonal 
guidance molecules (semaphorins and ephrins), and those related to CNS myelin 
(Nogo, MAG, OMgp). 
Inhibitory molecules in the meningeal/glial scar  
CSPGs are proteoglycans comprising of a core protein with variable numbers of 
glycosaminoglycan side chains. CSPGs may have their effects by activating the 
Rho-A signalling pathway within injured axons (Monnier et al., 2003). CSPGs are 
characteristically distributed in and around the lesion site and are expressed both 
by invading meningeal cells and by glia (Tang, 2003).  
Vigorous axonal growth is inhibited by the expression of CSPGs (Snow et al., 
1990). Dorsal root ganglion neurons transplanted within the degenerating dorsal 
columns of rats with spinal cord injuries regenerated only up to the outskirts of 
the lesion site, which expressed high levels of chondroitin-6-sulphate (Davies et 
al., 1999). In addition, following injury to the central process of the DRG, the 
axons extend up to the dorsal root entry zone (DREZ) then were repelled back 
towards the DRG (Cajal, 1928). The inhibition of growth past the DREZ is 
associated with high levels of expression of CSPG, NG2 and tenascin-C (Zhang 
et al., 2001). However, deletion of NG2 is not associated with regeneration or 
improved recovery (Donnelly et al., 2012; Hossain-Ibrahim et al., 2007), although 
lentiviral vector-mediated knockdown of NG2 does promotes neurite outgrowth in 
culture models of glial scars (Donnelly et al., 2010). 
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Further evidence for the inhibitory role of CSPGs comes from experiments using 
chondroitinase ABC, a bacterial enzyme that can remove their 
glycosaminoglycan side chains (Hynds and Snow, 1999; McKeon et al., 1995; 
Snow et al., 1990). Chondroitinase ABC infusion encouraged corticospinal tract 
regeneration past the lesion site in rats following a crush injury to the dorsal 
columns of the cervical spinal cord (Bradbury et al., 2002). Chondroitinase ABC 
had similar effect on mice encouraging more regenerative sprouts to enter the 
injury site following CST lesions (Carter et al., 2008). Furthermore, when 
chondroitinase ABC was applied to the site of injury to the dorsal spinocerebellar 
and rubrospinal tracts there was apparently impressive axonal regeneration 
beyond the injury site and into distant spinal segments (Yick et al., 2003; Yick et 
al., 2004). 
Axonal guidance molecules 
Semaphorin 
Several repulsive guidance cues may be involved in regulating axonal 
regeneration (Anderson and Lieberman, 2000). Semaphorins, a large family of 
secreted and membrane-bound glycoproteins, are expressed widely in the CNS 
(de Wit and Verhaagen, 2003; Dickson, 2002; Kruger et al., 2005). Semaphorins 
have been categorised into 8 classes by their sequence similarity and structural 
features (Pasterkarnp and Verhaagen, 2006). Plexins and neuropilins act as 
receptors for semaphorins, to induce signalling cascades involving, Rho family 
GTPases (Liu and Strittmatter, 2001), cyclic nucleotides, redox signalling 
(Terman et al., 2002), eicosanoids (Mikule et al., 2003) and cyclic GMP (Song et 
al., 1997). 
Following injury to spinal cord motor pathways, the corticospinal and rubrospinal 
tracts express receptor components for class 3 semaphorins. This makes them 
susceptible to scar-derived semaphorins (De Winter et al., 2002; Lindholm et al., 
2004; Pasterkamp and Verhaagen, 2001). Of the different semaphorins, the 
soluble semaphorin 3A (Sema 3A) has been frequently investigated in 
regeneration of the spinal cord. When injured ascending dorsal column axons are 
stimulated to regenerate into a transection lesion site, they avoid areas of 
Sema3A expression (Pasterkamp and Verhaagen, 2001). Furthermore, 
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interfering with Sema3A signalling, by injecting galectin-1 (Gal-1) to the injury site 
of mice with a complete lesion of the lower thoracic spinal cord, has been reported 
to promote axonal regeneration and functional recovery (Quinta et al., 2014). 
Ephrins 
Ephrins are major contact-dependent guidance molecules in the development of 
the nervous system, which bind to the Eph family of receptor tyrosine kinases 
(Pasquale, 2005). The predominant effects of ephrins are repulsion of migrating 
cells and growth cones (Kullander et al., 2001; Williams et al., 2003). The 
principal mediators of ephrin-induced repulsion are the Rho family of small 
GTPases, particularly RhoA (Kullander and Klein, 2002). Eph and ephrin 
expression (Bundesen et al., 2003; Fabes et al., 2006; Figueroa et al., 2006; 
Miranda et al., 1999) has been implicated in gliosis, scar formation, cell death 
and inhibition of axonal regeneration.  
Following partial spinal cord transection, ephrin B2 is upregulated by reactive 
astrocytes, while its corresponding receptor EphB2 is upregulated by meningeal 
cells (Bundesen et al., 2003). Ephrin B2 deficient mice, showed reduced 
astrogliosis, smaller glial scar, exhibited increased regeneration of injured 
corticospinal axons and accelerated motor function recovery after spinal cord 
injury (Ren et al., 2013). 
Astrocytes in the injured rat spinal cord express EphA4 (Cruz-Orengo et al., 2006; 
Cruz-Orengo et al., 2007; Fabes et al., 2006). EphA4 knockout mice exhibit more 
axonal regeneration following spinal cord injury (Goldshmit and Bourne, 2010). 
In addition, infusion of a peptide antagonist of EphA4 around the injured spinal 
cord increased corticospinal axonal sprouting and enhanced behavioural 
recovery after injury (Fabes et al., 2007). Furthermore, 2-week administration of 
EphA4 blockers in mice with spinal cord injury promoted substantial axonal 
regeneration, functional recovery by 5 weeks, and a reduction in astrocytic gliosis 
(Goldshmit et al., 2011). In contrast, in other studies knockdown of EphA4 failed 
to enhance regeneration (Cruz-Orengo et al., 2007; Herrmann et al., 2010)  
Myelin-derived inhibitors 
Myelin proteins affecting axonal outgrowth include Nogo (Chen et al., 2000), 
myelin-associated glycoprotein (MAG) (McKerracher et al., 1994) and 
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oligodendrocyte-myelin glycoprotein (OMgp) (Wang et al., 2002), but also include 
semaphorins, ephrins and CSPGs.  
Nogo-A was identified as a myelin-associated neurite outgrowth inhibitor (Chen 
et al., 2000). Nogo-A is found in CNS Myelin, it is expressed by neurons and 
oligodendrocytes, but not astrocytes or Schwann cells (Josephson et al., 2001). 
Nogo-A downregulates cytoskeletal systems responsible for neurite growth and 
long-term potentiation (Pernet and Schwab, 2012). Antibodies against Nogo 
promote recovery after spinal cord injury in rats (Liebscher et al., 2005) and 
monkeys (Freund et al., 2007). Blockade of Nogo-A or its receptors enhances 
sprouting and plasticity of surviving white matter tracts in injured spinal cords 
(Freund et al., 2009; Harel et al., 2010; Hoogewoud et al., 2013). Nogo A/B 
deficient mice demonstrate an abundant number of corticospinal axons sprouting 
past the injury site and improved locomotor function after spinal cord injury (Kim 
et al., 2003). Likewise, following unilateral pyramidotomy, corticospinal tract 
regeneration and forelimb motor function is significantly improved in Nogo-AB or 
knockouts (Cafferty and Strittmatter, 2006). 
The myelin-associated proteins, Nogo-A, MAG and OMgp, work in synergy to 
inhibit axonal regeneration and functional recovery following spinal cord injury. 
Mice deficient of OMgp (Ji et al., 2008) and MAG (Bartsch et al., 1995) show 
limited axon growth following corticospinal tract injury and no enhancement in 
behavioural recovery (Cafferty et al., 2010). However, Nogo-A deletion is 
associated with more regeneration of injured corticospinal and raphespinal 
axons, as well as greater behavioural recovery than MAG and OMgp knockout 
mice. But, the triple-mutant mice exhibits greater axonal growth and improved 
locomotion than Nogo-A deficient mice (Cafferty et al., 2010). Although these 
findings have not always proven repeatable (Lee et al., 2010). A summary of the 
inhibitory molecules in the spinal cord following injury is found in figure 3. 
Neurotrophins  
Neurotrophins contribute to the successful regeneration of axons in injured 
peripheral nerves (Funakoshi et al., 1993; Heumann et al., 1987; Naveilhan et 
al., 1997; Sendtner et al., 1994).  
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The neurotrophin family consists of nerve growth factor (NGF) (Cohen, 1960), 
brain-derived neurotrophic factor (BDNF) (Barde et al., 1982), NT-3 (Hohn et al., 
1990), and NT-4/5 (Berkemeier et al., 1991). Neurotrophins bind to tyrosine 
kinase receptors TrkA, TrkB, and TrkC and to the low-affinity p75 neurotrophin 
receptor (Boyd and Gordon, 2001; Cui, 2006).  
There is increased expression of neurotrophins and their receptors following 
spinal cord injury. In rats, BDNF and NT-3 is upregulated early after crush injury 
to the spinal cord (Hayashi et al., 1997). In the transected spinal cord of young 
adult cats and rats there is increased expression of trkB mRNA and protein 
several days to weeks after the lesion (Eidelberg et al., 1977). Expression of low-
affinity NGF receptor is also found in the scar tissue, motoneurons, and blood 
vessel-associated cells after ventral funiculus (cat) or contusion injuries (rat) 
(Reier et al., 1992; Risling et al., 1992). 
Increasing the levels of neurotrophins in the injured spinal cord augments the 
regenerative potential of injured CNS axons. Injections of NT-3 to the lesion site 
of adult rats with spinal cord injuries substantially increases sprouting from the 
injured CST. However, NGF and BDNF have weak or no effect on axonal 
sprouting, respectively (Mukhopadhyay et al., 1994). NT-3 promotes axonal 
sprouting but its application alone results in fibres remaining 1mm away from the 
injury site. However, combined delivery of NT-3 and an antibody against myelin-
associated neurite growth inhibitory proteins (IN-1) promotes long distance 
elongation of injured fibres caudal to the spinal cord injury site (Mukhopadhyay 
et al., 1994). Furthermore, grafts expressing a gradient of NT-3 along the spinal 
cord injury site in rats, promote axonal elongation past the lesion site (Taylor et 
al., 2006).  
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Figure 3: Axonal growth is prevented by the glial and fibrotic scar as well as inhibitory molecules 
in the spinal cord. After spinal cord damage, reactive astrocytes and microglial cells form the glial 
scar, and cells invade the injury site to form the fibrotic scar, which together create a physical 
barrier to axonal growth. Preventing axonal regeneration are various inhibitory molecules found 
in myelin and the fibrotic scar. Diagram edited from Schwab et al., (2006). 
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Role of corticospinal tract in skilled limb movement 
Skilled motor function is dependent on both the direct action of lower motor 
neurons on muscles and their control by neurons in the brain and spinal cord. 
Spinal cord injury can result in damage to a number of structures involved in 
motor control. 
Skilled Motor Function 
Behavioural studies have demonstrated that rats are able to carry out skilled 
movements, such as reaching and grasping food, using an individual forelimb 
(Whishaw et al., 1981; Whishaw et al., 1986; Whishaw and Kolb, 1988; Whishaw 
and Pellis, 1990; Whishaw et al., 1992). 
The skilled task of food reaching involves a sequence of actions which include: 
locating food using olfactation, positioning body in front of food source, lifting, 
aiming, advancing, pronating the paw as the limb is advanced, and opening the 
digits, grasping, supinating and releasing the food as the limb is withdrawn 
(Whishaw and Pellis, 1990). To execute food reaching successfully, proximal and 
distal forelimb muscles must work together in a coordinated manner (Holstege, 
1991).  
Corticospinal Tract 
The corticospinal tract (CST) has an important role in the fine motor control 
involved in skilled movements. Other structures that also exert influence include 
the striatum, substantia nigra, red nucleus, and dorsal columns (McKenna and 
Whishaw, 1999; Whishaw et al., 1986; Whishaw et al., 1991; Whishaw et al., 
1993; Whishaw et al., 1998). 
The CST originates from layer V in the motor cortex, descends through the 
internal capsule and forms the pyramids at the brainstem. At the level of the spinal 
cord, it is found divided to the dorsal, ventral, lateral and dorsolateral 
components. The dorsal component comes from the contralateral motor cortex 
and contains 95% of descending axons in rodents. The ventral component 
originates ipsilaterally and contains less than 5% of all CST axons. The lateral 
and dorsolateral components together only represent around 2% of the CST 
(Weidner et al., 2001). 
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CST projects to both dorsal and ventral horns. Most of the CST fibres end in the 
dorsal horn or in the intermediate laminae of the ventral horn with very sparse 
direct connections to the motor neurons in laminae IX (Armand, 1982). Single 
corticospinal neuron axons make synaptic contacts within many of the spinal cord 
laminae and extend through several spinal segment (Kuang and Kalil, 1990). 
In general, activation of proximal forelimb muscles is generated primarily by 
neurons of the medial motor neuron column in the spinal cord, and distal forelimb 
muscles are innervated primarily by neurons of the lateral motor neuron column 
(Holstege, 1991). 
Effects of neural lesions on skilled movement 
Skilled forelimb movements in reaching depend on a number of neuroanatomical 
areas. 
Lesions to the motor cortex in rats result in reduced reaching success using the 
contralateral forelimb proportionate to increasing injury size in the contralateral 
forelimb. Severe defects are found in pronation and supination of the contralateral 
limb, with milder effects on aiming, advancing and lifting (Whishaw et al., 1991), 
as well as digit use (Castro, 1972b). Injury to the striatum and dopaminergic 
substantia nigra results in similar contralateral deficits as those seen with motor 
cortex lesions (Whishaw et al., 1986). 
Pyramidal tract injury results in a less severe impairment of skilled reaching motor 
function but with a deficit pattern similar to that following large motor cortex injury 
(Whishaw et al., 1993). Loss of dorsal or ventral CST results in similar deficits, 
with greater severity following dorsal CST injury (Weidner et al., 2001). However, 
the functional effects of injury to individual dorsal or ventral components of the 
CST are mostly transient with recovery in reaching behaviour occurring weeks 
after injury (Weidner et al., 2001). 
Injury of the red nucleus results in deficit in limb guidance, pronation, supination 
and aiming which are similar deficits to those seen after CST injury. In addition 
red nucleus injury results in loss of arpeggio grasping movements seen in food 
reaching. Deficits that result from injuries of both red nucleus and CST are 
additive (Whishaw and Gorny, 1996; Whishaw et al., 1998). 
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The sensory information from the dorsal columns also plays an important role in 
reaching movements. Injury results in deficits similar to those seen after CST or 
red nucleus injury indicating the importance of sensory feedback in skilled limb 
movement. However, these deficits are very short lived with rapid functional 
recovery after dorsal column injury (McKenna and Whishaw, 1999). 
Experimental lesions used in spinal cord injury research can encompass damage 
to any of the structures described above and therefore can cause different levels 
of functional loss. In this regard, it is important to note that CST injury can also 
inadvertently be associated with injury to the grey matter. Dorsal CST lesions can 
be associated with major damage throughout the medio-lateral extent of the grey 
matter, Rexed's laminae V, VI and VII. This type of grey matter injury results in 
deficits very similar to those seen after CST injury but which are permanent 
(Yamamoto et al., 2009). 
Spontaneous recovery 
As described above, spontaneous functional recovery can occur following CST 
injury. There is evidence that this can happen through behavioural compensatory 
mechanisms or through structural compensation mediated by uninjured motor 
pathways (Weidner et al., 2001; Whishaw et al., 1991; Whishaw et al., 1993). 
Normally, reaching for food involves a number of specific component 
submovements which culminate in the end point of the rat placing food in its 
mouth. However, success in this end point may be achieved using alternate motor 
strategies, without carrying out certain submovements in the reaching process. 
Part of the fast recovery of end point success seen after CST injury has been 
explained by behavioural compensation using whole body movements (Weidner 
et al., 2001; Whishaw et al., 1991; Whishaw et al., 1993). 
Another mechanism of functional recovery occurs over a more protracted time 
period and appears to involve structural changes. Spontaneous functional 
recovery has been demonstrated in the spinal cord after injury that spares 
components of the CST. After unilateral lesion of a pyramid, where all 
components of the CST are injured, there is irreversible loss of certain 
submovements of the reaching action. However, injury limited to the dorsal CST, 
sparing the ventral component, is associated with recovery of function of these 
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submovements. Spontaneous functional recovery appears to be mediated by 
axonal sprouting from the uninjured ventral CST terminating on motor neuron 
pools in the lamina IX (Weidner et al., 2001). 
Treatments for spinal cord injury 
Therapies treating spinal cord injury mainly focus on producing or improving 
functional recovery. The therapeutic strategies that have been examined in 
animal models and clinical trials are based on cellular, molecular and 
rehabilitative approaches. Cellular therapeutic interventions aim to bridge any 
cyst or cavities and replace dead cells at the injury site, and provide a favourable 
environment for axon regeneration (Table 1-blue columns). In addition, molecular 
therapeutic interventions aim to promote axonal growth, enhance conduction and 
protect neurons from secondary cell death (Table 1-orange columns). Finally, 
rehabilitative therapies use peripheral input to maintain the spinal circuitry below 
the lesion site active and functional Table 1-green column). Many of these 
therapies have shown moderate functional recovery as well as axonal 
regeneration in rodents, canine, non-human primates and humans (Thuret et al., 
2006). The therapy type, intervention and observed effects in various animal 
models are summarised in table 1. 
Table 1: Summary of the observations following different therapeutic interventions in animals and 
humans with spinal cord injury. Columns highlighted in blue, orange or green are therapies based 
on cellular, molecular or rehabilitate approaches, respectively 
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Therapy Type Intervention Observed effects 
Transplantation 
of peripheral 
nerve 
 Avulsed peripheral nerves are implanted 
into the spinal cord.  
 
 Various combinations of this  therapy involve 
the implanting the nerve and the local 
delivery of anti-inflammatory drugs, 
vertebral wiring, fibrin glue, acidic fibroblast 
growth factor, the transplantation of bulbar 
olfactory ensheathing cells, or bone-
marrow-derived mesenchymal stem cells.  
 In rats: Functional recovery is improved and axonal 
regeneration is evident following peripheral nerve implantation 
(Cheng et al., 1996; Cheng et al., 1997; Lee et al., 2002b; Lee 
et al., 2004b). 
 
 In non-human primates: No functional recovery but some 
spinal axons regenerate after inserting peripheral nerves into 
the spinal cord (Levi et al., 2002). 
 
 In humans: Some functional recovery is found when 
peripheral nerves were implanted, however some studies 
lacked control patients (Amr et al., 2014; Cheng et al., 2004; 
Tabakow et al., 2014). 
 
Transplantation 
of Schwann 
cells 
 Schwann cells from the peripheral nerve are 
injected as suspension or implanted into 
channels containing extracellular matrix into 
the spinal cord.  
 
 Therapies that involve the transplanting of 
Schwann cells and a concomitant delivery of 
neurotrophins, a steroid, or olfactory 
ensheathing glia have also been tested. 
 
 In rats: Spinal cord injury cavitation is reduced when shawnn 
cells are transplanted into the spinal cord. Sensory and spinal 
neurons with cell bodies near to the graft enter the implants 
and become myelinated (Bamber et al., 2001; Takami et al., 
2002; Xu et al., 1995). Some but not all studies found 
functional improvement (Pearse et al., 2004a; Takami et al., 
2002). 
 
Transplantation 
of olfactory 
nervous system 
cells 
 Cells from the embryonic and adult olfactory 
bulb or mucosa are transplanted after spinal 
cord injury. 
 In rats: Functional recovery and/or CNS regeneration has 
been reported after transplanting cells from the olfactory bulb. 
Transplantation of these cells can also enhance myelination 
(Li et al., 1997; Li et al., 2003; Lu et al., 2001a; Plant et al., 
2003; Ramon-Cueto et al., 2000). However, some studies 
show that CNS regeneration and functional recovery not 
always occurs (Ramer et al., 2004; Riddell et al., 2004; 
Ruitenberg et al., 2005; Takami et al., 2002). 
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 In humans: Improvement of motor and sensory function has 
been reported following treatment, but studies do not include 
controls (Amador and Guest, 2005; Guest et al., 2006; Huang 
et al., 2003).  
 
Transplantation 
of embryonic 
CNS tissue 
 After spinal cord transection, foetal spinal 
cord is transplanted into the lesion site. At 
the same time neurotrophic factors can be 
delivered at the injection site. 
 In rats: Few axons regenerate but terminate at the transplant 
border (Bregman et al., 1997; Jakeman and Reier, 1991). 
Functional recovery has also been observed following the 
transplantation of embryonic tissue (Bregman et al., 2002; 
Coumans et al., 2001; Kunkel-Bagden et al., 1993). 
 
Transplantation 
of embryonic 
stem/progenitor 
cells 
 Multipotent progenitor cells and stem cells 
have the ability to differentiate into many cell 
types. These cells can be injected into the 
site of injury.  
 
 The cells can also be pre-differentiated to a 
desired lineage before transplantation.     
 In rodents: Modest functional recovery is found after 
transplanting stem or progenitor cells (Cummings et al., 2005; 
McDonald et al., 1999; Ogawa et al., 2002; Teng et al., 2002). 
 
Transplanting neuron- and glia- restricted precursor cells 
resulted in the reduction of the cavity size, the presence of 
cells with characteristics of neurons and the sparing/sprouting 
of axons (Mitsui et al., 2005). Early delivery of 
oligodendrocyte-restricted stem cells to the injury site 
enhanced myelination and improved motor function (Keirstead 
et al., 2005). 
 
 In non-human primates:  Improvements in behavioural 
recovery were evident after transplanting human neural 
progenitor cells (Iwanami et al., 2005).  
 
Transplantation 
of adult 
 Cells transplanted into the spinal cord after 
injury, include those from the adult bone 
marrow (haematopoietic stem cells and 
bone marrow stromal cells) or neural 
progenitors cells, which are isolated from the 
 In rodents: Transplantation of bone marrow-derived stem 
cells promotes functional recovery (Hofstetter et al., 2005; 
Koda et al., 2005; Koshizuka et al., 2004; Wu et al., 2003).  
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stem/progenitor 
cells 
dentate gyrus, subventricular zone or spinal 
cord. 
Treating mice with neural progenitor cells results in the 
differentiation of these cells into astrocytes or 
oligodendrocytes (Cao et al., 2001; Shihabuddin et al., 2000; 
Vroemen et al., 2003). Neural progenitor cells taken from the 
brain of mice and then transplanted into the rat spinal cord 
changed to oligodendrocytes that remyelinated injured axons, 
and promoted functional recovery (Karimi-Abdolrezaee et al., 
2006). 
 
Transplantation 
of activated 
macrophages 
 Blood-derived macrophages are activated 
by exposing them to peripheral nerve 
segments or skin pieces of the same animal. 
Activated microglia are then transplanted 
into the spinal cord injury site. 
 In rats:  Activated macrophages injected into the spinal cord 
injury site were associated with axonal regeneration through 
the injury site and improvement of hind limb function 
(Bomstein et al., 2003; Rapalino et al., 1998). In line with this 
study, injecting an inflammatory agent (GM-CSF) into the 
microglia has shown to promote axonal regeneration and 
functional recovery (Huang et al., 2009). 
.  
However, it has also been shown that activating microglia with 
another pro-inflammatory agent (zymosan) can have 
deleterious effects on hindlimb function (Popovich et al., 
2002). In addition, depleting macrophages in rats with spinal 
cord injury show improved functional recovery, spared white 
matter and reduced tissue cavitation (Popovich et al., 1999). 
These studies delineate the negative as well as the positive 
properties inflammation can have on spinal cord regeneration. 
 
 In canines: There was no functional recovery or axonal 
regeneration following the transplantation of activated 
microglia injected into the injury site. 
 
Neuroprotective 
therapies 
 Animals with spinal cord injury receive 
intravenously injections of a chosen 
neuroprotective substance. 
 In rodents:  intravenous injection of an antibody against a cell 
adhesion molecule found on neutrophils and macrophages 
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reduces secondary damage and improves motor function 
(Baptiste and Fehlings, 2006).  
 
Additionally, injecting the antibiotic minocycline, after spinal 
cord injury, reduces cell death and improves motor function in 
rats and mice (Lee et al., 2003; Stirling et al., 2004; Teng et 
al., 2004).  
 
Delivery of 
growth factors 
 Different growth factors have been tested on 
spinal cord injury models including, BDNF, 
GDNF, NGF, NT3, NT4 and NT5. These 
growth factors have been delivered to the 
injured spinal cord by transient injection, 
continuous infusion or insertion of an 
artificial carrier saturated with neurotrophic 
factors. 
 
Other methods to promote a prolonged 
expression of the growth factors in the spinal 
cord involve transplanting fibroblasts that 
have been transduced with genes to encode 
growth factors, or delivering adenoviruses 
and lentiviruses that carry the genes for the 
neurotrophic factors. 
 
 In rats: Delivery of NGF is associated with the regeneration of 
coerulospinal axons (Grill et al., 1997b; Tuszynski et al., 
1996), NT3 promotes corticospinal axon growth (Grill et al., 
1997a), BDNF improves functional recovery and axonal 
growth of rubrospinal, reticulospinal, vestibulospinal, 
raphespinal, and local sensory and motor neurons (Jin et al., 
2000; Jin et al., 2002; Liu et al., 1999; Lu et al., 2001b). 
Delivery of NT3 and BDNF enhances bladder and hindlimb 
function after spinal cord injury (Blitts et al., 2003; Mitsui et al., 
2005). In addition, treating rats with GDNF promotes motor 
and dorsal column sensory axon elongation and remyelination 
(Blesch and Tuszynski, 2003).  BDNF or GDNF and NT-3 
expression induced axonal elongation and sprouting into the 
spinal cord injury site (Blesch and Tuszynski, 2007). 
Modulation of 
cAMP or small 
GTPases 
 Substances known to affect or interact with 
cAMP or GTPases can be given orally, 
systemically or locally in the spinal cord after 
injury. 
 In rodents: Elevating the levels of cAMP and transplanting 
foetal tissue (Nikulina et al., 2004) or Schwann cells (Pearse 
et al., 2004b) into the injury site, improves functional recovery 
following spinal cord injury. 
 
Factors that limit axonal regeneration signal trough Rho and 
Rac GTPases (Jain et al., 2004; Niederost et al., 2002; 
Schweigreiter et al., 2004). In rats inhibition of Rho is 
associated with axonal regeneration and some functional 
 52 
recovery (Dergham et al., 2002). However, this could not be 
replicated by another study (Fournier et al., 2003). 
Nonetheless, inhibiting Rho kinases accelerated functional 
recovery following spinal cord injury (Dergham et al., 2002; 
Fournier et al., 2003; Hara et al., 2000; Sung et al., 2003; 
Tanaka et al., 2004). 
 
The safety of elevating cAMP and inhibiting GTPases must be 
further studied in bigger animal models to determine its 
therapeutic value. 
 
Modulation of 
myelin-derived 
inhibitors 
 Following spinal cord injury factors that 
modulate myelin inhibitors can be delivered 
to the spinal cord. 
 In rodents: Axonal regeneration and functional recovery has 
been reported in animals that have been treated with an 
antibody against Nogo following spinal cord injury (Bregman 
et al., 1995; Schnell and Schwab, 1990; Schnell and Schwab, 
1993; Thallmair et al., 1998; von Meyenburg et al., 1998; 
Z'Graggen et al., 1998).  In addition, deletion of Nogo-A, 
deletion or inhibition of Nogo-receptor promotes axonal 
regeneration and functional recovery. However, some have 
been unable to replicate these findings (Guest et al., 1997; 
Oudega et al., 2000).  
 
 In non-human primates: Treating marmoset monkeys with 
Nogo-A antibody promoted corticospinal tract regeneration 
after spinal cord injury (Fouad et al., 2004). 
 
Modulation of 
inhibitory 
molecules of the 
glial scar 
 Local infusion of substance to alter the 
inhibitory molecules found in the spinal cord 
injury site.  
 In rodents: Infusion of bacterial enzyme chondroitinase ABC, 
which degrades the inhibitory chondroitin sulphate, improves 
axonal regeneration and functional recovery after spinal cord 
injury (Bradbury et al., 2002; Moon et al., 2001). Application of 
chondroitinase ABC and transplantation of peripheral nerves 
into the spinal cord resulted in CNS axons to extend into the 
peripheral nerves (Yick et al., 2000). Also, the delivery of 
chondroitinase ABC and transplantation of hemichannels 
containing Schwann cells into the spinal cord promoted the 
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growth of injured axons beyond the hemichannels (Chau et al., 
2004).   
 
Rehabilitative 
Training 
 Interventions after spinal cord injury include 
weight-supported treadmill training, upper 
extremity exercise, robotic or manually 
assisted training, or functional electrical 
stimulation.  
 In rats: weight supported treadmill training accelerates 
functional recovery, reduces muscle atrophy (Singh et al., 
2011) and can restore normal pattern of hindlimb movements 
(Van Meeteren et al., 2003) after spinal cord injury. 
 
 In humans: Locomotor training enhances the ability of 
humans to walk on a treadmill, particularly when the body 
weight is being supported (Engesser-Cesar et al., 2005). 
Training humans to step and stand after incomplete spinal 
cord injury can stimulate independent walking (Dobkin et al., 
2006; Wolpaw, 2006). Treadmill training combined with 
functional electrical stimulation improved the quality of 
stepping in a patient with an incomplete spinal cord injury 
(Herman et al., 2002).  
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Inflammatory and astrocytic response to CNS injury 
Microglia 
Pio del Rio-Hortega first recognised microglia as a separate glial entity (Del Rio-
Hortega, 1932). They originate from neuroectodermal matrix cells and establish 
themselves in the brain during the embryonic stage (Ginhoux et al., 2010). The 
microglial plasma membrane contains a large variety of receptor and adhesion 
molecules. They express receptors that are also found on macrophages on non-
neuronal tissues, which underscores their close relationship to the 
myelomonocytic cell lineage. They are known as the macrophages of the brain 
parenchyma. The major histocompatibility complex (MHC) is expressed in the 
surface of microglia, as well as endothelial cells and perivascular macrophages 
(Hayes et al., 1987; Streit et al., 1989a). In addition to receptors such as Fcɣ and 
complement receptors, macrophages express cell adhesion molecules including 
members of the integrin superfamily of adhesion molecules such as lymphocyte 
function antigen, CD4 antigen and leucocyte common antigen (Akiyama and 
McGeer, 1990; Perry and Gordon, 1987) constitutively in normal brain. 
Morphological changes associated with microglial activation 
In non-pathological conditions, microglia are in the resting state. They have an 
elongated soma bearing two or more processes extending from both poles of the 
cells (Fig. 4A). From these primary processes, a variable number of secondary 
braches emanate (Kershman, 1939). In the grey matter they display stellate 
morphology, while in the white matter they are orientated parallel to the nerve 
fibres. They can cover territories of up to 40 micrometres in diameter (Compston 
et al., 1997). They occupy non-overlapping areas and their constantly moving 
processes actively perform surveillance of their microenvironment (Nimmerjahn 
et al., 2005; Ransohoff and Perry, 2009). 
In pathological conditions microglia respond in a stepwise manner and can 
transform rapidly from a resting to an activated state. This is characterised 
morphologically by an increase in cell body size, a thickening of proximal 
processes and decrease in the ramification of distal branches (Fig. 4B) (Del Rio-
Hortega, 1932). Microglia also show membrane ruffling which is consistent with 
motile exploratory behaviour (Raivich et al., 1999). Microglial also proliferate in 
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many pathological situations. If there is no cellular debris to phagocytose 
microglia revert back to a resting state, characterised by decrease in the number 
of microglia, and a territorial, non-overlapping, distribution of microglia with a 
ramified morphology (Del Rio-Hortega, 1932). However, in the presence of 
neuronal cell death there are further changes in microglia. Microglia lose their 
processes, become amoeboid in shape and phagocytic to remove neuronal 
debris (Fig. 4C) (Del Rio-Hortega, 1932). In addition, when it is required to 
remove large structures such as pyramidal neurons or degenerating motor 
neurons, microglial clusters are formed. Microglial clusters consist of three to 
twenty microglial phagocytes (Moller et al., 1996; Streit and Kreutzberg, 1988), 
which are 60-100 um in diameter. Bystander microglial activation gradually 
decreases the further away they are from the microglial cluster (Raivich et al., 
1999). 
 
Molecular changes during microglial activation 
On the molecular level, microglial activation proceeds through a series of steps 
in which their expression of molecules for cell adhesion, cytoskeletal 
organisation, and antigen presentation are altered summarised in Fig. 5. 
In rodents, twenty-four hours following injury to axons of the peripheral nervous 
system, microglia around cell bodies of injured motor neurons are in a state of 
alert. They increase the expression of molecules with immune functions including 
IgG and thrombospondin (Kloss et al., 1999; Moller et al., 1996; Raivich et al., 
Figure 4: Microglia have different morphology according to their activation states. Micrographs 
show microglia in the motor cortex of rats stained for IBA1. A: Resting microglia have a ramified 
morphology. B: Microglia that are activated have a larger cell body with fewer but thicker 
branches. C: Phagocytic microglia lose their processes and have a round/amoeboid shape. 
 
Figure 4: Microglia have different orphology according to their activation states. Micrographs 
show microglia in the motor cortex of rats stained for IBA1. A: Resting microglia have a ramified 
morphology. B: Microglia that are activated have a larger cell body with fewer but thicker 
branches. C: Phagocytic microglia lose their processes and have a round/amoeboid shape. 
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1998a). There is an increase in expression of ICAM1, and αMβ2 and αLβ2 
integrins (Hynes and Lander, 1992), which mediate the adhesion of microglia to 
other microglia or infiltrating white blood cells including macrophages, 
granulocytes or lymphocytes (Fig 5: alert). 
Microglia home-in on and adhere to damaged structures such as neurons or 
degenerating neurite terminals (Fig 5: homing). In addition, microglia upregulate 
α5β1 and α6β1 integrins in mice, and in rats, microglia increase the expression 
of α4β1 and αLβ2 integrins (Hailer et al., 1997; Kloss et al., 1999; Moneta et al., 
1993). To enhance posttraumatic mobility cytoskeletal proteins such as vimentin 
are also expressed (Graeber et al., 1988b; Raivich et al., 1993). Markers of the 
alert state, such as ICAM1, and αMβ2 are now down regulated (Raivich et al., 
1998a; Werner et al., 1998). Receptors for microglial mitogens such as 
macrophage colony stimulating factor (M-CSF) and granulocyte macrophage 
colony stimulating factor (GM-CSF) are increased (Raivich et al., 1991a; Raivich 
et al., 1998a). This coincides with the proliferation of microglia (Graeber et al., 
1988c; Kloss et al., 1999; Moneta et al., 1993). Microglia proliferation around the 
cell bodies of facial motor neurons is maximal around three days following facial 
nerve injury (Raivich et al., 1994) or around hippocampal neurons following injury 
to the entorhinal cortex (Gall et al., 1979). By this time, microglia express major 
histocompatibility complex class 1 molecules (MHC1) (Raivich et al., 1993; Streit 
et al., 1989b), and immunoaccessory glycoproteins such as B7.2 (Bohatschek et 
al., 1998).  
Microglial transform into phagocytic cells in the presence of neuronal cell death 
(Fig 5: phagocytosis). They remove neuronal debris (Graeber et al., 1989; Moller 
et al., 1996), disconnected axons and myelin in Wallerian degeneration, and 
myelin debris in demyelinating diseases including multiple sclerosis (Bauer et al., 
1995; McGeer et al., 1993; Trapp et al., 1998). Phagocytic microglia now more 
strongly express most activation markers including the adhesion molecules α5β1, 
α6β1 and αMβ2 integrins, thrombospondin and ICAM1 (Kloss et al., 1999; 
Werner et al., 1998). These molecules may mediate the adhesion to and 
internalisation of diverse components of the cellular debris. Molecules with an 
immune function are upregulated with a strong increase in FC-gamma receptors, 
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B7 and MHC class I (Bohatschek et al., 1999; Desimone et al., 1995). In addition, 
antigen presenting complexes MHC I and/or MHC II (Butter et al., 1991; Kosel et 
al., 1997; Schmitt et al., 1998) and co-stimulatory molecules like B7.2, ICAM and 
αXbeta2 integrin are also up regulated (Bohatschek et al., 1998; Giulian et al., 
1986). In the presence of specific antigens, these co-stimulatory molecules are 
potent stimuli for the activation of T-cells  (Bretsche and Cohn, 1970; Robey and 
Allison, 1995) (Fig 5: T-cells).  
Around areas of phagocytosis, adjacent microglia increase the expression of 
MHCI, B7.2, α4β1 and αMβ2 integrin (Bohatschek et al., 1998; Kloss et al., 1999; 
Raivich et al., 1998b) (Fig 5: bystander activation). These activated microglia are 
arranged concentrically with phagocytic cells residing in the centre (Raivich et al., 
1999). A similar pattern is observed when lymphocytes infiltrate into the CNS 
around injured neurons; lymphocytes aggregate around phagocytic microglial 
clusters (Raivich et al., 1998b). 
A graded microglial response is also evident during an immune response 
provoked by viral, bacteria, or parasite infection, autoimmune-mediated 
inflammation (multiple sclerosis, encephalomyelitis), or in graft versus host 
disease. In contrast to non-immune mediated pathologies there is a strong 
increase in MHC II and the inducible nitric oxide synthase (iNOS). Both changes 
appear to be mediated by infiltrated lymphocytes which produce a large number 
of microglia activating cytokines such as interferon gamma which is a potent 
inducer of MHC II and iNOS in vitro and in vivo (Schluter et al., 1998; Wong et 
al., 1984). Overall, the induction of MHC II is critical for antigen presentation to 
the CD4 positive T helper/inducer cells. In the case of iNOs the enzyme is 
responsible for the production of nitric oxide which can react with superoxide to 
produce peroxynitrite (van der Veen et al., 1997). Peroxynitrite is an extremely 
aggressive oxidant which causes lipid, protein, and DNA damage. 
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Figure 5: Stages of microglial activation. Diagram shows the different morphologies 
microglia acquire in response to CNS injury. From a ramified morphology (normal) they 
become activated and lose their ramifications (alert), they home-in on the injure neuron 
(homing), and in the presence of cell death they become amoeboid and remove debris 
(phagocytosis). They can cause neighbouring microglia to become activated (bystander 
activation) and can communicate with T-cells. Each of the boxes lists the different 
molecules which microglia up regulate at each stage of activation. Edited from Raivich et 
al., (1999).  
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Classical vs Alternative microglial activation 
Microglial activation can also be defined by the pattern of pro-inflammatory or 
anti-inflammatory and neurotrophic factors they secrete. Like peripheral 
macrophages, microglia can shift from a pro-inflammatory to a protective state, 
changes which are known as ‘classical’ activation or ‘alternative’ activation, 
respectively. 
Microglia have membrane and cytosolic receptors, called pattern recognition 
receptors (PRRs), which include toll-like receptors (TLRs), nucleotide-binding 
oligomerization domain (NOD) proteins, and non-TLR (C-type lectin receptors). 
Cellular defence is initiated when these receptors interact with pathogen-
associated molecular patterns (PAMS) or with damage-associated molecular 
patterns (DAMPS) (Colton, 2009; Han and Ulevitch, 2005; Rubartelli and Lotze, 
2007). Downstream signalling culminates in the induction of genes that trigger 
the expression of reactive oxygen species, pro-inflammatory cytokines, such as 
tumour necrosis factor alpha (TNF-α), interleukin (IL)-1β and IL-12 and 
expression of inducible nitric oxide synthase, which are necessary for defence 
against pathogens but in the process cause tissue damage (Boche et al., 2013). 
The reinforcement of this pattern of expression by surrounding cells leads to the 
classical activation. In particular, it has been found that interferon gamma (IFN-
ɣ), which is known to be secreted by T-helper cells type 1 in the periphery and 
microglia or astrocytes in the CNS, induces/maintains the toxic state of microglia 
(Merson et al., 2010). 
Macrophages can change their activation phenotype from one that is pro-
inflammatory to one that supports repair and tissue reconstruction. The latter 
phenotype has been termed alternative activation. Anti-inflammatory cytokines, 
including IL-4, IL-3, IL-10 and TGF-β induce alternative activation by suppressing 
macrophage pro-inflammatory gene expression (Bogdan et al., 1991; Hamilton 
et al., 1999; Martinez et al., 2008; Mills et al., 2000). Like macrophages, microglia 
can also become alternatively activated. In vitro, microglia stimulated with LPS, 
expressed lower levels of NOS, IL-2, IL-1β, IL-6, and TNF-α  when treated with 
anti-inflammatory IL-4 or IL-3  (Colton et al., 2006; Kitamura et al., 2000; 
Ledeboer et al., 2000; Lee et al., 2002a), and showed increased expression of 
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anti-inflammatory cytokines IL-10, TGF-β and growth factors, including insulin 
growth factor-1 and NGF (Kitamura et al., 2000; van Rossum et al., 2008). 
Phagocytosis of neurons 
Microglia are the professional phagocytes of the brain and are able to engulf 
whole neurons within hours (Fuhrmann et al., 2010; Neher et al., 2011). 
Phagocytosis of dead and dying neurons and neuronal debris is beneficial in part 
because it reduces inflammation (Neumann et al., 2009; Sierra et al., 2013). 
However, microglia can also phagocytose live neurons causing death of the 
engulfed cells (Fricker et al., 2012a; Fricker et al., 2012b; Neher et al., 2011; 
Neher et al., 2013; Neniskyte et al., 2011; Neniskyte and Brown, 2013). 
Phagocytosis begins with the recognition of pro-phagocytosis signals on the 
surface of target cells to be phagocytosed (e.g. phosphatidylserine, calreticulin; 
de-sialylated glycoproteins) (Neumann et al., 2009; Sierra et al., 2013). Such 
signals can be picked up by opsonins in the extracellular environment such as, 
Milk fat globule EGF factor 8, Annexin A1, tubby, galectin 3, growth arrest specific 
protein 6 or protein S, and components of complement C1q, C3, or C3b. 
Opsonins aid recognition by receptors on phagocytes, including vitronectin 
receptors – alphaVbeta3 or alphaVbeta5, MER receptor tyrosine kinase 
(MERTK), low density lipoprotein receptor related protein, and αMβ2. This 
induces signalling cascades and remodelling of the actin cytoskeleton, which 
culminate in the engulfment and digestion of neurons through the fusion of 
phagosomes with lysosomes (Fu et al., 2014; Hochreiter-Hufford and 
Ravichandran, 2013). 
Astrocytes 
Astrocytes exist in two typical forms: stellar fibrillary astrocytes and protoplasmic. 
Fibrillary astrocytes are normally found in the white matter, with long slender 
processes which stain for glial fibrillary acid protein (GFAP), a typical astrocyte 
cytoskeletal protein (Bignami et al., 1972). Protoplasmic astrocytes are located in 
the grey matter and exhibit numerous short and highly ramified processes with 
many membranous extensions. In non-pathological conditions protoplasmic 
astrocytes cannot be stained for GFAP, but can be visualised by staining for 
S100b or endothelial NOS (eNOS). Nonetheless, it is difficult to stain the entire 
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cellular contour of protoplasmic astrocytes, as S100b or endothelial NOS (eNOS) 
only stain the cell body and the main processes (Cammer and Tansey, 1988; 
Didier et al., 1986; Gabbott and Bacon, 1996). 
Astrocytes have various roles in the nervous system. They provide physical 
support to neighbouring neurons, meninges and vasculature, they give nutrients 
to the highly energy consuming neurons, their dendrites and synapses, they 
maintain ionic balance in the extracellular space by removing water and 
excitotoxic amino acids (Nedergaard et al., 2003; Stobart and Anderson, 2013; 
Tsacopoulos and Magistretti, 1996). In addition, astrocyte induce tight junctions 
on endothelial cells (Janzer, 1993; Pekny et al., 1998; Taocheng et al., 1987), the 
ramified phenotype in microglia and blood derived monocytes (Kloss et al., 1997; 
Schmidtmayer et al., 1994). They are a source for numerous trophic factors 
(NGF, CNTF, PDGF, IGF-1, TGFa, BDNF, bFGF) for adjacent neurons and 
oligodendrocytes particularly following injury (Eddleston and Mucke, 1993; 
Hermanson et al., 1995; Ridet et al., 1997).  
Astrocyte activation following neuronal injury 
Following injury to the CNS, astrocytes undergo a series of changes that lead to 
their activation. Protoplasmic astrocytes around motor neurons increase the 
production of GFAP within 24 hours after injury to peripheral nerves (Tetzlaff et 
al., 1988b). By two to three days after injury there are numerous GFAP-positive 
fibrillary astrocytes around the cell body of the injured neuron (Graeber and 
Kreutzberg, 1986). There is an early appearance of GFAP-positive astrocytes 
with a velate morphology in the brains of mice following ischaemic, traumatic or 
infective brain injuries (Raivich et al., 1999). This early activation is controlled by 
cytokines. IL-6-deficient mice have a reduced presence of fibrillary astrocytes 
(Klein et al., 1997b), while TGFβ1 deficient mice have increased numbers of 
GFAP-positive fibrillary astrocytes and protoplasmic astrocytes with a velate 
morphology both of which are positive for the CD44 integrin (Jones et al., 1998; 
Makwana et al., 2007). 
Reactive fibrillary astrocytes create a physical barrier between damaged and 
healthy cells. The scars are composed of a dense network of hypertrophic 
astrocytes with thick, interdigitating processes and associated extracellular 
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matrix. They inhibit neurite outgrowth, a phenomenon attributed to both 
molecules on the cell surface of reactive astrocytes and components of the 
extracellular matrix including, chondroitin sulphate proteoglycans, collagen IV 
and tenascin (Brodkey et al., 1995; Giftochristos and David, 1988; Laywell et al., 
1992; Lips et al., 1995; McKeon et al., 1991; Stichel et al., 1999). 
Reactive astrocytes additionally synthesise collagens and proteoglycans which 
also impede neurite growth (Fidler et al., 1999; Ridet et al., 1997; Smiththomas 
et al., 1994). Astrocytes might promote remodelling of extracellular matrix 
components and influence scar architecture by producing matrix 
metalloproteases and their inhibitors (Ridet et al., 1997; Sivron and Schwartz, 
1995). They express the structural protein vimentin (Eng et al., 2000). Following 
brain injury, the expression of copper-zinc superoxide dismutase (SOD-1), 
glutathione peroxidase, and metallothionein is also increased in reactive 
astrocytes (Campagne et al., 2000; Liu et al., 1993; Neal et al., 1996; Takizawa 
et al., 1994). Similarly, astrocytes express the inducible form of haemoxygenase 
in response to brain insults which might be important in preventing metal 
catalysed free radical production (Geddes et al., 1996; Takeda et al., 1996). 
Astrocytes are players in innate immunity. Astrocytes intercommunicate with 
microglial through cytokines and growth factors. Specifically it has been found 
that astrocytes regulate microglial proliferation via M-CSF and GM-CSF 
production (Giulian and Ingeman, 1988; Malipiero et al., 1990; Sawada et al., 
1990), induce a ramified phenotype in microglia (Kloss et al., 1997; Lee et al., 
1994), reduce the production of nitric oxide by transforming growth factor beta 
(TGF-β) (Vincent (Vincent et al., 1997). Likewise, microglia regulate astrocyte 
proliferation trough the production of IL-1 (Giulian and Lachman, 1985; Giulian et 
al., 1986) and stimulate astrocytes to make tenascin via the production of 
Transforming growth factor beta (TGF-β) and basic fibroblast growth factor 
(bFGF) (Smith and Hale, 1997). Activated astrocytes can also express TNF, IL-
6, IFNβ, TGF-β and chemokines (CCL2, CCL5, CCL20, CXCL8 and CXCL10) 
(Farina et al., 2005; Jack et al., 2005; Park et al., 2006). Finally, reactive 
astrocytes can produce neurotrophic factors, notably NGF, bFGF, and BDNF 
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which can stimulate neurite outgrowth (Mocchetti and Wrathall, 1995; Schwartz 
and Nishiyama, 1994; Strauss et al., 1994; Tokita et al., 2001). 
Leukocyte recruitment into the injured brain 
The extent of leukocyte recruitment to the brain is dependent on the severity of 
injury (Raivich et al., 1999). In the normal brain, few white blood cells are present. 
Cells of the monocyte lineage enter the brain to give rise to perivascular brain 
macrophages (Hickey and Kimura, 1988). In addition, cells of the monocyte 
lineage give rise to a small percentage of microglia in the adult brain. Mice that 
have undergone conjoined surgery to share the same blood circulation, have less 
than 5% of microglia of donor origin (Ginhoux et al., 2010). Furthermore, T-cells 
can enter the brain when they are activated (Hickey et al., 1991; Wekerle et al., 
1986). Also, work on Prion disease suggests that B-cells may also go into the 
brain. Making mice deficient of B-cells abolishes the spread of prions from the 
periphery to the CNS (Klein et al., 1997a).  
Following mild or indirect injury, T-cells are recruited to the affected brain region. 
T-cells invade the facial motor nucleus one day after facial nerve injury (Raivich 
et al., 1998b). Similarly, in rats with experimental autoimmune encephalomyelitis, 
T-cells can be found in the cryo-injured cerebral cortex (Phillips et al., 1997). In 
the presence of cell death numerous T-cells are recruited and accumulate around 
phagocytic microglia. The T-cells express CD44, ICAM1 and αLβ2, which are 
proteins upregulated when T-cells are activated. In addition, the phagocytic 
microglia are positive for MHC1, B7.2 and αXβ2, making them efficient at antigen 
presentation to the activated T-cells (Engelhardt et al., 1998; Werner et al., 1998).  
Direct trauma to the brain or spinal cord is not only associated with the 
extravasation of T-cells, but also with an abundance of macrophages and 
neutrophil granulocytes  (Carlson et al., 1998; Holmin et al., 1998; Popovich et 
al., 1997). The entry of activated neutrophils may play a part in causing secondary 
tissue damage in the brain injured by hypoxia/ischemia. Reducing the number of 
recruited neutrophils to the injured brain by inhibition of neutrophil 
chemoattractants (Bell et al., 1994; Garcia et al., 1995) or transgenic deletion of 
endothelial adhesion molecules ICAM1 and P-selectin (Connolly et al., 1996; 
Kurkowska-Jastrzebska et al., 1999), protects the brain from tissue damage. 
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Similarly, macrophages contribute to secondary axonal degeneration and tissue 
damage. When rats with spinal cord injuries received intravenous injections of 
liposome-encapsulated clodronate to deplete peripheral macrophages, a 
reduction of peripheral macrophages at the site of injury was associated with 
decreased cavitation, enhanced axonal sprouting and improved hindlimb usage 
(Popovich et al., 1999). 
Cytokine expression and function in the injured CNS 
Pro-inflammatory and anti-inflammatory cytokines are expressed in the injured 
CNS in a graded fashion (Raivich et al., 1999). In the normal adult brain M-CSF 
and TGFβ-1 are present in moderate amounts (Jones et al., 1998; Kiefer et al., 
1993; Raivich et al., 1998a; Streit et al., 1998). Mild or indirect trauma leads to 
the induction of IL-6 and an increase expression of TGFβ-1 (Kiefer et al., 1993; 
Klein et al., 1997b; Streit et al., 1998). Direct brain injury, ischaemia, convulsion 
and Alzheimer’s disease typically lead to the additional production of IL1-β and 
TNF-α. Infectious inflammation due to viral and bacterial meningitis and 
encephalitis, HIV, malaria, and autoimmune disease including multiple sclerosis 
also cause the additional synthesis of IFN-ɣ (Frei et al., 1988; Gallo et al., 1989; 
Merrill et al., 1992). 
Macrophage colony stimulating factor (M-CSF) 
M-CSF is involved in the proliferation and activation of microglia (Roth and 
Stanley, 1992).  Microglial proliferation in the facial motor nucleus is severely 
reduced in mutant mice lacking biologically active M-CSF, which have undergone 
facial nerve axotomy (Raivich et al., 1994; Wiktor-Jedrzejczak et al., 1990). These 
mice show little expression of the markers of microglial activation, αMβ2 and M-
CSFR (Raivich et al., 1996).  
The effect of M-CSF on neuronal survival and regeneration is dependent on the 
severity of injury. Axonal regeneration following facial nerve axotomy is not 
affected in mice with a mutation in the M-CSF gene, even though the microglial 
reaction and early lymphocyte recruitment is muted. However, in severe forms of 
damage M-CSF plays a role in recovery. The absence of M-CSF enhances 
neuronal cell death in the brain of mice that have undergone hypoxia ischemia. 
But when astroglia secreting M-CSF were transplanted into the brain, the 
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microglia response was restored and there was an enhancement of neuronal 
survival (Berezovskaya et al., 1995). 
Tumour Necrosis Factor-alpha (TNF-α) 
TNF-α, a proinflammatory cytokine, acts on a variety of cells including neurons, 
oligodendrocytes, astrocytes and microglia. There is little expression of TNF-α in 
the early phase to facial nerve injury (Kiefer et al., 1993; McClellan, 1994), but 
the expression is pronounced following direct brain trauma, ischaemia, infection 
or excitotoxic injury (Bruce et al., 1996; Seilhean et al., 1997; Uno et al., 1997; 
Yang et al., 1993).  
TNF-α plays a toxic and protective role in the CNS. Neurons and glia express two 
TNF receptors, TNFR1 and TNFR2. In the mouse facial axotomy model, deletion 
of the TNFR1 reduces the cytotoxic potential of macrophages by limiting their 
iNOS production. The absence of TNFR2 inhibits the expression of endothelial 
ICAM 1, and thus reduces the neurovascular response in infection. The absence 
of both receptors reduces both the numbers of microglial clusters found in the 
facial nucleus during neuronal cell death and the associated expression of 
markers of the phagocytic phenotype, including MHC I, B7.2 and thrombospondin 
(Raivich et al., 2002). However, the absence of both TNF receptors exacerbated 
neuronal damage following focal cerebral ischaemia or epileptic seizures 
suggesting that TNF may be neuroprotective (Bruce et al., 1996). 
Neuroprotection may be mediated by the stimulation of TNFR2. In vitro, neurons 
stimulated with TNF that express TNFR2-only, are protected against glutamate 
mediated excitotoxic insult (Dolga et al., 2008). In vivo, mice lacking neuronal 
TNFR1 that underwent retinal ischemia exhibited a strong reduction in neuronal 
cell death, while lack of TNFR2 led to an enhancement in neuronal cell death in 
three retinal layers: the outer nuclear layer, inner nuclear layer, and ganglion cell 
layer (Fontaine et al., 2002). 
Interleukin 1 
IL-1 is strongly upregulated in severe brain injury (Wang et al., 1997). IL-1 family 
consists of three members, IL-1 alpha, IL beta, IL receptor antagonist (IL1ra) for 
which there are two receptors IL-1R1 and IL-1R2 (Alheim and Bartfai, 1998). 
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Although, astrocytes, invading immune cells, vascular cells and probably neurons 
can produce IL-1, it is activated microglia that are the first to express IL-1 (Gibson 
et al., 2004) and are the major source of the three members of the IL-1 family 
(Eriksson et al., 1998; Schluter et al., 1997; Sheng et al., 1997; Zhang et al., 
1998). Inhibiting the activity of IL1 is associated with a reduction in neuronal cell 
death, microglial activation and leucocyte recruitment following focal or global 
ischemia, excitotoxic or traumatic injury to the CNS (Panegyres and Hughes, 
1998; Relton and Rothwell, 1992; Toulmond and Rothwell, 1995; Yang et al., 
1998). Most neuronal effects are apparently due to the IL1β isoform (Alheim and 
Bartfai, 1998; Horai et al., 1998; Shibayama et al., 1996). Interleukin 1 beta but 
not alpha activity requires the presence of IL1 converting enzyme. Mice deficient 
of this enzyme have reduced neurological damage in cerebral ischaemia 
(Loddick et al., 1997).   
Interleukin 6 
Neurons and astrocytes but not microglia express IL-6 receptors and the 
expression pattern remains constant in the normal and injured brain (Klein et al., 
1997b). IL-6 is markedly expressed by endothelial cells, microglia and astrocytes 
following spinal cord injury, ischaemia, infection, neurodegeneration (Alzheimer, 
Parkinson), autoimmune disease, and following indirect injury in the facial nerve 
axotomy model (Hopkins and Rothwell, 1995; Raivich et al., 1999; Stammers et 
al., 2012). A variety of cells are affected when IL-6 is not expressed in the injured 
CNS. IL-6-deficient mice that have sustained facial nerve injury, show few 
astrocytes expressing GFAP in the facial nucleus and lymphocyte recruitment is 
limited (Raivich et al., 1999). In addition, injured neurons respond by a late and 
strong increase in galanin. IL-6 has indirect effects on microglial proliferation, as 
there were fewer microglia in IL-6 deficient mice than controls (Klein et al., 1997b) 
Interferon gamma (IFNɣ) 
Interferon gamma is a critical regulator of T-cell mediated inflammation. It induces 
the production of cytotoxic oxygen radicals, phagocytosis and molecules involved 
in the presentation of antigen such as MHC II predominantly in microglia 
(Suzumura et al., 1987). Genetic ablation of IFNɣ or its receptor, causes 
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inefficient upregulation of iNOS, TNF alpha or MHC II, and compromises the 
ability to fight neuronal infection (Deckert-Schluter et al., 1996; Geiger et al., 
1997; Hooper et al., 1998; Nansen et al., 1998; Schluter et al., 1998). 
Transforming growth factor beta 1 (TGF-β1) 
Transforming growth factor beta 1 is an anti-inflammatory cytokine with potent 
neurotrophic properties. The expression of receptors for TGF-β1 is restricted to 
neurons and is upregulated in the facial nucleus following facial nerve axotomy 
(Jones et al., 1998; Unsicker et al., 1996). It is present at low levels in the normal 
CNS, but the expression is strongly upregulated in almost all forms of brain 
pathology (Kiefer et al., 1993). TGF-β1-deficient animals exhibit a severe 
decrease in microglial cell density, their ability to proliferate in the axotomised 
facial nucleus, diminished expression of activation markers, and a striking 
reduction of their normal ramified morphology. In addition, these mice show an 
increase in astrocyte activation following facial axotomy (Jones et al., 1998). 
Intrinsic ability for CNS neurons to regenerate 
Although inhibitory and trophic molecules at the site of injured CNS are clearly 
important, the success of axonal regeneration is also determined by the intrinsic 
ability of neuronal cell bodies to mount an appropriate response to axonal injury 
(Anderson et al., 1998). Neurons whose axons extend to the PNS, display a 
hypertrophic cell body following axonal injury. However neurons with axons 
confined to CNS, such as the rubrospinal neurons (Kwon et al., 2002) and 
corticospinal neurons, atrophy in response to injury, showing a decrease in cell 
body volume and number of dendrites, and low levels of protein synthesis 
(Lieberman, 1971).  
Neurons projecting axons into the PNS also mount a strong molecular response 
at the cell body, upregulating growth-related molecules that include transcription 
factors, cytoskeletal proteins, and adhesion molecules. In contrast, neurons 
whose axons are confined to the CNS mount a weak, transient or incomplete 
response to axotomy, or none at all (Anderson et al., 1998). The strong neuronal 
cell body response seen after peripheral axotomy to motor, autonomic and dorsal 
DRG neurons is associated with vigorous axonal regeneration. However, the 
feeble or absent cell body response following CNS lesions to Purkinje cells and 
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corticospinal (CS) neurons is not normally accompanied by axonal regeneration.  
Some CNS neurons such as rubrospinal and thalamic reticular neurons and 
retinal ganglion cells mount a transient cell body response and this may allow 
them an opportunity to regenerate axons if a suitable environment is provided 
(Anderson et al., 1998). 
Correlation between the cell body axotomy response and axonal 
regeneration into peripheral nerve grafts 
Implanting peripheral nerve grafts into the rodent CNS promotes axonal 
regeneration (David and Aguayo, 1985; Morrow et al., 1993; Richardson et al., 
1980). This effect however, is not common to all injured CNS neurons but it 
appears to be differential; with implants in the thalamus promoting the 
regeneration of axons of thalamic reticular neurons but not dorsal thalamic 
neurons, and cerebellar implants promoting axonal regeneration of deep 
cerebellar neurons (DCN) but not of Purkinje neurons (Anderson et al., 1998; 
Anderson and Lieberman, 1999).  
Interestingly, neurons that regenerate their axons into peripheral nerve grafts 
show a transient upregulation of regeneration associated molecules (GAP-43, 
CAP-23, SCG-10) following injury, which is prolonged in response to the graft. 
However, neurons which do not regenerate into peripheral nerve grafts do not 
mount such a response (Campbell et al., 1991; Chaisuksunt et al., 2000; Mason 
et al., 2002; Vaudano et al., 1995). Thus, the regenerative potential of neurons 
may be determined by their intrinsic ability to upregulate growth related molecules 
in response to axotomy. 
In addition, peripheral nerve graft experiments provide evidence that the axotomy 
response mounted by injured CNS neurons may be increased by providing 
regenerating axons with a more pro-regenerative environment. For example, 
delivery of chondroitinase to the spinal cord resulted in GAP-43 upregulation in 
DRG neurons after dorsal rhizotomy (Bradbury et al., 2002), and delivery of an 
anti-Nogo antibody to the cerebellum led to the upregulation of c-jun in Purkinje 
cells (Zagrebelsky et al., 1998). However, corticospinal neurons do not mount an 
axotomy response nor regenerate their axons following spinal cord injury or 
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pyramidotomy, even when the injured axons are exposed to neurotrophin-
producing peripheral nerve grafts (Richardson et al., 1980).  
This suggests that corticospinal neurons might be intrinsically unable to mount 
an axotomy response. However, corticospinal neurons have, in fact, been shown 
to mount a significant response to axotomy if injured very proximally (intracortical 
lesion); upregulating most of the aforementioned growth associated molecules 
(Mason et al., 2003; Tetzlaff et al., 1991). Indeed, they might even extend 
regenerating axons into peripheral nerve grafts in the cortex (Benfey and Aguayo, 
1982) This indicates that although the ability of corticospinal neurons to 
regenerate their axons may be limited by their lack of an axotomy response after 
distal axotomy, they are capable of mounting a similar response as neurons and 
successfully regenerating, given a sufficiently strong stimulus. The most likely 
explanation of the requirement for a very proximal axotomy is the need to 
eliminate axon collaterals with intact synapses, which may suppress the 
response to injury of the main axon. 
Neuroinflammation and the axotomy response 
There is evidence that the neuronal cell body response to axotomy is connected 
to the activation of inflammatory cells around injured neurons. Following 
peripheral nerve injury there is a vigorous axotomy response, and microglia in the 
vicinity of motor neurons become activated, proliferate and migrate towards the 
cell bodies of axotomised neurons (Kreutzberg, 1996; Svensson et al., 1994). 
Similarly, macrophages surrounding peripherally axotomised DRG neurons also 
become activated (Fenzi et al., 2001; Hu and McLachlan, 2003; Lu and 
Richardson, 1993) and insinuate themselves between the neurons and the 
satellite cells. Such inflammatory changes may be explained by the fact that 
motor, DRG and autonomic neurons upregulate a variety of inflammation-related 
genes following peripheral nerve injury (Boeshore et al., 2004; Costigan et al., 
2002; Raivich et al., 1999).  
In contrast, axonal injury at the CNS is associated with varying levels of microglial 
activation around the injured neurons. Corticospinal tract injury in  the spinal cord 
results in no increase in microglia number or activation around the injured 
pyramidal neurons (Leong et al., 1995), whereas following rubrospinal tract injury 
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microglia activation in the red nucleus has been reported to be absent (Barron et 
al., 1990), minimal and transient (Streit et al., 2000), or noticeable (Tseng et al., 
1996; Xu et al., 1998). However, the levels of microglial activation even in the 
latter case are modest in comparison to those that may be observed around 
motor neurons following facial nerve injury, for example. 
Correlation between the neuroinflammatory response and 
axonal regeneration into peripheral nerve grafts 
Interestingly, peripheral nerve graft experiments have demonstrated that the 
extent of perineuronal microglial activation correlates well with axonal 
regeneration. Shokouhi et al. (2010) demonstrated that axonal growth into 
peripheral nerve implants provokes a substantial increase in perineuronal 
neuroinflammation, which is most obvious around the highly regenerative TRN 
neurons. Increased microglial activity is also found around rubrospinal neurons 
which regenerate into peripheral nerve grafts in the spinal cord (Harvey et al., 
2005; Richardson et al., 1984).  
In contrast, corticospinal neurons do not regenerate axons into peripheral nerve 
grafts (Richardson et al., 1982) and no microglia activation at the motor cortex 
can be observed (Shokouhi et al., 2010). Similarly, little microglia activation can 
be found around the regeneration competent TRN and rubrospinal neurons under 
conditions where axonal regeneration does not occur (i.e. following axotomy 
alone or after insertion of freeze-killed peripheral nerve grafts). Thus, there is little 
microglial activation around intrinsic CNS neurons in the absence of axonal 
regeneration (Shokouhi et al., 2010). Interestingly, this pattern of perineuronal 
microglial activation is in keeping with that of the cell body response of intrinsic 
CNS neurons in peripheral nerve graft experiments (Mason et al., 2003). Figure 
6 summarises the characteristics demonstrated by neurons that can and cannot 
regenerate into the peripheral nerve graft. 
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Figure 6: Factors determining CNS regeneration into a peripheral nerve transplant. A: Diagram 
indicates that injured neurons that fail to regenerate into a peripheral nerve graft do not show a 
change in the cell body and perineuronal microglia remains ramified. B: Neurons that extend their 
axons into the peripheral nerve graft demonstrate changes in the cell body, characterised by an 
increase in the expression of growth related genes. Additionally, it is evident that microglia 
surrounding the cell body of the injured neuron become activated.  
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Neuroinflammation, neuronal axotomy response and axonal 
regeneration 
Stimulating the neuronal cell body response can dramatically enhance axonal 
regeneration (Chong et al., 1994; Chong et al., 1996; Leon et al., 2000; Neumann 
and Woolf, 1999; Richardson and Issa, 1984). For example, while dorsal root 
injury has little effect on the expression of growth associated molecules by DRG 
neurons and results in weak axonal regeneration into the CNS (Chong et al., 
1996), a conditioning lesion to the corresponding peripheral nerve provokes a 
strong inflammatory and neuronal cell body response that enhances axonal 
regeneration in the dorsal root (Richardson and Verge, 1987). 
Interestingly, work on DRG neurons and retinal ganglion cells (RGCs) 
demonstrates that simply provoking an inflammatory response around the cell 
bodies of axotomised neurons is enough to enhance the regeneration of their 
axons. Injection of Corynebacterium parvum into DRG prior to dorsal root injury 
stimulates the upregulation of growth associated molecules in the cell bodies of 
injured neurons (Lu and Richardson, 1995) and dramatically increases axonal 
regeneration (Lu and Richardson, 1991). 
Similarly, inflammation in the retina, following lens injury or injection of zymosan 
into the vitreous body of the eye, causes RGCs to upregulate growth associated 
molecules and enhances regeneration of axons after optic nerve injury (Leon et 
al., 2000). This positive effect of perineuronal inflammation on CNS axonal 
regeneration appears to be mediated by activated-macrophages which produce 
neurotrophic molecules, termed macrophage derived factors (MDFs). Identified 
MDFs include BDNF (Zhi et al., 2005), GDNF (Yan et al., 1999), platelet-derived 
growth factor (PDGF) (Mekada et al., 1998), IL-6 (Schuettauf et al., 2005), basic 
fibroblast growth factor (FGF-2) (Rappolee and Werb, 1992), and oncomodulin, 
a novel 14-kDa molecular weight factor which requires elevated cAMP to promote 
axon growth (Leon et al., 2000; Yin et al., 2000).  
Neuroinflammation and corticospinal tract regeneration 
Like peripheral macrophages, activated microglia are potent producers of 
neurotrophic factors and cell adhesion molecules that can exert survival and 
regenerative effects on neurons; these include: BDNF (Bouhy et al., 2006), IGF1 
(Lalancette-Hebert et al., 2007), TGFb1 (Makwana et al., 2007) and osteopontin 
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(Schroeter et al., 2006). Thus it has been hypothesized that activating microglia 
in the rodent motor cortex might induce the characteristically quiescent 
corticospinal neurons to regenerate following spinal cord injury.  
To test this, Hossain-Ibrahim et al. (2006) applied lipopolysaccharide (LPS) to the 
pial surface of the rat motor cortex, producing a gradient of inflammation through 
all cortical layers, characterized by the presence of activated amoeboid microglia 
and macrophages. This inflammatory response was found to stimulate 
corticospinal neurons to upregulate the expression of growth associated genes 
ATF3, GAP-43, c-Jun and SCG10. However, LPS treatment was unable to 
enhance of corticospinal tract (CST) regeneration in animals with a concomitant 
spinal cord injury (Hossain-Ibrahim et al., 2006).  
The challenges of promoting corticospinal tract regeneration 
through perineuronal inflammation 
The failure of LPS application to enhance CST regeneration may be explained 
by the following possibilities: a) LPS is not a potent enough inflammogen or may 
induce the wrong type of inflammation b) insufficient inflammation is achieved in 
the corticospinal neuron layer because of the superficial application of LPS; c) 
the inflammatory effect of LPS is too transient.  
Although LPS is a potent inflammatory agent , it is interesting to note that injecting 
it to the vitreous body is not a sufficient stimulus to enhance retinal ganglion cell 
axonal regeneration after optic nerve injury (Leon et al., 2000). Thus, LPS might 
be less potent than zymosan which, as described earlier, does stimulate 
regeneration of RGC (Leon et al., 2000).  
Application of LPS to the pial surface of rat cortex might limit the level of 
inflammation at the deeply located cortical layer V, which contains corticospinal 
neurons. However, Hossain-Ibrahim et al. (2006) report that injection of LPS 
directly into deep motor cortex did not result in neither a detectably greater 
inflammatory response nor greater upregulation of growth-associated proteins in 
layer V.  
Finally, the transient effect of LPS treatment might suggest that methods to 
deliver LPS chronically to the motor cortex would be more suitable to promote 
CST regeneration. However, microglia when activated express a number of 
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potentially cytotoxic molecules such as TNF, IL-1beta, NO, oxygen radicals and 
components of the complement cascade (Raivich et al., 1999). Thus, unlike pial 
application (Hossain-Ibrahim et al., 2006), chronic infusion of LPS has been 
shown to produce neurotoxic focal necrosis at the infusion site (Szczepanik et al., 
1996), which would be counterproductive to regeneration. Thus it remains to be 
seen whether other approaches to inducing cortical inflammation would promote 
a stronger and longer-lasting expression of growth-associated proteins, with the 
effect of stimulating CST axon regeneration and without causing neurotoxicity. 
Inflammation to model neurotoxicity 
Increasing inflammation in the brain to toxic levels could be detrimental. Perinatal 
brain damage is a major cause of motor (e.g. cerebral palsy), cognitive, 
behavioural, attentional or socialisation deficits (Becher et al., 2004; Kubota et 
al., 2002). The neuropathological correlate that accounts for most brain damage 
in the immature brain is injury to the cerebral and periventricular white matter, 
known as periventricular leukomalacia (PVL) (Volpe, 2009). PVL is followed by 
neuronal and axonal damage in the cerebral cortex, basal ganglia, brainstem and 
cerebellum (Inder et al., 1999). The main factors initiating perinatal brain damage 
include, hypoxia, ischemia, infection and/or inflammation (Bell and Hallenbeck, 
2002; Dammann and Leviton, 1997; Pleasure et al., 2006; Volpe, 2009). 
Microglial activation and white matter damage 
The normal immature brain contains clusters of amoeboid microglia within the 
supraventricular corpus callosum and are known as the fountains of microglia 
(Del Rio-Hortega, 1932). They appear in the 2nd gestational trimester in humans 
(Monier et al., 2007; Rezaie and Male, 1999), and in mice and rats from a week 
before to 10 days after birth (Brockhaus et al., 1996; Hirasawa et al., 2005; Hurley 
et al., 1999; Leong and Ling, 1992). In mice, phagocytic microglia in the white 
matter are highly activated, as they show strong expression of activation markers 
α5, α6, αM, αX, and β2 integrins, B7.2, IGF-1 and M-CSF. In addition, microglial 
activation in the white matter is transient; highest at 0 days after birth and 
disappearing at day 10 in mice (Hristova et al., 2010).  
The presence of activated phagocytic microglia in the vicinity of vulnerable white 
matter could play an important role in initiating axonal damage in the immature 
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brain. Following hypoxia/ischaemia, rats demonstrated significant death of pre-
oligodendrocytes within the pericallosal white mater. This coincided with 
abundant microglial activation. Rats that received intraperitoneal injections of 
minocycline to decrease microglial activation, showed less white matter damage 
(Lechpammer et al., 2008). In addition, microglial activation and astrocyte cell 
death are observed in the mouse model of excitotoxic white matter damage 
(Tahraoui et al., 2001). Furthermore, maternal intrauterine infection and perinatal 
foetal inflammation (both systemic and affecting the CNS) is correlated with the 
development of PVL and subsequent cerebral palsy (Leviton and Paneth, 1990; 
Saliba and Marret, 2001; Svigos, 2001; Yoon et al., 1997a) 
Inflammation may mediate white matter damage through the production of toxic 
factors. Necrosis of oligodendrocyte precursors and axonal damage is associated 
with the presence of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF-α, 
in foetal plasma (Gomez et al., 1998), cerebrospinal fluid and spinal cord blood 
(Romero et al., 1990). Activated microglia, peripheral macrophages and 
hypertrophic astrocytes can produce the pro-inflammatory cytokines (Kadhim et 
al., 2001; Yoon et al., 1997b). The release of these cytokines may cause brain 
damage by exacerbating the production of cytotoxic inflammatory cytokines 
(TNF-α and IL-6) and free radicals such as superoxide and NO by microglia (Hu 
et al., 1995).  
Models of white matter damage 
Infectious and inflammatory models used to investigate the development of white 
matter damage include intrauterine and intrauterine administration of LPS, the 
direct delivery of LPS into the subcortical white matter, intravenous injection of 
LPS into the foetus, or intraperitoneal injection into the mother or the pup (Wang 
et al., 2006).  
Intracerebral administration of LPS in rodents induces the expression of TNF-α, 
IL-1b and iNOS by microglia/macrophages, reduces myelination and 
oligodendroglial numbers, and causes astrogliosis and cystic lesions in the white 
matter. Ventricular dilatation as well as some neuropathological changes in grey 
matter have been found (Cai et al., 2003; Coumans et al., 2003; Lehnardt et al., 
2002; Pang et al., 2003).  
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Intrauterine injection of LPS was associated with cell death in the brain of foetal 
rats (Bell and Hallenbeck, 2002). There was increased expression of TNF-α and 
IFN-ɣ increased, whereas IL-6 and IL-10 levels declined following LPS exposure 
(Bell et al., 2004). However, there were no differences between LPS-injected and 
control rats in their ability to carry out motor tasks in adult animals (Poggi et al., 
2005). 
Intravenous injections of LPS into the sheep foetus was associated with the 
presence of IL-6 in foetal plasma. Analysis of the brains of sheep exposed to LPS 
showed gliosis, subcortical and white matter damage, as well as a reduction in 
the size of corticospinal tracts in the brainstem (Duncan et al., 2002). In addition, 
sheep injected with LPS had increased microglial activation in the white matter, 
astrocyte damage and loss of oligodendrocytes (Peebles et al., 2003). 
Intraperitoneal injection of LPS into the mothers is associated with increased 
foetal mortality (Silver et al., 1995). There is a higher concentration of IL-1 β, TNF-
α and IL-6 in the placenta and of TNF-α in the amniotic fluid in rats injected with 
LPS than those injected with PBS (Urakubo et al., 2001). LPS also increases the 
expression of IL-1β and TNF-α, and causes astrogliosis and hypomyelination in 
the foetal brain (Cai et al., 2000). 
Intraperitoneal injection of LPS into neonatal mouse pups initiates an acute 
inflammatory response, both systemically as well as centrally. Systemically, there 
is a marked increase in IL-1β and IL-6 protein. Centrally, there is increased 
expression of IL-1β and microglial activation. Neonatal rats injected  
Intraperitoneally with LPS can show impaired memory function in adulthood 
(Wang et al., 2006). 
Despite the associations between LPS-induced inflammation and damage to 
subcortical white matter, there is, as yet, no direct experimental model available 
that specifically induces white matter damage. In addition, the aforementioned 
models are limited by the fact that LPS-mediated inflammation is only transient 
and multiple injections are often required. A model which affects white matter 
specifically through a more targeted chronic stimulation of resident fountains of 
microglia may overcome these limitations.  
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Poly I:C and GMCSF to promote corticospinal tract 
regeneration 
Microglial activation may play a role in promoting axonal regeneration but may 
also cause neurotoxic effect. Polyinosinic:polycytidylic acid (Poly I:C) and 
granulocyte-macrophage colony stimulating factor (GM-CSF) are two agents 
known to produce inflammation. The effect of producing perineuronal 
inflammation on axonal regeneration and degeneration using these substances 
has not yet been determined. 
Poly I:C 
Poly I:C is a synthetic double-stranded RNA, injections which has been shown to 
mimic the effects of systemic viral infection (Cunningham et al., 2007). Microglia, 
astrocytes, and even neurons can recognise Poly I:C via cell surface or 
endosomal TLR3 (Bsibsi et al., 2002; Bsibsi et al., 2003; Cameron et al., 2007; 
Jack et al., 2005; Kim et al., 2008), cytoplasmic MDA-5 (melanoma differentiation-
associated protein 5) (Yoneyama and Fujita, 2010) and/or cytoplasmic retinoic 
acid inducible gene (RIG-I) I receptors (Peltier et al., 2010). Poly I:C binding to 
these receptors induces activation of IFN-regulatory factor 3, NF-κB and PI3K 
signalling pathways (Cameron et al., 2007; Deleidi et al., 2010; Patro et al., 2010). 
In vitro studies have shown that Poly I:C stimulates microglia and astrocytes to 
produce cytokines IL-6, TNF-α IFN- β and nitric oxide (Furie and Randolph, 1995; 
Matsui et al., 2013; Wahl et al., 1996). In vivo, intra-ventricular administration of 
Poly I:C also results in the expression of IL-1β and NO (Melton et al., 2003), whilst 
intraperitoneal Poly I:C in mice provokes a global upregulation of a range of 
chemokines, including CXL1 and 2 and CCL2 and 4 (Bajetto et al., 2001; Bell et 
al., 1996; Hausmann et al., 1998). 
Inflammatory and glial response to Poly I:C in the CNS 
Infusion of Poly I:C into the brain of rats was associated with an increase in the 
number of reactive microglia and phagocytic microglia in the hippocampus (Patro 
et al., 2010). Similarly, microglial and astocyte activation was evident in the 
substantia nigra and striatum following intranigral injection of Poly I:C (Deleidi et 
al., 2010). After intra-ventricular injections of Poly I:C , gliosis is seen in the mouse 
cerebral cortex (Town et al., 2006). Poly I:C-mediated neuroinflammation is 
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associated with neuronal damage. In rats, prolonged intraventricular Poly I:C 
administration is associated with neuronal cell loss in the septal nucleus, 
hippocampus, cortex and thalamus (Melton et al., 2003). Systemic Poly I:C 
aggravates neurodegeneration in hippocampus in a mouse model of prion 
disease (Field et al., 2010). Intra-nigral injections of Poly I:C are associated with 
dopaminergic neuronal degeneration (Patro et al., 2010). In addition to the toxic 
effects exerted on neurons, Poly I:C causes oligodendrocyte precursor cell death 
in vitro (Steelman and Li, 2011). 
Neurite collapse 
Poly I:C produces a strong and long-lasting inhibition of neurite growth from DRG 
neurons in vitro (Cameron et al., 2007). Toll like 3 receptors are found in cell 
bodies, axons and growth cones of growing neurons. The absence of these 
receptors abolishes the effects of Poly I:C on neurite outgrowth. In vivo, 
intrathecal injections of Poly I:C in neonatal mice resulted in fewer axons exiting 
the dorsal root ganglia and the animals displayed sensory motor deficits 
(Cameron et al., 2007). Similarly, axonal outgrowth from cerebellar granule cells 
in vitro is also decreased by Poly I:C exposure. This effect appears to be 
mediated via the epidermal growth factor (EGF) receptor (ErbB) pathway as the 
inhibitory effect of Poly I:C effect was eliminated when ErbB1 was knocked out 
from neurons or ErbB1 kinase activity was blocked (Leinster et al., 2013). 
GMC-SF 
GM-CSF is a cytokine belonging to the family of colony stimulating factors (CSF). 
Colony stimulating factors are crucial for survival, proliferation, differentiation, 
maturation and functional activation of haematopoietic cells (Metcalf, 2008). 
GM-CSF receptor activation 
GM-CSF is involved in the generation of granulocytes, macrophages, and 
dendritic cells from hematopoietic cells (Metcalf, 1989). It is a 24 kDa glycoprotein 
protein that exerts its effects by activating the GM-CSF receptor (GM-CSFR) 
(Rozwarski et al., 1996). The GM-CSFR is a heterodimer consisting of the 
transmembrane glycoproteins α-subunit and β-subunit. The α-subunit is 
responsible for ligand ligation and is specific for GM-CSF, while the β-subunit is 
required for signal transduction and is shared with IL-3 and IL-5 receptors (Chiba 
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et al., 1990). Two GM-CSFRβ-subunits need to be in close proximity for the 
phosphorylation of the downstream receptor-associated Janus Kinase-2 (JAK2) 
kinase to occur. The activation of JAK2 leads the activation of subsequent 
signalling pathways (Quelle et al., 1994) including the Jak/signal transducer and 
activator of transcription (STAT), Ras/mitogen activated protein kinase (MAPK), 
phosphatidylinositol 3 (PI-3) kinase, nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB) pathways. Activation of the JAK/STAT induces cell 
differentiation. JAK/STAT and the PI3K pathways can also lead to apoptosis 
inhibition and cell survival. While, Ras/MAPK and NFκB pathways are 
responsible for GM-CSF induced proliferation and inflammation (de Groot et al., 
1998).  
Expression and effects of GM-CSF 
Following stimulation with cytokines, antigens, microbial products or inflammatory 
agents (IL-1, TNFα or LPS) a number of cells strongly upregulate GM-CSF 
expression; these include cells of the adaptive system (T-cells and B-cells), 
innate immune cells (natural killer cells, macrophages, neutrophils, mast cells 
eosinophils), constitutive immunity (Paneth’s cells, Pneumocyte II cells, 
endothelial cells, mesenchymal stromal cells, osteoblasts, chondrocytes and 
smooth muscle) (Conti and Gessani, 2008; Fukuzawa et al., 2003; Sallerfors, 
1994), and cells of the nervous system (astrocytes) (Aloisi et al., 1992b). 
GM-CSF has roles in the proliferation and survival of macrophage and 
granulocyte precursors (Verdrengh and Tarkowski, 1998). It promotes 
chemotaxis (Cheng et al., 2001; Gomez-Cambronero et al., 2003; Khajah et al., 
2011), the release of oxygen radicals and phagocytosis by neutrophils (Bourgoin 
et al., 1992; Corey and Rosoff, 1989; Kumaratilake et al., 1996). Similarly, GM-
CSF promotes a phagocytic phenotype in monocytes. 
When monocytes isolated from human peripheral blood were grown in serum 
containing GM-CSF, they increased in size and granularity, had increased 
phagocytic activity, and expressed various adhesion molecules, CD14 and major 
histocompatibility complex (MHC) class II. 
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Deletion of the GM-CSF gene results in mice having abnormalities in the lungs, 
such as an extensive presence of lymphocytes in the peribronchovascular 
interstitium and large intra-alveolar phagocytic macrophages. Mice are also 
vulnerable to lung infections caused by bacterial or fungal organisms (Stanley et 
al., 1994). However, mouse development and haematopoiesis is normal. On the 
other hand the global over-expression of GM-CSF protein by transgenic mice is 
associated with effects in peripheral tissues as well as in the nervous system. 
GM-CSF over-expressing mice develop blindness resulting from the increased 
presence of macrophages in the eye and retinal damage. They also show signs 
of generalised muscle wasting with hind limb weakness or paralysis associated 
with increased presence of macrophages in skeletal muscle. In addition, there is 
accumulation of large numbers of macrophages and neutrophils in the peritoneal 
and pleural cavities (Lang et al., 1987; Metcalf and Moore, 1988). 
GM-CSF has potent effects on microglia in vitro. It promotes ameboid 
morphology, phagocytosis (Giulian and Ingeman, 1988), antigen presentation 
(Fischer et al., 1993) activation marker expression and proliferation (Giulian and 
Ingeman, 1988; Kloss et al., 1997). In vivo, similar effects on microglial 
morphology, phagocytosis and proliferation have been observed (Giulian and 
Ingeman, 1988; Mangano et al., 2011; Mausberg et al., 2009; Schermer and 
Humpel, 2002). In addition, GM-CSF can stimulate the production of IL-6 and 
TNF-α by microglia (Reddy et al., 2009). 
As well as having effects on immune cells, GM-CSF has been shown to act on 
cells of the nervous system such as astrocytes and neurons. It promotes 
astrocyte proliferation and activation in vitro and in vivo (Guillemin et al., 1996; 
Mangano et al., 2011; Reddy et al., 2009). GM-CSF receptors are also found in 
neurons (Schaebitz et al., 2008). In vitro, GM-CSF protects neurons from nitric 
oxide-induced cell death (Schaebitz et al., 2008). In vivo, GM-CSF is 
neuroprotective in models of stroke and spinal cord injury, probably through the 
stimulating the production of neurotrophins by microglia (Bouhy et al., 2006; Ha 
et al., 2005; Huang et al., 2009; Kong et al., 2009; Schaebitz et al., 2008).
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Aims 
 
In contrast to the PNS, the CNS displays limited axonal regeneration after injury, 
which is associated with a lack of perineuronal inflammation. Stimulation of 
microglia around the cell bodies of injured neurons has been demonstrated to 
promote CNS regeneration. However, it is well known that microglial activation 
can impair neuronal survival and cause CNS degeneration by the production of 
cytotoxic molecules. The current project used Poly I:C and GM-CSF to stimulate 
microglial activation around the cell bodies of injured neurons in the aim of 
boosting axonal growth following injury. In addition, the study also wanted to 
evaluate the possible toxic effects associated with Poly I:C and GM-CSF 
mediated microglial activation in the CNS. 
 
Poly I:C was used to investigate the effects of acute inflammation in the rat CNS. 
The primary aim here was to stablish a safe dose of Poly I:C and to characterize 
the inflammatory response generated by Poly I:C in the rat motor cortex. It was 
also investigated whether Poly I:C injected into motor cortex will improve the 
regeneration of corticospinal tract axons. In addition, to determine the effect of 
perineuronal Poly I:C on peripheral nerve regeneration, Poly I:C was injected 
near the facial nucleus of rats with facial nerve injuries.  
 
GM-CSF was used to investigate the effects of chronic inflammation in the normal 
and injured rodent CNS. For the prolonged expression of GM-CSF in the CNS, a 
non-integrating lentivirus encoding for GM-CSF and for the marker enhanced 
Green Fluorescent Protein was created. As a next step the transfection levels 
over time, microglial activation and other parameters of the inflammatory 
response, and effects on cell survival and toxic side effects were evaluated in the 
adult rat CNS. 
The effect of GM-CSF-virus in mice was also studied. Mice are particularly 
interesting due to the availability of the many well characterized strain 
backgrounds and genetically modified mouse lines. The responses of one inbred 
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and six outbred mouse strains to GM-CSF-virus were characterised. To further 
characterize possible detrimental effects prolonged inflammation may cause the 
FVB mouse stain was used to model potential neurotoxic effects following fetal 
delivery of GM-CSF. 
Finally, potential neuroprotective or regenerative effects of GM-CSF were studied 
in rats. The principal aim of the project was to define the specific effects delivering 
GM-CSF-virus around the neuronal cell body of injured corticospinal neurons 
would have on axonal regeneration and functional recovery after corticospinal 
tract injury. 
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CHAPTER TWO 
Materials and Methods 
Materials  
The following materials were used for the production of replication deficient and 
integration deficient lentivirus. 
Molecular cloning  
1kb Plus DNA ladder Invitrogen 
Restriction enzymes New England Biolabs 
T4 DNA ligase Promega 
T4 DNA ligase buffer Promega 
Ethidium bromide Sigma-Aldrich 
QIAquick gel extraction kit Qiagen 
Qiagen Spin Miniprep kit Qiagen 
Qiagen Plasmid Maxiprep Qiagen 
Agarose Invitrogen 
Agar MERCK 
Ampicillin Stratagene 
 
Solutions 
TAE 40mM Tris-acetate and 5mM EDTA 
from (Sigma-Aldrich) 
Orange G- DNA loading dye 10% glycerol, 0.1% Orange G (Sigma-
Aldrich) 
LB broth 1% bactotryptone, 0.5% yeast extract, 
1% NaCl: (Sigma-Aldrich) 
S.O.C. medium For 250mLs: 5g Tryptone Peptone, 
1.25g Yeast extract, 0.15g NaCl, 0.05g 
KCl, 0.51g MgCl2, 2.5mLs MgSO4. 
Autoclave. Add 10mLs 20% glucose 
after autoclaving. (Sigma-Aldrich) 
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LB (Luria‐Bertani) Broth 10g NaCl, 5g Yeast extract, 10g 
tryptone peptone for 1L. (Sigma-
Aldrich). Autoclave. Add 100μg/ml 
ampicillin when cool. 
LB (Luria‐Bertani) Agar For 1L: 10g NaCl, 5g Yeast extract, 
10g tryptone peptone, 15g bacto agar. 
Autoclave. Add 100μg/ml ampicillin 
when cool. 
 
Methods 
Production of replication and integration deficient lentivirus 
The current study used a HIV-1 based, replication-deficient, non-integrating 
lentivirus encoding for GM-CSF and enhanced Green Fluorescent Protein 
(eGFP). As a control to the GM-CSF-virus, a lentivirus carrying eGFP-only was 
used.  
Cloning GM-CSF lentiviral plasmid 
To create the GM-CSF lentiviral plasmid (Fig. 1B), GM-CSF cDNA (0.5kB), kindly 
provided by Dr. C-O Yun, Yonsei University College of Medicine, Korea, and the 
Xiap-derived Internal Ribosome Entry Site (IRES) element was inserted between 
the Spleen Focus-Forming Virus (SFFV) promoter and eGFP-gene encoded in 
the eGFP-plasmid (Fig. 1B) (Yanez-Munoz et al., 2006). 
 
  
Figure 1: Schematic representation of the lentiviral plasmid constructs used in the study. A) The 
eGFP lentiviral plasmid (eGFP-virus). The lentiviral plasmid carries Spleen Focus-Forming Virus 
promoter (SFFV), driving the expression of eGFP. The promoter is preceded by long terminal 
repeats (LTRs), a rev Response Element (RRE) and a central PolyPurine Tract (cPPT) and 
followed by the Woodchuck Hepatitis Post-transcriptional Regulatory (WPRE) element to stabilize 
the eGFP mRNA. In this study this plasmid was used as a control to the current GM-CSF virus. B) 
The GM-CSF lentiviral plasmid was cloned by inserting the murine GM-CSF gene and the xiap 
derived Internal Ribosome Entry Site (xIRES), between the SFFV promoter and eGFP of the eGFP 
plasmid. SFFV directs the expression of GM-CSF and xIRES permits bicistronic expression of 
eGFP (GM-CSF/eGFP). 
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Cloning strategy 
As seen in figure two, the creation of the GMCSF/eGFP lentiviral plasmid required 
four cloning steps (Fig. 2A-D): 
A. The 220 base pair long xIRES was cloned from its parental DNA plasmid 
pMA-xIRES into pSL301 plasmid (3.2Kb- Invitrogen) using KpnI and SacI 
enzymes (pSL-xIRES) (Fig.2A).  
B. Similarly, from the pGL3-GM-CSF plasmid, GM-CSF (854bp) was inserted 
to pSL301 using XhoI and NheI (pSL-GMCSF) (Fig. 2B).  
C.  GMCSF from pSL-GMCSF was inserted into pSL-xIRES using BglI and 
KpnI enzymes, resulting with pSL-GMCSF/xIRES (Fig. 2C).  
D. Finally, GMCSF/xIRES insert was placed between the SFFV and eGFP 
genes, of the eGFP-only plasmid, by digesting pSL-GMCSF/xIRES with 
BclI enzyme and the eGFP-only plasmid with BamHI (Fig. 2D) 
The cloning of the plasmid required the following steps: plasmid digestion with 
restriction enzymes, analysis of plasmid derived fragment using gel 
electrophoresis, purification of DNA fragments from gel fragments, ligation of 
restricted bands, and plasmid replication using bacteria. Cloning of the viral 
plasmid was carried out by me, Francia Carolina Acosta-Saltos, under the 
supervision of Dr Roman Gonitel. 
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Figure 2: Cloning strategy. Diagram represents the four steps required for the production of GM-
CSF/eGFP-lentivirus plasmid. 
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Molecular Cloning  
RESTRICTION ENZYME DIGESTION OF PLASMID DNA  
Restriction digest reactions were typically a final volume of 30ul. Reactions 
contained 1ug-2ug of plasmid DNA, 1.5ul of one or two restriction enzymes (New 
England Biolabs), 1x buffer and 1x BSA (0.1mg/mL) (supplied with restriction 
enzymes: New England Biolabs). The reactions lasted for 1-2 hours and were 
carried at the temperature recommended by the manufacture.  
ISOLATION AND PURIFICATION OF DNA FRAGMENTS BY 
ELECTROPHORESIS 
DNA fragments were resolved by electrophoresis through 1% agarose gels in 
1xTAE buffer. Gels were prepared by boiling 1xTAE (40mM Tris-acetate and 5mM 
EDTA from Sigma-Aldrich), dissolving agarose (Invitrogen), adding ethidium 
bromide (0.5g/ml- Sigma-Aldrich) before the being allowed to set in an appropriate 
gel tray. DNA samples were loaded with Orange G loading dye (10% glycerol, 
0.1% Orange G- Sigma-Aldrich) along with 1kb Plus DNA ladder (Invitrogen). Gels 
were electrophoresed at 100-150V and visualised by exposure to ultraviolet light 
using UviDoc gel documentation system.  
Following electrophoresis, DNA fragments were extracted from agarose gel using 
a clean scalpel blade under ultraviolet light. DNA was purified using QiAquick gel 
extraction kit (Qiagen) gel extraction kit as recommended by the manufacture.  
DNA LIGATION 
Digested plasmid backbone was ligated to insert DNA in a 1:1 or 1:4 molar ratio 
using T4 DNA ligase (Promega) and 1X T4 DNA ligase buffer (Promega) in a final 
volume of 20μl. Ligation of sticky ends was performed for 1 hour at room 37°C. 
Ligation products were transformed into competent chemically competent Stbl3 
E. coli (Invitrogen). 
BACTERIAL MANIPULATION  
GROWTH AND MAINTENANCE OF E. COLI  
Chemically competent Stbl3 E. coli were grown at 37°C in LB broth (1% 
bactotryptone, 0.5% yeast extract, 1% NaCl: Sigma-Aldrich) while shaking at 
250rpm or streaked out on solid LB agar plates (1.5% agar dissolved in LB by 
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heating). For antibiotic selection, 100μg/mL ampicillin was added into LB broth or 
agar.  
TRANSFORMATION OF BACTERIAL CELLS  
For every transformation, Stbl3TM E.coli were thawed slowly in ice. In a 50ul vial 
of bacteria, 10pg-100ng of DNA was added and gently mixed. The mixture was 
left to incubate for 30 minutes in ice. Bacteria were then heat shocked for 45 
seconds at 42°C and placed immediately in ice for 2 minutes. 250ul of preheated 
S.O.C. medium was added to cells and placed in a shaking incubator at 250rpm 
for 1 hour at 37°C. The bacteria were plated out on agar LB plate with ampicillin 
(50ug/mL). 
PLASMID DNA PREPARATION  
Colonies were picked from agar plates using a 20ul pipette tip. E. coli containing 
plasmids of interest were subsequently grown overnight in 5mL (small-scale), 
100mL or 500mL (large-scale) LB broth at 37°C in a shaking incubator. DNA 
plasmids were extracted by alkaline lysis using Qiagen Spin Miniprep kit (≤ 20uL 
plasmid DNA), Qiagen Plasmid Maxiprep (≤500μg) as instructed by the 
manufacturer.  
Plasmid DNA concentration was quantified by measuring the absorbance of light 
with a wavelength of 260nm using a NanoDrop ND-100 spectrophotometer with 
a 0.2mm path length.  
ANALYTICAL DIGESTS 
To find out the presence of and orientation of the inserts, analytical digests on 
the various plasmids was carried out. 
Following restriction reaction of pSL 301 variants with SacI and MfeI enzymes, it 
was confirmed that pSL-xIRES (Fig. 3A lane 3) contained xIRes insert (292bp), 
pSL-GMCSF (Fig. 3A lane 4) had GM-CSF insert present (584bp), and pSL-
GMCSF/xIRES  plasmids (Fig. 3A lane5) had both GM-CSF and xIRES present 
(754bp). 
Lentiviral plasmids digested with EcoR1 and Nhe1 enzymes confirmed that GM-
CSF and xIRES are present and in the right orientation (Fig. 3B). Three digestion 
products were found: lentiviral plasmid backbone (7.15 kb), 
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GMCSF/xIRES/eGFP/WPRE (2.71 kb) and SFFV promoter (486 bp) (Fig. 3B lane 
two). 
Cloned plasmids were sequenced at the Wolfson Institute of Biomedical 
Research, UCL. Sequencing confirmed that GM-CSF and xIRES were present in 
the lentiviral vector and in the right orientation. 
 
 
 
Cell culture and virus preparation  
PROPAGATION AND STORAGE OF MAMMALIAN CELL LINES  
Adherent cells, Human Embryonic Kidney 293 (HEK-293T) cells and murine BV-
2 cells, kindly provided by Dr Jennifer Pocock, Institute of Neurology ULC, were 
maintained in Dulbecco’s Modified Eagle Medium (DMEM- Invitrogen) containing 
Figure 3: Analytical digests of pSL301 and lentiviral plasmids cloned in this study. A) Lane 4, 5 
and 6 show the reaction products of pSL-xIRES (3.4kb), pSL-GMCSF (4.1 kb), pSL-
GMCSF/xIRES plasmids after SacI and MfeI digestion. The xIRes (292bp) (line 4), GMCSF 
(584bp) (line 5) and GMCSF+xIRES (754) (line 6) are evident after digestion of pSL301 variants. 
Lane 1, 2 and 3 demonstrate the 1kb+ ladder, undigested pSL-xIRES and pSL-GMCSF, 
respectively. B) eGFP-only (9.7 kb) and GMCSF/eGFP (10.3 kb) lentiviral plasmids where 
digested with EcoR1 and Nhe1 enzymes. The GMCSF/eGFP lentiviral plasmid (lane 2) shows 
three digestion products: lentiviral plasmid backbone (7.15 kb), GMCSF/xIRES/eGFP/WPRE 
(2.71 kb) and SFFV promoter (486 bp). The reaction products of eGFP-only plasmid (lane 3) are 
the lentiviral backbone (7.25kb) and SFFV/eGFP/WPRE genes (2.4kb), confirming the presence 
of GMCSF and xIREs genes in the GMCSF/eGFP lentiviral plasmid. 
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GlutaMAX supplemented with 10% foetal calf serum (FCS- Invitrogen) and 1% 
penicillin/streptomycin (hereafter referred to as ‘complete DMEM’). All cells were 
incubated at 37°C and a 5% CO2 atmosphere.  
LENTIVIRUS PREPARATION  
To produce non-integrating lentiviral vector, 1.2 x 107 HEK293T cells were 
seeded in 175cm2 flasks (Sigma-Aldrich) one day before transfection to reach 
>90% confluence. For each flask, 50μg vector plasmid (Fig. 4 A or B) , 32.5μg 
non-integrating virus packaging plasmid pCMV-dR8.74 D64V, and 17.5μg 
vesicular stomatitis virus envelope plasmid pMDG2 was added to 5ml Optimem 
and 0.22μm filtered. 1μl PEI was added to 5ml Optimem and also 0.22μm filtered. 
The two mixtures were combined and allowed to complex for 20min. Cells were 
washed with PBS, overlaid with the complex, and incubated at 37°C 5% CO2 for 
4 hours. The complex was removed and replaced with complete DMEM 24 hours 
later, the medium was replaced 48 and 72 hours after transfection, the medium 
was removed, 0.22μm filtered, and centrifuged at 98,000g for 2 hours. Virus 
pellets were re-suspended in Optimem and aliquots were stored at -80°C.23.  
 
 
Lentiviral Plasmids (A or B) 
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FLOW CYTOMETRY  
To calculate the titre of eGFP-lentivirus and GM-CSF/eGFP-lentivirus, 105 HEK-
293Tcells were seeded in a 24 well plate, in a final volume of 300μL and were left 
overnight. The next day the cells were treated with 2ul, 0.4ul, 0.08ul, 0.016ul of 
eGFP-lentivirus or GM-CSF/eGFP-lentivirus. As a negative control, cells were 
treated with vehicle medium (DMEM). Two days following transduction, the cells 
were harvested, washed with PBS and pelleted in a FACS tube by centrifugation 
at 1500rpm for five minutes. The samples were then re-suspended in 200μL of 
PBS and were then analysed by flow cytometry using a CyAn ADP flow cytometry 
analyser and FlowJo software. Figure 4 and 5 show an example of the results 
obtained from flow cytometry after the cells transduced with increasing 
concentrations of eGFP-lentivirus (Fig. 5) or GM-CSF/eGFP-lentivirus (Fig. 6) 
were analysed. The histograms represent the correlation between side scatter 
(Y-axis) and eGFP fluorescence (X-axis).  
VIRAL TITRE CALCULATION 
Using the flow-cytometry histograms obtained from the above section, a region 
of the histogram was gated to pick up viable cells expressing eGFP, which are 
most likely infected with one viral particle. Only samples that had between 2% 
and 5% of eGFP-fluorescent cells within the gated area were used to quantify the 
titre. A typical example might be 105 cells transduced with 0.016ul eGFP-virus 
resulting in 2.89% of green fluorescent cells (Fig. 5) or 105 cells transduced with 
0.08ul GM-CSF-virus resulting in 4.67% of green fluorescent cells (Fig. 6).  
Subsequently, the titre of the vector can be calculated by using the following 
formula: 
 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑎𝑛𝑠𝑑𝑢𝑐𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑣𝑖𝑟𝑢𝑠 𝑢𝑠𝑒𝑑 𝑡𝑜 𝑡𝑟𝑎𝑛𝑠𝑑𝑢𝑐𝑒 𝑐𝑒𝑙𝑙𝑠
= viral titre 
Figure 4: Lentivirus production. Non-integrating lentiviral particles were produced by transient 
transfection of HEK293T cells with three plasmids: Lentiviral genome plasmid (A or B), the 
integrase deficient Gag-pol packaging plasmid and an envelope plasmid expressing vesicular 
stomatitis virus G protein (VSVG), which pseudotypes the virus to predominantly transduce 
neurons in vivo, as described by Rahim et al., (2009). 
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For example, the following calculation was carried out to determine the titre of 
eGFP-virus (Fig. 5):  
(2.89/100) × 105
0.016𝑢𝑙
=  180625 TU/ul  
 
*105= the number of cells seeded in in one well 
 
To calculate titre in TU/ml: 
180625 TU/ul × 1000 = 1.8 ×  108 
 
Additionally, the following calculation was carried out to determine the titre of GM-
CSF-virus (Fig. 6):  
(4.67/100) × 105
0.08𝑢𝑙
=  58375 TU/ul  
 
To calculate titre in TU/ml: 
58375 TU/ul × 1000 = 5.84 ×  107 
 
INTENSITY OF FLOURESCENCE 
Flow cytometry histograms (Fig. 5 & 6) were also used to determine the intensity 
of fluorescence of cells infected with eGFP-only (Fig 5) or GM-CSF/eGFP-
lentivirus (Fig. 6) at 0µl, 0.032µl, 0.016µl, 0.08µl, 0.4µl and 2µl. The median 
fluorescent intensity of cells within the gated area was measured using FlowJo 
software. 
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Figure 5: eGFP-expression from HEK293T cells infected with eGFP-only lentivirus. eGFP-
expression was determined by flow cytometry 2 days following transfection of HEK293T cells with 
0µl (untransduced), 0.032µl, 0.016µl, 0.08µl, 0.4µl and 2µl of eGFP-lentivirus. The proportion of 
HEK293T cells expressing eGFP is given as a percentage within the gated area. 
0.016ul 
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Figure 6: eGFP-expression from HEK293T cells infected with GM-CSF/eGFP lentivirus. eGFP-
expression was determined by flow cytometry 2 days following transfection of HEK293T cells with 
0µl (untransduced), 0.032µl, 0.016µl, 0.08µl, 0.4µl and 2µl of GM-CSF/eGFP-lentivirus. The 
proportion of HEK293T cells expressing eGFP is given as a percentage within the gated area. 
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Lentivirus was produced by me or Dr Roman Gonitel. 
In vitro assay 
GM-CSF/EGFP-lentivirus bioactivity assay  
0.3 X 106 HEK293T cells were seeded to a 6 well plate. Once confluent, cells 
were treated with medium or increasing titres of GM-CSF/eGFP-lentivirus or 
eGFP-lentivirus (102 to 105 TU/ml). Supernatant from transfected HEK293T cells, 
obtained 24 hours after infection was used to treat 105 BV2 microglial cells. BV2 
cells were seeded in a 96 well plate 24hrs before treatment. BV2 cells were 
maintained for 24hr in: a) GM-CSF-lentivirus conditioned medium b) eGFP-
lentivirus conditioned medium or c) medium with GMCSF recombinant peptide 
(Gibco) at concentrations from 1 to 100 ng/ml.  
BV2 cell proliferation was measured using 3(4,5-dimethythiazol-2-yl)-25-
diphenyltetrazolium bromide (MTT) assay kit (Sigma-Aldrich). Briefly, 20ul of 
MTT was added per well and placed to incubate for 4 hours to allow the formation 
of formazan crystals. Medium was carefully removed and 200ul of sterile PBS 
was added. The formazan crystals were then dissolved in MTT solubilisation 
solution provided with the kit. Light absorbance was measured using 595 nm 
wavelength FLUOstar OPTIMA (BMG Labtech, Offenburg, Germany). This assay 
was performed by me. 
In vivo experiments 
Surgical procedures 
All surgical procedures were approved by the UK Home Office and the University 
College London local ethics committee. Experiments used adult female Sprague 
Dawley rats, outbred and inbred mice. Animals had access to adequate food and 
water ad libitum. 
Anaesthesia was induced with a mixture of 4% Isoflurane and oxygen and then 
maintained with 1.5% Isoflurane and oxygen. All animals received 0.1ml of intra-
peritoneal amoxicillin at the end of surgery whilst still under anaesthetic and all 
wounds were closed with skin clips or sutures. 
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RAT  
STEREOTACTIC MOTOR CORTEX INJECTIONS  
Adult female Sprague-Dawley rats (275-300g) (Charles Rivers) were 
anaesthetised with isofluorane. To expose the surface of the motor cortex, a scalp 
incision 1mm lateral to the midline, followed by craniotomy was performed. 
Subsequently, rats were placed in a stereotaxic frame (World Precision 
Instruments). Using a 10μl Hamilton syringe (Hamilton Company) attached to a 
micromanipulation pump (World Precision Instruments), 2ul of experimental 
substance was delivered into the motor cortex at a rate of 0.4μl/min. Injections 
were completely withdrawn after 5 minutes. The scalp incision was closed with 
Michel clips (Vet Tech). Substances were delivered into the motor cortex at four 
different sites. When anterograde tracing of the corticospinal tract was required, 
biotinylated dextran amine (BDA), was injected into the motor cortex at five 
different sites (Table 1). 
Poly I:C project 
Dose response: Animals received injections of Poly I:C (Sigma-Aldwich) at either 
5.6mg/ml, 1.0mg/ml or 0.1mg/ml and a control injection of PBS to the contralateral 
motor cortex described above. The animals were allowed to survive for 3 days. 
Surgery was performed by Prof. Patrick Anderson. 
Time course: Poly I:C 1.0mg/ml injections into the left motor cortex, with a control 
injection of PBS contralateral hemisphere. Rats survived up to 3 days, 7 days and 
14 days following injection. Surgery was performed by Prof. Patrick Anderson. 
GM-CSF project 
Dose response: Animals received injections of eGFP-virus at 108 or GM-
CSF/eGFP-virus at concentrations from 103 TU/ml to 107 TU/ml. GM-CSF-virus 
dilutions were carried out using eGFP-virus at 108. The animals were allowed to 
survive for 14 days. Surgery was performed by Prof. Patrick Anderson, Dr Roman 
Gonitel and me. 
Time course: eGFP-virus (108 TU/ml) or GM-CSF/eGFP (107 TU/ml) injections 
into the motor cortex. Rats survived up to 3 days, 7 days, 14 and 28 days following 
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injection. Surgery was performed by Prof. Patrick Anderson, Dr Roman Gonitel 
and me. 
Table 1: Co-ordinates for injections into the rat motor cortex. The coordinates are given as three-
dimensional (x, y and z) distances (in mm) relative from the bregma. The x plane represents the 
medial-to-lateral (left-to-right) distance from bregma, the y plane represents the rostral-to-caudal 
(front-to-back) distance from bregma and the z plane represents the dorsal-to-ventral (up-and-
down) distance from bregma. 
 
Rat Caudal Lateral Ventral 
Motor Cortex injection 0.0mm 3mm 1.8mm 
 0.5mm 2mm 1.6mm 
 1.0mm 2mm 1.6mm 
 1.5mm 2mm 1.6mm 
Additional injection for BDA  2.5mm 2mm 1.6mm 
 
RETROGRADE FLUOROGOLD (FG) CORTICOSPINAL NEURON 
LABELLING. 
Under continuing anaesthetic and with the rodent neck supported in flexion, the 
cervical spine was exposed by incising through skin and soft tissue along the 
midline. A laminectomy was performed to expose the dura and spinal cord. A 
bilateral incision was made through the corticospinal tract at C4 level with 
microscissors, and a small piece of Gelfoam (Johnson and Johnson, Skipton, UK) 
impregnated with 2µl of 2% Fluorogold (Molecular Probes) in distilled water was 
inserted into the incision. In addition to Fluorogold retrograde labelling: 
Poly I:C project: rats received Poly I:C 1.0mg/ml injections into the left motor 
cortex and a PBS injection into the right motor cortex as described previously. 
Surgery was performed by Prof. Patrick Anderson. 
GM-CSF project: rats received GM-CSF/eGFP-virus injection into the left or 
eGFP-virus injection into the right motor cortex as described previously. Surgery 
was performed by Prof. Patrick Anderson and Dr Roman Gonitel. 
The animals injected with the Poly I:C project were allowed to survive for 7 days 
and those of the GM-CSF project survived 14 days. 
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CORTICOSPINAL TRACT INJURY  
Anesthetised adult female Sprague-Dawley rats (275-300g) were injected into the 
motor cortex with experimental substances and BDA (10mg/ml) anterograde 
tracer. They also underwent a contralateral dorsal corticospinal tract injury (Fig. 
7).  
 
Experimental substances and anterograde tracer injection 
In the Poly I:C and GM-CSF experiments injections to the left motor cortex were 
carried out the as previously described.  
 Poly I:C experiments: Rats were injected into the motor cortex with 
PBS/BDA or Poly I:C/BDA (1mg/ml).  
 GM-CSF experiments: Rats were injected into the motor cortex with GM-
CSF-lentivirus (104, 105.5, 107 TU/ml) mixed in eGFP-lentivirus (108 TU/ml) 
or eGFP-lentivirus (108 TU/ml). Rats were injected with BDA 14 days prior 
to sacrifice. In addition, animals were injected intravenously with 
Fluorospheres via the tails 24h before sacrifice at 1ul/g. 
 
Figure 7: Surgical procedure. Rats were injected with experimental substances and anterograde 
tracer into the motor cortex. They endured a dorsal corticospinal tract injury contralateral to the 
injected motor cortex (in red). Edited from Hutson et al., (2012). 
Chapter Two 
 
 
99 
Dorsal corticospinal tract injury  
Following motor cortex injection, with the rat neck supported in flexion, the 
cervical spine was exposed by incising through skin and soft tissue along the 
midline. At cervical segment 4, a laminectomy was performed to expose the dura 
and spinal cord. A dorsal incision was made to the corticospinal tract, 
contralateral to the motor cortex injection. Time line of surgical procedures are 
presented in figure 8. 
 
Post-surgery care included an injection of 1 ml of Clamoxyl antibiotic and an 
analgesic regimen. A dose of 0.1 mg/kg of vetergesic was injected 
subcutaneously pre-surgery on the first day and a follow up injection was given 7 
hours after surgery. Maintenance vetergesic administration was provided orally 
via cherry gelatine to be eaten ad libitum. 
Corticospinal tract injury experiment contributions: For the Poly I:C project, 
surgery was performed by Prof. Patrick Anderson. The surgery for the GM-CSF 
project was carried out for two separate purposes: histological or behavioural 
assessments. Surgery for histological assessments was carried out by Prof. 
Patrick Anderson, Dr Roman Gonitel and me. Surgery for behavioural 
assessments was performed by Patrick Anderson and me. 
FACIAL NERVE INJURY 
Adult female Sprague-Dawley rats (275-300g) received a unilateral right 
craniotomy and then one injection of either 1µl of Poly I:C 1.0mg/ml or 1µl of PBS 
Figure 8: Experimental time line of GM-CSF (A) and Poly I:C (B) corticospinal tract injury 
projects. 
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near the right facial nucleus at the following coordinate from bregma; 2mm lateral, 
10.8mm posterior, 8.5mm deep. 
Right facial nerve axotomy was performed by making a 1cm skin incision 
posterior to the right ear at the level of the mastoid process. Superficial muscles 
were bluntly dissected to expose the facial nerve. The facial nerve was transected 
completely with microscissors at the stylomastoid foramen and included the retro-
auricular branch. The skin was closed with wound clips (Autoclip, USA). Two days 
prior to sacrifice (28 days), a piece of Gelfoam (Johnson and Johnson, Skipton, 
UK) impregnated with 30µl of Fluorogold (Fluorochrome, Denver, USA) diluted to 
2% with distilled water was inserted under the left and right whisker pads. The 
animals were allowed to survive for 30 days (Fig. 9). Surgeries were performed 
by Prof. Patrick Anderson and me. 
 
 
MOUSE 
Adult females (6-8 weeks) of one outbred and six inbred mouse strains were 
used, including outbred strain CD1 and inbred strains- 129S2/Sv, FVB/N, SJL, 
Balb/C, C3H/N, C57/BL6 (Charles Rivers).  
Figure 9: Facial nerve axotomy model and retrograde tracing of the facial nerve. Rats were 
injected with Poly I:C or PBS near the facial motor nucleus (FMN) and subsequently received a 
facial nerve axotomy. At 28 days post injury fluorogold was inserted into the whisker pad. Rats 
were sacrificed at 30 days post facial nerve injury. Picture edited from Peeva et al., (2006). 
PBS or 
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MOTOR CORTEX INJECTION:  
CD1 mice had a scalp incision at 0.5mm lateral to the midline and craniotomy 
was performed to expose the surface of the motor cortex. Mice were placed in 
the stereotaxic frame. Using a 10μl Hamilton syringe attached to a 
micromanipulation pump, 0.5ul of eGFP-virus (107 TU/ml) or GM-CSF/eGFP-
virus (107 TU/ml) was delivered into the motor cortex at a rate of 0.1μl/min. 
Injections were completely withdrawn after 2 minutes. The scalp incision was 
closed with Michel clips (Vet Tech). Mice received three virus injections: 1.0mm 
lateral and 0.5 rostral, 1mm caudal, or 1.5mm caudal to the bregma. All injections 
were 0.5mm deep into the motor cortex. Mice were allowed to survive for 3, 7, 14 
or 28 days after injection. Surgeries were performed by Dr Roman Gonitel and 
me. 
CORPUS STRIATUM INJECTION 
eGFP-virus (107 TU/ml) or GM-CSF/eGFP-virus (107 TU/ml) was injected into the 
corpus striatum of CD1, 129S2/Sv, FVB/N, SJL, Balb/C, C3H/N, or C57/BL6. 
Mice had a scalp incision at 1mm lateral to the midline and craniotomy was 
performed to expose the surface of the brain. Mice were then placed in the 
stereotaxic frame. Using a 10μl Hamilton syringe attached to a micromanipulation 
pump, 2.5μl of the virus was injected at 0.5 μl/ml. Mice received one injection: 
0.5mm rostral and 1.8mm lateral to bregma. The needle was inserted 3mm deep. 
All mice survived 14d post-surgery. Surgeries were performed by me. 
INTRAVENTRICULAR INJECTIONS IN FOETAL FVB MICE 
Pregnant female FVB mice at gestational day 14 were anaesthetised. To access 
the uterus a full-depth midline laparotomy was performed. A 34-gauge needle 
(Hamilton) was used to deliver 5 μl of eGFP-only vector (108 TU/ml) or mixed with 
GM-CSF/eGFP (107 TU/ml) into the lateral ventricle located on the left or right 
side of the foetal brain. GM-CSF/eGFP or eGFP-only pups were taken at 
postnatal day 0, 7, and 14. Surgeries were performed by Dr Simon Waddington 
and me. 
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RAT BEHAVIOURAL ASSESSMENT 
FOREPAW REACHING AND REARING ASSESSMENT 
The behaviour of rats with right dorsal corticospinal tract injury at cervical level 4 
and with injections of eGFP-virus or GM-CSF/eGFP-virus (104 TU/ml, 105.5 TU/ml 
or 107 TU/mL) into the left motor cortex was examined. Rats were tested at 2 time 
points prior to injury, and from 3 days to 42 days following injury, in 3 to 4 day 
intervals. Behaviour was recorded using a Canon digital video camera (VIXIA HF 
S10, Canon, UK). Behaviour was recorded by me and Lucas Topham. 
Behavioural analysis was carried out blindly using video recordings. Behaviour 
was assessed by Lucas Topham and Dr Alejandro Acosta Saltos and me.  
Forepaw reaching assessment  
In order to ensure consistent participation from female Sprague-Dawley rats 
(275-300g), all rats went through a two week training session before baseline 
function was assessed. Before training, rats were habituated to the reaching cage 
in groups of four cage-mates for two days. The cage had a vertical slit (8 cm x 
1.5 cm) in the middle of cage with a rectangular platform (3 cm x 4 cm) protruding 
at the bottom of the slit. During training, Cheerios were broken into thirds to 
provide food motivation and were given to the rats using a set of forceps. To 
encourage reaching through the slit, with either the right or left forepaw, the 
Cheerio was held to the left or right of the slit in the cage. Once the rat 
demonstrated an ability to perform 25 reaches with each forepaws, the rat was 
considered trained. During testing, rats were required to reach 25 times with each 
forepaw for a total of 50 reaches per behavioural testing session. 
Sub-movement scoring 
Rats were evaluated on the function of their proximal and distal muscles, such as 
shoulder, arm and lower arm muscles (Whishaw and Pellis, 1990). Ability to 
perform a certain movement was scored on a scale of 1-3 (1-attempted but with 
no use, 2-partial use, or 3-complete use). Proximal shoulder movements included 
abduction, adduction and flexion; the elbow was used as a landmark to evaluate 
these movements. Upper arm movement studied was biceps flexion. Distal, lower 
arm movements included wrist flexion and extension, and paw opening and 
closure.  
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Eating Success 
This was a quantitative measure. The number of times a rat carried out a 
successful eating movement were counted. A successful eating consisted of a 
sequence of lifting paw from floor, exiting the slit, covering the food, grasping the 
food, withdrawing food, and transporting it to mouth to eat the pellet.  
REARING TEST 
The rearing test was carried out in parallel to the reaching assessment. The 
rearing test assesses the ability of the rat to use the forelimb for weight bearing 
during exploration of a cylinder. Rats were placed in a transparent vertical 
Plexyglas cylinder (30 cm height and 20 cm diameter) (Gharbawie and Whishaw, 
2003) with two mirrors (30 cm x 30 cm) placed at 90˚ behind the cylinder, so that 
a 360˚ view of the rat was available. Using video recordings, the experimenter 
counted the number of times the left paw (uninjured), right paw (uninjured) or both 
paws were used during pushing off from the floor, rearing and landing. 
WHISKER MOTOR ASSESSMENT  
Rats with facial nerve injury, which were injected with Poly I:C or PBS into the 
hindbrain, were assessed for whisker movement from day 7 to 28. Whisker 
movement was scored in 0.5 increments, on a scale of 0.0 (no movement) to 3.0 
(normal movement as on the operated side) (Raivich et al., 2004). Behaviour was 
assessed by me and Dr Alejandro Acosta Saltos. 
Rodent perfusion 
Adult rat perfusion: Rats were terminally anaesthetised with an overdose of 
Halothane. The paw withdrawal reflex was used as an indication of sufficient 
anaesthesia. Rats were then perfused through the heart with 300mls of PBS 
followed by 300mls of 2% paraformaldehyde in PBS. During perfusion, 3ml of 
blood from rats injected with Fluorospheres was taken. Blood was added to 15ml 
tubes containing heparin (0.5-2.0 IU/ml-Sigma-Aldrich) to prevent coagulation. 
Following perfusion, the brains and spinal cords of rats were dissected out, as 
well as livers and spleen of those injected with Fluorospheres.  
Adult mouse perfusion: Mice were terminally anaesthetised by means of a 
16.6ul/g of body weight, intraperitoneal injection of 2,2,2,tribromoethanol 
(Avertin). The paw withdrawal reflex was used as an indication of sufficient 
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anaesthesia. Transcranial perfusions were carried out using PBS at a rate of 
0.02l/min for 5 minutes, which was followed by 10 minutes with 2% PFA solution 
at the same rate. Brains were subsequently dissected. 
Neonatal mouse perfusion: Neonate mice at post natal day 0 to 3 were killed by 
placing them in ice for 5 minutes. Neonate mice at postnatal day 7 were killed by 
intraperitoneal injection of pentobarbitone. Mice were perfused intracardially for 
2.5 min (8 mL/min) with PBS followed by 2.5 mutes with 4% FA/PBS. The brains 
were dissected. 
Perfusions and dissections were performed by me or Prof. Patrick Anderson. 
Cryoprotection 
Adult mice and rat tissue: tissue was post fixed by rotating (8 rpm) immersion for 
1 hour in 2% PFA/PBS before being cryoprotected in 30% sucrose in 0.1 M PBS 
buffer for 48 hours. Subsequently, tissue was embedded in OCT and frozen with 
dry ice. All tissue samples were stored at -80˚C prior to use.  
Neonate mice: brains were post-fixed for 1h by rotating (8 rpm) immersions in 4% 
FA/PBS at 4˚C and then cryoprotected for 24h in 30% sucrose in 0.1 M PBS 
buffer. 
Cryostat sectioning 
A cryostat (Leica, Germany) with the chamber set at -20˚C was used for tissue 
sectioning. Tissue was collected on warm, 0.5% gelatine coated slides (MECK), 
refrozen in dry ice and stored at –80˚C. 
Forebrains and hindbrains: Adult rat, adult mouse and neonate mouse forebrains, 
as well as rat hindbrains were cut in the coronal plane. Sections were 30um in 
thickness for adult rodents and 40um for neonate mice. Symmetry between the 
two hemispheres was checked regularly using a light microscope.  
Spinal cord: Rat spinal cords taken from cervical segment 1 to 8. They were 
suspended in a well of OCT and frozen with dry ice. Subsequently, transverse 
and horizontal sections of the spinal cord were taken. Sections were 40μm thick.  
Spleen: Coronal sections through the spleen were cut at 20um thickness. 
Cryostat sectioning was carried out by me or a BSc/MSc student. 
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Light-microscopic immunohistochemistry and fluorescence-
labelling 
General staining protocol 
All phosphate buffer (PB) and phosphate buffer /bovine serum albumin 
(PB/BSA) solutions had a pH of 7.4. 
A. Tissue preparation for antigen presentation and primary antibody 
incubation: 1) Frozen sections were rehydrated in distilled water and 
spread onto the slide. 2) Dry sections were fixed for 5 min in 4% 
formaldehyde (FA) in 0.1M phosphate buffer (PB). 3) They were then 
placed in 0.1M PB, washed in acetone (50%, 2 min; 100%, 2 min; 50%, 2 
min) to remove tissue fat, 4) transferred to PB (2min), moved to 0.1% 
bovine serum albumin (BSA: Sigma-Aldrich) in 0.1M PB (PB/BSA). 5) 
Subsequently, washed sections were incubated in goat serum (5%, 30 
min) (Vector). 6) Serum was removed from sections and a primary 
antibody was added and left to incubate over night at 4˚C. A list of primary 
anti-bodies used in this project is listed in Table 2. 
 
These steps were followed by two different tissue staining processes:  
B. Light microscopic immunohistochemistry: 1) Sections were washed by 
dipping the slide sequentially in 1% PB/BSA, 0.1M PB, 0.1M PB and 1% 
PB/BSA. 2) Then sections were incubated with biotinylated secondary 
anti-rabbit antibody for 1hr (table 2). 3)This was followed by 1 hour 
incubation with Avidin Biotinylated horse radish peroxide Complex or ABC 
(ABC kit, Vector; 1:200) and 5) staining with diaminobenzidine (DAB) 
(Sigma) and hydrogen peroxide (Sigma). The reaction mixture contains 
0.5 g/l DAB, 1:3000 dilution of 30% H202 in PBS (pH7.4). The reaction was 
allowed to run for a maximum of 5 minutes. 6) To stop the reaction, 
sections were transferred to 10mM PB, washed with distilled water and 
dehydrated with increasing concentrations of alcohols and xylene. 7) 
Sections were mounted on a glass cover slip using DePex mounting 
medium (BDH,UK). Figure 10 demonstrates the main steps in the 
immunohistochemical process. 
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Figure 10: A diagram showing the steps of the immunolabelling process used for light 
microscopy. A) Antigen presentation. B) Primary antibody incubation. C) Secondary antibody 
incubation. D) ABC complex exposure. E) DAB staining. 
 
C. Fluorescent labelling: 1) Sections were sequentially washed in 0.1 MPB, 
0.1 MPB, PB/BSA and PB/BSA. 2) Subsequently, sections were 
incubated with fluorescent secondary antibody, 3) rinsed (PB/BSA, 
PB/BSA, 0.1M PB, 0.1M PB), 4) dried and covered with Vectashield 
mounting medium with DAPI or without DAPI (Vector). Secondary 
antibodies fluoresced green (Alexa 488) or red (Cy3). Figure 11 
demonstrates the main steps in the process of fluorescent labelling. 
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Figure 11: A diagram showing the steps of the fluorescent labelling process.  A) Antigen 
presentation. B) Primary antibody incubation. C) Incubation of secondary antibody conjugated 
with a fluorescent tag. 
Double-fluorescent labelling 
This process can be divided into two parts: the first is the presentation of the 
antigen and biotin conjugate (Fig.12A1, A2, & B1), while the second is the 
visualisation of both of them (Fig.12A3, & B2, B3).  
Part 1: Presentation of biotin conjugate and antigen  
Three different double labelling procedures were carried out in this project. Below 
is the description of part 1 of each. 
1) TUNEL/IBA1/eGFP: TUNEL assay relies on terminal Deoxynucleotidyl 
Transferase (TdT-Roche) to mediate the addition of dUTP-biotin to the 
ends of DNA fragments.  
Forebrain sections that had been shown to contain eGFP-positive cells 
were spread on to the slide and fixed in PFA, then incubated for 15 minutes 
in 3% hydrogen peroxide in methanol. Next, they were washed 
sequentially in acetone, 0.1PBS (2mins) and PB/BSA (2mins). TdT 
solution (1ul TdT (400U/ul-from stock; Roche), 1.5ul dUTP, 100ul 
cacodylate buffer and 8975 ul H2O) was pipetted on to sections which were 
then incubated at 37˚C for 2 hours. Sections were then moved into TUNEL 
stop solution (1753.2mg NaCl in 100ml ddH2O and 882.3mg Sodium 
Citrate in 100ml of ddH2O) for 10 minutes. Sections were washed with 
0.1M PB before incubating them with goat serum for 30 mins. After that 
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antibody to IBA1 was added and the sections were left to incubate at 4˚C 
overnight. Continue to Part 2: visualisation of biotin conjugate and antigen. 
Endogenous peroxidase (EP)/IBA1/eGFP stain: Forebrain sections 
containing eGFP-positive cells were treated using the tissue preparation 
for antigen presentation protocol previously described (A: steps 1-5). 
Subsequently, sections were incubated with antibody to IBA1 overnight. 
The next day sections were washed sequentially in PB/BSA, 0.1M PB, 
0.1M PB and PB/BSA. Then sections were incubated with 0.1% 
biotinylated tyramide (NEN, Cologne, Germany, in 0.1M PBS) in 0.01% 
hydrogen peroxide for 10 minutes. Continue to Part 2: visualisation of 
biotin conjugate and antigen. 
 
GFAP/BDA labelling: Spinal cord sections containing the corticospinal 
tract were treated using the tissue preparation for antigen presentation 
protocol previously described (A: steps 1-5). Subsequently, sections were 
incubated with antibody to GFAP overnight. Continue to Part 2: 
visualisation of biotin conjugate and antigen. 
 
Part 2: Visualisation of biotin conjugate and antigen  
Sections are washed sequentially in 0.1 MPB, 0.1 MPB, PB/BSA and PB/BSA. 
The sections are then incubated with ABC for 1 hour, then washed with 0.1M PB, 
0.1 MPB, PB/BSA and PB/BSA. Sections are then incubated with fluorescent 
secondary antibody: anti-rabbit Cy3 was used to bind to IBA1-antibody or anti-
rabbit Alexa Fluor 488 to bind to GFAP-antibody. To remove excess secondary 
antibody, sections were washed sequentially in PB/BSA, PB/BSA, 0.1M PB and 
0.1M PB. To visualise the biotin conjugate, sections were incubated with avidin-
AMCA or avidin-Texas red for 1 hour. After that, sections were washed four times 
with 10mM PB.  A cover slip was mounted using vectashield. Figure 12 
demonstrates the main steps in the process of double-fluorescent labelling. 
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Figure 12: A diagram showing the steps of the process of double fluorescent labelling. A: 1) 
Antigen presentation. 2) Primary antibody incubation. 3) Incubation of secondary antibody 
conjugated with fluorescent tag. B: 1) Biotin conjugate presentation. 2) Incubation with ABC 
complex. 3) Incubation with avidin-fluorescent tag conjugate. 
 
Other stains 
BDA tracer detection: To detect corticospinal axons in injured rats, spinal cord 
and hindbrain sections were rehydrated and spread sections onto slides. 
Sections were dried and then fixed for 5 min in 4% FA/PB.  Then they were placed 
in 0.1M PB, 50% acetone, 100% acetone and then 50% acetone before being 
transferred to PB and then moved to PB/BSA. Sections were then incubated with 
ABC peroxidase complex for 1 hour at room temperature and stained with DAB 
and H2O2. The reaction was enhanced by adding cobalt/nickel to the DAB 
mixture. 
Endogenous peroxidase (EP) stain: For granulocyte visualisation sections were 
prepared as described in A, but omitting the step 5 and 6. Next, sections were 
incubated with 0.1% biotinylated tyramide (in 0.1M PBS) in 0.01% hydrogen 
peroxide for 10 minutes. Sections were then incubated with ABC peroxidase 
complex for 1 hour at room temperature. Sections were then stained with DAB 
and H2O2.  
Blood samples: Blood samples taken from rats were spread onto a slide. Slides 
were left to dry and then mounted under a glass cover slip using vectashield with 
DAPI, to visualise cellular nuclei. 
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Spleen and livers: Sections were thawed and left to dry on glass slides. Sections 
were mounted under a glass cover slip using vectashield with DAPI, to visualise 
cellular nuclei. 
Table 2: Summary of antibodies and avidin conjugates used. 
  Dilution Source 
 
 
Primary 
Antibody 
ATF3 (Rabbit polyclonal) 1:100 Santacruz 
Biotechnol
ogy 
c-Jun (Rabbit polyclonal) 1:200 Santacruz 
Biotechnol
ogy 
eGFP (Rabbit polyclonal) 1:500 Millipore, 
CA 
GFAP (Rabbit polyclonal)  1:6000 Dako, UK 
IBA1 (Rabbit polyclonal) 1:3000 Wako, 
Germany 
TCR (Rabbit polyclonal) 1:1000 Abcam, UK 
 
Secondary  
Antibody 
Anti-rabbit IgG-Cy3 produced in donkey 1:200 Jackson, 
UK 
Anti-rabbit IgG-Alexa flour 488 produced 
in goat 
1:600 Life 
technologi
es 
Anti-rabbit IgG biotinylated secondary 
antibody made in goat 
1:100 Vector, UK 
Avidin 
conjugates 
Avidin TEXAS red conjugate  1:1000 Jackson, 
UK 
Avidin AMCA conjugate 1:200 Jackson, 
UK 
 
Stains were carried out by me and a BSc/MSc student. 
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Cellular and axonal quantifications  
For cell and axonal quantifications a Nikon Eclipse E600 fluorescent/light 
microscope was used. 
Rat motor cortex cell counts:  
Light microscopy 
Coronal sections through the PBS and Poly I:C injection site in the motor cortex 
were cut in the rostro-caudal direction at 30um thickness. Sections were 
immunostained for IBA1, GFAP, TCR, endogenous peroxidase, c-Jun or ATF3 to 
visualise, microglia, astrocytes, T-cells, granulocytes, c-Jun-positive or ATF3-
positive nuclei, respectively. Cells or nuclei were counted, using four fields of a 
x40 objective, at the injection site, 0.5mm, 1mm, or 2 mm lateral to it. Four tissue 
samples were quantified per animal per stain. The mean counts of the four visual 
fields were calculated per location, i.e. at the injection site or lateral to it (Fig, 13). 
Then the mean per animal and then the mean of the experimental condition were 
calculated. 
 
 
 
 
Figure 13: Cell quantifications in the motor cortex along the injection site (red circles) or 
lateral (+) to it (green circles). Quantifications were carried out at x40 objective lens. Not drawn 
to scale. 
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Fluorescent microscopy 
Coronal sections through the eGFP-virus or GM-CSF-virus injection site in the 
motor cortex were cut in the rostro-caudal direction at 30um thickness. Sections 
containing eGFP-positive cells were fluorescently labelled with Cy3 and/or avidin-
Amca for IBA1, GFAP, TCR, endogenous peroxidase, c-Jun or ATF3 to visualise, 
microglia, astrocytes, granulocytes, T-cells, c-Jun-positive or ATF3-positive 
nuclei, respectively. If visualisation of nuclei was required sections were 
additionally labelled with DAPI. Counts were performed on a fluorescent 
microscope using 340-380 filter for u.v. (DAPI or avidin-AMCA), 450-490 filter for 
green (eGFP), 510-560 filter for red (Cy3). Cells or nuclei were counted, using 
four fields of a x40 objective, at the injection site. Four tissue samples were 
quantified per animal per stain. The mean counts of the four visual fields were 
calculated at the injection site. The mean per animal and then the mean per 
experimental condition were subsequently calculated. 
Rat pyramidal and corticospinal tract cell and axon counts 
Cell counts 
Light microscopy  
Pyramids: Coronal sections trough the pyramids of rats injected with eGFP-virus 
or GM-CSF/eGFP-virus into the motor cortex were cut in a caudo-rostral direction 
at a 30um thickness. Sections through the pyramids were stained for microglia or 
astrocytes. Using one field at x40 objective lens, cells within the pyramids were 
counted. For every stain, three tissue samples five consecutive sections apart 
were quantified per animal. Mean cellular counts of the left or right pyramids were 
calculated per animal per experimental group.  
Corticospinal tract: Spinal cords were dissected from cervical segment 1 to 8. 
Longitudinal horizontal sections through the spinal cords of animals injected with 
eGFP-virus or GM-CSF/eGFP-virus into the motor cortex were cut in an anterior-
posterior direction at a 30um thickness. Sections through the spinal cord were 
stained for microglia or astrocytes. For every stain, three sections through the 
corticospinal tract, around 10 consecutive sections apart were quantified per 
animal. Using 13 fields of a x40 objective lens, cells within the left and right 
corticospinal tracts were counted caudal to cervical segment 1. The mean 
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number of cells counted per field calculated. Then the mean number of cells per 
animal and per experimental condition was calculated. 
Axon counts 
PYRAMIDS AND PYRAMIDAL DECUSSATION 
Light microscopy 
Pyramidal decussation: Coronal sections trough the pyramidal decussation of 
rats with corticospinal tract injury and injected with eGFP-virus or GM-CSF/eGFP-
virus and BDA, 14 days prior to sacrifice, were cut in a caudo-rostral direction at 
a 30um thickness. Sections through the pyramidal decussation were stained for 
BDA. Using x40 objective lens, BDA-positive axons within the whole of the 
pyramidal decussation were counted. Four tissue samples five consecutive 
sections apart were quantified per animal. Mean BDA-positive axons counts in 
the pyramids per field were calculated, then per animal and subsequently per 
experimental group.  
Fluorescent labelling 
Pyramids: Coronal sections trough the pyramids of rats with corticospinal tract 
injury and injected with PBS/BDA or Poly I:C/BDA were cut in a caudo-rostral 
direction at a 30um thickness. Sections through the ipsilateral pyramid were 
stained for BDA using fluorescent avidin-Texas red. Using x40 objective lens, 
BDA-positive axons within the whole of the pyramidal were counted. Four tissue 
samples five consecutive sections apart were quantified per animal. The total 
BDA-positive axons counts in the pyramids were calculated per animal. 
CORTICOSPINAL TRACT 
Light microscopy 
Corticospinal tract: Spinal cords were dissected from cervical segment 1 to 8. 
Longitudinal horizontal sections through the spinal cords of animals with 
corticospinal tract injury and injected with eGFP-virus or GM-CSF/eGFP-virus 
into the motor cortex were collected. Sections were cut in an anterior-posterior 
direction at a 30um thickness. Sections through the spinal cord were stained for 
BDA. 
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Fluorescent labelling 
Corticospinal tract: Spinal cords were dissected from cervical segment 1 to 8. 
Longitudinal horizontal sections through the spinal cords of animals with 
corticospinal tract injury and injected with PBS/BDA or Poly I:C/BDA into the 
motor cortex were collected. Sections were cut in an anterior-posterior direction 
at a 30um thickness. Sections through the spinal cord were fluorescently stained 
to visualise BDA using avidin-Texas red, GFAP-positive astrocytes using Alexa 
flour 488 and nuclei using DAPI.  
For corticospinal tracts analysed using both light and fluorescent microscopy, six 
sections through the corticospinal tract, around 10 consecutive sections apart 
were quantified per animal. Using a x40 objective lens BDA-labelled axons and 
retraction bulbs in the spinal cord, crossing a line on a microscope graticule grid 
every 0.5mm from 4.5mm above (rostral) to 4.5mm below (caudal) to the injury 
site were counted. The middle of the lesion site was taken as point zero. 
Corticospinal tract axon or retraction bulb counts were normalised for the success 
of anterograde labelling in each animal by comparison with the corresponding 
count of labelled axons in the pyramidal decussation or spinal axon counts, 
respectively. 
Adult mouse striatum cell scoring or counts  
Light microscopy 
Coronal sections through the eGFP-virus or GM-CSF-virus injection site in the 
striatum were cut in the rostro-caudal direction at 30um thickness. Sections were 
immunostained for IBA1, GFAP, CD3, endogenous peroxidase and eGFP to 
visualise microglia, astrocytes, T-cells, granulocytes and eGFP-expressing cells. 
The injection site was evaluated using four fields of a x40 objective lens (Fig. 14). 
The injection site was given a score from 0-3 for granulocyte density, local 
reactive microglial density, spread of reactive microglia, phagocytic microglial 
density, amount of necrosis, and astrocyte activation. Alternatively, microglia, 
astrocytes, T-cells and eGFP-positive cells were counted along the injection site. 
Five tissue samples were quantified per animal per stain. The mean counts of the 
four visual fields were calculated. This mean was used to calculate a mean per 
animal and then a mean per experimental condition. 
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Neonate brain scoring 
Light microscopy 
Coronal sections through the hippocampus or lateral ventricles of neonate mice 
injected with eGFP-virus or GM-CSF-virus injections were cut in the rostro-caudal 
direction at 30um thickness. Four sections were collected per animal: two through 
the hippocampus or two through the lateral ventricle. Sections were 
immunostained for IBA1 or eGFP, to visualise, microglia or eGFP-expressing 
cells. Using two fields of a x40 times objective the amount of microglial activation 
or eGFP-expression was scored for each different area of the brain; cortex, white 
matter, septum, striatum, hippocampus, ventricular epithelium, choroid plexus 
and meninges. A score was given for each area of 0 to 3 for the level of microglial 
activation (0 being no cells transduced or no activated microglia and 3 being the 
majority of cells transduced and lots of activated or phagocytic microglia). Mean 
scores of the two visual fields were calculated per location. This mean was used 
to calculate a mean per slide, per animal and then an mean per experimental 
condition. 
Cellular quantifications were performed by me or a BSc/MSc student 
Figure 14: Cell quantifications in the striatum along the injection site (red circles). Quantifications 
were carried out at x40 objective lens. Not drawn to scale. 
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Fluorescent and light microscopy image acquisition 
A Sony 3CCD colour video camera (AVT-Horn, Aachen, Germany) was used to 
obtain 8-bit digital images of the antibody stained sections. Digital micrographs 
of fluorescently labelled sections were taken using Leica TCS SP2 confocal laser 
microscope with x20 or x40 objective for illustrations. The software used was 
Application Suite 2.6.0.7266 (Leica). Images were further edited using Optimas 
6.2 software (Bothwell, WA). 
Image acquisitions were performed by me. 
Statistical analysis 
When two groups were compared a two-tailed, unpaired Student’s t-test. When 
more than two groups were evaluated, statistical analysis was done using 
repeated measures ANOVA or one-way ANOVA followed by post-hoc Tukey or 
Bonferroni corrected test. 
Statistical analyses were performed by Prof Gennadij Raivich or myself. 
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CHAPTER THREE 
Perineuronal Poly I:C can be protective and proregenerative 
in the injured central and peripheral nervous system 
 
Introduction 
Peripheral nervous system (PNS) axons, such as those of the facial nerve, 
regenerate spontaneously after injury, a process that is accompanied by an 
inflammatory response around the neuronal cell bodies. Central nervous system 
(CNS) axons such as the corticospinal tract, however, lack both this spontaneous 
regenerative capacity and the accompanying perineuronal inflammation. 
However, when inflammation is experimentally induced around the cell bodies of 
neurons that project into the CNS there is an increase in axonal regeneration 
following injury. Activating macrophages in the dorsal root ganglion (DRG) via 
injection of Corynebacterium increases regeneration following dorsal rhizotomy 
(central axotomy) (Lu and Richardson, 1991). Similarly, injection of zymosan or 
injury to lens in the eye produces greater retinal ganglion cell (RGC) survival and 
more vigorous axonal regeneration following optic nerve crush (Leon et al., 2000). 
Polyinosinic:polycytidylic acid (Poly I:C), is a synthetic double stranded RNA 
which stimulates innate immunity through Toll-Like Receptor 3 (TLR3) in 
macrophages, dendritic cells, microglia and astrocytes (Alexopoulou et al., 2001; 
Town et al., 2006). Activation of TLR3 signalling has been suggested to induce 
the strongest pro-inflammatory response in human microglia promoting the 
secretion of high levels of IL-12, TNF-α, IL-6, CXCL-10, and IL-10, and the 
expression of IFN-ɣ (Field et al., 2010; Jack et al., 2005). In vivo delivery of Poly 
I:C is associated with the expression of ionised calcium-binding adaptor 
molecule-1 (IBA1) in microglia (Patro et al., 2010). Like microglia, primary 
astrocyte cultures treated with Poly I:C induces a strong proinflammatory 
response (increased expression of inflammatory cytokines) (Bsibsi et al., 2002; 
Bsibsi et al., 2006; Carpentier et al., 2005; Farina et al., 2005; Scumpia et al., 
2005) and the increased expression of glial fibrillary acidic protein (GFAP) 
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(Brahmachari et al., 2006). Poly I:C can also interact with Retinoic acid Inducible 
Gene-1 (RIG-1) receptor which is expressed in neurons (Peltier et al., 2010). 
In addition to the immune role, Poly I:C intraventricular injections in to the rat CNS 
has been associated with decreased motor activity (Patro et al., 2010). Intranigral 
injections trigger nigrostriatal dopaminergic degeneration which is associated 
with the cytoplasmic mislocalization of neuronal TDP-43, a change normally 
observed following peripheral nerve axotomy of motor neurons (Moisse et al., 
2009). Furthermore, there is evidence that Poly I:C may be inhibitory to 
regeneration in vitro. It produces a strong and long-lasting inhibition of neurite 
growth by hippocampal neurons and DRG neurons, probably by acting on TLR3 
expressed on neuronal growth cones (Cameron et al., 2007). However, whether 
its effect on stimulating microglia around the neuronal cell body may overcome 
its direct effects on the growth cones of axotomised neurons has not been 
studied. I therefore decided to stimulate microglia in vivo around injured 
corticospinal neurons, whose axons do not normally regenerate, and facial motor 
neurons, whose axon regenerate vigorously after injury. 
This chapter is divided into three parts: Part 1 explains the preliminary work 
undertaken to find the concentration of Poly I:C required for optimal microglial 
activation. Part 2 evaluates the time-dependent effects of Poly I:C on 
inflammation. Finally, Part 3 demonstrates the effect of Poly I:C on the 
regeneration of corticospinal and facial motor neuron axons. 
 
Results 
Part 1: Titration of Poly I:C 
Poly I:C produces a dose dependent and widespread activation of microglia 
in rat motor cortex 
Microglia, the macrophages of the brain, become activated in response to injury. 
They undergo a sequence of changes in response to neuronal injury. These can 
be divided into stages: resting microglia (Stage 0), state of alert (Stage 1), homing 
and adhesion (Stage 2), phagocytosis in the presence of neuronal cell death 
(Stage 3a), and bystander activation of surrounding non-phagocytic microglia 
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(Stage 3b) (Raivich et al., 1999). The first step in this study was to evaluate the 
effects of Poly I:C on the normally dormant cortical microglia. 
Rats received injections into the left motor cortex of one of three different 
concentrations of Poly I:C: 0.1 mg/ml (n=3), 1 mg/ml (n=3) or 5.6 mg/ml (n=3). As 
an internal control, PBS was injected in the contralateral motor cortex of each 
animal. To analyse effects on microglia, coronal sections through the motor 
cortex were immunostained for IBA1, a calcium-binding protein specifically 
expressed by mononuclear phagocytes (Imai et al., 1996) that is upregulated in 
activated macrophages and microglia (Ito et al., 1998). 
Three days following injection, coronal sections through the Poly I:C-injected 
motor cortex (Fig. 1B, D & F) demonstrated a higher level of IBA1 
immunoreactivity and microglial density than the PBS injected cortex (Fig. 1A, C 
& E). This effect was found at the injection site and 2mm beyond. Following Poly 
I:C injection, microglial morphology changed from the ramified form, typical of the 
quiescent/resting state (Fig. 1A-insert), to the alert/activated type as evident by 
their proximal processes becoming shorter and thicker (Fig. 1B-insert) and to the 
phagocytic state with a rounded amoeboid shape and loss of ramification of their 
distal processes (Fig. 1F-insert). These effects were dose-dependent; microglial 
morphology at the injection site was largely resting at 0.1 mg/ml Poly I:C 
concentration, activated at 1mg/ml and phagocytic at 5.6 mg/ml. Additionally, 
some necrosis could be observed in the motor cortex of animals treated with the 
5.6mg/ml Poly I:C (not shown in figure), but this was absent in animals treated 
with 1mg/ml, despite the presence of microglial activation. Microglia in the PBS-
injected motor cortex were mainly in the ramified, resting state (Fig. 1A, C & E 
inserts), with a few phagocytic microglia/macrophages directly at the site of 
injection. 
To quantify the level and spread of microglial activation following Poly I:C 
treatment, microglia were counted in layers II to V of the motor cortex at the 
injection site and 0.5mm, 1mm, and 2mm lateral to it (Fig. 2). The motor cortex 
was evaluated using x40 objective lens. 
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The effect of Poly I:C on microglial numbers was dose-dependent, and greatest 
close to the injection site. In comparison to the PBS side (Fig. 2A-D blue bars), 
cortex injected with 1mg/ml (Fig. 1C & D; Fig. 2A-D-middle red bars) showed 
significantly higher numbers of microglia per field up to 1mm away from the 
injection site (p<0.004, in a paired student t-test; post hoc to a mixed measures 
ANOVA, Bonferroni corrected). Although higher numbers of microglia were also 
found in animals treated with 5.6mg/ml Poly I:C (Fig. 1E & F; Fig. 2-right red bars) 
and 0.1mg/ml Poly I:C (Fig. 1E & F; Fig. 2-left red bars) this did not reach 
statistical significance compared to PBS-injected cortex. 
After averaging across all the distances (Fig. 2E), a dose response emerged. 
Rats injected with 5.6 mg/ml Poly I:C (Fig. 1F; Fig. 2E-right red bar) had 162±18 
(M±SEM) microglia per visual field, which was significantly higher than 55±19 
microglia sampled following 0.1 mg/ml Poly I:C (Fig. 1B; Fig. 2E-left red bar) 
(p<0.02: post hoc comparison after a mixed measures ANOVA: Bonferroni 
corrected). The PBS-injected motor cortex had 53±3 IBA1-positive microglia 
contralateral to an injection of 5.6mg/ml Poly I:C (Fig. 1E; Fig. 2E-blue right bar), 
which was mildly elevated compared to 31±3 microglia found contralateral to 
injections of 0.1mg/ml Poly I:C (Fig. 1A; Fig. 2E-blue left bar) (p<0.02: post hoc 
comparison after a mixed measures ANOVA: Bonferroni corrected). This shows 
that Poly I:C at 5.6mg/ml acted diffusely; having an effect on microglia even in 
the contralateral motor cortex. 
 
 
Figure 1: Poly I:C produces microglial activation in rat motor cortex in a dose-dependent manner. 
Coronal brain sections of IBA1-immunostained rat motor cortex through the PBS injection sites 
(A,C,E) and  Poly I:C injection sites  (B,D,F) and at concentrations 0.1mg/ml (B), 1.0mg/ml (D), or 
5.6mg/ml (F). Enhanced IBA1 immunoreactivity is present in the Poly I:C-injected cortex 
compared to the contralateral PBS-injected side. Inserts show at higher magnification the 
morphological changes in microglia from resting (B), to reactive (D) to phagocytic states (F). Only 
resting (A) or reactive (C-E) microglia were found in PBS-injected cortex. 
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Poly I:C produces astrocyte activation in the rat motor cortex 
Protoplasmic astrocytes that reside in the grey matter become activated in 
response to injury or inflammation resulting in an increased expression of GFAP 
(Raivich et al., 1999; Tetzlaff et al., 1988a) and a change in morphology so that 
they become more fibrous with characteristically long extended processes 
(Graeber and Kreutzberg, 1986; Graeber et al., 1989; Kreutzberg et al., 1989; 
Raivich et al., 1999). Here we characterised the effect of increasing doses of Poly 
I:C on astrocytes in the rat motor cortex. 
Three days following injection of Poly I:C into the motor cortex (Fig. 3B, D &F), 
GFAP immunoreactivity was higher than in the PBS-injected side (Fig. 3A, C & 
E). The increase in astrocyte reactivity was widespread, being evident more than 
3mm away from the injection site. High magnification images of Poly I:C-injected 
cortex showed that GFAP was more strongly expressed in the cell bodies of 
astrocytes than was the case in the PBS-injected cortex (Fig. 3-inserts). 
Additionally, the cell processes appeared longer in the Poly I:C-injected animals 
than the PBS. 
Figure 2: Poly I:C injection into motor cortex increases microglial density in a dose-dependent 
manner. Graphical representation of microglial numbers at varying distances away from the Poly 
I:C (red bars) and PBS (blue bars) injection sites, n=3 for each concentration. A-D Histograms 
show mean number of Iba1 positive (+) microglia at (A) 0mm (injection site), (B) 0.5mm, (C) 1mm 
and (D) 2mm (+) lateral from the injection site. E: Average microglia number across all distances 
(0mm to 2mm). (*) denotes statistical significance following Bonferroni corrected post hoc 
comparisons to a mixed measures ANOVA. Bars and error bars represent, mean and standard 
error of the mean (SEM). 
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The number of GFAP-positive astrocytes at the injection sites and 2mm lateral to 
it, counted using a x40 objective magnification, was greater following injection of 
Poly I:C at 0.1, 1 and 5.6 mg/ml (Fig. 4A-D red bars) than in the contralateral, 
PBS-injected cortex (Fig. 4A-D blue bars). However, this increase was not 
significant (p>0.004 post hoc comparison after a mixed measures ANOVA: 
Bonferroni corrected).  
Averaging across all the distances from the injection site (Fig. 4E), Poly I:C 
significantly increased the number of astrocytes in the motor cortex. 1mg/ml Poly 
I:C-injected cortex had 43±3 GFAP-positive astrocytes per field and 5.6mg/ml 
had 40±3 astrocytes; both concentrations were significantly higher than the 23±3 
astrocytes seen following 0.1mg/ml (p<0.02: post hoc comparison after a mixed 
measures ANOVA: Bonferroni corrected). The number of astrocytes in the PBS-
injected motor cortex (blue bars), did not significantly increase when rats received 
a contralateral injection of Poly I:C at 5.6mg/ml, 1mg/ml or 0.1mg/ml doses 
(p>0.02: post hoc comparison after a mixed measures ANOVA: Bonferroni 
corrected).  
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 Figure 3: Poly I:C increases GFAP immunoreactivity in rat motor cortex. Rats were injected with 
poly I:C in one hemisphere and PBS in the contralateral hemisphere. Coronal sections through 
the PBS-injected (A,C,E) and Poly I:C-injected (B,D,F) motor cortex at doses of 0.1mg/ml Poly 
I:C (B), 1.0mg/ml Poly I:C (D) and 5.6 mg/ml (F). Inserts show astrocytes with greater GFAP+ 
expression in their cell bodies following Poly I:C rather than PBS injection. 
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Part 2: Time Course 
Microglia activation persists up to 14 days following Poly I:C injection into 
motor cortex 
The overall aim of the project was to determine if Poly I:C-mediated perineuronal 
inflammation is pro-regenerative. Here we examined the timing of microglial 
activation following cortical injections of Poly I:C. A dose of 1mg/ml was chosen, 
as it causes microglial activation without tissue damage, as shown in the previous 
section. Rats were injected with 1mg/ml Poly I:C in the right motor cortex and with 
PBS on the contralateral side, and were allowed to survive 3 (n=3), 7 (n=3), or 14 
(n=4) days following injections.  
Compared to PBS-injected cortices (Fig. 5-right column), the Poly I:C- injected 
(Fig. 5-left column) cortices demonstrated higher levels of IBA1-positive microglia 
at days 3 (Fig. 5A-B), 7 (Fig. 5C-D) and 14 (Fig. 5E-F). However, Poly I:C-treated 
cortices showed a gradual decrease in IBA1 immunoreactivity from day 3 to 14 
(Fig. 5-left column). High magnification images at day 3 revealed that microglia 
Figure 4: Poly I:C injection into motor cortex increases astrocyte density in a dose-dependent 
manner. Graphical representation of astrocyte numbers at varying distances away from the Poly 
I:C (red bars) and PBS (blue bars) injection sites, n=3 for each concentration. A-D Histograms 
show mean number of astrocytes at (A) 0mm (injection site), (B) 0.5mm, (C) 1mm and (D) 2mm 
(+) lateral to the injection site. E: Average astrocyte number across all distances (0mm to 2mm). 
(*) denotes statistical significance following Bonferroni corrected post hoc comparisons to a mixed 
measures ANOVA. Bars and error bars represent, mean and standard error of the mean (SEM). 
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in the Poly I:C-injected cortices had a phagocytic morphology (Fig. 5B-inserts) 
whereas by day 7 the microglia had a reactive morphology(Fig. 5D-inserts). On 
the other hand, by day 14 after Poly I:C injection (Fig. 5F-inserts) microglia 
returned to a more resting type, but retained a higher IBA1 immunoreactivity. The 
PBS-treated cortices had resting microglia at all time-points. 
Using a x40 objective the number of IBA1-positive microglia were counted in four 
fields down the PBS (Fig. 6A-blue bars) and Poly I:C (Fig. 6A-purple bars) 
injection sites. In the Poly I:C-injected motor cortex there was a peak in the 
number of activated microglia per field at day 3 (149±23 microglia per field) which 
was significantly higher than the numbers counted at day 7 (73±3) and day 14 
(46±2) (p<0.05; post hoc comparison to a mixed measures ANOVA). However, 
in the PBS injected cortex microglial numbers remained constant across all time 
points; at day 3 there were 28±3 microglia per field, at day 7 there were 25±2 and 
at day 14 post injection 28±2 were found (p<0.05; post hoc comparison to a mixed 
measures ANOVA). Compared to PBS, Poly I:C injections resulted in significantly 
higher number of IBA1-positive microglia at all time-points. Inflammation 
remained up to 14 days following Poly I:C injection (the maximum time 
examined), as almost twice the number of activated microglia were still present 
at day 14 compared with the contralateral side (p<0.01; Bonferroni corrected post 
hoc comparison following a repeated measures ANOVA).  
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 Figure 5: Inflammation persists up to two weeks following Poly I:C injection to the motor cortex. 
Coronal sections immunostained for IBA1 at 3 days (A-B), 7 days (C-D) and 14 days (E-F) after 
PBS (A,C,E) and Poly I:C (B,D,F) injections to the motor cortex. Poly I:C-treated cortex showed 
greater IBA1 intensity than PBS-treated cortex at day 3 (A-B), 7 (C-D) and 14 (E-F); this difference 
peaks at day 3. (Inserts show reactive microglia gradually returning to the resting state following 
Poly I:C injections whereas microglia were in the resting state at all time-points following PBS 
injections.  
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Poly I:C-induced astrocyte activation is transient 
To evaluated how long astrocyte activation was maintained following Poly I:C 
injections, sections through the rat motor cortex were collected at 3 (n=3), 7 (n=3) 
and 14 (n=4) days after injection of Poly I:C (1mg/ml) into the right motor cortex 
and PBS into the contralateral cortex. Coronal brain sections were subsequently 
immunostained for the astrocyte marker GFAP.  
The Poly I:C-injected cortices were always more strongly GFAP-immunoreactive 
than the contralateral PBS-injected cortices. There was a strong increase in 
GFAP reactivity following Poly I:C injections at day 3 (Fig. 7A-B & inserts), and 
moderate at day 7 (Fig. 7C-D & inserts) and 14 (Fig. 7E-F & inserts). At high 
magnification it could be seen that astrocytes had darkly stained cell bodies and 
elongated processes at 3 days (Fig. 7B-insert) post Poly I:C delivery; thereafter 
GFAP intensity at the cell body and the size of the processes appeared to 
decrease (Fig. 7F-inserts). GFAP immunoreactivity of astrocytes remained 
broadly similar at days 3-14 post injection. 
The number of GFAP positive astrocytes per field using a 40x objective were 
quantified at the Poly I:C and PBS (control) injection sites. The number of GFAP 
positive astrocytes per field significantly decreased from days 3 to 14 (p<0.05; 
post hoc comparison to a mixed measures ANOVA) in Poly I:C-injected cortices 
(Fig. 6B-purple bars). Similarly, a time dependent decrease in astrocyte number 
Figure 6: Quantitation of microglia and astrocyte numbers following PBS or Poly I:C injections 
into the rat motor cortex. A-B: Histograms representing the number of microglia per field (A) or 
astrocytes per field (B) at 3 (n=3), 7 (n=3) and 14 (n=4) days post injection. (*) p<0.01 in a 
Bonferroni corrected post hoc comparison following a mixed measures ANOVA. Bars and error 
bars represent the mean and standard error of the mean (SEM). 
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per field was seen in the PBS-injected cortices (p<0.05; post hoc comparison to 
a mixed measures ANOVA) (Fig.6B-blue bars).  
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Figure 7: Astrocytes were temporarily activated following Poly I:C delivery to the motor cortex. 
Coronal sections stained for GFAP 3 days (A-B: D3), 7 days(C-D: D7) or 14 days (E-F: D14) after 
injection of PBS (left column) or Poly I:C (right column) into the motor cortex. Notice that in 
comparison to PBS, there is strong GFAP expression following Poly I:C at day 3 (B) and moderate 
at day 7 (D) and 14 (F). (A-B) Inserts demonstrate astrocytes at day 3 (A-B) with highly stained 
cell bodies and extended processes, at day 7 (C-D) and 14 (E-F) the intensity and sizes of 
processes decreases. 
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Unlike the persistent microglia activation found following Poly I:C delivery, 
astrocyte activation was transient. At day 3 Poly I:C had 60±2 GFAP-positive 
astrocytes per field, which was higher than the 39±1 astrocytes found in the PBS-
injected motor cortex (p<0.01; post hoc to a mixed measure ANOVA). 
Comparisons between PBS-injected and Poly I:C-injected cortices were not 
significant at days 7 and 14 (Fig. 6B). 
T-cells are recruited to the motor cortex by three days post Poly I:C 
treatment 
To further characterise the inflammatory response to Poly I:C, coronal brain 
sections of rats injected with Poly I:C (1mg/ml) and PBS to the right and left 
hemispheres respectively, were collected at 3 (n=3), 7 (n=3) and 14 (n=4) days 
post injection. Sections were stained for endogenous peroxidase to identify 
granulocytes or T-cell receptor antibody (TCR) to identify T-cells. Granulocytes 
or T-cells were counted in four fields using x40 objective, starting near the surface 
of the cortex and passing progressively deeper. No granulocytes were observed 
at any time points studied following PBS-injection or Poly I:C-injection. 
When sections were evaluated for the presence of T-cells, the Poly I:C-injected 
cortex had 7±2 T-cells per field at day 3 (Fig. 8B & C), which was significantly 
higher than 1±0.1 T-cells found in the PBS-treated cortices (Fig. 8A) (p=0.02, 
post hoc comparison following a mixed measures ANOVA; Bonferroni corrected). 
All other comparisons were not significant. The Poly I:C-injected cortices (Fig. 
8C-purple bars) showed a peak in T-cell recruitment that sharply decline by day 
7 and 14 (p<0.05; post hoc comparison to a mixed measures ANOVA). While the 
PBS-injected cortices (Fig. 9C-blue bars) had some T-cell influx at day 3, T-cells 
were absent at subsequent time points. 
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Poly I:C-induced inflammation does not cause death of corticospinal 
neurons 
In vitro and in vivo models have shown that Poly I:C can be toxic when applied to 
neuronal cultures or brain. To find out whether Poly I:C at 1mg/ml was associated 
with neuronal death four rats received PBS and Poly I:C (1mg/ml) injections to 
the left and right motor cortex, respectively. Corticospinal (CST) neurons were 
retrogradely labelled with fluorogold from the fourth cervical segment of the spinal 
cord. Sections through the motor cortex containing fluorogold-labelled 
corticospinal neurons were fluorescently labelled for IBA1 antibody to visualise 
microglia. Rats survived for seven days post-surgery. 
Quantification of fluorogold-positive CST neurons in layer V of the motor cortex 
and neighbouring IBA1-positive microglia were carried out using a x20 objective. 
The Poly I:C treated group (Fig.9-red bar) had 178±15 IBA1 positive microglia 
per visual field, which was significantly higher than 109±11 found in the PBS 
group (Fig.9- yellow bar) (paired samples student t-test; p<0.05). However, no 
Figure 8: Poly I:C delivery to the rat motor cortex is associated with transient T-cell recruitment. 
A-B: Coronal brain sections through the motor cortex of rats 3 days post PBS (A) and Poly I:C 
(1mg/ml) (B) injections, stained for T-cells using T-cell receptor antibody. C: Histogram 
representing the mean number of T-cells quantified per field using a x40 objective, at 3 (n=3), 7 
(n=3) and 14 (n=4) days following PBS injection to the left cortex (blue bars) and Poly I:C injection 
to the right cortex (purple bars). The Poly I:C-injected cortex has significantly higher T-cells per 
field at day 3 than the PBS-injected cortex. (*) p<0.02 in a post hoc comparison to a mixed 
measures ANOVA; Bonferroni corrected. Bars and error bars represent mean and standard error 
of the mean (SEM), respectively. 
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difference between Poly I:C-injected (110.3±7.3) (Fig. 11-red bar) and PBS-
injected (96.3±9.3) cortices in the number of fluorogold labelled CST neurons per 
field (Fig. 11-red bar: paired samples student t-test; p>0.05). 
 
 
Part 3: Regeneration experiments 
 
Spinal Cord Injury  
Poly I:C has a protective effect on the corticospinal tract following injury 
Since Poly I:C at 1mg/ml causes microglial activation with no significant 
cytotoxicity, we tested its effects on the regeneration of corticospinal axons in 
injured cervical spinal cord. Rats were injected with a mixture of BDA (biotinylated 
dextran amine) and Poly I:C (Poly I:C/BDA: n=4) or BDA and PBS (PBS/BDA: 
n=3) into the motor cortex contralateral to a unilateral transection of the 
dorsolateral spinal cord, which injured the dorsal and lateral corticospinal tract 
(CST) at C4. The animals were allowed to survive 14 days after surgery. Axons 
in the pyramids and in the cervical spinal cord were visualised by fluorescent 
labelling of BDA. 
BDA-positive CST axons in transverse sections of the pyramids were counted 
using two fields of a x40 objective. The Poly I:C-injected group had 252±32 BDA-
labelled axons per field (Fig. 10-blue bar), which was not significantly different 
Figure 9: Poly I:C-mediated inflammation does not cause neuronal cell death. Histogram showing 
the mean number of IBA1-positive microglia and fluorogold-positive corticospinal tract neurons 
(CST) counted per field following injection of  PBS (yellow bars) and Poly I:C (red bars) into the 
motor cortex. Rats (n=4) survived 7 days post-surgery. Notice that Poly I:C and PBS have similar 
number of CST neurons even though there is greater microglia density in the Poly I:C-injected 
cortex (*) p<0.05 significance following a paired samples T-test. Bars and error bars represent 
the mean and standard error of the mean (SEM), respectively.  
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Figure 10: CST axonal density at the pyramids is the same following PBS or Poly I:C injections 
into the motor cortex. Histogram representing the mean number of BDA positive axons per visual 
field in the pyramids (PXY) of rats injected with PBS (n=3; grey bars) or Poly I:C (n=4; blue bars). 
Cortical injections were contralateral to a C4 corticospinal tract injury. There was no difference 
between PBS and Poly I:C groups: p>0.05 unpaired student t-test. 
from the PBS-injected group that had 288±32 per field (Fig. 10-grey bar) 
(unpaired student t-test; p>0.05). This result shows that there was similar success 
in the anterograde labelling of the CST in Poly I:C-injected and PBS-injected 
groups.  
 
 
 
 
 
 
 
Longitudinal horizontal sections through the spinal cord were stained for 
astrocytes (GFAP; Fig. 11A&B in green) to visualise the injury site, and BDA to 
visualize CST axons (Fig. 11A&B in red). In the corticospinal tract of both Poly 
I:C (Fig. 11B) and PBS (Fig. 11A) injected groups, there was evidence of 
successful BDA axonal labelling rostral to the injury site. Axons can be seen to 
reach the injury site in both Poly I:C and PBS groups, with an apparent higher 
density of BDA axons in the Poly I:C injected group than PBS. 
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The number of BDA-labelled axons and retraction bulbs, were quantified at the 
corticospinal tract injury site (0mm), rostrally (-4.5mm to -0.5mm), and caudally 
(0.5mm to 4.5mm) to it using a x40 objective (Fig. 12). Corticospinal tract axonal 
counts in the spinal cord were normalised for the success of anterograde labelling 
in each studied animal with their corresponding count of labelled axons in the 
pyramid. Higher numbers of BDA-positive axons were found in the spinal cord of 
Poly I:C-injected rats (Fig. 12- pink bars) compared to PBS-injected controls (Fig. 
12- blue bars) at the majority of distances rostral to the injury site. However, this 
effect was not significant for any individual distance from the injury site (p<0.05; 
in an unpaired student T-test). No axons were found in the dorsal corticospinal 
tract caudal to the injury site in both groups. 
However, there was an overall effect of Poly I:C treatment independent of 
distance from the injury site. The average number of axons at all distances rostral 
to the injury site was over 30% greater in the Poly I:C-treated group (Fig. 12- 
insert pink bars) compared to PBS-treated controls (Fig. 12- insert blue bars) 
Figure 11: The effect of Poly I:C on corticospinal axons after injury. A-B: Micrographs show 
longitudinal horizontal sections through the spinal cord of rats with a right C4 corticospinal tract 
injury, which received a PBS/BDA (A) or Poly I:C/BDA (B) injection to the motor cortex, 
contralateral to the injury site. The absence of astrocytes (green) permit identification of the injury 
site (*) at the bottom of each image and BDA (red) show axons of the corticospinal tract. 
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(p<0.05; in an unpaired student T-test). This suggest that cortical injections of 
Poly I:C preserves a higher number of axons in the dorsal corticospinal tract 
within the cervical spinal cord after spinal cord injury. 
 
 
 
To further evaluate the axonal response, axonal retraction bulbs which are 
characterised by the accumulation of BDA positivity in the axonal stumps were 
analysed. Retraction bulbs were found rostral to the injury site in both PBS-
treated (Fig.13A) or Poly I:C-treated (Fig.13B) groups. Quantification normalised 
with spinal axon counts, demonstrated that there was a similar number of bulbs 
at every distance rostral to the injury site in both Poly I:C (Fig.13-pink bars) and 
PBS groups (Fig.13-blue bars) (p<0.05; in an unpaired student T-test). In 
addition, irrespective of distance from injury site, the average number of bulbs 
Figure 12: Poly I:C injection to the motor cortex has a protective effect on CST axons following 
injury. Histogram showing the axonal density rostral (-0.5 to -4.5 mm) and caudal (0.5 to 4.5 mm) 
to the corticospinal tract injury site (CSTI). Blue bars represent PBS-injected animals and pink 
bars represent Poly I:C-injected animals. Insert: Histogram showing the axonal density after 
averaging (SUM) the counts for all distances rostral to the injury site. (*) p<0.05 significance in an 
unpaired student T-test. Bars represent the percentage of the ratio between the mean numbers 
of axons in the spinal cord to those in the pyramid. Error bars show the standard error of the mean 
(SEM).  
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found in the Poly I:C (Fig. 13-insert pink bars)-treated animals was not different 
from PBS-treated animals (Fig. 13-insert blue bars) (p<0.05; in an unpaired 
student T-test). 
 
 
Facial Nerve Axotomy 
Poly I:C Accelerates Behavioural Improvement Following Rat Facial Nerve 
Axotomy. 
To further evaluate any effects that Poly I:C may have on axonal regeneration, 
the facial nerve axotomy model was used. Rats injected into the hindbrain with 
PBS (n=5) or Poly I:C (n=5) underwent an ipsilateral facial nerve axotomy. Their 
whisker movement was assessed, from day 7 to 28 post injury. Movement was 
compared to that on the non-injured side and given a score of 0 (no movement) 
to 3 (strong normal movement). To examine reinnervation of the whisker pad, at 
Figure 13: Poly I:C treatment into the motor cortex does not affect axonal retraction in the injured 
corticospinal tract. Histogram represent the retraction bulb density, rostral (-0.5 to -4.5 mm) and 
caudal (0.5 to 4.5 mm) to the corticospinal tract injury site (CSTI), following PBS (blue bars) or Poly 
I:C (pink bars) cortical injections. Insert: Histogram shows the retraction bulb density after averaging 
(SUM) the counts at all the distances rostral to the injury site. Bars represent the number of retraction 
bulbs as a percentage of the number of axons in the spinal cord. Error bars show the standard error 
of the mean (SEM). 
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day 28 rats had fluorogold pads inserted into their control and experimental 
whisker pad for retrograde labelling and then were sacrificed at day 30. 
Functional improvement was observed in PBS (Fig. 14A- blue line) and Poly I:C 
(Fig. 14A- pink line)-injected rats but neither reached full recovery. Poly I:C-
treated rats showed greater recovery than PBS–treated rats at days 9,11, 14, 23, 
26 and 28 (all p<0.05 in an unpaired samples T-test).  
Finally, to evaluate target reinnervation fluorogold labelled facial motor neurons 
were quantified, the percentage fluorogold positive neurons 
(experimental/control) in the Poly I:C (53%±7%) injected rats were somewhat 
different from PBS (46%±1%), but this was not statistically significant (p>0.05 in 
an unpaired samples T-test). 
 
 
Discussion 
The level of perineuronal inflammation around axotomised neurons has been 
correlated with their ability to regenerate axons (Leon et al., 2000; Lu and 
Richardson, 1991; Shokouhi et al., 2010). In this study Poly I:C, a synthetic 
double stranded RNA, was used to enhance inflammation around regeneration-
Figure 14: Poly I:C injection to rat hindbrain led to increased functional recovery after facial nerve 
axotomy. A: Histogram shows the whisker movement assessment score (0-3) at days 7 to 28 
following facial nerve axotomy combined with and Poly I:C (pink line) or PBS (blue line) injections. 
The improvement in functional recovery in Poly I:C-injected compared to PBS-injected animals 
was statistically significant at days 9, 11, 14, 23, 26 and 28. (*) p<0.05 in an unpaired student T-
test. B: Histogram represent the mean number of axons in the injured facial motor nucleus as a 
percentage of the number of neurons at the uninjured facial nucleus of rats injected with PBS 
(pink bar) or Poly I:C (blue bars), which underwent facial nerve axotomy  
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incompetent corticospinal neurons and regeneration-competent facial motor 
neurons and the effects on the neuronal response to axonal injury were 
assessed. In the motor cortex, Poly I:C at 1mg/ml was established as the 
preferred dose, as it was associated with widespread microgliosis and 
astrogliosis, but produced little tissue loss. Temporal analysis of Poly I:C revealed 
a peak in cortical microglial and astrocyte activation, and the recruitment of T-
cells at day 3. Inflammation in the motor cortex was apparent without corticospinal 
neuron cell loss. 
In the rat corticospinal tract and facial nerve injury models Poly I:C mediated a 
protective and a pro-regenerative effect, respectively. Following delivery of Poly 
I:C into the motor cortex and a concomitant C4 dorsal corticospinal tract injury, 
rats demonstrated an overall greater number of CST axons in the cervical spinal 
cord, with little evidence of axonal retraction from the injury site. In rats with facial 
nerve axotomy, Poly I:C injections adjacent to the facial nucleus enhanced the 
regenerative response by accelerating functional recovery, but we did not 
demonstrate an increased number of neurons retrogradely labelled from the 
whisker pad in Poly I:C-injected rats. 
Poly I:C-mediated activation of microglia and astrocytes in the 
motor cortex  
Poly I:C has been shown to mimic the effects of systemic viral infection 
(Cunningham et al., 2007). In the CNS, Poly I:C can be recognised by microglia, 
astrocytes and even neurons, through cell surface or endosomal TLR3 (Bsibsi et 
al., 2002; Bsibsi et al., 2003; Cameron et al., 2007; Jack et al., 2005) and 
cytoplasmic recognition has been postulated to also involve RIG (Peltier et al., 
2010) and MDA-5 (Yoneyama and Fujita, 2010) receptors in neurons and 
astrocytes, respectively. In vitro and in vivo studies have shown that Poly I:C 
exposure results in a signalling cascade that leads to the expression of cytokines, 
chemokines, and oxidative species which are associated with neurodegenerative 
effects (Cameron et al., 2007; Deleidi et al., 2010; Patro et al., 2010). 
We have evaluated the effect of increasing doses (0.1, 1 or 5.6 mg/ml) of Poly 
I:C on cortical microglia and astrocytes. In line with previous in vivo studies, we 
have shown that Poly I:C exposure is associated with a dose-dependent increase 
in numbers of reactive microglia and microglia taking on a phagocytic phenotype 
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by the retraction of their processes. Patro et al.(2010) found that infusion of a low 
dose (0.01 mg/ml) of Poly I:C into the lateral ventricle of rats provoked some 
microgliosis in periventricular areas. In addition, Deleidi et al. (2010) injected 
larger doses (2.5-10mg/ml) of Poly I:C into the substantia nigra, and found a 
dose-dependent effect on microglia. Furthermore widespread neurotoxicity was 
seen when Poly I:C was injected at the highest dose of 10mg/ml (Deleidi et al., 
2010). This is compatible with our results, in which 5.6mg/ml Poly I:C produced 
necrotic areas around the injection site. In addition to the microglial response, 
increased GFAP expression in astrocytes was found in the Poly I:C-injected 
motor cortex. This effect was also reported by Town et al., (2006), where an 
increase in GFAP expression in the mouse cerebral cortex was found after 
intracerebroventricular Poly I:C (50ug/ml) injections. 
At day 3 in our study Poly I:C appeared to have a strong effect on microglia and 
only a mild one on astrocytes, which is contrary to the results reported by Town 
et al. (2006), which showed a greater density of GFAP-positive astrocytes than 
CD11b-positive microglia at 24 and 48 hours post intracerebroventricular 
injections. This discrepancy might be attributable to the use of different species 
(rat vs mouse) and the time-point at which the brains were examined. (Town et 
al., 2006) also used a different marker to detect microglia. The current experiment 
used IBA1 to identify microglia. IBA1 is a marker that can be used to identify 
microglia at all activation states (Ito et al., 1998) but is highly upregulated in the 
reactive and phagocytic states. CD11b, the α-m integrin receptor used to detect 
microglia by Town et al., (2006), is very weakly expressed in the resting state and 
difficult to detect in well-fixed sections, but is strongly upregulated by reactive and 
phagocytic microglia (Kloss et al., 1999). If we had used the more capricious OX-
42 antibody to detect CD11b in our rats, it would have provided a better 
comparison for the results in Town et al., (2006). However, the level of TLR3 
expressed in microglia in vitro (Olson and Miller, 2004) is around six times more 
than that in astrocytes (Carpentier et al., 2005) suggesting that microglia are 
better candidates to respond rapidly to Poly I:C than astrocytes. 
The results from the time course experiments demonstrated that cortical 
microglial and astrocyte activation peaked at day 3 and gradually declined over 
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time, as could be seen at day 7 and 14. However, unlike the effects on astrocytes, 
the effects of Poly I:C on cortical microglia were still present at day 14. This 
pattern is somewhere in between that seen following intraventricular infusion 
(Patro et al., 2010), where the peak was reached at day 7 and effects were gone 
by day 14, and the effect of nigrostriatal injection that peaked at day 12 and were 
still present a month later (Deleidi et al., 2010). This pattern might be explained 
by the differences in delivery method and site of injection, as well as by the doses 
used in the different studies. The dose used in the present study was 3 times 
higher than that used by Patro et al., (2010) and around 6 times lower than Deleidi 
et al., (2010). 
Compared to other agents Poly I:C appears to be a potent inflammatory 
substance with relatively lower cytotoxic effects. Other substances have been 
used in the past to promote perineuronal inflammation. (Hossain-Ibrahim et al., 
2006), used topical application of LPS to the adult motor cortex in rats and found 
weaker, less widespread and less prolonged inflammation than what we can see 
with Poly I:C, disappearing 7 days following application. However, others have 
reported that the effects of Poly I:C may be more transient than those of LPS. 
(Patro et al., 2013) reported that intraperitoneal injections of Poly I:C had acute 
effects whilst those of LPS were chronic. 
Poly I:C is a strong inflammatory substance and can causes necrosis at the 
highest dose; however, when Zymosan was applied to the motor cortex, it caused 
high levels of necrosis (Hossain-Ibrahim et al., 2006). Therefore, Poly I:C can be 
considered a more potent and safer candidate to promote perineuronal 
inflammation than LPS or Zymosan. 
T-cell recruitment to the Poly I:C injection site  
Peripheral immune cell infiltration to the CNS is critical for defence against 
infection and for repair after injury (Hauwel et al., 2005). Three days post Poly I:C 
(1mg/ml) injection we found a surge of T-cells infiltrating the injection site from 
the periphery. Leukocyte recruitment involves the adherence of leukocytes to 
vascular endothelial cells in a 4 step process: 1) the lymphocyte makes transient 
contact with the vascular endothelium, allowing the cell to roll along the 
endothelial cell surface and sample the environment for chemokines. 2) T-cells 
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are activated by chemokines. 3) T-cell activation leads to the increased 
expression of integrins, such as VCAM and ICAM1, which then mediate firm 
arrest of the lymphocyte to the vessel wall. 4) Following T-cell adherence to the 
vascular wall, T-cells migrate across the BBB through the endothelial tight 
junctions (Engelhardt, 2006).  
In vitro studies have shown that upon Poly I:C exposure, microglia and astrocytes 
are able to produce cytokines IL-6 and TNF-α, which are associated with the 
increase in intercellular adhesion molecules (ICAMs) (Furie and Randolph, 1995; 
Wahl et al., 1996), which may help T-cells traversing the walls of blood vessels 
to enter the injection site. In vivo, a peripheral challenge with intraperitoneal Poly 
I:C in mice evokes a global upregulation of a range of chemokines, including 
CXL1 and 2 and CCL2 and 4. The CXC family of chemokines (IL-8/CXCL8, 
CXCL1,2,3,10, MIP-2) attract neutrophils and CC chemokines (MCP-1, MIP1α, 
MIP1β, RANTES), summon monocytes, lymphocytes, eosinophils and basophils 
(Bajetto et al., 2001; Bell et al., 1996; Hausmann et al., 1998). In vitro data shows 
that neonatal and adult microglia produce chemokines MIP1β and RANTES 
(Pattison et al., 2013; Pratt et al., 2013), and astrocytes IL-8 and IP-10 (CXCL-
10) (Park et al., 2006) upon challenge with Poly I:C, which may be involved in the 
T-cell migration seen in this study. In addition to the indirect effects, Poly I:C can 
act on the T-cell TLR3 receptor and lead to their activation (Funderburg et al., 
2008). Poly I:C promotes the production of MIP-1, GMCSF and IL-10 and TGF-β 
by bovine T-cells (McGill et al., 2013). 
Poly I:C and corticospinal neuron death 
Intracerebroventricular (Melton et al., 2003) and systemic (Field et al., 2010) 
administration of Poly I:C is associated with neuronal cell death in various regions 
of the brain. To evaluate the level of toxicity we injected rats with Poly I:C at 
1mg/ml and retrogradely labelled their corticospinal neurons with fluorogold. We 
found that Poly I:C-treated rats showed microglial activation in the motor cortex 
but had similar numbers of fluorogold-positive corticospinal neurons as controls.  
In these retrograde labelling studies the axons of corticospinal neurons were 
injured, which might have promoted axotomy-induced cell death. Reports in rats 
(Barron et al., 1988; Kneubuhl and Steward, 2008; McBride et al., 1989; McBride 
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et al., 1991), hamsters (Barron et al., 1988; Merline and Kalil, 1990; Ramirez and 
Kalil, 1985), and primates (Wannier et al., 2005) show no corticospinal cell death 
following corticospinal tact injury in the spinal cord. Nonetheless, Hains et al., 
(2003) observed substantial apoptotic cell death of corticospinal neurons 7 days 
after injury to the thoracic spinal cord. Field et al., (2010) reported that systemic 
challenge with Poly I:C in mice with a model of Alzheimer’s disease, amplified 
CNS inflammation and exacerbated neuronal cell death in the hippocampus and 
thalamus. The rats in the present study survived 7 days like those reported in 
(Hains et al., 2003). However, there was no exaggerated neuronal cell death 
following Poly I:C injection compared to control rats. 
The effect of Poly I:C on regeneration of the PNS and CNS 
Facial nerve axotomy: regenerative effects of Poly I:C 
In the present study, injection of Poly I:C into the brainstem close to the facial 
motor nucleus of rats accelerated functional recovery following facial nerve 
axotomy. Poly I:C may encourage fast regeneration by enhancing inflammation 
around the neuronal cell bodies. PBS-treated rats did not show complete 
functional recovery following facial nerve axotomy. Heaton et al., (2008) 
determined functional recovery of whisker movements in Wistar rats with facial 
nerve transection by measuring the amplitude and speed of movement occurring 
both spontaneously, as well as following a stimulus (puff of air). At six weeks, the 
measurement for whisker movement of injured rats was 80% lower than that 
achieved by sham injured or intact rats. In the present experiment, the whisker 
movements on the injured side was 70% lower at four weeks post-injury 
compared to the non-injured side. 
Although Poly I:C had a positive effect on functional recovery, it apparently had 
no effect on the number of axons that successfully reinnervate the whisker pad. 
The disparity between the functional and anatomical effects of Poly I:C, may be 
explained by the methodology used to identify a regenerating neurons. 
Fluorogold is a retrograde tracer that can label neurons whose axons have 
formed endplates on muscle fibres and those that have not (Richmond et al., 
1994). Fluorogold labelling cannot resolve small differences in the speed of 
regeneration of axons. In the present study, the fluorogold pad inserted in the 
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whisker pad would label both neurons that have rapidly regenerated their axons 
and formed endplates with the muscles of the whisker pad, and those that are 
more slowly regenerating their axons, have not formed endplates but are in close 
proximity to the whisker pad. Accordingly, it could be that Poly I:C-injected 
animals have regenerated their axons and formed functional endplates with the 
muscle fibres faster than the PBS-injected rats. A better method to evaluate the 
effect of Poly I:C on the speed of regeneration, would  involve examining 
longitudinal sections of facial nerves taken 4 days after axotomy, stained for the 
neuropeptides galanin or calcitonin gene-related peptide (CGRP) that 
accumulate in the growth cones (Makwana and Raivich, 2005). Subsequently, 
the speed of axonal regeneration can be determined by measuring the distance 
travelled by fastest (most distal) growth cone from the crush side. 
Alternatively, Poly I:C may have an effect on axonal branching and muscle 
reinnervation. The facial motor nucleus contains 5 subnuclei; lateral, dorsal, 
intermediate, medial and ventromedial (Kempf and Schwab, 2013; Martin and 
Lodge, 1977; Papez, 1927; Semba and Egger, 1986). The dorsal, lateral and 
intermediate subnuclei contain neurons that extend their axons into the 
zygomatic, buccal and mandibular branches of the facial nerve that control 
movements of the eyelid, whisker and lip movements. Streppel et al., (2002), 
used triple retrograde labelling to estimate the degree of collateral branching of 
axons. They injected retrograde tracers Dil (red) Fluorogold (yellow) and Fast 
Blue (blue) into the zygomatic, buccal and mandibular branches in intact rats, or 
rats with facial nerve axotomy and ligation. In intact rats the motor neurons that 
extend their axons through these branches were not double or triple labelled, 
suggesting that intact neurons send only one unbranched axon to the different 
branches. However, following injury there is around 53% of double or triple 
labelled neurons, suggesting that there is collateral branching following injury. 
Collateral branching has been associated with polyinnervation of neuromuscular 
junctions and the poor functional recovery observed in the rat following peripheral 
nerve injury (Al-Majed et al., 2000a; Zhang et al., 2013).The method described 
by Streppel et al., (2002), could be used to shed light on weather Poly I:C can 
exacerbate or prevent axonal branching following axonal transection. 
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Finally, Poly I:C could have an effect on the number of axons forming connections 
with the muscle fibre. Grosheva et al., (2008) estimated the degree of 
reinnervation of the levator labii superioris muscle, which is the main muscle that 
controls whisker movement in the rat. They counted the number of axons and 
endplates in confocal images of longitudinal muscle sections staining for 
bungarotoxin to visualise motor endplates and neuronal class III β-tubulin to 
visualise intramuscular axons. The same technique could be used to evaluate the 
number of axons innervating endplates following Poly I:C injection into the 
hindbrain of rats with an ipsilateral facial nerve axotomy. 
Corticospinal tract injury: protective effects of Poly I:C 
The corticospinal tract relays instructions for voluntary movements. Following 
injury the corticospinal tract cannot regenerate. To determine whether Poly I:C-
mediated perineuronal inflammation enhances axonal regeneration following a 
dorsal corticospinal tract injury, a mixture of BDA and Poly I:C was injected into 
the motor cortex in adult rats and a contralateral corticospinal tract injury was 
carried out. There were more anterogradely labelled axon in the spinal cord than 
in the pyramids in both Poly I:C-injected and PBS-injected animals. This suggests 
that the corticospinal axons in the pyramids had branched or sprouted in the 
spinal cord. There was a higher axonal density in the spinal cord, rostral to the 
injury site, in the Poly I:C-treated group compared to PBS controls. This effect 
was not explained by differences in the efficacy of anterograde labelling between 
groups, as the number of axons at the level of the pyramids was the same for 
both. Thus it appears that Poly I:C might either protect axons from dying back 
after spinal cord injury or promote axonal sprouting. 
Completely severed axons in the spinal cord undergo retrograde degeneration 
(dieback) (RamonyCajal, 1928). The distance the corticospinal axons retract has 
been reported to increase with time, from approximately 1.4 mm at 1 week and 
4.1 mm at 16 weeks post injury (Seif et al., 2007). Our results somewhat reflect 
this since at 2 weeks post injury the greatest numbers of corticospinal axons were 
found about 2mm from the lesion site. 
Axonal retraction can also be evaluated by counting the number of axonal 
retraction bulbs present at varying levels from the injury site. (RamonyCajal, 
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1928) reported that areas of axonal swelling may be sites of axonal retraction. 
The ends of severed spinal axons develop into spherical swellings known as 
terminal bulbs, which are clearly seen within 1 day after injury and persist many 
months (Fishman and Kelly, 1984a; Pallini et al., 1988; Pasquale-Styles et al., 
2003). Terminal bulbs contain dense accumulations of axoplasmic organelles 
and are surrounded by a fluid filled microcyst, were BDA can be stored. These 
spherical swellings are consistently retracted away from the original site of injury 
after significant time intervals post injury (Borgens et al., 1986; Fishman, 1987; 
Hill et al., 2001; Houle and Jin, 2001; Kalil and Schneider, 1975; Pallini et al., 
1988; Pasquale-Styles et al., 2003). We found that there was no significant 
difference in the numbers of axonal bulbs in Poly I:C-injected rats and PBS-
injected controls.  
As well as axonal degeneration, a weak regenerative response is provoked in 
corticospinal axons following injury without any intervention, in the form of axonal 
sprouting (Li and Raisman, 1995). In the current experiment, rostral to the injury 
site there was a greater number of axons in the Poly I:C-injected than PBS-
injected rats, which may be explained by a greater presence of axonal sprouts in 
the Poly I:C-injected rats. However, the current study did not directly address this 
point due to the methodology employed in axonal counting. To evaluate axonal 
sprouts images can be taken at the level of the lesion, 1mm rostral to lesion and 
4mm rostral to the lesion, for each consecutive sections. A virtual transverse 
plane perpendicular to the CST can then be created for each image and the 
number of CST branches and sprouts intersecting this virtual plane can be 
counted (Schnell and Schwab, 1993).  
It is important to note that Poly I:C has been shown to inhibit neurite growth in 
vitro (Cameron et al., 2007; Leinster et al., 2013) by acting on TLR-3 receptors at 
the growth cone (Cameron et al., 2007). In the present study, the corticospinal 
axons did not regenerate past the lesion even in PBS-treated animals, so it would 
have been difficult to measure any inhibitory effects on regeneration.  
Conclusion 
In this chapter we have demonstrated that injection of Poly I:C to the rat motor 
cortex produces inflammation and glial activation that is dose dependent, and 
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which can be seen up to 14 days following administration. Poly I:C was also found 
to increase the expression of regeneration related transcription factors in nuclei 
that appear to belong to glial cells. In addition to its inflammatory effects, 
injections of Poly I:C into the motor cortex are associated with  an axon-protective 
effect after spinal cord injury. Furthermore, injection of Poly I:C near the 
axotomised facial nucleus enhanced functional recovery after facial nerve injury.
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CHAPTER FOUR 
Characterising the effects of prolonged perineuronal 
inflammation using GM-CSF lentivirus in the rat CNS 
 
Introduction 
Achieving long-distance axonal growth that results in functional recovery after 
central axonal injury remains one of the biggest practical challenges in 
experimental biology. The failure of the CNS to regenerate their axons may be at 
least in part due to CNS neurons mounting a weak, transient or incomplete 
molecular response to axonal injury. This muted response to injury has been 
shown to be associated with low or absent perineuronal inflammation (Shokouhi 
et al., 2010) probably wrong reference. Previous studies aiming to enhance 
axonal regeneration through perineuronal inflammation had a number of 
limitations that may have restricted the extent of axonal regrowth, such as the 
agents used may have not been potent enough inflammogens and their effects 
may have been too transient (Hossain-Ibrahim et al., 2006; Yin et al., 2000). 
An alternative inflammatory agent that could be suitable to promote perineuronal 
regeneration is the cytokine Granulocyte Macrophage-Colony Stimulating Factor 
(GM-CSF). GM-CSF is a potent microglial mitogen (Kloss et al., 1997) which also 
enhances microglial production of the pro-inflammatory cytokines IL1β and 
TNFα, (Kloss et al., 1997). GM-CSF promotes phagocytosis and functional 
antigen presentation by cultured brain-derived macrophages (Giulian and 
Ingeman, 1988) as well as microglia in vivo (McQualter et al., 2001; Mirski et al., 
2003; Ponomarev et al., 2007). In addition to its intrinsic immunological actions, 
recombinant GM-CSF peptide delivered by intraperitoneal injection has been 
shown to be neuroprotective and to promote functional recovery following spinal 
cord injury (Bouhy et al., 2006; Ha et al., 2005; Huang et al., 2009).  
To evaluate the effects of long-term inflammation around neuronal perikarya, a 
non-integrating lentiviral vector expressing GM-CSF was developed for this 
study. The ability of lentiviruses to transduce non-dividing cells, their ease of 
production and the option to change their cell tropism by pseudotyping make 
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them useful gene delivery vectors. However, recent in vivo and clinical trial data 
has highlighted the potential risk of insertion mutagenesis following integration of 
the viral DNA into sensitive areas of the host genome (Hacein-Bey-Abina et al., 
2003). The concern surrounding insertional mutagenesis has naturally led to 
interest in using non-integrating lentiviruses, by introducing class 1 mutations into 
the integrase gene. The result is a failure of vector DNA to integrate so that it 
exists episomally in a functional double-stranded circular form produced by host 
nuclear enzymes.  
The following chapter is divided into three parts: Part 1: shows the successful in 
vitro expression of lentiviral genes, GM-CSF and enhanced green fluorescent 
protein (eGFP). Part 2: evaluates in vivo the time-dependent effects of high doses 
of GM-CSF non-integrating lentiviruses on the CNS and blood. Part 3: 
demonstrates in vivo the dose necessary to produces optimal microglia activation 
and little cell death in the motor cortex. 
Results 
To determine the effect of prolonged inflammation in the rodent CNS, two viruses 
were created: the experimental encoding for GM-CSF and eGFP (GM-CSF-virus) 
and the control that only encodes for eGFP (eGFP). Figure 1 shows the two 
lentiviral plasmids. The eGFP-virus plasmid used was previously described by 
Yanez-Muñoz et al. (2006); here the spleen focus-forming virus (SFFV) promoter 
drives eGFP expression (Fig. 1A). The GM-CSF plasmid, was created by cloning 
the GM-CSF gene and the xIRES genes between the SFFV and eGFP genes 
(see Methods). Therefore the expression of GM-CSF is driven by SFFV promoter 
and the expression of eGFP is controlled by xiap derived Internal Ribosome Entry 
Site (xIRES) (Fig. 1B).  
To produce the non-integrating lentivirus particles, the lentiviral plasmids (eGFP-
virus or GM-CSF-virus), the non-integrating virus packaging plasmid and the 
vesicular stomatitis virus (VSVG) envelope plasmid were used to transduced 
HEK293T cells, which are required for viral assembly (see Methods). Previous 
research has demonstrated that pseudotyping the lentiviral particle with VSVG is 
associated with efficient gene delivery to neurons (Rahim et al., 2009). 
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Part 1: In vitro studies 
GM-CSF-virus produces expression of eGFP protein in vitro 
The first step of the project was to evaluate whether the GM-CSF-virus can cause 
the production of eGFP. The expression of eGFP permits the identification of 
virally transduced cells. The eGFP-virus has consistently been shown to strongly 
produce expression of eGFP protein in vitro and in vivo (Rahim et al., 2009; 
Yanez-Munoz et al., 2006). To examine whether GM-CSF virus can produce 
eGFP in vitro, six different volumes of GM-CSF-virus or eGFP-virus virus were 
added to HEK293T cells: 0µl, 0.032µl, 0.016µl, 0.08µl, 0.4µl and 2µl. The 
following day the percentage of eGFP-positive cells was measured as well as the 
median fluorescence intensity (MFI), using flow cytometry. 
Delivering increasing volumes of eGFP-virus (Fig. 2-green) or GM-CSF-virus 
(Fig. 2-red) to HEK293T cells increased the percentage of transfected cells and 
the intensity of eGFP fluorescence. In comparison to eGFP-virus, GM-CSF-virus 
displayed a lower level of eGFP fluorescence intensity between 2% and 75% of 
HEK293T cell transfection. 
Figure 1: Schematic representation of the lentiviral plasmid constructs used in the study. A) The 
eGFP lentiviral plasmid (eGFP-virus). In this study this plasmid was used as a control to the 
current GM-CSF virus. B) The GM-CSF lentiviral plasmid, carrying the GM-CSF gene, xIRES, 
and eGFP. SFFV directs the expression of GM-CSF and xIRES permits bicistronic expression of 
eGFP (GM-CSF/eGFP). 
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A viral vector producing GM-CSF enhances microglial proliferation in-vitro  
To test viral vector-mediated production of GM-CSF in vitro; supernatant from 
eGFP-virus or GM-CSF-virus infected HEK 293T cells was applied onto BV2 
microglial cells. As a positive control BV2 cells were separately treated with 
murine GM-CSF recombinant protein. The next day BV2 cells were incubated 
with 3(4,5-dimethythiazol-2-yl)-25-diphenyltetrazolium bromide (MTT) to assess 
cell number and viability, MTT is an insoluble tetrazolic salt that is hydrolysed by 
mitochondrial dehydrogenases to produce an insoluble formazan that has a 
purple colour (van Meerloo et al., 2011). The activity of this enzymes can reflect 
the number of viable cells present. Therefore, if the number of viable cells 
increases this would increase the purple colouring. Here, the amount of formazan 
formation by the viable cells was quantified by measuring the level of light 
absorbance. 
As shown in figure 3, the MTT colometric assay demonstrated no effect of eGFP-
condition medium on BV2 cell proliferation, as the amount of light absorbance 
remained constant (Fig. 3-green bars). In contrast, conditioned medium from 
HEK293T cells transduced with GM-CSF-virus elicited a 1.5-fold increase in light 
absorbance, with half-maximal effect at 1:1000 dilution, which is equivalent to a 
Figure 2: Comparative eGFP expression efficiency of eGFP and GM-CSF viruses in HEK293T 
cells. Five volumes of eGFP (green) or GM-CSF (red) virus was added to HEK293T cells: 0µl, 
0.032µl, 0.016µl, 0.08µl, 0.4µl and 2µl. Using flow cytometry the median fluorescent intensity for 
each vector (Y axis) was measured along with the percentage of infected cells (X axis). The MFI 
of cells transduced by GM-CSF virus is lower than the MFI of cells transduced by the eGFP-virus, 
between 2% and 75% of transfection. 
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viral titre of 100 (TU/ml) (Fig. 3-red bars). Addition of recombinant GM-CSF 
peptide to otherwise untreated BV2 cells, showed a 2.2-fold increase and a half-
maximal effect at 1ng/ml in comparison the control (Fig. 3-blue bars). 
 
 
Part 2: Time course in vivo 
Delivery of GM-CSF-virus to the motor cortex of Sprague Dawley rats 
increases microglial numbers  
Following confirmation that the GM-CSF-virus works in vitro, the next step was to 
analyse whether the virus would work in vivo. To determine the effect of 
prolonged expression of GM-CSF, rat motor cortex was injected with eGFP-virus 
(108 TU/ml) or a mixture of GM-CSF-virus (107 TU/ml) and eGFP-virus (108 
TU/ml) (GM-CSF/eGFP-virus). Rats were allowed to survive for 3 (eGFP n=1 & 
GM-CSF/eGFP n=4), 7 (n=2 & n=4), 14 (n=2 & n=4) or 28 (n=2 & n=4) days after 
viral delivery.  
 
Figure 3: Viral vector-mediated production of GM-CSF causes microglial cell proliferation in vitro. 
Histogram showing the intensity of light absorbance by BV2 cells following treatment with 
conditioned medium (CM) from HEK293T cells treated with increasing concentrations of EGFP 
(green bars) or GM-CSF (red bars) viral vectors. Blue bars represent the effect of increasing GM-
CSF concentrations. GM-CSF condition medium was a more effective mitogen that 30ng/ml GM-
CSF. Bars and error bars represent the mean and standard error of the mean (SEM), respectively. 
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At day three there was little evidence of eGFP-positive cells in the motor cortices 
of animals injected with eGFP-virus or GM-CSF/eGFP-virus. However, at days 7 
(Fig. 4C), 14 (Fig. 4E) and 28 (Fig. 4G), motor cortices injected with eGFP-virus 
(Fig. 4-right column) showed numerous eGFP-positive neurons up to 200µm 
away from the needle track, and normal consistency of injected tissue, In 
contrast, rats injected with GM-CSF/EGFP-virus (Fig 4-left column), revealed a 
high number of eGFP-positive glial-like cells at day 7 (Fig. 4D). However, at days 
14 (Fig. 4F) and 28 (Fig. 4H) there was only a moderate number of eGFP-positive 
cells and evidence of fluid filled spaces at the site of the needle track. 
To quantify the level of viral transduction, eGFP-positive cells were counted in 
layers II to V along the needle track using a 40x objective lens (Fig. 5A). After 
eGFP-virus injection (Fig 5. A-green bars) there was a strong increase in the 
number of eGFP-positive cells per field as time increased. However, this increase 
was more moderate after intracranial delivery of GM-CSF/eGFP-viral mixture (Fig 
5. A-red bars). At each time point, the number of transduced cells present per 
field was considerably less after GM-CSF/eGFP-viral mixture injection to the 
motor cortex than after an eGFP-virus injection. However, this difference did not 
reach statistical significance (p>0.05; unpaired student’s T-test). 
 
Since GM-CSF is a microglial mitogen, the numbers of IBA1-positive microglia 
were counted in sections through the injection sites. At three days after delivery 
of eGFP-virus to the motor cortex (Fig.4A), IBA1-positive microglia demonstrated 
a rounded morphology typical of phagocytic microglia. At 7 (Fig. 4B), 14 (Fig. 4C) 
and 28 days (Fig. 4D) microglia surrounding the numerous green-fluorescent 
cells had a ramified (resting) morphology. However, at day 3 the GM-CSF/eGFP-
injected cortex (Fig. 4E) showed IBA1-positive microglia that had short process 
that is associated with a state of activation. By day 7 (Fig. 4F), the density of 
activated microglia surrounding eGFP-positive cells increased. At 14 (Fig. 4G) 
and 28 (Fig.4H) days post injection of GM-CSF/eGFP virus, most local IBA1-
positive microglia/macrophages showed rounded phagocytic morphology, with 
many densely packed clusters around the injection site. A large number of 
microglial clusters were seen at the boundaries of the of fluid filled spaces and 
Chapter Four 
 
 
154 
tissue, but many spread as far as the white matter of the internal capsule and 
corpus callosum, approximately 100µm away from the eGFP-positive cells.  
IBA1-positive microglia were counted Using a 40x objective lens in four fields 
along the needle track of eGFP (Fig. 5B-green bars) and GM-CSF/eGFP-injection 
sites (Fig. 5B-red bars). Initially, the total numbers of microglial cells at the resting, 
reactive and phagocytic activation states were quantified. Following eGFP-virus 
injection, at day 3 there were 101 microglia per field. However, this increase was 
transient and gradually disappeared at later time points: the eGFP-virus injection 
was associated with 91±4 microglia per field at day 7, 58±18 microglia per field 
at day 14, and 20±15 microglia per field at day 28. In contrast, following injection 
of GM-CSF/eGFP-viral mixture, there were 102±15 microglia per field at day 3, 
151±15 microglia per field at day 7, 155±29 microglia per filed at day 14 and 
158±15 microglia per field at day 28. The GM-CSF/eGFP viral mixture produced 
a significantly higher number of IBA1-positive microglial cells per field than eGFP-
virus at all time-points apart from day 3 (p<0.05; unpaired student’s T-test ). 
To assess the effect of GM-CSF on microglial morphology, the numbers of IBA1-
positive cells that had a round or amoeboid shape (phagocytic microglia) were 
quantified along the injection site. At day 3 the eGFP-virus treated (Fig. 5C-green 
bars) and eGFP/GM-CSF-treated animals (Fig. 5C-red bars), both showed 
phagocytic cells at the injection site. These phagocytes disappeared at later time 
points in the cortices injected with eGFP-virus, but increased in number following 
the GM-CSF/eGFP virus injection. Cortices injected with GM-CSF/eGFP virus 
had 111±21 phagocytic microglia per field at day 14 and 113±24 microglia per 
field at day 28, which was significantly higher than the 23±1 phagocytic microglia 
per field found at 14 days and 4±4 microglia per field counted at 28 days post 
eGFP-virus injection (p<0.05 unpaired student’s t-test).  
Since microglial phagocytes tend to form clusters – defined as 3 or more tightly 
aggregating phagocytes - cluster formation was also examined. Although, there 
was a trend for more clusters per field to be present in GM-CSF/eGFP- injected 
rats (Fig. 5D-red bars) than in those injected with eGFP (Fig. 5D-green bars) at 
days 14 and 28,  this did not reach statistical significance (p>0.05; unpaired 
student’s t-test). 
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GM-CSF-mediated microglial activation is associated with a reduction in 
the numbers of corticospinal neurons  
To examine the potentially toxic effects that GM-CSF-mediated inflammation may 
have on corticospinal neurons, a rat was injected with eGFP-virus (108 TU/ml) to 
the left motor cortex and GM-CSF/eGFP-virus (107 & 108 TU/ml) to the right motor 
cortex. Corticospinal neurons were retrogradely labelled with fluorogold from the 
fourth cervical segment of the spinal cord. Coronal brain sections containing 
fluorogold-labelled corticospinal neurons (Fig. 6A & B-gold) were fluorescently 
stained for IBA1 to visualise microglia (Fig. 6 A & B-red). 
 
Figure 5: Quantitation of microglial and eGFP-positive cell numbers following eGFP- or GM-
CSF/eGFP- virus injections to the motor cortex. A-D: Histograms representing the number of 
eGFP-positive (+) cells per field (A), total microglia per field (B), phagocytic microglia per field (C) 
or microglial clusters per field (D), 3, 7, 14, or 28 days post eGFP-virus (green bars) or GM-
CSF/eGFP-virus (red bars) injection to the motor cortex. (*) p<0.05; unpaired student’s t-test. Bars 
and error bars represent the mean and standard error of the mean (SEM). 
Figure 4: Long-term expression of GM-CSF-virus increases microglial activation in the motor 
cortex. Coronal brain sections of motor cortex stained for IBA1 (in red), and also showing eGFP-
positive cells (in green), at 3 (A&E), 7 (B&F), 14 (C&G) or 28 days (D&E) following eGFP-virus or 
GM-CSF/eGFP-virus injections. From day 7 to 28, GM-CSF virus increased the number of 
microglia (F-H), but the control virus produced no increment (B-D). The number of eGFP-positive 
cells decreased in cottices injected with GM-CSF virus (F-H), but increased in those injected with 
the control virus (B-D). High magnification inserts, show that rounded microglia can be seen 
surrounding the green cells only at day 28 following GM-CSF virus treatment. Scale Bar: 50um 
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Fourteen days following eGFP-virus delivery (Fig. 6A), there were numerous 
fluorogold-labelled neurons present in layer V of the motor cortex. The IBA1-
positive microglia surrounding these fluorogold-positive neurons had a ramified 
morphology typical of the resting state (Fig. 6A-red). However, the GM-
CSF/eGFP-injected cortex had fewer fluorogold-positive corticospinal neurons 
than the eGFP-virus injected cortex (Fig. 6) but had a higher density of IBA1-
positive phagocytic microglia surrounding the fluorogold-labelled neurons (Fig. 
6B-red). This shows that the delivery of GM-CSF viral vector at this titre to the 
motor cortex was toxic to corticospinal neurons, either by direct effects on 
neurons or via the induction of phagocytic microglia. 
Prolonged exposure to GM-CSF virus increases astrocyte density 
As well as having effects on microglia (Lee et al., 1994), GM-CSF has been 
shown to stimulate the proliferation of astrocytes in primary cultures derived from 
simian brains (Guillemin et al., 1996). To characterise the effects of GM-CSF on 
astrocytes, coronal sections of cortex injected with GM-CSF/eGFP or eGFP 
viruses were examined at 3 (eGFP-virus group n=1 & GM-CSF/eGFP group n=4), 
7 (n=2 & n=4), 14 (n=2 & n=4), and 28 (n=2 & n=4) days post injection. 
Three days following eGFP (Fig. 7A-green) or GM-CSF/eGFP (Fig. 7B-green) 
injections there was no evidence of eGFP positive cells. However, the expression 
of GFAP was higher in the motor cortex of GM-CSF/eGFP-injected rats (Fig. 7B-
Figure 6: GM-CSF viral expression is associated with corticospinal neuron cell death. A-B: Coronal 
sections of IBA1-stained (in red) motor cortex with fluorogold-positive (in gold) neurons through the 
injection sites of eGFP (A) or GM-CSF/eGFP (B) viruses. The GM-CSF/eGFP injected cortex has 
greater numbers of phagocytic microglia but fewer fluorogold-positive neurons. 
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red) than in the motor cortex injected with eGFP (Fig. 7A-red). Longer exposure 
to eGFP-virus (Fig. 7C-green) produced an increase in the number of eGFP-
positive cells that had a neuronal shape. In comparison, the GM-CSF/eGFP-
injected cortex (Fig. 7D-green) had a lower number of eGFP-positive cells and 
they resembled glia rather than neurons. eGFP-injected cortex had few GFAP-
positive astrocytes and these cells had thin processes (Fig. 7C-red & insert). In 
contrast, the GM-CSF/eGFP virus injection (Fig. 7D-red) produced a greater 
density of astrocytes and they demonstrated a hypertrophic appearance with 
thick GFAP-positive processes (Fig. 7D-red insert). In addition, there were clear 
astrocytic scars surrounding areas of tissue damage in the GM-CSF/eGFP 
injected cortex. 
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Using a 40x objective, the number of GFAP-positive astrocytes were counted 
along the eGFP (Fig. 7D-green bars) or GM-CSF/eGFP injection sites (Fig. 7D-
red bars). The number of GFAP-positive astrocytes per field remained constant 
after longer exposure to the eGFP viruses. However, the GM-CSF/eGFP-injected 
motor cortex showed a gradual increase in the number of GFAP-positive 
astrocytes per field. There was a significantly greater number of GFAP-positive 
Figure 7: The effect of long-term expression of GM-CSF on astrocyte activation. A-D: Coronal 
brain sections of motor cortex, showing eGFP-positive cells (in green) and GFAP-positive (red) 
astrocytes, at 3 (A&B) or 28 days (C&D) following injections of eGFP-virus or GM-CSF/eGFP-
virus into the motor cortex. E-F: Histograms representing the number of GFAP-positive astrocytes 
per field (E) or eGFP-positive (+) astrocytes per field (F), 3, 7, 14, or 28 days after injection of 
eGFP-virus (green bars) or GM-CSF/eGFP-virus (red bars) into the motor cortex. (*) p<0.05; 
unpaired student’s t-test. Bars and error bars represent the mean and standard error of the mean 
(SEM). 
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astrocytes per field following GM-CSF/eGFP-injections at day 7, 14 and 28 in 
comparison to eGFP-injected brains. The GM-CSF/eGFP-injected cortex showed 
73±4 GFAP-positive astrocytes per field at day 7, 91±10 at day 14 and 90±3 at 
day 28. In contrast there were 44±13 GFAP+ astrocytes per field at day 7, 36±2 
at day 14 and 39±10 at day 28 (p<0.05; unpaired student’s t-test) in eGFP-
injected brains.  
In addition, to find out if astrocytes were being transduced by the viral vectors, 
the number of cells that were both GFAP- and eGFP-positive were counted along 
the eGFP (Fig. 7E-green bars) or GM-CSF/eGFP (Fig. 7E-red bars) injection 
sites. The presence of eGFP-positive astrocytes was evident at 7, 14 and 28 days 
following GM-CSF/eGFP injection to the motor cortex. However, eGFP-positive 
astrocytes were found only at 28 days after eGFP-virus injection. At all time-
points except day 3, the GM-CSF/eGFP-injected motor cortex appeared to have 
more eGFP-positive astrocytes per field than those injected with eGFP. However 
this difference was not significant (p>0.05; unpaired student’s t-test). 
The effect of cortical injection of GM-CSF viral vectors on leukocytes. 
To further evaluate the inflammatory response to GM-CSF granulocytes, T-cells 
and monocytes where counted along the injection sites in brains injected with 
eGFP-virus (108 TU/ml) or GM-CSF/eGFP viral mixture (107 & 108 TU/ml). The 
animals were killed at 3 (eGFP-virus group n=1 & GM-CSF/eGFP group n=4), 7 
(n=2 & n=4), 14 (n=2 & n=4), or 28 (n=2 & n=4) days post injection.  
Granulocyte recruitment 
To identify granulocytes, sections demonstrating eGFP-positive cells (Fig. 8-
green) along the needle tack were fluorescently stained for endogenous 
peroxidase (Fig. 8-red). Three days after injection of eGFP-virus there was a 
strong recruitment of endogenous peroxidase-positive cells to the site of injection 
(Fig. 8A). However, by day 28 post injection the numbers of presumptive 
granulocytes had declined (Fig. 8B). There was also an extensive granulocyte 
influx at 3 days after injection of GM-CSF/eGFP viral mixture (Fig. 8C) but these 
numbers remained high even at day 28 post injection (Fig. 8D). Unlike microglial 
activation, GM-CSF-mediated granulocyte recruitment did not extend far beyond 
the injection sites. 
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These observations were quantified. eGFP-virus injection produced 124 
granulocytes per field at day 3 (Fig. 9A-green bars) but less than one granulocyte 
per field by day 7. At day 14 and 28 there were 2±1 and 4±2, granulocytes per 
field respectively. Like eGFP-virus, GM-CSF/eGFP-virus injection was 
associated with an initial increase and subsequent decrease in granulocyte 
numbers (Fig. 9A-red bars). At day 3 there were 91±7 granulocytes present, this 
number decreased to 12±6 at day 7 and to 5±2 at day 14. At the day 28 time point 
there was a second peak; there were 50±11 granulocytes per field in the GM-
CSF/eGFP-injected motor cortex. In comparison to eGFP-virus, GM-CSF/eGFP-
delivery resulted in a greater granulocyte influx at day 28 (p<0.05; unpaired 
student’s t-test). All other comparisons were not significant. 
 
 
 
Figure 8: GM-CSF increases granulocyte recruitment to the motor cortex. A-D: Coronal brain 
sections of motor cortex stained for endogenous peroxidase (EP) to identify granulocytes (in red), 
and showing eGFP-positive cells (in green), at 3 (A&C) or 28 days (B&D) following eGFP-virus or 
GM-CSF/eGFP-virus injections to the motor cortex. At 28 days there is greater granulocyte 
recruitment to the motor cortex following injection of GM-CSF/eGFP-virus rather than eGFP-virus. 
Chapter Four 
 
 
162 
T-cells recruitment 
To examine the effect of GM-CSF/eGFP-virus on T-cell recruitment, sections 
through the eGFP-virus (Fig. 9B-green bars) and GM-CSF/eGFP-virus (Fig. 9B-
red bars) injection sites were stained for T-Cell Receptor (TCR). As time 
increased, the number of T-cells per field being recruited to the site of eGFP-virus 
injection increased: three days following eGFP-virus injection to the motor cortex 
there were 2±2 T-cells per field and by day 28 there were 22±73 T-cells per field. 
In contrast T-cell recruitment following GMSF/eGFP injection remained constant: 
There were 18±3 T-cells per field at day 3 and 18±6 T-cells per field at day 28. In 
comparison to eGFP control, GM-CSF/eGFP viral mixture delivery to the motor 
cortex showed significantly higher recruitment of T-cells per field at day 3, 
suggesting that there is an earlier T-cell recruitment following GM-CSF/eGFP-
virus injection than eGFP-virus injection. 
 
 
Monocyte recruitment 
Following GM-CSF/eGFP treatment to the motor cortex there was an abundant 
presence of IBA1-positive cells that had a rounded shape typical of a phagocytic 
microglia or a peripheral macrophage. To evaluate whether macrophages are 
being derived from the periphery, the effect of GM-CSF/eGFP on blood-derived 
monocytes recruitment to the motor cortex was assessed. Twenty-four hours 
Figure 9: Quantitation of granulocytes and T-cell number following eGFP- or GM-CSF/eGFP- 
injections to the motor cortex. A-D: Histograms representing the number of granulocytes per field 
(A), or TCR-positive T-cells (B), at 3, 7, 14, or 28 days after injection of eGFP-virus (green bars) 
or GM-CSF/eGFP-virus (red bars) into the motor cortex. (*) p<0.05; unpaired student’s t-test. Bars 
and error bars represent the mean and standard error of the mean (SEM). 
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prior to perfusion, rats injected with eGFP-virus or GM-CSF/eGFP-virus received 
an intravenous injection of fluorospheres (10ul/g), which are red fluorescent 
spheres that can be phagocytosed by circulating monocytes. To distinguish 
between failed (Fig. 10 A) and successful (Fig. 10 B) intravenous injections, 
transverse sections through the spleen were taken and examined for 
fluorosphere presence. Only rats with successful fluorosphere delivery were 
examined at 3 (eGFP-virus n=0 & GM-CSF/eGFP-virus n= 3), 7 (n=1 & n= 2), 14 
(n=2 & n=2), or 28 (n=2 & n=3) days post eGFP-virus or GM-CSF/eGFP 
intracranial injections. 
First, the total number of leukocytes in the blood was measured by counting 
DAPI-positive nuclei using a 40x objective lens along the midline of blood smears 
of eGFP-virus or GM-CSF/eGFP-virus injected rats. Leukocytes were divided into 
two groups according to the shape of the nucleus: multilobulated nuclei 
corresponded to granulocytes (Fig. 10C-blue) and rounded nuclei belonged to 
monocytes/lymphocytes (Fig. 10D-blue). Following eGFP-virus (Fig. 10E-blue 
line) or GM-CSF/eGFP-virus (Fig. 10E-pink line) cortical injections, there were 
more monocytes/lymphocytes per field in the blood than granulocytes at all time-
points. In addition, the percentage of monocytes/lymphocytes and granulocytes 
in the blood remained essentially unchanged across all time points post eGFP-
virus or GM-CSF/eGFP-virus injections. 
Next, the number of fluorospheres that were in close proximity to the nuclei of 
granulocytes or monocytes/lymphocytes (i.e. incorporated by the corresponding 
cell) were counted. It was observed that in both the eGFP and GM-CSF/eGFP 
groups, monocytes/lymphocytes (Fig. 10D-red) rather than granulocytes (Fig. 
10C-red) avidly phagocytosed fluorospheres. 
Fewer fluorospheres were incorporated by monocytes/lymphocytes as time 
passed in eGFP-virus injected rats. There were 20%±20% of 
monocyte/lymphocytes with an incorporated fluorosphere per field at day 14 but 
by day 28 there was no evidence of fluorosphere incorporation (Fig. 10G-blue 
line). In contrast, GM-CSF/eGFP-virus injection showed an initial decrease in the 
percentage of monocytes/lymphocytes that had incorporated fluorospheres from 
day 3 to 7 (Fig. 10G-pink line), then at day 14 and 28 there was an increase in 
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the percentage of monocyte/lymphocytes showing fluorosphere incorporation. 
Fluorospheres had been incorporated into 44%±12% of monocytes/lymphocytes 
per field at day 14 and 32%±32% at day 28. Nonetheless, there was no significant 
difference at day 14 and 28 (p>0.05; unpaired student’s t-test) between the 
percentage of monocyte/lymphocytes that had incorporated fluorospheres 
between the eGFP and GMCSF/eGFP groups. 
With regard to the non-incorporated fluorospheres, eGFP-virus injection was 
associated with an increasing percentage of free-floating fluorospheres per field 
as time increased (Fig. 10F-blue line). In contrast, across all time points the 
percentage of non-incorporated fluorospheres in the blood remained essentially 
unchanged in rats injected with GM-CSF/eGFP-virus at the motor cortex (Fig. 
10F-pink line). Although, in the eGFP group there was a greater percentage of 
free floating fluorospheres at day14 and 28 than in the GM-CSF/eGFP group, this 
difference was not significant (p>0.05; unpaired student’s t-test). 
Finally, monocyte recruitment to the injection site in the motor cortex of rats 
injected with eGFP-virus (Fig. 10H-blue line) or GM-CSF/eGFP-virus (Fig. 10H-
pink line) was determined by counting the number of fluorospheres co-localising 
with amoeboid-shaped IBA1-positive cells. The delivery of GM-CSF/eGFP-virus 
to the motor cortex failed to provoke the recruitment of IBA1-
positive/fluorosphere-positive monocyte to the injection site. Following GM-
CSF/eGFP injection there was around 1 IBA1-positive cell containing a 
fluorosphere per field at 14 and 28 days post virus delivery to the motor cortex, 
which was similar to that observed when eGFP-virus was injected. 
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The inflammatory effect of GM-CSF-virus, injected into the motor cortex, at 
the level of the hindbrain and spinal cord 
As intracortical injections of GM-CSF/eGFP-viral mixture have been found to 
promote microglia activation around corticospinal neurons, the next step was to 
evaluate whether GM-CSF/eGFP-virus can stimulate an inflammatory response 
in the CST, at the level of the pyramids and in the cervical spinal cord.  
Rats injected with eGFP-virus (108 TU/ml) or GM-CSF/eGFP (107 & 108 TU/ml) 
to the motor cortex were allowed to survive for 3 days (eGFP-virus & GM-
CSF/eGFP-virus: n=1 & n=4), 7 days (n=2 & n=4), 14 days (n=2 & n=2) and 28 
days (n=2 & n=4). Coronal sections through the pyramids and longitudinal 
horizontal sections through the spinal cord, where stained for IBA1 to visualise 
microglia or GFAP to visualise astrocytes.  
Microglia 
In the pyramids, corticospinal axons are ipsilateral to their cells of origin. 
Transverse sections through the hindbrain at day 28 showed that eGFP-virus- 
injected rats (Fig. 11A) had fewer IBA1-positive microglia and weaker IBA1 
immunoreactivity in both the ipsilateral (EXP) and contralateral (CON) pyramids 
than did GM-CSF/eGFP-virus- injected rats Fig. 11B).  
The number of IBA1-positive microglia were counted in the control and 
experimental pyramids using a 40x objective lens. Prolonged exposure of eGFP-
virus to the forebrain failed to show an increase in the number of IBA1–positive 
Figure 10: The effect of GM-CSF on blood leukocytes and the recruitment of monocytes to the 
brain. A-H: Rats injected with eGFP-virus or GM-CSF/eGFP-virus into the motor cortex were 
injected i.v. with fluorospheres 24hrs before sacrifice. A-B: Sections through the spleen showing 
the absence (A) or presence (B) of fluorospheres (red) in the spleen, corresponding to a failed or 
a successful fluorosphere injection, respectively. C-D: Cells in the blood smear. Cells were 
identified by the shape of the DAPI-positive nucleus. Lobed nuclei allowed granulocytes(C) to be 
identified and rounded nuclei allowed monocytes/lymphocytes (D to be identified. (E) Line graphs 
representing the percentage of nucleated blood cells per field. (F) The percentage of non-
incorporated fluorospheres in the blood. (G) The percentage of fluorospheres incorporated by 
monocyte/lymphocytes in the blood. (H) The percentage fluorospheres incorporated by IBA1-
positive monocyte in the brain, at 3, 7, 14 or 28 days after injections of eGFP-virus (blue line) or 
GM-CSF/eGFP-virus into the motor cortex (pink line). Data points and error bars represent the 
mean percentage and standard error of the mean (SEM). 
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microglia per field in the control (Fig. 11C-green patterned bars) and experimental 
pyramids as time passed (Fig. 11C-green bars). In contrast, GM-CSF/eGFP-
injection was associated with a gradual increase in the number of IBA1-positve 
microglia per field in both the control (Fig. 11C-red patterned bars) and 
experimental pyramids (Fig. 11C- red bars). 
Across all the time points studied, the GM-CSF/eGFP-group showed a greater 
number of microglia per field in both pyramids than the eGFP-group, but a 
significant difference was only observed at day 14 and 28. In the control 
pyramids, the GM-CSF/eGFP- group had 48±6 (eGFP: 29±4) microglia per field 
at day 14 and 57±10 (eGFP: 27±8) at day 28 whereas in the experiment pyramid, 
there were 61±18 (eGFP: 27±4) microglia per field at day 14 and 71±5 (eGFP: 
29±3) at day 28 (p<0.05; unpaired student’s t-test). 
 
 
 
Figure 11: GM-CSF/eGFP virus increases microglia activation in the control and experimental 
pyramids.  A-B: Coronal brain sections of hindbrain stained for IBA1 showing control pyramid 
(CON) and experimental pyramid (EXP), at 28 days after injection of eGFP-virus (A) or GM-
CSF/eGFP-virus into the motor cortex (B). C: Histogram representing the number of IBA1-positive 
microglia per field in the control (patterned bars) or experimental pyramids (plain bars), at 3, 7, 
14, or 28 days after injection of eGFP-virus (green bars) or GM-CSF/eGFP-virus (red bars) into 
the motor cortex. (*) p<0.05; unpaired student’s t-test. Bars and error bars represent the mean 
and standard error of the mean (SEM).  
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In the spinal cord, the dorsal corticospinal tracts are contralateral to their cells of 
origin. Longitudinal horizontal sections through the cervical spinal cords showed 
the corticospinal tract that is ipsilateral (CON: control) and contralateral (EXP: 
experimental) to the eGFP-virus (Fig. 12A) or GM-CSF/eGFP-virus (Fig. 12B) 
injection site. At 28 days after injection of eGFP-virus, rats had few IBA1-positive 
microglia in the control and experimental corticospinal tracts and there was little 
difference between the two tracts. In contrast, after GM-CSF/eGFP-virus injection 
to the motor cortex, there was higher microglial density in the experimental 
corticospinal tract than in the control corticospinal tract. In comparison to the 
eGFP-virus group, the GM-CSF/eGFP injected rats had more IBA1-positive 
microglia in the control and experimental corticospinal tracts and they were more 
strongly immunoreactive. 
The number of IBA1-positive microglia was counted along the corticospinal tract 
using four fields of a 40x objective lens. As with the pyramids, eGFP-virus at the 
motor cortex had little effect on IBA1-positive microglia in the control (Fig. 10C-
green patterned bars) and experimental corticospinal tracts (Fig. 10C-green 
bars). However, from 3 to 28 days following GM-CSF/eGFP-injection, there was 
a steady increase in the number of IBA1–positive microglia in both the control 
and experimental corticospinal tracts. In comparison to the eGFP-group, the GM-
CSF/eGFP-injected groups had greater microglial density in both corticospinal 
tracts at all time-points and a significant difference was evident at day 14 and 28. 
The experimental corticospinal tracts of the GM-CSF/eGFP treated animals had 
10±0 microglia per field at day 14 and 15±1 at day 28; this was significantly higher 
than the 8±1 microglia per field found at day 14 and 8±0 at day 28 in those 
injected with eGFP-virus to the motor cortex (p<0.05; unpaired student’s t-test). 
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Astrocytes 
Astrogliosis was also evident in the pyramids of animals injected with GM-
CSF/eGFP-virus at the motor cortex, although it was not as pronounced as 
microgliosis. At day 28, rats injected with GM-CSF/eGFP-virus (Fig. 13A) had 
stronger immunoreactivity for GFAP in the control and experimental pyramids 
than did rats injected with eGFP-virus (Fig. 13B). To quantify this effect, GFAP-
positive astrocytes in the control and experimental pyramids were counted using 
a 40x objective lens. The effect of eGFP-virus on the number of GFAP-positive 
astrocytes per field in the control (Fig. 13C-green patterned bars) and 
experimental pyramids was minimal (Fig. 13C-green bars), as there was no 
change in astrocyte density between 3 to 28 days post injection. Rats exposed to 
GM-CSF/eGFP-virus also showed little change with time in the number of GFAP-
Figure 12: GM-CSF/eGFP-virus increases microglial activation in the control and experimental 
corticospinal tracts. A-B: Longitudinal horizontal sections of spinal cords stained for IBA1 showing 
control corticospinal tract (CON) and experimental corticospinal tract (EXP), 28 days after 
injection of eGFP-virus (A) or GM-CSF/eGFP-virus (B) into the motor cortex. C: Histogram 
showing the number of IBA1-positive microglia per field in the control corticospinal tract (patterned 
bars) or experimental corticospinal tract (plane bars), 3, 7, 14, or 28 days after injection of eGFP-
virus (green bars) or GM-CSF/eGFP-virus (red bars) into the motor cortex. (*) p<0.05; unpaired 
student’s t-test. Bars and error bars represent the mean and standard error of the mean (SEM). 
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positive astrocytes per field in the control (Fig. 13C-red patterned bars) and 
experimental pyramids (Fig. 13C-red bars). Nonetheless, GM-CSF/eGFP-
injected rats had a greater number of GFAP-positive astrocytes from day 3 to day 
28 in the control and experimental pyramids. At 28 days post GM-CSF/eGFP 
injections to the motor cortex, the experimental pyramid had 32±3 astrocytes per 
field, which was significantly higher than the 21±2 astrocytes per field present in 
the eGFP-virus injected rats (p<0.05; unpaired student’s t-test). All other 
comparisons were not significant. 
 
 
Astrocyte activation was also evident at the corticospinal tract in the cervical 
spinal cord. At 28 days post GM-CSF/eGFP-injection (Fig. 14B) to the motor 
cortex there was higher astrocyte density and GFAP immunoreactivity in the 
control and experimental corticospinal tracts than eGFP-injected rats (Fig. 14A). 
Quantification of GFAP-positive astrocytes, revealed that EGFP-virus injection 
failed to have an effect on astrocyte activation in the control (Fig. 14C- green 
patterned bars) and experimental corticospinal tracts as time increased (Fig. 14C-
Figure 13: GM-CSF/eGFP virus increases astrocyte activation in the experimental pyramid at 
day 28. A-B: Coronal brain sections of hindbrains stained for GFAP showing the control 
pyramid (CON) and experimental pyramid (EXP), 28 days after injection eGFP-virus (A) or GM-
CSF/eGFP-virus into the motor cortex (B). C: Histogram representing the number of GFAP-
positive astrocytes per field in the control (patterned bars) or experimental pyramids (plane 
bars), 3, 7, 14, or 28 days after injection of eGFP-virus (green bars) or GM-CSF/eGFP-virus 
(red bars) into the motor cortex. (*) p<0.05; unpaired student’s t-test. Bars and error bars 
represent the mean and standard error of the mean (SEM). 
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green bars). In comparison, from day 3 to day 28, GM-CSF/eGFP-injected rats 
had an increasing number of GFAP-positive astrocytes per field in the control 
(Fig. 14C- red patterned bars) and experimental corticospinal tracts (Fig. 14C- 
red bars). Although there were greater numbers of astrocytes per field in the 
control corticospinal tract of the GM-CSF/eGFP injected rats than eGFP-injected 
rats at all of the time points, it was only at day 7 that there was a significant effect. 
However, the experimental corticospinal tract showed significantly higher 
numbers of GFAP-positive astrocytes in GM-CSF/eGFP injected rats than it did 
in eGFP-injected rats, at day 7 (GM-CSF= 11±2 vs eGFP= 7±0), 14 (11±1 vs 8±0) 
and 28 (12±2 vs 8±0) (p<0.05; unpaired student’s t-test). 
 
 
Figure 14: GM-CSF/eGFP virus increases astrocyte activation in the control and experimental 
corticospinal tracts. A-B: Horizontal sections of spinal cords stained for GFAP showing the control 
corticospinal tract (CON) and experimental corticospinal tract (EXP), 28 days after injections of 
eGFP-virus (A) or GM-CSF/eGFP-virus into the motor cortex (B). C: Histogram showing the 
number of GFAP-positive astrocytes per field in the control corticospinal tract (patterned bars) or 
experimental corticospinal tract (plain bars), 3, 7, 14, or 28 days after injections of eGFP-virus 
(green bars) or GM-CSF/eGFP-virus (red bars) into the motor cortex. (*) p<0.05; unpaired 
student’s t-test. Bars and error bars represent the mean and standard error of the mean (SEM). 
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Part 3: Dose response 
Increasing dose of GM-CSF virus increases cell death and microglial 
proliferation, and decreases the number of surviving transduced cells  
The time course experiments have demonstrated that injecting GM-CSF virus at 
107 TU/ml successfully increases perineuronal inflammation. However this effect 
is associated with substantial tissue damage and corticospinal neuron loss. 
Therefore, the next step was to find a concentration that causes moderate 
microglia activation and little tissue damage. 
Rats received intracranial injections of eGFP-virus at 108 TU/ml (n=2) or GM-
CSF/eGFP virus mixture at the following dilutions: 103 (GM3: n=2), 104 (GM4: 
n=2), 105 (GM5: n=2), 106 (GM6: n=2), or 107 (n=2) TU/ml. Animals were allowed 
to survive 14 days after injection. Coronal sections through the injection site 
containing eGFP-positive cells were fluorescently stained for IBA1 to visualise 
microglia and for TUNEL, to identify cell death associated with DNA damage. 
Fourteen days following eGFP-virus injection to the motor cortex (Fig. 15A) there 
were very few or no TUNEL positive cells (Fig. 15A- in red), a large number of 
eGFP-positive neurons (Fig. 15A-in green) and no surrounding phagocytic 
microglia (Fig. 15A-in blue). However, delivery of GM-CSF/eGFP at a 
concentration of 107 (TU/ml) to the motor cortex (Fig. 15B) produced fluid-filled 
spaces, a high number of TUNEL-positive cells (Fig. 15B-in red), few eGFP-
positive cells (Fig. 15B- in green) and a high density of phagocytic microglia.  
Using a 40x objective lens, the number of resting, reactive and phagocytic IBA1-
positive microglia (Fig. 15C-all MG) were counted along the injection site. 
Injecting higher doses of GM-CSF/eGFP-virus into the motor cortex, increased 
the number of IBA1-positive microglia per field. Concentrations GM4 (Fig. 15C-
yellow bar), GM5 (Fig. 15C-blue bar) and GM6 (Fig. 15C-purple bar) showed a 
trend towards producing more IBA1 positive microglia than did eGFP-virus (Fig. 
15C-green bar). However, GM7-injected cortices (Fig. 15C-red bar) had a 
significantly higher number of IBA1-positive microglia per field than those injected 
with eGFP, GM3, GM4 and GM5 (p<0.05; Tukey post hoc test to a univariate 
ANOVA). 
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From all the microglia analysed at the injection site, the subpopulation of microglia 
with a rounded morphology, typical of the phagocytic state, were counted 
separately (Fig. 15C-Phagocytic). The number of phagocytic microglia per field 
increased with higher doses of GM-CSF/eGFP-virus. In comparison to eGFP 
(0±0), there was a trend towards more phagocytic microglia per field in the motor 
cortex of rats injected with GM4 (16±6). Concentrations GM5 (27±6) and GM6 
(50±1) produced a greater phagocytic microglia density than did the eGFP and 
GM3 (1±0) groups. Finally, the GM7-injected motor cortex had more phagocytic 
microglia per field (83±112) than did eGFP, GM3, GM4 and GM5 (p<0.05; Tukey 
post hoc test to a univariate ANOVA). 
As well as increasing the number of phagocytic microglia, the presence of higher 
doses of GM-CSF/eGFP-virus also increased the number of TUNEL-positive 
cells (Fig. 15C-TUNEL). Injecting control virus or lower doses of GM-CSF/eGFP 
virus (GM3 to GM5) resulted in a few cells being TUNEL-positive. However, a 
sharp increase in the number of TUNEL-positive cells per field was evident at 
concentrations GM6 (65±26) and GM7 (101±9). Injecting GM6 to the motor cortex 
was associated with a trend towards higher numbers of TUNEL-positive cells per 
field than eGFP (7±2) and GM3 (6±2). A significantly higher number of tunnel-
positive cells per field was found in the cortex of rats injected with GM-
CSF/eGFP-virus at GM7 than in the cortex of eGFP, GM3, GM4 (13±3) and GM5 
(15±1)-injected animals (p<0.05; Tukey post hoc test to a univariate ANOVA).  
The increase in the number of TUNEL-positive cells coincided with a reduction in 
the number of eGFP-positive cells following GM-CSF/eGFP-injections. 
Increasing the concentration of GM-CSF/eGFP virus produced a decrease in the 
number of eGFP-positive cells per field (Fig. 15C-eGFP). There were significantly 
fewer eGFP-positive cells per field in the motor cortex of rats injected with GM4 
(40±7), GM5 (22±6), GM6 (19±4) or GM7 (13±3), when compared to cortex 
injected with eGFP-virus (85±4) (Fig. 13: C-green bar) (p<0.05; Tukey post hoc 
test to a univariate ANOVA). 
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Despite moderate microglial activation, there was little cell death and a low 
number of phagocytic microglia at the GM-CSF 104-105 TU/ml doses; this makes 
them good candidates to investigate effects of inflammation without toxicity. 
 
 
GM-CSF-induced inflammation is evident in the corticospinal tracts 
It has been shown above that 14 days after cortical injections of GM-CSF/eGFP 
there is a dose-dependent increase in cell death and phagocytic microglia in the 
motor cortex. The inflammatory effects of GM-CSF expression in the corticospinal 
tracts in the pyramids and the cervical spinal cord were also studied. Fourteen 
days after intracortical injections of eGFP-virus (108 TU/ml:  n=2) or different 
Figure 15: Dose dependent effects of GM-CSF/eGFP virus in the motor cortex of rats. A-B: 
Coronal brain sections of motor cortex stained for IBA1 (in blue) and TUNEL (in red) and showing 
eGFP-positive cells (in green), 14 days after injection of eGFP-virus (A) or GM7-virus (B) into the 
motor cortex. Bar Scale: 250 C: Histogram representing the number of eGFP-positive cells per 
field, TUNEL-positive nuclei per field, IBA1-positive microglia per field, or IBA1-positive 
phagocytic microglia per field, following cortical injections of eGFP-virus (green bar), or GM-
CSF/eGFP-virus at 103 TU/ml (GM3:grey bar), 104 TU/ml (GM4: yellow bar), 105 TU/ml (GM5: 
blue bar), 106 TU/ml (GM6: purple bar), or 107 TU/ml (GM7: red bar). (*) p<0.05 Tukey post hoc 
test to univariate ANOVA. Bars and error bars represent the mean and standard error of the mean 
(SEM). 
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doses of GM-CSF/eGFP (103 to 107 TU/ml: n=2 per dose), transverse sections 
through the hindbrain and longitudinal horizontal sections through the cervical 
spinal cord were collected. Sections were immunostained for IBA1 to visualise 
microglia. 
Delivery of moderate to high doses of GM-CSF/eGFP virus to the motor cortex 
increased the level of IBA1 immunoreactivity in the control (Fig. 16-CON) and 
experimental (Fig. 16-EXP) pyramids in rats injected with GM5 (Fig. 16B) or GM7 
(Fig. 16C) than those injected with eGFP (Fig. 16A).  
 
To quantify this effect, the number of IBA1-positive microglia were counted in the 
control (Fig. 16D-blue bar) and experimental pyramids (Fig. 16D-pink bar) using 
a 40x objective lens. The experimental pyramid of the rats injected with GM-
CSF/eGFP at doses GM5 (30±3), GM6 (41±4) and GM7 (49±5) had more IBA1-
positive microglia than those injected with eGFP (18±0), GM3 (14±1), GM4 
(18±1) and GM5 (30±3) (p<0.05; Tukey post hoc test to a univariate ANOVA).  
It was noted that there was also an increased microglial density in the control 
pyramid in rats injected with GM-CSF/eGFP-virus at GM6 (27±2) and GM7 (32±2) 
Figure 16: GM-CSF/eGFP-virus increases microglial activation in the control and experimental 
pyramids. A-C: Coronal brain sections of hindbrains stained for IBA1 showing control pyramid 
(CON) and experimental pyramid (EXP), 14 days after injection of eGFP (A), GM5 (B) or GM7 
(C) into the motor cortex (B). D: Histogram representing the number of IBA1-postive microglia per 
field (D) in the control pyramid (blue bars) and experimental pyramids (purple bars), following 
cortical injections of eGFP-virus, or GM-CSF/eGFP virus at 103 TU/ml (GM3), 104 TU/ml (GM4), 
105 TU/ml (GM5), 106 TU/ml (GM6), or 107 TU/ml (GM7). (*) p<0.05 Tukey post hoc test to 
univariate ANOVA. Bars and error bars represent the mean and standard error of the mean 
(SEM). 
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compared to those injected with eGFP-virus (17±3) or GM3 (13±1). (p<0.05; 
Tukey post hoc test to a univariate ANOVA).  
A heightened microglial response was also seen in the corticospinal tract at the 
level of the cervical spinal cord. Horizontal sections through the cervical spinal 
cord of rats injected with GM7-virus into the motor cortex (Fig. 17B) showed 
stronger immunoreactivity for IBA1 in the control and experimental corticospinal 
tracts than those injected with eGFP-virus (Fig. 17A). 
 
To confirm this observation, the number of IBA1-positive microglia were counted 
along the control and experimental corticospinal tracts using a 40x objective lens. 
The control side corticospinal tract in the eGFP group, concentrations GM3 to 
GM7 failed to show any significant difference in the number of IBA1-postive 
microglia compared with eGFP-injected animals (Fig. 17C-blue bars) (p>0.05; 
univariate ANOVA). With regard to the experimental corticospinal tract (Fig. 17C-
purple bars), only rats injected with the GM7 (12±1) dose showed a greater IBA1-
Figure 17: GM-CSF/eGFP virus increases microglial in the corticospinal tracts. A-B: Horizontal 
sections of spinal cords stained for IBA1 showing the control pyramid (CON) and the experimental 
corticospinal tracts (EXP), 14 days after injection of eGFP (A), or GM7 (B) into the motor cortex. 
C: Histogram representing the number of IBA1-postive microglia per field in the control 
corticospinal tract (blue bars) and experimental corticospinal tract (purple bars), following cortical 
injections of eGFP-virus, or GM-CSF/eGFP virus at 103 TU/ml (GM3), 104 (GM4), 105 TU/ml 
(GM5), 106 TU/ml (GM6), or 107 TU/ml (GM7). (*) p<0.05 Tukey post hoc test to univariate 
ANOVA. Bars and error bars represent the mean and standard error of the mean (SEM). 
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positive microglia per field than eGFP–injected animals (8±1) (p<0.05; Tukey post 
hoc test to a univariate ANOVA).  
Discussion 
GM-CSF is a 14.5-35 kDa glycoprotein that exerts its effects on a large variety of 
cells by binding to GM-CSF receptor, which is made of an α-subunit and a β-
subunit (Chiba et al., 1990). GM-CSF induces granulocyte and macrophage 
maturation from myeloid progenitor cells (Francisco-Cruz et al., 2014). It can 
promote the expression of pro-inflammatory cytokines and cytotoxic molecules 
during inflammation (Hamilton, 1993; Hamilton, 2002), but it has also been 
associated with pro-regenerative effects in spinal cord injury models (Bouhy et 
al., 2006; Ha et al., 2005; Huang et al., 2009).The GM-CSF-virus created in this 
study was efficient at expressing GM-CSF and eGFP protein in vitro. In vivo, 
prolonged exposure of rat motor cortex to GM-CSF/eGFP virus at high 
concentration (107TU/ml) was found to produce areas of tissue damage, a 
reduction in the number of eGFP-positive cells, extensive microglial/macrophage 
and astrocyte activation, recruitment of peripheral granulocytes and T-cells to the 
injection site. This was associated with reduced numbers of corticospinal 
neurons. In addition, activation of microglia and astrocytes was seen along the 
corticospinal tracts of rats injected with high doses of GM-CSF in the motor 
cortex. A dose-response experiment was therefore performed to determine a viral 
concentration that resulted in moderate microglial activation with little CNS 
damage. From 103 to 107 TU/ml there was a dose-dependent increase in overall 
microglia density and in the number phagocytic microglia/macrophages, 
correlated with an increase in TUNEL labelling and a decrease in eGFP-positive 
cells. Motor cortex injections with 104-105 TU/ml of GM-CSF virus produced 
moderate microglia activation but little or no cell death and little phagocytosis. 
Therefore, this range of doses makes them good candidates to investigate the 
possible pro-regenerative effects GM-CSF-mediated perineuronal inflammation 
may have in models of spinal cord injury (Nimmervoll et al., 2013; Taylor et al., 
2005). 
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Efficient lentiviral-mediated expression of GM-CSF in vitro 
The GM-CSF-virus in this study was shown to be effective in producing the 
expression of GM-CSF protein in vitro. Application of supernatant from GM-CSF-
virus transfected HEK 293T cells provoked the proliferation of mouse microglia-
derived BV2 cells in a titre-dependent manner. GM-CSF-condition medium was 
a more effective mitogen than 30ng/ml GM-CSF recombinant protein. The 
proliferative effect caused by GM-CSF on BV2-cells, is line with previous studies 
using primary microglial cultures (Giulian and Ingeman, 1988; Kloss et al., 1997). 
Giulian and Ingeman (1988), demostrated that increasing concentrations of 
mouse GM-CSF recombinant protein augmented the number of rat ameboid 
microglia per field. It was also shown that GMCSF was a more potent microglial 
mitogen than M-CSF, G-CSF, IL-1, , IL-2, IL-3, IFN-ɣ and TNF-α. In addtion, Kloss 
et al., (1997), showed that ramified mouse microglia grown on a rat astrocyte 
monolayer proliferated in the presence of mouse GM-CSF in a dose-dependent 
manner.  
 
In the current study the effect of GM-CSF on microglial morphology and function 
in vitro was not specifically analysed. However, other studies have suggest that 
GM-CSF promotes microglial ramification in vitro (Fujita et al., 1996), 
phagocytosis (Giulian and Ingeman, 1988) and antigen presentation (Fischer et 
al., 1993). Fujita et al. (1996), showed that GMCSF facilitated the ramification of 
rat microglia in a mixed brain cell culture. In addition, Giulian and Ingeman (1988) 
showed that cultured rat microglia treated with GM-CSF showed greater 
incorporation of fluorescently labelled microspheres than M-CSF, G-CSF, IL-1, 
IL-2, and FGF. Fischer et al., (1993) showed that microglial cultures of new born 
rats exposed to GM-CSF acquired characteristics of macrophages, such as the 
expression of complement receptor macrophage-1 (MAC-1) and F4/80, which is 
a transmembrane protein found in macrophages. In addition, GM-CSF rather 
than M-CSF was able to efficiently induce antigen-directed proliferation of helper 
T cells in culture.  
Work on BV-2 cells has found that the effect of GM-CSF on microglial proliferation 
is mediated by the JAK/STAT and MAK pathways. Following exposure to GM-
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CSF, BV-2 microglial cells expressed components of the JAK/STAT pathway, 
such as JAK2, STAT5A and STAT5B. In addition, GM-CSF exposure mediated 
the  phosphorylation of MAP kinases, ERK1 and ERK2 in BV-2 cells (Liva et al., 
1999). The expression of JAK2, STAT5A, STAT5B and ERKs are known to be 
important in controlling cellular proliferation (Francisco-Cruz et al., 2014)  
Inflammation and astrogliosis in the motor cortex following 
GM-CSF delivery using a lentiviral vector 
Microglia activation 
The current study shows that the prolonged exposure of GM-CSF-virus in the rat 
motor cortex at a high titre increases the number of IBA1-positive microglia, 
induces a phagocytic phenotype in microglial, and promotes phagocytic 
microglial cluster formation at the injection site and at the borders of fluid filled 
areas. There is limited research specifically evaluating the effect of GM-CSF in 
the cortex of rats. However, support for the finding that GM-CSF produces 
microglial proliferation and activation in vivo comes from Giulian et al. (1988). 
Forty-eight hours following injection of recombinant GM-CSF into the cortex of 
rats, a large number of mononuclear phagocytes were present at the injection 
site. In addition, co-injecting GM-CSF with polystyrene microspheres showed an 
accelerated clearance of polystyrene microspheres from the brain compared to 
rats injected with PBS and polystyrene microspheres. A similar effect was also 
seen following the intracerebral delivery of IL-3 and a less intense effect when M-
CSF or G-CSF was injected. Another study looking at the effect of GM-CSF in 
the cortex of organotypic slice cultures showed that GM-CSF stimulated 
proliferation and migration of small round microglia from a rat cortex slice. These 
cells were positive for CD11b (Ox42), isolectin B4-lectin-binding, the monocyte 
marker ED1 and partially expressed major histocompatibility complex (MHC) II 
(Schermer and Humpel, 2002).  
The present study has shown that high concentrations of GM-CSF may be having 
a toxic effect. In addition to the presence of phagocytic microglia, there is 
apparent tissue damage characterised by the appearance of fluid-filled areas, 
and a reduction in the number of eGFP-positive cells and corticospinal neurons 
present in the motor cortex. Activated microglia are known to contribute to 
secondary damage by releasing cytotoxic molecules. Intracerebroventricular 
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injections of recombinant mouse GM-CSF protein in C57/BL6 mice increased the 
production of pro-inflammatory cytokines TNF-α, IL1-β and IL-6 in the cerebral 
cortex (Reddy et al., 2009). These cytokines have been associated with neuronal 
damage in the CNS. 
Astrocyte activation 
Astrocytes play an important role in the regulation of immune-mediated 
processes in the central nervous system. They are able to proliferate, to form the 
glial scar in astrogliosis, to perform phagocytosis, to express MHC class I and II 
(Aloisi et al., 1992a; Frei et al., 1994; Sawada et al., 1989; Vidovic et al., 1990) 
and to secrete cytokines involved in the inflammatory process (Aloisi et al., 
1992b; Malipiero et al., 1990; Rubio and Sierra, 1993; Sawada et al., 1989). 
The expression of GM-CSF in the rat motor cortex increased astrocyte activation, 
characterised by a change in morphology, GFAP fluorescence intensity and 
astrocyte density. Reddy et al. (2009) showed that following 
intracerebroventricular injections of GM-CSF there was increased expression of 
GFAP mRNA in the brain C57/BL6 mice as well as GFAP immunoreactivity by 
astrocytes in the hippocampus and midbrain. However, it may be that astrocyte 
activation may be mediated by the secretion of inflammatory cytokines by 
microglia rather than GM-CSF directly affecting astrocytes. Microglia secrete 
TNF-α in response to LPS exposure, when murine astrocytes were grown in the 
presence of TNF-α it induced astrocyte activation and the secretion of GM-CSF 
(Malipiero et al., 1990). However, evidence of GM-CSF having a direct effect on 
astrocytes comes from work on simian astrocyte cultures by Guillemin et al., 
(1996). They found that the α-subunit of the GM-CSF receptor is expressed in 
the membrane of cultured simian astrocytes. Furthermore, they demostrated that 
similar to TNF-α and IL-6, GM-CSF stimulated in vitro the proliferation of simian 
astrocytes in primary cultures; this was further confirmed by using an antibody 
against GM-CSF to block proliferation. Nonetheless, little is known about the 
effect of GM-CSF in astrocytes of rats. An in vitro study of rat astrocyte cultures 
would confirm whether GM-CSF expressed by the virus can directly stimulating 
astrocyte proliferation. 
Chapter Four 
 
 
181 
Leukocyte recruitment 
GRANULOCYTES 
The current experiment shows that the GM-CSF attracts large numbers of 
granulocytes to the injection site, which coincides with tissue damage. GM-CSF 
supports the proliferation and survival of granulocytic precursors in the bone 
marrow. GM-CSF potentiates the release of oxygen and nitrogen radical ions, 
and phagocytosis by neutrophils (Bourgoin et al., 1992; Corey and Rosoff, 1989; 
Kumaratilake et al., 1996) and inhibits their apoptosis (Bourgoin et al., 1992; 
Corey and Rosoff, 1989; Kumaratilake et al., 1996). In addition, GM-CSF has 
been found to have a potent effect in inducing the expression on neutrophils of 
receptors for CC chemokines (Cheng et al., 2001). These are cytokines that have 
chemoattractant properties whose main documented role is leukocyte 
recruitment to inﬂammatory sites. 
The recruitment of granulocytes may be due to the direct or indirect effects of 
GM-CSF. GM-CSF-mediated chemotaxis has been demonstrated using transwell 
plates, here human granulocytes have been shown to choose to migrate to a 
chamber containing GM-CSF buffer rather than PBS buffer (Gomez-Cambronero 
et al., 2003). In an in vivo mouse model of intestinal inﬂammation GM-CSF 
neutralisation using antibodies reduced infiltration of neutrophils into the intestine 
(Khajah et al., 2011). However, leucocyte influx into the central nervous system 
is frequently a feature of severe brain pathology. The amount and number of 
different cell types being recruited is dependent on the severity of brain pathology. 
In contrast to slight or indirect injury, direct brain injury, infection and autoimmune 
disease results in granulocyte influx into the brain parenchyma (Holmin et al., 
1998; Popovich et al., 1997). In the current experiment the influx of granulocytes 
to the injected motor cortex might be due to the direct chemotactic effects of GM-
CSF or the secondary brain damage associated with GM-CSF mediated 
inflammation. 
T-CELLS 
There was faster T-cell recruitment to the motor cortex following injection of GM-
CSF-virus than eGFP-virus. GM-CSF is known to be released by activated T-
cells (Ponomarev et al., 2007) and the release of GM-CSF by autoreactive T-cells 
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is required for the onset of experimental autoimmune encephalomyelitis 
(Ponomarev et al., 2007). There is evidence that T-cells contain the GM-CSF 
receptor α-subunit in their cell membrane, but the direct effect of GM-CSF on T-
cells remain elusive (Shi et al., 2006). As GM-CSF can stimulate the production 
of IL-6 and TNF-α by microglia (Reddy et al., 2009), evidence points to GM-CSF 
having an indirect effect on T-cell recruitment. IL-6 and TNF-α can increase ICAM 
expression (Furie and Randolph, 1995; Wahl et al., 1996), which may help T-cells 
to cross blood vessels and enter the injection site. GM-CSF has also been 
reported to induce in microglia the transcription of genes important for T-cell 
chemotaxis (MIP-1α), and antigen processing (MHC II proteins) (Re et al., 2002), 
which suggest that the T-cell recruitment may be mediated by microglia. 
MONOCYTES/MACROPHAGES 
The fluorosphere experiments showed that only a few monocytes/macrophages 
are recruited following GM-CSF injection. Monocytes are hematopoietic cells 
belonging to the myeloid lineage (van Furth et al., 1979). Monocytes originate 
from the bone marrow and seed into the tissue to become tissue specific 
macrophages (Varol et al., 2007). Differentiating between activated microglia and 
monocytes is difficult because microglia do not express unique surface markers. 
The similarity between monocytes and activated microglia has led to the idea that 
microglia are derived from the bone marrow to become brain macrophages 
(Ginhoux et al., 2010). In the adult brain there is recruitment of low numbers of 
haematogenous cells that become microglia in the brain. Using adult parabiotic 
mice, which are mice that have undergone conjoined surgery to share the same 
blood circulation, it was demonstrated that less than 5% of microglia were of 
donor origin at 1 and 12 months post-parabiosis (Ginhoux et al., 2010). However, 
95% of microglia were of host origin and were derived from mesodermal cells 
during development (Alliot et al., 1999; Ginhoux et al., 2010). This may suggest 
that microglia are maintained independently of circulating monocytes throughout 
life. Following GM-CSF-injection to the motor cortex there were very few recruited 
monocytes in motor cortex, which may suggest that the abundant round IBA1-
positive cells present in the motor cortex injected with GM-CSF may be microglia 
that have taken up a phagocytic phenotype. However, in models of intracerebral 
inflammation following experimental contusion injury, it was claimed that there 
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was monocyte/macrophage recruitment to the site of injury (Holmin et al., 1998). 
However, they identified the monocytes/macrophages by staining for ED1 
antigen and ED1 is also a microglial marker (Graeber et al., 1988a). The 
presence of ED1-positivwe cells coincided with that of T-cells. The low number 
of monocytes/macrophages found in the GM-CSF injection site may be due to 
the technique used to visualise macrophages not being sensitive enough. The 
macrophages were recognised as round IBA1-positive cells containing 
fluorospheres. The success rate of injecting fluorospheres intravenously was 
around 70%, which considerably reduced the number of animals per group; this 
reduces the statistical power and could have masked any effects GM-CSF-virus 
may be having on macrophage recruitment. 
The effect of GM-CSF on leukocytes circulating in the blood 
GM-CSF can cross the blood brain barrier. Schaebitz et al. (2008) showed that 
rats injected i.v with iodinated GM-CSF had more radioactivity in the brain than 
those injected with iodinated bovine serum albumin, which suggests that GM-
CSF can cross the intact blood brain barrier. This result was in concordance with 
a previous report that showed the transport of GM-CSF across the blood brain 
barrier (McLay et al, 1997). For this reason it was hypothesised that GM-CSF 
expressed in the motor cortex following injection of the viral vector could have an 
effect on monocytes, lymphocytes or granulocytes circulating in the blood. When 
mouse GM-CSF protein was injected in mice i.v., there was a trend towards more 
monocytes/lymphocytes and neutrophils being present in the blood compared to 
controls (Verdrengh and Tarkowski, 1998). However, rats injected with GM-CSF-
virus into the motor cortex showed no increase in the number of 
monocytes/lymphocytes or granulocytes in the blood when compared to those 
injected with eGFP-virus. In addition, GM-CSF can have an effect on the 
phagocytic activity of monocytes. When monocytes isolated from human 
peripheral blood were grown in serum containing GM-CSF, they increased in size 
and granularity, had increased phagocytic activity, and expressed various 
adhesion molecules, CD14 and major histocompatibility complex (MHC) class II. 
In our study, monocytes/lymphocytes of GM-CSF-injected rats did not show an 
effect on phagocytosis, as the level of fluorosphere incorporation by 
monocytes/lymphocytes in rats injected with GM-CF-virus into the motor cortex 
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was similar to those injected with eGFP-virus. This may be explained by 
presumably low concentrations of GM-CSF protein entering the blood from the 
brain, concentrations which fail to produce a significant increase in the number of 
leukocytes or the phagocytic activity of monocytes/lymphocytes circulating in the 
blood. 
Cell-death is associated with the production of GM-CSF 
Cell death can be characterised by morphological changes in cells, such as DNA 
damage fragmentation (Stoica and Faden, 2010). TUNEL detects DNA 
fragmentation by labelling the terminal end of nucleic acids (Gavrieli et al., 1992). 
Cortical delivery of GM-CSF-virus at high concentrations produced TUNEL-
positive cell death. This is in line with research by Holmin and Mathiesen (2000), 
who evaluated the effect of proinflammatory cytokines IL-1 and TNF-α in the rat 
cerebral cortex. Twenty-four hours after rats received an intracerebral injection of 
IL-1, rather than TNF-α, there was a significantly higher number of TUNEL-
positive cells at the injection site compared to those injected with PBS. In addition, 
when rats were injected with IL-1 rather than PBS, a large number of 
macrophages/phagocytic microglia and T-cells were evident at the injection site. 
The effects of injecting IL-1 into the cerebral cortex returned to baseline at 72 
hours post injection. Holmin and Mathiesen (2000), found that 40% of the TUNEL-
positive cells were neurons, 20% were mononuclear phagocytes was also 
detected, and 5% oligodendrocytes. However, there were no GFAP-positive 
astrocytes that were also TUNEL-positive (Holmin and Mathiesen, 2000). In the 
current study the identity of the dying cells remains to be characterised. It would 
appear that GM-CSF-virus injection to the motor cortex is killing neurons, as a 
reduction in corticospinal neuron number was observed in the GM-CSF-virus 
injection site compared to the eGFP-virus injection site, but whether they were 
dying by apoptosis is unknown. Finally, Holmin and Mathiesen (2000) found that 
the activation of caspase pathway may be promoting TUNNEL-positive cell 
death. Cells that were TUNEL-positive were in the majority also Bax-positive. Bax 
is a molecule of the Bcl-2 family that can directly permeabilise mitochondria, 
which then release cytochrome c from the mitochondrial intermembrane space to 
the intracellular fluid, which in turn can activate caspases leading to the 
fragmentation of DNA resulting in cell death (Oltvai et al., 1993).  
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Microgliosis and astrogliosis along the corticospinal tracts  
Corticospinal neurons have long-range axonal projections to the spinal cord so  
viral transduction of their cell bodies could lead to actions at distant sites along 
the corticospinal tract (Wong et al., 2006). In fact, mice injected with eGFP-virus 
to the motor cortex showed eGFP-protein in corticospinal axons within the spinal 
cord (Rahim et al., 2009). In both the control and experimental pyramidal tracts 
of the hindbrain there was an increase in the number of microglia and astrocytes 
following injections into the motor cortex of GM-CSF-virus rather than eGFP-
virus. The increased microgliosis and astrogliosis in the control pyramid may be 
the product of GM-CSF protein diffusing through the corticospinal fluid from the 
motor cortex to the control corticospinal tract in the pyramid. If this was the case 
then there would be increased inflammation throughout the CNS rather than 
specifically in the corticospinal tracts. To examine this it would be necessary to 
evaluate whether other areas within the control forebrain, hindbrain and spinal 
cord are also show enhanced inflammation. Alternatively, GM-CSF diffusion may 
occur at the level of the hindbrain and spinal cord. The corticospinal tracts from 
the right and left motor cortices remain predominantly segregated before and 
after the pyramidal decussation. Thus the increased inflammation seen within the 
control tract may be explained by GM-CSF travelling along the experimental 
corticospinal axons, being released by those axons and then diffusing from the 
experimental to control pyramid. 
The present study has provided evidence that at high concentrations GM-CSF 
virus cause corticospinal neuron cell death so inflammation in the experimental 
pyramid and spinal cord could have been produced by Wallerian degeneration. 
We found an approximately 50% increase in number of microglia in the control 
pyramid after 107 TU/ml GM-CSF-virus treatment. Microglial activation in the 
experimental corticospinal tract could be causing by-stander activation of 
microglia in the control corticospinal tract through the diffusion of microglial-
derived factors. However, Jacobowitz and colleagues (2012) reported the 
presence of increased microglial reactivity around degenerating axons along the 
length of the experimental corticospinal tract following traumatic brain injury in 
rats. Activated microglia were, however, not observed on the control side. It is 
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thus likely that the microgliosis observed in the control corticospinal tract in our 
study could be due to the GM-CSF diffusion from the experimental to control CST.  
Conclusion 
A non-integrating lentiviral vector that encodes for both GM-CSF and eGFP was 
created. In vitro, the virus led the production of eGFP and bioactive GM-CSF. In 
vivo, injections of high titre GM-CSF virus causes chronic inflammation and 
astrocyte activation in the rat motor cortex which is associated with neurotoxic 
effects. Microglia and astrocyte activation was also observed along the 
corticospinal tract following cortical injections of the virus. Action of GM-CSF in 
the brain and spinal cord appears to be mediated locally without any systemic 
effect on peripheral leucocytes. 
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CHAPTER FIVE 
Mouse strain-dependent neuroinflammatory response to 
lentiviral delivery of GM-CSF: Modelling toxic effects of 
microglia activation 
 
Introduction 
In peripheral tissues, macrophages can be classified in two main groups: 
classically activated macrophages that express pro-inflammatory cytokines 
(TNF-α, IL1-β, IL-12 and IL-6), chemokines (CXCL1, CCL5) and NO (Chhor et 
al., 2013; Colton, 2009; Ransohoff and Perry, 2009). In contrast, alternatively 
activated macrophages are characterized by the release of anti-inflammatory 
cytokines IL-10 and IL-1RA (IL-1 receptor antagonist) (Rutschman et al., 2001). 
Microglia can also acquire diverse activation states or phenotypes known as 
classical activation or alternative activation (Colton, 2009; Schwartz et al., 2006; 
Thored et al., 2009). Classical activation can cause bystander damage in the 
CNS by the production of pro-inflammatory cytokines, while alternative activation 
may be supportive to the CNS by the expression of anti-inflammatory or 
neurotrophic factors (Giunti et al., 2014). 
The role of GM-CSF in the CNS is dual, as it can be proinflammatory and 
protective. GMCSF induces the secretion by microglia of proinflammatory 
cytokines, such as IL1-β and TNF-α (Kloss et al., 1997; Malipiero et al., 1990) 
and promotes phagocytosis and functional antigen presentation in cultured brain-
derived macrophages (Giulian and Ingeman, 1988) as well as microglia in vivo 
(McQualter et al., 2001; Mirski et al., 2003; Ponomarev et al., 2007). In addition, 
GM-CSF can enhance regeneration and functional recovery in models of spinal 
cord injury (Bouhy et al., 2006; Ha et al., 2005; Huang et al., 2009). 
White matter damage in both term and preterm infants is strongly associated with 
motor disabilities in adulthood such as cerebral palsy (Devries et al., 1993). The 
factors that have been identified to cause white matter damage in the immature 
brain include hypoxia, ischemia, infection and/or inflammation (Bell and 
Hallenbeck, 2002; Dammann and Leviton, 1997; Pleasure et al., 2006; Volpe, 
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2009). Inflammation may cause injury to the cerebral white matter via microglial 
activation. Activated microglia can cause white matter injury by the production of 
neurotoxins, nitric oxide and proinflammatory cytokines. During development, 
amoeboid microglia can be found in clusters in the supraventricular corpus 
callosum and are known as fountains of microglia (Del Rio-Hortega, 1932). They 
can be found in the 2nd gestational trimester in humans (Monier et al., 2006; 
Rezaie and Male, 1999), and in mice and rats from a week before to 10 days after 
birth (Brockhaus et al., 1996; Hirasawa et al., 2005; Hurley et al., 1999; Leong 
and Ling, 1992) It has been found that an increase in microglial cell density in the 
cerebral white matter of the human foetus coincides with the peak window of 
vulnerability for periventricular leukomalacia (Billiards et al., 2006; Monier et al., 
2006). Activated phagocytes in the vicinity of vulnerable white matter could play 
an important role in the axonal damage in the foetus and premature neonate 
(Lechpammer et al., 2008; Rezaie and Dean, 2002; Tahraoui et al., 2001; Yoon 
et al., 1997b). 
The use of transgenic mice allows the analysis of mechanisms through which 
GM-CSF may be having its proinflammatory or protective effects in the CNS. This 
chapter evaluates the inflammatory effect of lentiviral-mediated expression of 
GM-CSF in adult mice of one outbred and six inbred strains. In addition, since 
undue perinatal activation of periventricular phagocytes has been suggested to 
result in white matter damage (Wang et al., 2009), the lentiviral delivery of GM-
CSF in the FVB/N mouse strain was chosen to model potential neurotoxic effects 
of inflammatory processes in the immature brain. 
Results 
CD1 mouse-strain shows variable responses to GM-CSF-virus 
Since there is a wide choice of transgenic mutant mice that could help us to study 
the molecular mechanisms of GM-CSF action on the CNS, we wanted to 
investigate the effect of GM-CSF-virus in the mice. This study used two non-
integrating lentiviruses: one that contains GM-CSF and eGFP genes (GM-CSF-
virus), and one with only eGFP (eGFP-virus) (Fig.1A&B). As a starting point, it 
was decided to investigate the effects of eGFP-virus and GM-CSF-virus on the 
comparatively widely-used outbred CD1 mouse strain. CD1 mice were injected 
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with eGFP-virus (107 TU/ml) or GM-CSF-virus (107 TU/ml) into the motor cortex 
and were allowed to survive for 3 days, 7 days, 14 days or 28 days following 
cortical injections. Coronal sections through the motor cortex were 
immunoreacted for IBA1. As seen in figure 1, at 14 days following virus injection 
there was some microglial activation in response to eGFP-virus (Fig. 1C). This 
was not evident in saline-injected controls (not shown). The results were variable 
in mice injected with GM-CSF-virus. A minority (~ ¼) showed small fluid-filled 
areas, clusters of activated microglia and a small number of eGFP positive cells 
(Fig. 1D). In contrast, the majority of mice had no tissue damage, a large number 
of eGFP positive cells and little sign of microglial activation (Fig. 2E). Similar, 
predominantly low level of microglia activation was also observed at other time 
points following GM-CSF-virus injections into the motor cortex (day 3-7 and day 
28) (not shown). 
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Inbred and outbred mice show a strain-dependent response to 
GM-CSF-virus 
To investigated whether the response in this outbred mouse strain was 
representative of all mice. CD1 and six inbred strains: 129S2/Sv, FVB/N, SJL, 
Balb/C, C3H/N, C57/BL6 received striatal injections of GM-CSF-virus at 107 
TU/ml.  
Firstly, it was necessary to establish whether the effect of GM-CSF in mouse CNS 
was reproducible. The 7 strains were injected two months apart in two batches of 
3 animals per strain (42 animals in total). Mice were sacrificed 14 days following 
striatal injections. Coronal sections through the injection site in the striatum were 
stained for microglial IBA1, and granulocyte endogenous peroxidase. Using a 40x 
objective lens, sections through the injection site in the striatum were given a 
score from 0-3 for granulocyte density (Fig. 2A), local reactive microglial density 
(Fig. 2B), spread of reactive microglia (Fig. 2C), phagocytic microglial density 
(Fig. 2D), amount of necrosis (Fig. 2E), and astrocyte activation (Fig. 2F) (0 being 
the lowest score and 3 being the highest). Scores obtained for each strain in 
batch 1 and batch 2 were correlated and the R-squared correlation coefficient 
was taken as a representative for the strength of correlation. 
A high variability and therefore a low correlation was observed between average 
scores obtained for each strain in batch 1 and batch 2 for granulocyte density 
(R2=0.01) and reactive microglia density (R2=0.001) at the GM-CSF-virus 
injection site. However, the inter-batch scores showed a moderate positive 
correlation for necrosis at (R2= 0.33), a strong positive correlation for phagocytic 
microglia (R2= 0.58) and astrocyte density (R2=0.41) at the injection site, and for 
reactive microglia 2mm away from the injection site (R2= 0.51). 
Figure 1: The outbred CD1 mice demonstrate a variable microglial response to GMCSF virus, 
and also respond to eGFP-virus. A-B: Schematic representation of the eGFP-lentiviral (eGFP-
virus) (A) and the GM-CSF-lentiviral plasmid constructs used in the study. C-E: Coronal brain 
sections of motor cortex of CD1-mice stained for IBA1 (red) and also showing eGFP-positive cells 
(green) following eGFP-virus (C) or GM-CSF-virus injection (D-E). The left, middle and right 
pictures correspond to eGFP-virus controls, high-responders (High R), and low-responders (Low 
R) to GM-CSF-virus, respectively.  
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Secondly, inter-strain differences were analysed for the parameters that showed 
good correlation namely; spread of reactive microglia, phagocytic microglia, 
necrosis, and astrocytes activation. This was achieved by averaging the scores 
obtained per parameter for each strain in batch 1 and 2. 
Figure 2: Correlating the effects of GM-CSF-virus injection into the striatum of inbred and outbred 
mice from two separate batches. Scatter plots representing the average score from 0 to 3 given 
for C57/BL6 (black dot), BALB/c (purple dot), FVB/N (green dot), 129S2/Sv (yellow dot), SJL (red 
dot) or CD1 (white dot) mice injected with GM-CSF/eGFP-virus in two separate batches; Batch 1 
and Batch 2. The R2 correlation coefficient shows no correlation for the average scores of 
granulocyte influx (A) and local reactive microglia (B). A good correlation was found for microglia 
spread (C), phagocytic microglia (D), necrosis (E) and astrocytes (F). 
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Fourteen days following injection of GM-CSF-virus into the striatum, there was 
low IBA1-immunoreactivity in the 129S2/Sv strain (Fig. 3C), moderate in C57/BL6 
(Fig. 3A), C3H/N (Fig. 3B) and SJL (Fig. 3F), widespread though moderate in 
BALB/c (Fig. 3E), and high immunoreactivity in the FVB/N strain (Fig. 3G). It was 
observed that the high responder FVB/N-strain (Fig. 3H) had more amoeboid-
shaped IBA1-positive monocytes/macrophages at the GM-CSF-virus injection 
site than the 129S2/Sv-mice, which showed predominantly ramified IBA1-positive 
microglia (Fig. 3D). 
This observation was reflected in the statistical analysis. The FVB/N mouse 
(Mean=3± SEM=0.3) showed more phagocytic microglia per field following 
injection into the striatum of GM-CSF-virus (Fig. 3I-green bar), than the 129S2/Sv 
(0.2±0.1) (Fig. 3I-yellow bar) C57/BL6 (1±0.3) (Fig. 3I-black bar), and SJL mouse 
Figure 3: Inbred and outbred mice show a strain dependent inflammatory response to GM-CSF. 
A-H: Coronal brain sections of the striatum of six different inbred mouse strains (A-C & E-G) 
immunostained for microglial IBA1 at 14 days following injections of GM-CSF-virus. Mouse strains 
showed weak (C), medium (A, B & F), widespread (E), and strong local responses (G). High 
magnification micrographs (H/M) showed that in the high (H) responder strain the microglia were 
of a rounded morphology and more densely packed than in the low responder (D). I-K: 
Histograms representing the average scores given for phagocytic microglia, necrosis or microglial 
spread in the striatum of the outbred and six different inbred strains that received striatal injections 
of GM-CSF-virus. (*) p<0.05 Tukey post hoc test to univariate ANOVA. Bars and error bars 
represent the mean and standard error of the mean (SEM). 
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strains (1±0.2) (Fig. 3I-red bar) (p<0.05; Tukey post hoc test to a univariate 
ANOVA). The enhanced microglial response to GM-CSF-virus in the striatum of 
FVB/N mice was also accompanied with high levels of necrosis. FVB/N (1±0.2) 
had more necrotic areas in the GM-CSF-virus injection site than any other mouse 
strain (p<0.05; Tukey post hoc test to a univariate ANOVA). When the level of 
microglial activation 2mm away from the GM-CSF-virus injection site was studied, 
there was more widespread microglial activation in the BALB/c (1±0.2) strain than 
C57/BL6 (0.3±0.1), 129S2/Sv (0.4±0.1), SJL (0.2±0), C3H/N (0.4±0.1) and CD1 
(0.6±0.2) (p<0.05; Tukey post hoc test to a univariate ANOVA). The 129S2/Sv 
mouse strain (0.2±0.1) had significantly fewer phagocytic microglia than FVB/N 
(3±0.3), BALB/c (2±0.3), C3H/N (2±0.4) and CD1 (2± 0.5) and negligible necrotic 
damage (p<0.05; Tukey post hoc test to a univariate ANOVA). In addition, 
129S2/Sv mice (1.2±0.4) had less astrocyte activation than BALB-c (2±0.2) or 
C57/BL6 mice (3±0.2) (Fig. 3) (p<0.05; Tukey post hoc test to a univariate 
ANOVA). In summary, this study revealed that the inflammatory response to the 
expression of GM-CSF was strain-dependent; low in the 129S2/Sv strain, 
widespread though moderate in BALB/c, and high in the FVB/N strain. 
 
 
Chapter Five 
 
 
194 
 
 
Exploring the effects of different doses of viral GM-CSF in the 
129S2/Sv, BALB/c and FVB/N mouse strains 
Building on the work on mouse strain specific responses to GM-CSF, the 
inflammatory effects of increasing GM-CSF doses in the three most interesting 
strains namely, 129S2/Sv, BALB/c and FVB/N, were examined. Mice received 
striatal injections of a mixture of GM-CSF/eGFP-virus from 103 to 107 (TU/mL) 
(n=3-4 per concentration per strain) or eGFP-virus (108 TU/mL) (n=2-3 per 
concentration per strain). Animals survived for 14 days. Coronal sections were 
immunoreacted for eGFP+ cells, microglia (IBA1), astrocytes (GFAP) and T cells 
(CD4). 
eGFP-positive cells 
There was a trend for the number of eGFP-positive cells to decrease in the 
striatum of FVB/N mice when exposed to high concentrations of GM-CSF/eGFP-
virus. Following eGFP-virus injection to the striatum (CON) of 129S2/Sv (Fig. 5A), 
BALB/c (Fig. 5B) or FVB/N (Fig. 5C) mice, the eGFP-positive cells had a neuronal 
morphology. However, when GM-CSF/eGFP-virus at 107 TU/mL (GM7) was 
injected to the striatum of 129S2/Sv (Fig. 5D), BALB/c (Fig. 5E) or FVB/N (Fig. 
5F) the eGFP-positive cells were glial-shaped. When the number of eGFP-
positive cells were counted along the eGFP-injection site in the striatum there 
were 28±9 eGFP-positive cells per field in 129S2/Sv mice, 14±6 in BALB/c, and 
27±1 in FVB/N (Fig. 5G-eGFP+ cells). In contrast, following injection of GM-
CSF/eGFP 107 TU/mL into the striatum the number of eGFP-positive cells per 
field was similar in BALB/c mice (19±3) and 129S2/Sv mice (19±2), while there 
was a strong decrease in FVB/N mice (4±3). Nonetheless, comparisons did not 
reach statistical significance (p>0.05; univariate ANOVA).  
Figure 4: Astrocyte activation following GM-CSF delivery is mouse strain dependent. The 
129S2/Sv mice (A), showed a lower astrocytic response to GM-CSF expression in the striatum 
compared to BALB/c mice (B). The 129S2/Sv mouse strain showed more GFAP-
immunoreactivity than BALB/c 14 days after injection of the vector. C: Histogram representing 
the average scores given for astrocyte density in the striatum of the outbred and six different 
inbred strains that received striatal injections of GM-CSF-virus. (*) p<0.05 Tukey post hoc test to 
univariate ANOVA. Bars and error bars represent the mean and standard error of the mean 
(SEM). 
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Microglia 
Microglia change morphology in the striatum of 129S2/Sv BALB/c and FVB/N 
mice following GM-CSF/eGFP-virus treatment. Microglia had a reactive 
morphology in the striatum of 129S2/Sv (Fig. 6D) and BALB/c (Fig. 6E) mice, and 
a phagocytic morphology in FVB/N mice (Fig. 6F) following an striatal injection of 
GM-CSF/eGFP-virus at 107 TU/mL (GM7). In contrast, injecting eGFP-virus 
(control) into the striatum of 129S2/Sv (Fig. 6A), BALB/c (Fig. 6B) or FVB/N (Fig. 
6C) mouse-strains resulted in in no microglial activation- the cells maintained a 
resting morphology.  
Figure 5: The FVB/N strain injected with high concentrations of GM-CSF/eGFP-virus shows a 
trend for fewer eGFP-positive cells. A-F: Coronal brain sections of the striatum 14 days after 
injection of eGFP-virus (A-C) or GM7-virus (D-F) immunoreacted for eGFP (visualized with DAB). 
C: Histogram representing the average number of eGFP-positive cell per field following injection 
of eGFP-virus (green bar) or GM-CSF/eGFP-virus a t103 TU/ml (GM3: light grey bar), 104 TU/ml 
(GM4: dark grey bar), 105 TU/ml (GM5: yellow bar), 106 TU/ml (GM6: blue bar), or 107 TU/ml 
(GM7: red bar). Bars and error bars represent the mean and standard error of the mean (SEM). 
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Using a 40x objective, the numbers of IBA1-positive microglial cells with a resting, 
reactive and phagocytic morphology were counted along the injection sites of 
eGFP-virus or GM-CSF/eGFP-virus (Fig. 6G-Total Microglia). 129S2/Sv, BALB-
c or FVB/N mice injected with GM-CSF/eGFP-virus showed a dose-dependent 
increase in the number of IBA1-positive microglia in the striatum (Fig. 6G-Total 
Microglia). 
 
When phagocytic microglia were specifically counted, there was an increase in 
the number of phagocytic microglia with GM-CSF exposure. The striatum of 
129S2/Sv mice or BALB/c mice injected with GM-CSF/eGFP-virus at 107 TU/ml 
had more phagocytic microglia at the injection site than those injected with eGFP 
(p<0.05; Tukey post hoc test to a univariate ANOVA). The FVB/N strain had more 
phagocytic microglia in the striatum following GM-CSF/eGFP-virus at 105 TU/mL 
(GM5) (7±0), 106 TU/mL (GM6) (9±0), or 107 TU/mL (GM7) (21±8) than in eGFP-
injected mice (p<0.05; Tukey post hoc test to a univariate ANOVA), showing that 
microglia in the FVB/N strain change morphology in response to lower viral titres. 
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Astrocytes 
The number of GFAP-positive astrocytes in the striatum of 129S2/Sv, BALB/c 
and FVB/N mice increased in animals injected with GM-CSF/eGFP-virus. There 
was more GFAP immunoreactivity in 129S2/Sv (Fig. 7D), BALB/c (Fig. 7E) and 
FVB/N (Fig. 7F) mice were injected with GM-CSF/eGFP-virus at 107 TU/mL 
(GM7) than those injected with the eGFP-virus (Fig. 7A-C). The number of GFAP-
positive astrocytes increased in a dose dependent manner in 129S2/Sv, BALB/c 
and FVB/N mice following the injection of GM-CSF/eGFP-virus at 104-107 TU/ml 
(p<0.05; Tukey post hoc test to a univariate ANOVA). 
Figure 6: Microglial activation is dose-dependent and strain dependent. A-F: Coronal sections of 
the striatum stained for IBA1 14 days after injection of eGFP-virus (A-C) or GM7-virus (D-F) into 
the striatum. C: Histogram representing the average number of IBA1-positive microglia per field 
following injection of eGFP-virus (green bar) or GM-CSF/eGFP-virus at 103 TU/ml (GM3: light 
grey bar), 104 TU/ml (GM4: dark grey bar), 105 TU/ml (GM5: yellow bar), 106 TU/ml (GM6: blue 
bar), or 107 TU/ml (GM7: red bar). (*) p<0.05 Tukey post hoc test to univariate ANOVA. Bars and 
error bars represent the mean and standard error of the mean (SEM). 
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T-cells 
There was no CD3-positive T-cells influx into the striatum of 129S2/Sv, BALB-c 
or FVB/N mice injected with eGFP virus. In contrast, GM-CSF/eGFP-virus 
injection into the striatum of FVB/N mice was associated with the presence in the 
striatum of large numbers of CD3-positive T-cells. The effects of the GM-
CSF/eGFP-virus were less in other strains of mice: there were a few CD3-postive 
T-cells in 129S2/Sv mice (Fig. 8A), moderate numbers in BALB/c mice (Fig. 8B), 
and abundant in FVB/N mice (Fig. 8C).  
Figure 7: There is more astrocyte activation at higher doses of GM-CSF/eGFP-virus. A-F: 
Coronal brain sections of the striatum stained for GFAP 14 days after injection of eGFP-virus (A-
C) or GM7-virus (D-F) into the striatum. C: Histogram representing the average number of GFAP-
positive astrocytes per field following injection of eGFP-virus (green bar) or GM-CSF/eGFP-virus 
at 103 TU/ml (GM3: light grey bar), 104 TU/ml (GM4: dark grey bar), 105 TU/ml (GM5: yellow bar), 
106 TU/ml (GM6: blue bar), or 107 TU/ml (GM7: red bar). (*) p<0.05 Tukey post hoc test to 
univariate ANOVA. Bars and error bars represent the mean and standard error of the mean 
(SEM). 
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Taken together this data is in line with our previous observations where a high 
inflammatory response was found in the FVB/N mouse strain, moderate in 
BALB/c and low in 129S2/Sv.  
 
 
 
The effect of injecting GM-CSF-virus into the foetal mouse brain 
 
Perinatal infants that are exposed to inflammation may be at risk of white matter 
injury that can cause motor disabilities such as cerebral palsy in adulthood (Wang 
et al., 2009). A preliminary study was carried out to investigate whether 
expression of GM-CSF in the immature mouse brain will lead to microglial 
activation in the white matter. The 129S2/SV strain was chosen for its low 
response to GM/CSF virus and the FVB/N strain was used for its neurotoxic 
response. In collaboration with Dr Simon Waddington (UCL), pregnant 129S2/SV 
(n=2) or FVB/N (n=2) mice (Fig. 9A) at embryonic day 14 had full-depth midline 
laparotomy to expose the uterus (Fig. 9B). Foetuses received intrauterine 
Figure 8: FVB/N mice are avid T-cell recruiters on exposure to GM-CSF/eGFP-virus. A-F: 
Coronal brain sections of the striatum stained for CD3 14 days after injection of eGFP-virus (A-
C) or GM7-virus (D-F) into the striatum. C: Histogram representing the average number of CD3-
positive T-cells per field following injection of eGFP-virus (green bar) or GM-CSF/eGFP-virus at 
103 TU/ml (GM3: light grey bar), 104 TU/ml (GM4: dark grey bar), 105 TU/ml (GM5: yellow bar), 
106 TU/ml (GM6: blue bar), or 107 TU/ml (GM7: red bar). (*) p<0.05 Tukey post hoc test to 
univariate ANOVA. Bars and error bars represent the mean and standard error of the mean 
(SEM). 
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injections of GMCSF/eGFP-viral mixture or eGFP-virus into the lateral ventricle 
of brain (Fig. 9C). In contrast to pregnant FVB/N mice, the two pregnant 
129S2/SV failed to handle the procedure, as one cannibalised her stillborn 
neonates and the other miscarried. 
FVB/N pups were taken at P0, P3 and P7. Coronal brain sections were collected 
and stained for eGFP and microglial IBA1. Injections resulted in the presence of 
eGFP-positive cells in the cerebral cortex, ventricular epithelium, choroid plexus 
and meninges. As we aimed for GM-CSF production to be in the vicinity of the 
white matter, animals were determined to have had successful injections if 
transduced cells were found in all of the above regions except the meninges. 
There were no successful injections of GMCSF/eGFP at P0 or and P7, but there 
was 1 out of 2 (1/2) pups at P3 that had choroid plexus transduction. With eGFP-
only delivery, 2/3 neonates had successful injections at P0, 2/2 at P3, and 2/2 at 
P7. When IBA1 stained sections of P3 GMCSF/eGFP group (Fig. 9E) were 
compared with those of the eGFP-only group (Fig. 9D), it was evident that the 
GMCSF/eGFP-injected mouse had lower eGFP-expression in the left and right 
choroid plexus in the lateral ventricles, but had higher IBA1-positive microglial 
density at the subcortical and periventricular white matter than the control. 
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eGFP positive cells are present in foetal FVB/N mice injected with GM-
CSF/eGFP-virus 
To confirm whether the above result was reproducible and if the difference 
between the effects of GM-CSF/eGFP-virus and eGFP-virus are consistent at 
other post-natal time points, FVB/N foetuses at embryonic day 14 received eGFP-
virus or GM-CSF/eGFP-viral mixture injection to the lateral ventricles. The eGFP-
Figure 9: Delivery of GM-CSF-virus in foetal FVB/N mice causes a heightened inflammatory 
response in the subcortical and periventricular white matter. A-E: Pregnant FVB/N mice (A) had 
a midline laparotomy, the uterus was exposed (B) and foetal mice at embryonic day 14 were 
injected with GM-CSF-virus or eGFP-virus control (C). At P3, injection of eGFP-virus (E) or GM-
CSF-virus (F) resulted in eGFP-positive (green) choroid plexus in the left and right lateral ventricle, 
which was associated with IBA1-positive (red) phagocytic microglia at the subcortical and 
periventricular white matter in the GM-CSF injected mouse compared to the eGFP treated mice. 
Insert: Enhanced eGFP-positive cells of the choroid plexus of the animal injected with GM-CSF-
virus. Bar Scale: 200um. 
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virus or GM-CSF/eGFP-virus injected pups were taken at postnatal day 0 (GM-
CSF/eGFP-virus vs eGFP-virus: n=11 vs n=3), day 3 (n= 11 vs n=2), and day 7 
(n=19 vs n=2). Coronal sections through the lateral ventricles and hippocampus 
were immunostained for IBA1 or eGFP. Eight brain areas were analysed: cortex, 
white matter, septum, striatum, hippocampus, ventricular epithelium, choroid 
plexus and meninges.  
eGFP-positive cells were widespread. Animals injected with eGFP or 
GMCSF/eGFP, had eGFP-positive cells in the choroid plexus/ventricular 
epithelium (Fig. 10A-F), meninges, cortex (Fig. 11A-F), septum, striatum and 
hippocampus (Fig. 12A-F).  
To quantify the level of viral transduction the eight brain areas were given a score 
of 0-3 for eGFP (0 being none, 1 low, 2 medium and 3 high stain intensity). Across 
all areas studied there was no significant difference in eGFP immunoreactivity 
between the control eGFP-virus (Fig. 13A-G-blue bars) and the mixture of 
GMCSF/eGFP-virus at any postnatal time point (Fig. 13 A-G -purple bars), 
demonstrating that there may be no difference in the levels of virus transduction 
or subsequent gene expression between the two lentiviral vectors (p> 0.05; 
Students t-test). This therefore suggests that the presence of GM-CSF did not 
affect the ability of eGFP-virus, in the experimental viral mixture, to transduce 
cells. It also suggests that the expression of GM-CSF may fail to kill cells that 
were transduced by the virus. 
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Figure 10: FVB/N foetal mice intraventricular injections of GM-CSF/eGFP-virus or eGFP-virus 
results in the expression of eGFP in the choroid plexus and ventricular epithelium. Coronal brain 
sections through the lateral ventricles, immunostained for eGFP, of FVB/N mice injected in utero 
at gestational day 14 with control (A-C) or GM-CSF/eGFP virus mixture (D-F). Mice were killed at 
postnatal day 0 (P0-top row), 3 (P3-middle row) and 7 (P7- bottom row). Similar eGFP expression 
can be seen in the choroid plexus (ChP) and ventricular epithelium (VE) at all time-points in the 
eGFP-injected and GM-CSF/eGFP-injected groups. 
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Figure 11: There is widespread eGFP-expression in the cortex of FVB/N mice that received 
intraventricular injections of GM-CSF/eGFP-virus or control-virus. Coronal brain sections through 
the cortex, immunostained for eGFP, of FVB/N mice that were injected in utero at gestational day 
14 with control (A-C) or GM-CSF/eGFP virus mixture (D-F). Mice were killed at postnatal day 0 
(P0-top row), 3 (P3-middle row) and 7 (P7- bottom row). Neuronal expression of eGFP can be 
seen in the motor and somatosensory cortex of mice injected with the control-virus (A-C) or GM-
CSF/eGFP-virus (D-F). Insert shows further expression in the granular insular area at P7 in the 
GM-CSF/eGFP-virus injected mouse. Bar scale: 200um 
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Figure 12: eGFP-expression is also evident in the hippocampus of FVB/N mice that received 
intraventricular injections of GM-CSF/eGFP-virus or control-virus. Coronal brain sections through 
hippocampus immunostained for eGFP of FVB/N mice that were injected in utero at gestational 
day 14 with control (A-C) or GM-CSF/eGFP virus mixture (D-F). Mice were killed at postnatal day 
0 (P0-top row), 3 (P3-middle row) and 7 (P7- bottom row). Hippocampal neurons can be seen 
expressing eGFP in mice injected with control-virus or GM-CSF/eGFP-virus. 
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There are activated and phagocytic microglia in various areas in the brain 
following foetal GM-CSF-virus injection 
In comparison to eGFP-virus treated pups (Fig.14-19A, B, C), those injected with 
the GM-CSF/eGFP-viral mixture had more IBA1 immunoreactivity and reactive 
and/or phagocytic microglia in the ventricular white matter (Fig.14D, E, F) and in 
areas where eGFP immunoreactivity was present, such as choroid plexus and 
ventricular epithelium (Fig. 15 D, E, F), septum (Fig. 16D, E, F), striatum (Fig. 17, 
E, F), and hippocampus (Fig. 18D, E, F).  
Figure 13: The level of eGFP expression is similar between control-virus and GM-CSF-virus 
injected FVB/N mice. Histograms show average eGFP intensity scores, normalised using the log 
(x+0.01) algorithm, of mouse brains injected with control (blue bars) or GFMCSF/eGFP virus 
(purple bars) at gestational day 14 that survive up to postnatal day 0 (P0), 3 (P3) or 7 (P7). 
Intensity was specifically evaluated in the choroid plexus, ventricular epithelium, cortex (top row), 
hippocampus, striatum, septum (middle row), and meninges (bottom row). Note no significant 
difference between mice injected with control or GMCSF virus, and that the expression of eGFP 
does not increase with time. Bars and error bars represent the mean and standard error of the 
mean (SEM). 
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Using a 40x objective, these areas were given a score from 0-3 for IBA1-
microglial activation (0 resting-activated, 1-reactive-phagocyic and 2-completely 
phagocytic 3-tissue necrosis). Pups injected with GM-CSF/eGFP-virus (Fig. 19-
purple bars) had more reactive and phagocytic microglia in the ventricular 
epithelium at postnatal day 0 and 3 (P0 & P3) (Fig. 19B) than those injected with 
eGFP-virus (Fig. 19- blue bars). In the white matter (Fig. 19A), cerebral cortex 
(Fig. 19C), septum (Fig 19D) and striatum (Fig. 19E) more reactive and 
phagocytic microglia were seen only at P0. Overall, this GM-CSF-mediated 
microglial activation in the brain of perinatal FVB/N mice was transient. It peaked 
at day 0 and decreased by day 7 (Fig. 19-purple bars). Injection of EGFP-only 
vector showed that injection per se was not a source of significant microglial 
activation (Fig. 19-blue bars).  
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Figure 14: Microglial activation is evident in the white matter of FVB/N mice that received 
intraventricular GM-CSF/eGFP-virus injection. Coronal brain sections, immunostained for IBA1, 
of FVB/N mice that were injected in utero at gestational day 14 with control (A-C) or GM-
CSF/eGFP virus mixture (D-F) and were collected at postnatal day 0 (P0-top row), 3 (P3-middle 
row) and 7 (P7- bottom row). Dashed lines in orange highlight the boundaries of the white matter. 
There are more phagocytic microglia at P0 (D), phagocytic and reactive microglia at P3 (E) and 
reactive microglia at P7 (F) in comparison to controls (A-C). 
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Figurer 15 Higher levels of microglial activation are present in the ventricular epithelium in GM-
CSF/eGFP-injected mice than those injected with control virus. Coronal brain sections through 
the lateral ventricle, immunostained for IBA1, of FVB/N mice that were injected in utero at 
gestational day 14 with control (A-C) or GM-CSF/eGFP virus mixture (D-F). Animals were killed 
at postnatal day 0 (P0-top row), 3 (P3-middle row) and 7 (P7- bottom row). There is more 
microglial activation in the ventricular epithelium of GM-CSF/eGFP-injected mice than those 
injected with control particularly at P0 and P3. 
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Figure 16: The septum of GM-CSF/eGFP-injected mice shows more IBA1 immunoreactivity than 
that of mice injected with control virus. Coronal brain sections through the septum (SEP), 
immunostained for IBA1, of FVB/N mice that were injected in utero at gestational day 14 with 
control (A-C) or GM-CSF/eGFP virus mixture (D-F). Mice were killed at postnatal day 0 (P0-top 
row), 3 (P3-middle row) and 7 (P7- bottom row). Microglial activation appears to be particularly 
high at P0 mice injected with GM-CSF/eGFP-virus rather than eGFP-virus 
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Figure 17: The striatum of GM-CSF/eGFP-injected mice shows more IBA1 immunoreactivity than 
that of mice injected with control virus. Coronal brain sections through the striatum (STR), 
immunostained for IBA1, of FVB/N mice that were injected in utero at gestational day 14 with 
control (A-C) or GM-CSF/eGFP virus mixture (D-F). Mice were killed at postnatal day 0 (P0-top 
row), 3 (P3-middle row) and 7 (P7- bottom row). 
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Figure 18: The hippocampus of GM-CSF/eGFP-injected mice shows more IBA1 immunoreactivity 
than that of mice injected with control virus. Coronal brain sections through the hippocampus 
(HIPP), immunostained for IBA1, of FVB/N mice that were injected in utero at gestational day 14 
with control (A-C) or GM-CSF/eGFP virus mixture (D-F). Mice were killed at postnatal day 0 (P0-
top row), 3 (P3-middle row) and 7 (P7- bottom row).  
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Discussion 
The wide choice of transgenic mutant mice available could help to identify the 
molecular mechanisms through which GM-CSF effects CNS regeneration or 
degeneration. As a starting point, the widely-used outbred CD1 mouse strain was 
evaluated. The majority of the tested CD1 mice demonstrated little microglial 
activation, and only a minority showed a prominent microglial response following 
Figure 19: FVB/N mice injected with GM-CSF/eGFP-virus showed widespread activation of IBA1-
positive microglia that decreases with increasing time to control levels. Histograms show average 
IBA1 microglia morphology scores, normalised using the log (x+0.01) algorithm, of mouse brains 
injected with control (CON-blue bars) or GFMCSF/eGFP virus (purple bars) in utero. The mice 
were killed at postnatal day 0 (P0), 3 (P3) or 7 (P7). Resting, reactive and phagocytic microglia 
were evaluated in the following areas: white matter (WM), ventricular epithelium (PVE) and cortex 
(top row), septum, striatum, choroid plexus (ChPx) (middle row), meninges and hippocampus 
(bottom row). In the white matter, ventricular epithelium, cortex, septum and striatum there were 
significantly higher levels of IBA1-positive microglia in GMCSF-virus-injected mice than eGFP-
virus-injected mice at day 0, as indicated by the green asterisks. Note that in all brain areas the 
level of microglial activation is dampened with increasing time. (*) p<0.05; Students t-test. Bars 
and error bars represent the mean and standard error of the mean (SEM). 
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GM-CSF/eGFP injection. To evaluate whether the genetic background influenced 
the effects of GM-CSF, GM-CSF/eGFP-virus was injected into six different inbred 
strains of mice. In each of these strains the effect of GM-CSF on the level of 
phagocytic microglia, necrosis, the spread of reactive microglia and astrocyte 
activation was reproducible. The mouse strains 129S2/Sv, BALB/c and FVB/N 
showed a low, medium and high inflammatory response to GMCSF/eGFP-virus, 
respectively. Subsequently, the FVB/N mouse strain was used to evaluate 
potential neurotoxic effects of GM-CSF in the immature mouse CNS. 
Transuterine injections of control or GMCSF/eGFP virus targeting the lateral 
ventricles of mice at embryonic day 14, resulted in virally transduced cells being 
widespread in the cerebral cortex, hippocampus, striatum, septum, meninges, 
ventricular epithelium, and choroid plexus. More reactive and phagocytic 
microglia were present in the areas of viral transduction. Of particular interest, 
there was a successful increase in inflammation at the subcortical and 
periventricular white matter. Although, the level of transduction remained 
relatively constant with increasing time, inflammation decreased, suggesting that 
sensitivity to GM-CSF is highest before or around birth. 
The effect of GM-CSF on microglial activation is reproducible in 
the striatum of adult mice 
Injecting GM-CSF into the CNS of one outbred strain and six inbred strains in two 
separate batches that were two months apart, showed that the effects of GM-
CSF were reproducible for the spread of microglia activation from the injection 
site, and for phagocytic microglia, necrosis and activated astrocytes at the 
injection site. In previous studies there is consistent evidence for microglial and 
astrocyte activation following GM-CSF treatment into the mouse CNS. Infusing 
GM-CSF into the substantia nigra of C57/BL6 mice stimulated microglial and 
astrocyte activation as identified by the expression of alpha-M integrin and GFAP, 
respectively (Mangano et al., 2011). In addition, delivering GM-CSF into the 
lateral ventricle of BALB/c mice produced high levels of phagocytic microglia 
(Mausberg et al., 2009). Furthermore, C57/BL6 mice had more GFAP 
immunoreactivity in the hippocampus and midbrain following 
intracerebroventricular injections of GM-CSF compared to PBS (Reddy et al., 
2009) 
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GM-CSF failed to produce a consistent effect on granulocyte recruitment into the 
injected striatum. The delivery of mouse GM-CSF protein intravenously has been 
associated with the recruitment of neutrophils into inflamed areas such as the 
joints in arthritic mouse models (Bischof et al., 2000), the intestine in a mouse 
model of intestinal inflammation (Khajah et al., 2011), and the cortex of rats 
injected with GM-CSF/eGFP-virus (Chapter 4).This might suggest that lentiviral 
GM-CSF in the mouse striatum does not have significant systemic effects that 
lead to a consistent granulocyte recruitment to the striatum. As direct injury to the 
brain has been associated with granulocyte influx into the brain parenchyma 
(Holmin et al., 1998), the varying levels of granulocytes in the injected striatum 
may be explained by the extent of mechanical injury caused by the injections of 
the virus. In fact, the level of granulocyte recruitment correlated well with the level 
of reactive microglia found directly at the injection site (another parameter that 
was not reproducible); the more reactive microglia present at the injection site 
resulted in more granulocyte influx to the injection site (data not shown). 
The degree of microglial activation in the adult mouse striatum 
is strain specific 
The phenotype that microglia acquire depends on the stimuli acting on different 
microglial receptors. The classical activation phenotype of microglia can be 
induced by LPS or amyloid-β. Stimulated microglia release great amounts of 
TNF-α and NO (Butovsky et al., 2005; Schwartz et al., 2006) which are associated 
with neuronal death (de Bock et al., 1998; Long-Smith et al., 2010; Ono et al., 
2010). Similarly, GM-CSF can promote the production of pro-inflammatory 
cytokines by microglia. Intracerebroventricular injection of GM-CSF in C57/BL6 
mice leads to the expression of IL-1β, IL-6 and TNF-α by microglia (Reddy et al., 
2009), which are cytokines that can promote neuronal death (de Bock et al., 1998; 
Long-Smith et al., 2010; Ono et al., 2010). In the current experiments, FVB/N 
mice injected into the striatum with GM-CSF/eGFP-virus at high concentrations 
showed fluid-filled areas in the brain parenchyma that were surrounded by 
abundant phagocytic microglia. The expression of GM-CSF in the striatum of 
FVB/N mice may be stimulating microglia to differentiate into the classically 
activated subtype that promotes the production of pro-inflammatory factors that 
can cause tissue damage. 
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In contrast, the alternative activation state of microglia can be induced by low 
doses of interferon gamma or the anti-inflammatory cytokine IL-4, leading to the 
release of growth factors including BDNF and IGF-1 (Butovsky et al., 2005; 
Schwartz et al., 2006). Although, GM-CSF is a pro-inflammatory cytokine that can 
cause tissue damage, it has also been associated with promoting the production 
of BDNF by microglia (Bouhy et al., 2006; Ha et al., 2005; Huang et al., 2009), 
and treatment with GM-CSF can be protective in stroke models (Kong et al., 
2009; Schaebitz et al., 2008), and pro-regenerative in spinal cord injury models 
(Bouhy et al., 2006; Ha et al., 2005; Huang et al., 2009). In the current experiment, 
GM-CSF expression in the striatum of the 129S2/Sv and BALB/c strains failed to 
promote tissue damage but resulted in a mild and moderate microglial activation, 
respectively. As the microglial response to GM-CSF in the 129S2/Sv and BALB/c 
strains is lower in comparison to the FVB/N strain, whereas the outbred CD-1 
strain showed a variable response, it suggests that the effects of GM-CSF are 
dependent not only on the type of stimulus but also on the genetic background of 
the mice. Furthermore, a disparity in the toxic effects of LPS-activated microglia 
from different mouse strains has also been reported. When neurons from rats 
were grown with LPS-activated microglia from the C57/BL6 or SWR/J mouse 
strains, there were fewer surviving neurons in the cultures containing microglia 
derived from C57/BL6 mice than in those containing microglia derived from 
SWR/J mice. Microglia from C57/BL6 mice produced higher levels of 
prostaglandin-E2 a major inflammatory mediator and inducible nitric oxide 
synthase, an enzyme that catalyses the production of nitric oxide (McLaughlin et 
al., 2006). 
There are at least two reasons why some mouse strains should show less 
inflammation following injection of GM-CSF virus: less GM-CSF may be produced 
in some strains or the microglia and astrocytes may be less sensitive to the GM-
CSF that is produced. In the three mouse strains there is no significant difference 
between the number of eGFP-positive cells in the GM-CSF-virus injected and 
eGFP-injected mice. This suggests that the mice allow similar expression of 
transgenes, therefore the difference in inflammatory responses in these strains 
may be presumably down to the sensitivity to GM-CSF. Nonetheless, to further 
investigate the differences between high and low responders to GM-CSF-virus, it 
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will be important to carry out in situ hybridisation and ELISA experiments to 
establish the levels of bioactive GM-CSF protein produced in the low-responding 
mouse strains. The responses of different strains to injection of recombinant GM-
CSF could be compared. In addition, the striatal tissue treated with GM-
CSF/eGFP-virus or control-virus should be extracted for gene expression 
profiling using DNA microarray technology. The results may identify candidate 
genes whose expression may mediate the toxic effects of GM-CSF.  
Finally, the mouse strains where GM-CSF expression results in moderate 
microglia activation may be used to evaluate the possible pro-regenerative 
effects of that cytokine.  
Why was the mouse striatal response to GM-CSF different 
between gross analysis and cell counting? 
To study whether the glial and inflammatory responses to a striatal injection of 
GM-CSF virus was different between mouse strains, a semi-quantitative and a 
quantitative analysis was carried out. To measure the glial and inflammatory 
response in six mouse strains a semi-quantitative scoring system that took into 
account cellular morphology and antibody reactivity was used, while to further 
analyse the differences between three strains the numbers of cells were counted. 
When the results of the semi-quantitative and quantitative studies were 
compared, it was found that the difference in astrocyte activation between mouse 
strains was inconsistent. In the semi-quantitative study astrocyte activation in the 
striatum of 129S2/SV mice was significantly lower than that in FVB/N mice. In 
contrast, the quantitative study failed to reveal any difference between these 
strains in terms of astrocyte activation. In addition, the semi-quantitative study 
apparently shows an obvious difference between strains in the amount of 
microglial activation and phagocytic microglial density, while in the quantitative 
study the differences between strains were dampened. This discrepancy may be 
due to the inherent differences between a semi-quantitative and quantitative 
analysis. In the semi-quantitative analysis an ordinal scale was used, where the 
differences between adjacent scale values do not necessarily represent equal 
intervals. Therefore it is difficult to compare the results of the two experiments. In 
addition, in the semi-quantitative study glial activation was characterised by a 
gross analysis of cell density as well as the level of antibody immunoreactivity. 
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However, in the quantitative analysis only the number of cells were considered. 
It would be interesting to carry out immunoreactivity measures to find out if the 
difference between strains is still exists.  
Mechanisms of GM-CSF- mediated inflammation 
When microglia become activated by GM-CSF they can produce pro-
inflammatory cytokines, such as IL-6 and TNF-α (Reddy et al., 2009), which are 
known to activate astrocytes (Malipiero et al., 1990) and can cause cell death (de 
Bock et al., 1998; Long-Smith et al., 2010; Ono et al., 2010). GM-CSF also 
increases ICAM expression (Furie and Randolph, 1995; Wahl et al., 1996), which 
may help T-cells to be recruited to the injection site. These mechanisms are 
discussed in greater detail in chapter four. 
Foetal FVB/N mice injected with GM-CSF/eGFP-virus into the 
lateral ventricles had virally- transduced cells present in several 
brain areas 
As FVB/N mice are high responders to GM-CSF, it was next investigated whether 
GM-CSF/eGFP-virus could be used to cause inflammation in cerebral white 
matter of the immature brain. Injury to the white matter is a common cause of 
cerebral brain injury leading to cerebral palsy. The causes of perinatal cerebral 
white matter injury are multifactorial: hypoxia, ischemia, infection and 
inflammation are thought to be involved (Volpe, 2009). A widely used model of 
infection and inflammation is the systemic or uteroplacental administration of LPS 
in pregnant female rodents (Hagberg et al., 2002; Silbereis et al., 2010). 
However, the effects of LPS are only transient and multiple injections are often 
required (Duncan et al., 2002). To model the effect of chronic inflammation in the 
immature brain, GM-CSF/eGFP-virus was injected into the lateral ventricles of 
foetal FVB/N mice. 
In the current study it was found that the lentiviral vector can be successfully 
delivered to the foetal brain and that there is long-term expression of the 
transgene. Foetal mice injected with eGFP-virus or GM-CSF/eGFP-virus had 
widespread eGFP-positive cells in the brain at postnatal day 0, 3 and 7. These 
results are in agreement with Rahim et al. (2009), who showed that mice which 
received an intraventricular injection of eGFP-lentiviral vector at embryonic day 
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14 had eGFP-positive neurons in the cingulate cortex, sensory motor cortex and 
hippocampus at day 21.  
The widespread expression of eGFP in the brain following viral vector injection 
may be due to cell migration. Tabata and Nakajima (2001) found that foetal mice 
injected with a DNA plasmid encoding for eGFP into the lateral ventricles at 
embryonic day 14 had eGFP-expressing cells in the ventricular zone at 
embryonic day 15. The ventricular zone is a pseudostratified epithelium 
containing multipotent neural stem cells located next to the ventricle walls. At 
embryonic day 16 neuroblasts had entered the intermediate zone, which recedes 
between the marginal zone and the pia mater in the developing cortex. At 
postnatal day 3 the eGFP-positive cells were observed beneath the marginal 
zone, were migration terminates and neuroblasts differentiate into mature 
neurons. By day 21 neurons were present in the layer II, III and IV of the cerebral 
cortex (Tabata and Nakajima, 2001). As there was eGFP-positivity in the choroid 
plexus and ventricular epithelium migration of virally-transduce neuroblasts from 
the ventricular zone to other cortical layers may be possible. However, it is also 
likely that the eGFP-virus and GM-CSF/eGFP virus diffused trough the brain 
transducing local cells.  
Microglial activation is transient in the immature CNS of FVB/N 
mice 
Mice injected with GM-CSF/eGFP-virus at embryonic day 14 had more 
phagocytic microglia in the white matter, cerebral cortex, septum, striatum and 
ventricular epithelium, at postnatal day 0 than those injected with eGFP-virus. 
The GM-CSF/eGFP-mediated increase in microglial activation decreased by day 
7. The transient increase in microglial activation may be reflecting the process of 
microglial maturation during development. In the foetal and neonatal brain 
microglia have a rounded amoeboid morphology that changes to a ramified one 
as the brain matures (Alliot et al., 1999; Ginhoux et al., 2010; Hristova et al., 2010; 
Prinz and Mildner, 2011). In mice phagocytic microglia in the white matter and 
cortex are present at postnatal day 0, processes protrude from the microglial cell 
body at day 7, and at day 14 microglia are fully ramified, having an almost adult 
phenotype (Hristova et al., 2010). Phagocytic microglia in the new-born mice may 
be more sensitive to GM-CSF than ramified microglia. Indirect evidence for this 
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comes from adult rats. In the facial motor nucleus of rats that have undergone 
facial nerve axotomy there is an increase in the expression of the GM-CSF 
receptor, which coincides with microglial proliferation and the transformation of 
microglia from a ramified to an activated morphology (Raivich et al., 1991a). In 
new born mice there may be greater expression of GM-CSF receptors in 
microglia making them more susceptible to the effects of GM-CSF. 
Alternatively, the transient effects of GM-CSF may be pertinent to the mouse 
brain being particularly vulnerable to damage during the embryonic and perinatal 
periods. In the developing cerebral white matter, premyelinating oligodendrocytes 
are more vulnerable to excitotoxic, oxidative and inflammatory forms of injury than 
mature oligodendrocytes (Volpe, 2009). In addition, subplate neurons have been 
shown to be vulnerable to excitotoxic cell death (Ghosh et al., 1990; Ghosh and 
Shatz, 1992) and hypoxic-ischemic injury (McQuillen et al., 2003). Subplate 
neurons are located beneath the immature cerebral cortex (Kostovic and Rakic, 
1990; Luskin and Shatz, 1985). They are transient cells (Alghoul and Miller, 1989; 
Chun and Shatz, 1988; Price et al., 1997) that undergo programmed cell death in 
the first postnatal week in mice (McQuillen et al., 2002). They are required for the 
formation of mature thalamocortical connections and for the proper development 
of motor, visual and cognitive functions in rodents and humans (McQuillen and 
Ferriero, 2005). Subplate neurons are selectively destroyed when the glutamate 
agonist kainate is injected into the brain of embryonic and postnatal kittens 
(Ghosh et al., 1990; Ghosh and Shatz, 1992). In addition, in the neonatal rat 
model of hypoxia-ischemia, selective subplate neuronal death is seen. This is 
associated with deficits in motor function, as in babies with periventricular white 
matter damage (McQuillen et al., 2003). Microglia stimulated with GM-CSF have 
been shown to produce proinflammatory factors that can cause cell death (Reddy 
et al., 2009) and further increase the level of microglial activation.  
In summary, the experiments have enabled the development of models of severe 
and moderate inflammation in the adult mouse brain and of inflammatory injury 
in the foetal mouse brain. The foetal mouse model offers a method of testing the 
effects of prolonged inflammation in the immature brain. Previous 
infectious/inflammatory models that have been developed, include intrauterine 
Chapter Five 
 
 
221 
administration of LPS, the direct delivery of LPS into the subcortical white matter, 
intravenous injection of LPS into the foetus, or intraperitoneal injection into the 
mothers or the pup (Wang et al., 2006). In these models the time points 
investigated are between 1 to 72 hours post injection as LPS-induced 
inflammation is transient. In contrast, using the current model the chronic effect 
of inflammation in the immature brain can be investigated. In addition, the delivery 
of GM-CSF into the ventricles of the foetal brain permits inflammation to be 
restricted to the CNS. In some other models inflammation this is both systemic 
and central (Wang et al., 2006). However, using the virally-delivered GM-CSF 
model the effects of local inflammation in the brain rather than that caused by 
circulating factors can be evaluated. The model could be used to test therapeutic 
strategies using pharmacological agents, e.g. hemichannel blockers (Takeuchi et 
al., 2006). In addition, brain injury is exacerbated in neonate mice injected with 
LPS when they undergo hypoxia-ischemia insult, which involves unilateral carotid 
ligation and exposure to 8% oxygen for 30 minute, (Kendall et al., 2011). Future 
experiments should investigate whether GM-CSF-virus has a similar 
preconditioning effect on cerebral hypoxia-ischemia. 
Conclusion 
In this chapter the viral delivery of GM-CSF to the brain of different mouse strains 
produces strain specific effects. The inflammatory and glial response was low in 
the 129S2/Sv strain, widespread though moderate in BALB/c, and high in the 
FVB/N strain. The FVB/N mouse strain was used to study the effect of GM-CS-
virus mediated inflammation in the foetal brain with the aim of modelling perinatal 
white matter damage. Intraventricular delivery of GM-CSF-virus enhances 
microglial activation in the early post natal period in various areas brain, including 
the white matter. 
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CHAPTER SIX 
Delivery of lentiviral GM-CSF to the motor cortex protects 
corticospinal axons and improves functional recovery in rats 
with corticospinal tract injury 
 
Introduction 
The neurons of the peripheral nervous system (PNS) have a well-documented 
ability to regenerate their axons following injury leading to successful functional 
recovery. This spontaneous recovery is associated with a cell body response that 
includes the upregulation of growth associated genes, adhesion molecules and 
structural proteins (Anderson and Lieberman, 1999; Becker, 2006), and 
pronounced activation and proliferation of microglia surrounding the neuronal 
perikarya (Kreutzberg, 1996; Liu et al., 1998). In contrast, neurons projecting 
within the central nervous system (CNS), such as corticospinal neurons, show no 
microglial activation and a weak or absent neuronal response to axonal damage, 
(Barron et al., 1990; Leong et al., 1995) and limited behavioural improvement 
(Whishaw et al., 1993). 
Microglial activation can be induced by Granulocyte Macrophage Colony 
Stimulating Factor (GM-CSF), a potent microglial mitogen that has been shown 
to strongly enhance microglial synthesis of neurotrophins such as BDNF, 
increase expression of regeneration-related proteins such as GAP-43, promote 
neuronal survival, increasing neurite outgrowth in vivo and improving functional 
recovery after spinal cord injury (Bouhy et al., 2006; Ha et al., 2005; Huang et al., 
2009). However, previous studies demonstrating pro-regenerative effects of GM-
CSF concentrated on inflammatory changes at the site of spinal cord injury and 
focused only on short-term effects of GM-CSF. 
The following chapter describes the effect of long-term GM-CSF/eGFP-virus 
mediated cortical inflammation on axonal regeneration and functional recovery. 
The chapter reports the histological assessments and behavioural tests carried 
out on rats with corticospinal tract injury injected into the motor cortex with GM-
CSF/eGFP-virus. 
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Results 
GM-CSF-virus has a protective effect on injured corticospinal 
axons 
To examine the effect of GM-CSF on corticospinal tract regeneration, Sprague-
Dawley rats had injections of eGFP control-virus (n=4) (Fig. 1A) or GM-
CSF/eGFP-viral mixture at titres 104 (GM4: n=4), 105.5 (GM5.5: n=4), 107 (GM7: 
n=4) /ml into the motor cortex (Fig.1B). The contralateral dorsal corticospinal tract 
was transected at the fourth cervical segment. Two weeks before sacrifice, BDA 
was injected into the motor cortex to label axons in the injured corticospinal tract. 
Rats were allowed to survive 42 days after initial surgery, and their BDA-positive 
axons were visualized using DAB enhanced with cobalt nickel. 
 
 
To examine whether the cortical injections of virus altered the numbers of labelled 
corticospinal axons in the brainstem, BDA-positive corticospinal axons were 
counted in transverse sections of the pyramidal decussation using two fields of a 
x40 objective. The GM4-virus group had 35±6 BDA-labelled axons per field (Fig. 
2B & E-grey bar), those injected with GM5.5-virus had 39±7 (Fig. 2C & E-yellow 
bar), and GM7-virus injected rats had 45±10 (Fig. 2D & E-red bar). The GM-CSF-
virus injected groups were not significantly different from the control-injected 
group that had 31±6 per field (Fig. 2A & E-green bar) (p<0.05; univariate 
ANOVA). This result shows that there was a similar success in the anterograde 
labelling of the corticospinal tract in GM-CSF/eGFP-virus injected and control-
virus injected groups and that the proximal parts of corticospinal axons were not 
adversely affected by the viral injections. 
Figure 1: Schematic representation of the lentiviral plasmids used in this study. A: The enhanced 
Green Fluorescent Protein (eGFP) lentiviral plasmid (control-virus). B: The Granulocyte 
Macrophage Colony Stimulating Factor (GM-CSF) lentiviral plasmid. In these experiments the 
GM-CSF virus was diluted from 108 TU/ml to 107,105.5, and 104 TU/ml using control-virus at a 108 
titre. 
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Longitudinal horizontal sections through the spinal cord demonstrated that after 
injecting control-virus into the motor cortex (Fig. 3A), there were a few axons and 
retraction bulbs in close proximity to the injury site. These increased in those 
animals injected with GM4 (Fig. 3B), were highest in those injected with GM5.5 
(Fig. C), and decreased in rats injected with GM7 (Fig. 3D) 
 
Figure 2: CST axonal density at the pyramidal decussation is the same following control-virus or 
GM-CSF/eGFP-virus injections into the motor cortex. Histogram representing the mean number 
of BDA positive axons per field in the pyramidal decussation (PXY) of rats injected with control-
virus (green bars), GM4 (grey bars), GM5.5 (yellow bars) or GM7 (red bars). Cortical injections 
were contralateral to a C4 corticospinal tract injury. There was no difference between the groups: 
p>0.05 univariate ANOVA. Error bars show the standard error of the mean (SEM). 
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Figure 3: The effect of GM-CSF/eGFP virus on axon and retraction bulb density after injury. A-D: Micrographs showing horizontal longitudinal sections through 
the cervical corticospinal tract of rats with C4 corticospinal tract injury, which received control-virus (A), or GM-CSF/eGFP-virus (B-D) at 104 TU/ml (GM4), 105.5 
TU/ml (GM5.5) or 107 TU/ml (GM7) injected into the motor cortex. Cobalt Nickel -stained sections showing BDA-positive axons with the injury site (*) at the 
bottom of each image. 
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Using a 40x objective lens, the number of BDA-labelled axons in the corticospinal 
tracts and their retraction end bulbs were quantified rostral (-4.5mm to -0.5mm) 
and caudal (0.5mm to 4.5mm) to the injury site (0mm). Corticospinal tract axon 
counts were normalised for the success of anterograde labelling in each animal 
by comparison with the corresponding count of labelled axons in the pyramidal 
decussation. Rats treated with GM5.5-virus (Fig. 4-yellow bars) and GM7-virus 
(Fig. 4-red bars) titres had significantly more corticospinal axons close to the 
injury site (1mm rostral) than those treated with control-virus (Fig. 4-green bars) 
(p<0.05; Tukey post hoc test to a univariate ANOVA). 
In addition, an overall effect of GM-CSF-virus treatment independent of distance 
from the injury site was also found. The average number of axons in the 
corticospinal tract within the spinal cord at all distances rostral to the injury site 
was over four times greater in the GM4 (Fig. 4- insert grey bar), GM5.5 (Fig. 4- 
insert yellow bar) and GM7-treated groups (Fig. 4- insert red bar) compared to 
control-virus treated group (Fig. 4- insert green bar) (p<0.05; Tukey post hoc test 
to a univariate ANOVA). 
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To further evaluate the axonal response, the number of BDA-filled axonal 
retraction bulbs were counted. Retraction bulb quantifications were normalised 
with spinal axon counts. Rats treated with GM5.5-virus (Fig. 5-yellow bars) or 
GM7-virus (Fig. 5-red bars) had more retraction bulbs at 1mm and 1.5mm rostral 
to the injury site, than those treated with control-virus virus (Fig. 5-green bars). 
Overall, independent of distance, all GMCSF/eGFP-virus treated animals had 
greater numbers retraction bulbs at spinal cord than the eGFP virus (Fig. 5-insert) 
(p<0.05; Tukey post hoc test to a univariate ANOVA).  
 
 
 
 
Figure 4: GM-CSF/eGFP-virus injection into the motor cortex has a protective effect on CST 
axons following injury. Histogram showing the axonal density rostral (-0.5 to -4.5 mm) and caudal 
(0.5 to 4.5 mm) to the corticospinal tract injury site (CSTI). Green bars represent animals injected 
with control virus, grey bars represent those injected with GM4-virus, yellow GM5.5-virus, red 
GM7-virus. Rats injected with GM5.5 and GM7 have significantly more axons 1mm rostral to the 
lesion site that those injected with control virus. Insert: Histogram showing the axonal density after 
averaging the counts for all distances rostral to the injury site. Animals injected with GM4, GM5.5 
and GM7 have significantly more axons in the cervical corticospinal tracts than those injected with 
control virus. (*) p<0.05 Tukey post hoc test to a univariate ANOVA. Bars represent the ratio 
between the numbers of axons in the spinal cord to those in the pyramidal decussation. Error bars 
show the standard error of the mean (SEM). 
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Inflammation, gliosis and expression of growth-related proteins 
in the motor cortex accompanied the GM-CSF-mediated axonal 
protection 
Inflammation and astrogliosis 
The next step was to analyse whether the axonal protection previously described 
could be correlated with the production of inflammation and astrogliosis in the 
motor cortex. Coronal sections through the motor cortex of rats with corticospinal 
tract injuries, injected with control-virus (n=4), GM4-virus (n=4), GM5.5-virus 
(n=4) or GM7-virus (n=4), were fluorescently stained to visualise microglia or 
astrocytes.  
Microglial and astrocyte activation was dose-dependent. At six weeks after 
injection coronal brain sections through the injection site stained for IBA1, 
contained microglia with a ramified morphology in rats injected with the control-
virus (Fig. 6A), an activated morphology in those injected with GM5.5-virus (Fig. 
6B), and a phagocytic morphology in GM7-virus injected rats (Fig. 6C). The 
numbers of IBA1-positive microglia were counted along the injection site using a 
x40 objective lens. Rats injected with GM5.5-virus (Fig 6. D-yellow bar) or GM7-
virus had more microglia at the injection site (Fig 6. D-red bar), than those injected 
with control-virus virus (Fig 6. D-green bar) (p<0.05; Tukey post hoc test to a 
univariate ANOVA).  
Similarly, astrocytes in the motor cortex changed in morphology with GM-CSF 
treatment. Astrocytes had a hypertrophic appearance with thick GFAP-positive 
processes in rats injected with GM5.5-virus (Fig. 6F) or GM7-virus (Fig. 6G), 
compared to those injected with control-virus (Fig. 6E). In addition, there was 
clear glial scaring in GM7 injected rats, which was not evident in control-virus or 
Figure 5: Quantification of axonal retraction following GM-CSF/eGFP-virus treatment. Histogram 
showing the retraction bulb density rostral (-0.5 to -4.5 mm) and caudal (0.5 to 4.5 mm) to the 
corticospinal tract injury site (CSTI). Green bars represent animals injected with control virus, grey 
bars represent those injected with GM4-virus, yellow GM5.5-virus, red GM7-virus. Rats injected 
with GM5.5 and GM7 have significantly more retraction bulbs 1mm and 1.5mm rostral to the lesion 
site that those injected with control virus. Insert: Histogram showing the retraction bulb density 
after averaging the counts for all distances rostral to the injury site. Animals injected with GM4, 
GM5.5 and GM7 have significantly more retraction bulbs in the cervical corticospinal tracts than 
those injected with control virus. (*) p<0.05 Tukey post hoc test to a univariate ANOVA. Bars 
represent the ratio between the numbers of retraction bulbs in the spinal cord to the number of 
axons in the corticospinal tract in the spinal cord. Error bars show the standard error of the mean 
(SEM). 
Chapter Six 
 
 
229 
GM5.5-virus-injected rats. Finally, the number of astrocytes per field was greater 
in those injected with GM5.5-virus (Fig. 6H-yellow bar) or GM7-virus (Fig. 6H-red 
bar), than those injected with control-virus (Fig. 6H-green bar) (p<0.05; Tukey 
post hoc test to a univariate ANOVA). 
Growth-associated proteins 
Regeneration competent neurons increase expression of regeneration-
associated genes such as ATF3 and c-Jun. Increasing inflammation in the vicinity 
of the injured neuronal perikarya is associated with the cell body response. With 
this in mind, the expression of growth-associated factors in the inflamed motor 
cortex was next examined. Brain sections of rats injected with control-virus or 
GM4-virus, GM5.5-virus or GM7-virus were fluorescently stained for c-Jun or 
ATF3. Sections were also stained with DAPI to visualise nuclei. DAPI-positive 
nuclei that were c-Jun- or ATF3-positive were counted using a x40 objective lens 
at various levels along the injection site. 
Coronal sections through the injection site showed that there was little expression 
of these transcription factors in the control-injected cortex, but there was more 
expression in and around the injection sites of GM5.5-virus and GM7-virus. 
However, the small size of c-Jun- (Fig.7-left column) and ATF3- (Fig. 7-right 
column) positive nuclei suggests that they belonged to glial cells rather than 
cortical neurons. 
There were more c-Jun-positive nuclei per field in rats injected with GM5.5 
(Fig.7D-yellow bar) and GM7 (Fig.7D-red bar) than in those injected with control-
virus (Fig.7D-green bar). Similarly, in comparison to control-virus injected rats 
(Fig.7H-green bar), GM7-virus injected rats had significantly more ATF3-positive 
nuclei (Fig.7D-red bar) (p<0.05; Tukey post hoc test to a univariate ANOVA).  
Figure 6: Long-term expression of GM-CSF-virus increases microglial and astrocyte activation in 
the motor cortex of rats with C4 corticospinal tract injuries. A-C&E-G: Coronal brain sections 
through motor cortex stained for IBA1 or GFAP (in red), and also showing eGFP-positive cells (in 
green), six weeks following injections of control-virus, GM4, GM5.5 or GM7-virus. Bar Scale: 
20um. The number of microglia (A-C) and astrocytes (E-G) increase with increasing GM-
CSF/eGFP-virus concentration. The number of eGFP-positive cells decreased in cortices injected 
with GM-CSF virus (A-C&E-H). D&H: Histograms representing the number of IBA1-positive (+) 
microglia per field (D) and GFAP-positive astrocytes per field (H), 6 weeks after injection into the 
motor cortex of control virus (green bars), GM4-virus (grey bars), GM5.5-virus (yellow bars) or 
GM7-virus (red bars). (*) p<0.05 following an univariate ANOVA statistical analysis. Bars and error 
bars represent the mean and standard error of the mean (SEM), respectively. 
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Increased microglial activation was also found along the 
corticospinal tract within the spinal cord 
In Chapter Four it was found that intracortical injections of GM-CSF/eGFP-viral 
mixture into the motor cortex of intact rats promoted microglial activation in the 
corticospinal tract. The next step evaluated whether rats with corticospinal tract 
injuries that received intracortical injections of control-virus (n=4), GM4-virus 
(n=4), GM5.5-virus (n=4), or GM7-virus (n=4) showed signs of an inflammatory 
response in the corticospinal tract within the cervical spinal cord. Longitudinal 
horizontal sections through the spinal cord were stained for IBA1 to visualise 
microglia and BDA to visualise axons in the corticospinal tract. 
The injured and intact corticospinal tracts were visualized in longitudinal 
horizontal sections through the cervical spinal cord. Six weeks after injection, the 
rats injected with GM5.5-virus had more microglia with a phagocytic morphology 
surrounding the BDA positive axons in the injured and intact corticospinal tracts 
than those injected with control-virus. Microglial activation in the corticospinal 
tract was highest in the injured corticospinal tract and less in the intact 
corticospinal tract. This effect was not present in the rats injected with control 
virus (Fig. 8). 
The number of IBA1-positive microglia was counted along the corticospinal tract, 
rostral to the injury site, using four fields of a 40x objective lens. In comparison to 
the control-group, the GM5.5-virus injected rats had significantly more microglia 
in the experimental corticospinal tract rostral to the injury site (p<0.05; Tukey post 
hoc test to a univariate ANOVA). However, GM-CSF-virus had no effect on the 
number of microglia in the intact corticospinal tract.  
 
Figure 7: Long-term expression of GM-CSF-virus increases c-Jun and ATF3 expression in the 
motor cortex of rats with C4 corticospinal tract injuries. A-C&E-G: Coronal brain sections through 
motor cortex stained for c-Jun or ATF3 (in red), nuclei (in blue), and also showing eGFP-positive 
cells (in green), six weeks following injections of control-virus, GM4, GM5.5 or GM7-virus. Bar 
Scale: 20um. With increasing GM-CSF/eGFP-virus concentration, the number of c-Jun-positive 
nuclei (A-C) and ATF3-positive nuclei increased (E-G). D&H: Histograms representing the 
number of c-Jun-positive (+) nuclei per field (D) and ATF3-positive nuclei per field (H), 6 weeks 
after injection into the motor cortex of control-virus (green bars), GM4-virus (grey bars), GM5.5-
virus (yellow bars) or GM7-virus (red bars). (*) p<0.05 following an univariate ANOVA statistical 
analysis. Bars and error bars represent the mean and standard error of the mean (SEM), 
respectively. 
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Preliminary assessment of functional recovery of rats with 
corticospinal tract injury  
The anatomical analysis has shown that rats that received cortical injections of 
moderate and high doses of GM-CSF lentivirus have more axons in the injured 
corticospinal tract than those that received the control-virus. To determine if this 
effect produces functional improvement, a rearing test and the directed forepaw 
reaching test were used to evaluate asymmetrical use of forelimb for weight 
bearing or forepaw reaching and food grasping, respectively. 
Preliminary experiments were carried out using four rats. With the direction of Dr 
Li Ying and Prof Raisman (UCL), the apparatus for the directed forepaw reaching 
test was produced by adapting a rat cage so as to have a vertical slit (8 cm x 1.5 
cm) in the middle of cage with a rectangular platform (3 cm x 4 cm) protruding at 
the bottom of the slit (Fig. 9A). For the rearing test, we used a transparent vertical 
Figure 8: GM-CSF/eGFP virus increased the number of microglia in the corticospinal tract within 
the spinal cord. A-B: Horizontal sections of spinal cords stained for IBA1 showing the intact and 
the injured corticospinal tracts, 6 weeks after injection of control-virus (A), or GM5.5-virus (B) into 
the motor cortex. C: Histogram showing the number of IBA1-postive microglia per field in the 
intact corticospinal tract (patterned bars) and injured corticospinal tract (plain bars), following 
cortical injections of control-virus, GM3-virus, GM5.5-virus, or GM7-virus. There were significantly 
more microglia in the injured corticospinal tract of GM5.5 animals compared to animals injected 
with control virus. (*) p<0.05 Tukey post hoc test to univariate ANOVA. Bars and error bars 
represent the mean and standard error of the mean (SEM). 
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Plexyglas cylinder (30 cm height and 20 cm diameter) (Gharbawie, Wishaw & 
Wishaw, 2003) with two mirrors (30 cm x 30 cm) placed at 90o behind the cylinder, 
so that a 360o view of the rat was available (Fig. 9B).  
Preliminary behavioural studies allowed us to optimise environmental factors, 
such as levels of light and sound, necessary to have efficient and effective data 
collection. In addition, for the food reaching task a battery of food samples were 
tested including noodles, raisins, marshmallows, Cheerios, etc. Sprague Dawley 
rats had a preference for Cheerios. To ease the rats’ manipulation of food each 
Cheerios were fragmented into thirds. Furthermore, for the rearing test, it was 
found that sticking four cotton buds covered in honey at different heights inside 
the cylinder promoted rearing. 
 
 
Rearing movements spontaneously improve following 
corticospinal tract injury  
Rats with right dorsal corticospinal tract injury at cervical segment 4 were injected 
into the left motor cortex with control-virus (CON: n=8) or a GM-CSF/eGFP-viral 
mixture at 104 (GM4: n=9), 105.5 (GM5.5: n=7) or 107 (GM7: n=8) (TU/ml). In 
addition, rats were injected with the anterograde tracer BDA at the motor cortex 
Figure 9: Measuring functional recovery of rats with spinal cord injury using the directed forepaw 
reaching test and rearing test. A: Shows a rat grasping a Cheerio fragment; this action is 
obliterated in rats with corticospinal tract hemisection.  B: A rat with right C4 corticospinal tract 
injury in the standing position using only the left forepaw to balance. Notice the inability to use the 
injured right forepaw for weight bearing. The arrows points at the paw on the side of the 
corticospinal tract injury. 
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3 weeks before sacrifice. To evaluate functional recovery of the right (injured side) 
paw the rearing assessment was used. The rearing action was broken down into 
three movements- push off (Fig.10A), rearing (Fig. 10C) and landing (Fig. 10E). 
The use of left (uninjured) paw, the right paw or both paws for weight bearing 
were quantified. Two baselines were taken prior to injury and data at 12 post-
injury time points, from day 3 to 42, were collected. The involvement of the injured 
right forepaw in the push off, rearing and landing movements was calculated 
using the index (2 x RP + BP)/(LP + RP +BP)/2, where RP, LP and BP are the 
number of times the right paw, left paw and both paws were used, respectively. 
Behavioural assessment was carried out blind by an examiner using video 
recordings. 
In all the different conditions, the right paw in the push off (Fig 10B), rearing (10D) 
and landing functions was used around 50% of the time in the pre-surgery time 
points. At day three in all the tested groups, the push off and rearing movements 
were more affected by the right corticospinal axotomy than the landing 
movement. The push off and rearing movements decreased to 2% and 9%, 
respectively, while the landing movements only decreased to 20%. All rats in 
each of the groups showed spontaneous recovery of the push off, rearing and 
landing functions, from day 7 to day 42 following corticospinal tract injury. When 
the GM-CSF/eGFP groups (GM4, GM5.5 and GM7) were averaged together and 
compared to the control, there was no significant difference (p>0.05; unpaired 
student t-test).  
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GM-CSF/eGFP-virus cortical injection improves behavioural 
recovery in the directed forepaw reaching test  
To further investigate the effect of GM-CSF on functional recovery, rats were 
evaluated on the directed forepaw reaching test. This task measures fine and 
voluntary movement, which are controlled by the corticospinal tract (Whishaw et 
Figure 10: Rats with corticospinal tract injury show spontaneous recovery of rearing movements 
independent of treatment. A, C & E: Photographs show the movements which were quantified in 
the rearing assessment. A rat with right C4 corticospinal tract injury uses only the left (uninjured) 
paw to balance when pushing off the floor (A), rearing (B) and landing (C). Red arrow points to 
the right (injured side) paw. B,D &F: Line graphs represent the percentage improvement of the 
right paw of C4 corticospinal tract injured rats injected with control-virus (CON-green) or 
increasing concentrations of GM-CSF/eGFP-virus at 104 (GM-4.0: yellow), 105.5 (GM-5.5: blue) 
or 107 (GM-7: red) at 0-42 days post lesion.  
Chapter Six 
 
 
237 
al., 1992; Whishaw et al., 1998). The reaching movement was separated into 
three categories, including eating success, distal muscle and proximal muscle 
movements.  
A successful eating movement consisted of the following sequence: lifting paw 
from floor (Fig. 11A), exiting the slit (Fig. 11B), grasping the Cheerio fragment 
(Fig. 11C), withdrawing the Cheerio fragment and transporting it to mouth to eat 
(Fig. 11C). The number of successful eating movement by the right (injured side) 
paw was calculated as a percentage of the total number of successful eating 
movement by the injured and intact paws. 
 
Distal muscle function was evaluated by assessing the movements of the lower 
forelimb and paw: wrist flexion and extension (Fig. 11G-H), and paw opening and 
closure (Fig. 11E-F). Proximal muscle function was assessed by the shoulder 
movements, which included abduction (Fig. 11I-J), adduction (Fig. 11K-L) and 
flexion (Fig. 11M-N), and biceps flexion (Fig. 11O-P). Ability to perform these 
movements was scored on a scale of 1-3 (1-attempted but ineffective, 2-partial 
use, or 3-complete use). To measure functional improving, for each movement a 
percentage score was calculated using the following index: (1 x ineffective + 2 x 
partial + 3 x complete)/ (ineffective + partial + complete)/3. 
 
Corticospinal tract injury produces loss of distal limb function 
During pre-surgery baseline testing, rats randomly assigned to the four 
experimental groups showed complete movements with the left and right 
forelimbs. Following a right C4 corticospinal tract injury a clear reduction in all 
movements was found in the right but not the left forelimb at the first postoperative 
date (Day 3). These effects were observed in rats injected into the left motor 
cortex with control-virus (n=8) as well as with GM4 (n=7), GM5.5 (n=6) or GM7 
(n=9) (TU/mL) (Fig. 12). 
Movements of injured side showed a graded response, with distal muscles being 
more affected than proximal. A strong effect, with a drop in function to just grade 
1 (i.e. attempted movement but of no use, =33%) was found for paw opening and 
closure (Fig. 12B-C). A more moderate decrease, between grade 1 and 2 (2 is 
equivalent to partial use, =67%) was observed for wrist extension and flexion (Fig. 
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12D-E), biceps flexion (Fig. 12F), and shoulder abduction (Fig.12G). Only very 
mild functional loss (between grade 2 and 3-complete use, =100%) was noted for 
shoulder adduction and flexion (Fig. 12H-I).  
Eating success (Fig. 12A) was especially heavily affected, dropping to 0% 
immediately after injury. Thus, in line with past research, current results 
demonstrate that injury to the corticospinal tract is primarily associated with 
deficits in the movement of distal limb, particularly the precision of reaching and 
grasping (Whishaw et al., 1993). 
Functional recovery 
As shown in Figure 12, GM-CSF improved eating success. Averaging across GM-
CSF/eGFP groups and comparing against eGFP controls, the rats showed a 
significant improvement in their ability to complete the eating task (Fig. 12A) at 
14, 17, 21, 31, 35 and 38 days post-surgery. There was no apparent dose-
dependence in the experimental groups that received the GMCSF vector at GM4, 
GM5.5 or GM7 (p<0.05; unpaired student t-test). 
Sub-movements controlled by distal muscles also showed a trend towards better 
recovery in rats treated with GM-CSF/eGFP-virus, again with no clear difference 
between different dosages. Thus, paw opening and closing functions showed a 
trend for improvement (Fig. 12B-C) at day 14 (p= 6%) and 17 (p= 6%; unpaired 
student t-test) following GM-CSF/eGFP-virus cortical injections rather than 
control-virus injection. In addition, there was a trend for GM-CSF/eGFP-virus to 
accelerate recovery of wrist flexion and extension (Fig. 12D-E), biceps flexion 
(Fig. 12F) and shoulder abduction (Fig. 12G) (p =6-9%; unpaired student t-tests). 
Spontaneous recovery of proximal movements, such shoulder adduction (Fig. 
12H) or flexion (Fig. 12I), were generally independent of treatment (p>0.05; 
unpaired student t-test).  
As with eating success, all recoveries seemed to plateau and show little 
improvement beyond approximately three weeks after corticospinal tract lesion. 
This suggests that the first 3 weeks is a sensitive phase for treatment with GM-
CSF/eGFP-virus. 
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Figure 11: Movements used to determine functional recovery in rats with C4 corticospinal tract 
injury injected with control-virus or increasing GMCSF/eGFP-virus concentrations. 1-3: 
Accurate/complete right arm movements of intact rats involved in the eating sequence (1-yellow 
outline), the proximal (2- blue outline) and distal muscles (3-green outline) used during reaching. 
Contours of forelimb and forepaw are highlighted with blue dotted lines and shadows in red (I&J). 
1A-D: An eating success (yellow outline) was quantified only when rats completed the following 
sequence of movements: A-B: lifting the forepaw from the floor, exiting the slit, covering the food, 
opening paw, B: closing paw and withdrawing food, and D: transporting it to mouth to eat the 
pellet. 2E-H: Movements of proximal muscles namely of the wrist and paw involved during the 
food reaching and grasping motions. Wrist extension (E) was determined by the arm being parallel 
to the floor and digits point upwards. Wrist flexion (F) was evident when the joint was bent resulting 
with the palm of the paw moving toward the forearm. Digits moving laterally away from the axial 
line showed a paw opening motion (G), and paw closing (H) was found when digits flexed around 
the food fragment. Inserts show close up of the wrists and paw movements. 3 I-P: Show proximal 
muscle movements in the shoulder (I-N) and biceps (O-P). Shoulder abduction (I-J) involved the 
lateral movement of the elbow away from the midline of the body; notice the shadow (red contour) 
of the arm expanding when the arm moves literally. Adduction (K-L) was noticed when elbow and 
paw toward the midline of the body in a horizontal plane. Flexion (M-L) was determined by the 
movement of the upper arm upward to the front. Biceps flexion (O-P) was determined by the rat 
lifting the forepaw from the floor. 
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Discussion 
The current study demonstrates for the first time that injections of GM-
CSF/eGFP-virus into the motor cortex of rats with corticospinal tract injuries can 
have a protective effect on injured corticospinal axons and promote functional 
recovery. It was also shown that cortical injections of GM-CSF/eGFP-virus results 
in prolonged microglial and astrocyte activation in the motor cortex and microglial 
activation in the corticospinal tract in the cervical spinal cord. The positive action 
of GM-CSF/eGFP-virus observed in C4 corticospinal tract injured rats may be at 
least partially mediated by enhancing the inflammatory response around the cell 
body and axons of injured corticospinal neurons.  
GM-CSF/eGFP-virus mediates the preservation of corticospinal 
tract axons 
Rats with C4 corticospinal tract injuries that received injections of GM-
CSF/eGFP-virus into the motor cortex, had more axons in the dorsal corticospinal 
tract of the spinal cord and these extended closer to the site of injury than those 
in animals injected with control-virus. The differences in the efficacy of 
anterograde labelling between groups could not explain this effect, as the number 
of axons at the level of the pyramids was similar for all the groups. GM-CSF may 
be mediating this effect by: a) activating a regenerative response in the injured 
neurons, b) suppressing the activation of an intrinsic neuronal program that leads 
to neurodegeneration, c) or by local effects on axonal viability (Luo and O'Leary, 
2005). Although the current study did not specifically examine these factors, other 
studies suggest that GM-CSF may play a role in all three processes.  
Figure 12: Eating success was most affected following right spinal cord injury and showed 
significant improvement following GM-CSF treatment. A-I: Line graphs represent the percentage 
(%) improvement of the right arm and paw of C4 corticospinal tract injured rats injected with 
control-virus (CON-green) or increasing concentrations of GM-CSF/eGFP-virus at 104 (GM-4.0: 
yellow), 105.5 (GM-5.5: blue) or 107 (GM-7: red) at 0-42 days post lesion. Eating success 
movements (A) were quantified, and the precision of the following sub-movements were scored: 
paw opening (B) and closing (C), wrist flexion (D), wrist extension (E) bicep flexion (F), shoulder 
abduction (G), adduction (H) and flexion (I). At post-operative day 3, a graded response to injury 
emerged with proximal to distal muscles showing little to high functional deterioration, 
respectively. Similarly, shoulder adduction (H) and flexion (I) movements showed spontaneous 
recovery; shoulder abduction, bicep flexion, wrist flexion and extension revealed acceleration 
towards recovery, and paw opening and closing showed a strong tend towards improvement. The 
average grades 1, 2 and 3 are represented on the graphs by the first, second and third 
intermediate grid lines. Eating success was most affected by injury and GM-CSF treatment was 
associated with significant recovery. (*) p<0.05 significance following unpaired student t-test. 
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GM-CSF/eGFP-injections into the motor cortex may promote axonal regeneration 
following injury. In the present study there was a pronounced increase in 
microglial activation in the motor cortex of GM-CSF/eGFP-injected rats with 
corticospinal tract injury. Following corticospinal tract injury there is no microglial 
activation around the cell bodies of corticospinal neurons (Leong et al., 1995). 
Stimulating microglial activation around the cell bodies of neurons that project 
their axons into the central nervous system is associated with enhanced axonal 
regeneration. Lu and Richardson, (1991) found that injection of Corynebacterium 
to the DRG activates macrophages and was associated with axonal regeneration 
following dorsal rhizotomy (central axotomy). Similarly, Leon et al., (2000) 
showed that macrophage activation following the intraocular injection of zymosan 
or injury to lens is associated with RGC survival and vigorous axonal regeneration 
following optic nerve crush.  
 
Peripheral nerve graft experiments have also demonstrated that the extent of 
perineuronal microglial activation correlates well with axonal regeneration. 
Shokouhi et al. (2010) demonstrated that axonal growth into peripheral nerve 
implants provokes a substantial increase in perineuronal neuroinflammation, 
which is most obvious around the highly regenerative thalamic reticular neurons. 
Increased microglial activity is also found around rubrospinal neurons which 
regenerate into peripheral nerve grafts in the spinal cord (Harvey et al., 2005; 
Richardson et al., 1980). Interestingly, neurons that regenerate their axons into 
peripheral nerve grafts show a transient upregulation of regeneration associated 
molecules (GAP-43, CAP-23, SCG-10) following injury, which is prolonged in 
response to the implantation of the graft. However, neurons which do not 
regenerate into peripheral nerve grafts, such as corticospinal neurons, do not 
mount such a response (Campbell et al., 1991; Chaisuksunt et al., 2000; Mason 
et al., 2002; Vaudano et al., 1995; Zhang et al., 1995). The current study 
evaluated the expression of c-Jun or ATF3 transcription factors, which are key 
players in the neuronal response to injury by participating in the transcriptional 
regulation of growth-associated genes. It was found that c-Jun or ATF3 may be 
expressed by glial cells rather than corticospinal neurons of GM-CSF/eGFP-
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injected rats. Nonetheless, more detailed analysis must be carried out to confirm 
this rather than just relying on the nuclear morphology. Coronal brain sections 
should be double-stained for neuronal marker (e.g. NeuN) and c-Jun or ATF3. In 
addition, other factors involved in the growth and guidance of regenerating 
neurons, such as GAP-43, CAP-23, SCG10, L1 and CHL1 (Mason et al., 2003), 
must be evaluated.  
 
In addition, GM-CSF has been found to promote axonal regeneration following 
injury by the enhancing expression of neurotrophic factors. Bouhy et al. (2006), 
investigated the effect of injecting GM-CSF intraperitoneally into rats four weeks 
after a closed spinal cord compression injury at the T8-T9 level. At 8 and 24 
weeks post injury they detected more regenerating fibres of the corticospinal tract 
entering the lesion site in GM-CSF treated rats than those injected with the 
vehicle. This was mediated by a transient increase in the number of macrophages 
at the injury site. These macrophages were expressing BDNF. Bouhy et al. 
(2006), concentrated on the changes in the spinal cord. However, when rats with 
a dorsal corticospinal injury to the thoracic spinal cord received BDNF near the 
cell bodies of the injured neurons, there was a significant increase in collateral 
sprouting by corticospinal fbres within the spinal cord (Vavrek et al., 2006). It 
remains to be investigated whether neurotrophic factors are produced in the 
vicinity of the cell bodies of corticospinal neurons in our experiments. 
 
Microglia can produce proinflammatory cytokines that can cause astrocyte 
activation and cell death. The current study found that high levels of microglial 
and astrocyte activation in the motor cortex following the injection of high 
concentrations of GM-CSF/eGFP was associated with a decrease in the number 
of virally-transduced (eGFP+) cells. Accordingly, the number of BDA-positive 
corticospinal axons appeared to decreased in rats injected with high 
concentration of GM-CSF/eGFP-virus compared to those injected with a medium 
concentration. Nonetheless, rats injected with medium and high concentrations 
had more axons closer to the injury site than those injected with eGFP-virus. GM-
CSF has been associated with increasing survival of neurons. Rats that 
underwent focal cerebral ischemia following unilateral occlusion of the middle 
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cerebral artery and were administered GM-CSF for five consecutive days had a 
decreased cerebral infarction volume. This was associated with the decreased 
expression of apoptosis-related genes, including Bcl-2, Bax, caspase 3, and p53. 
In vitro, experimenters found that GM-CSF increased the viability of a 
neuroblastoma cell line subject to glutamate-induced excitotoxicity, by reducing 
Bax gene expression and increasing Bcl-2 gene (anti-apoptotic) expression 
(Kong et al., 2009). Similarly, Schaebitz et al., (2008), reported that exposure of 
vulnerable neurons to GM-CSF was protective. GM-CSF induced anti-apoptotic 
BCL-2 and BCL-Xl gene expression in mouse and rat primary cortical neurons 
treated with nitric oxide. GM-CSF was also found to highly activate the PI3K/Akt 
pathway. When PI3K/Akt neuronal signalling was inhibited it strongly decreased 
the anti-apoptotic activity of GM-CSF, suggesting that the PI3K/Akt pathway is 
important in protection of primary cortical neurons. It remains to be investigated 
if GM-CSF/eGFP-virus enhances the survival of corticospinal neurons and 
whether this plays a role in axonal protection. 
 
Finally, GM-CSF has been found to preserve axonal integrity. Rats with a T9/10 
spinal cord injury induced using a vascular clip had GM-CSF administrated via 
intraperitoneal injection or administration on the dural surface using Gelfoam at 
the time of SCI. GM-CSF was shown to preserve the corticospinal axonal 
morphology and myelin structure after spinal cord injury. Longitudinal horizontal 
sections were immunostained for neuroﬁlament and Luxol fast blue, to detect 
axon fibres and myelin/myelinated axons, respectively. Axons were relatively well 
arranged and the myelin sheath was preserved relatively intact in the GM-CSF 
groups (Huang et al., 2009). The effect of GM-CSF/eGFP injection into the motor 
cortex of rats with corticospinal tract injury on axonal morphology needs to be 
evaluated in more detail. 
Distal movements are more affected by a corticospinal tract 
injury 
In the rat, axons of corticospinal neurons travel down to all levels of the spinal 
cord in the dorsal, ventral and lateral corticospinal tracts (Weidner et al., 2001). 
At different spinal cord segments, corticospinal axons can form synapses directly 
with motor neurons or, more frequently, indirectly through interneurons in the grey 
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matter of the spinal cord. These motor neurons innervate muscles involved in 
fine, voluntary and skilled movement (Arslan, 2001). In the current study, the 
directed forepaw reaching task was used to evaluate fine and voluntary 
movement (Whishaw et al., 1992; Whishaw et al., 1993). It was found that 
movements, such as those of the wrist and paw produced by distal muscles were 
more affected by a dorsal corticospinal tract injury at the fourth cervical segment 
than movements produced by proximal muscles, such as those of the shoulder 
and biceps. Findings from anatomical studies suggest that the level of the spinal 
cord at which the injury was carried out may produce the difference between 
proximal and distal muscles. Tosolini and Morris (2012) used fluorogold to identify 
the motor pools of 11 muscles in the forelimbs of Long-Evans rats. Motor neuron 
columns innervating the shoulder muscles span across cervical spinal cord 
segments 2–6 (C2-C6). Those innervating the upper forelimb muscles span 
across C3–C8, whereas the majority of the motor neurons innervating the lower 
forelimb muscles span across C5–C8 (Tosolini and Morris, 2012). In the current 
study rats had a dorsal corticospinal tract injury at spinal cord level C4 so more 
motor neurons for proximal limb muscles would have retained their corticospinal 
control.  
In agreement with Tosolini and Morris (2012) results, Whishaw et al. (1993) found 
that rats with a unilateral corticospinal tract lesion in the medullary pyramids had 
significant deficits in the function of both proximal and distal forelimb muscles. 
Using a reaching test, similar to the one used in the current study, Whishaw et al. 
(1993) found that advancing the forepaw to the pellet (proximal muscles), 
grasping the pellet (distal muscles), then retracting the limb into the testing box 
(proximal muscles) while the paw maintains a grip on the pellet (distal muscles), 
were significantly impaired following lesions of the pyramids. However, it was 
interesting to note that injured rats retained the ability to open their paw digits but 
had impaired their grasping ability. Other studies have reported that lesions of the 
pyramids show deficits in the ability to open their paw digits (Castro, 1972a; Kalil 
and Schneider, 1975). In the present study, the opening and closing of paw digits 
were both highly impaired, which is compatible to the studies of Castro, (1972) 
and Kalil and Schneider (1975), which have shown the importance of the 
corticospinal tract in the use of forepaw digits in rodents.  
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Spontaneous functional recovery following corticospinal tract 
injury 
It has been reported that rats with unilateral lesions of the corticospinal tract, at 
the level of the spinal cord or medullary pyramid, may retain or resume forelimb 
function without intervention (McKenna and Whishaw, 1999; Metz and Whishaw, 
2002; Weidner et al., 2001; Whishaw et al., 1993; Whishaw et al., 1998). In the 
current study, rats showed spontaneous recovery in the rearing test and in some 
movements of the directed forepaw reaching test four weeks after a dorsal 
corticospinal tract injury. The extent of spontaneous functional recovery has been 
associated to sprouting. Weidner et al. (2001) investigated the effect of different 
forms of corticospinal tract lesions on behavioural recovery. Rats received a 
unilateral dorsal-only, ventral-only or dorsal and ventral corticospinal tract 
transection. Using a reaching test to assess behaviour, they quantified the 
number of successful pellet retrievals. They also evaluated specific movement of 
forelimb use, including failed advances (proximal muscle function); missed aims 
(proximal muscle function); digit spread (distal muscle function); and food pellet 
drops, (either proximal or distal muscle function). Movements of the forelimb 
which required the use of both proximal and distal muscles, were transiently 
impaired in rats with a dorsal- or ventral- corticospinal tract transection. Rats with 
both dorsal and ventral corticospinal tract injury showed a permanent deficit in 
movements. Experimenters found that the rats with a dorsal corticospinal tract 
injury only had more corticospinal tract axon terminals on motor neurons in the 
medial motor columns in lamina IX of spinal grey matter, than rats that where 
intact. The greater number of motor neuron synapses were explained to originate 
from the uninjured ventral corticospinal tract. Correlational analysis suggested 
that rats with more corticospinal tract sprouts to the spinal grey matter showed 
greater functional recovery (Weidner et al., 2001). 
In the current study the eating success function did not show spontaneous 
recovery, as at 6 weeks, this function remained severely impaired in control-virus 
injected rats with a dorsal corticospinal tract injury. Weidner et al., (2001) 
evaluated successful pellet retrievals and found that after four weeks, rats with a 
dorsal corticospinal tract lesion recovered function similar to that of non-injured 
rats. At least two reasons may explain the difference between the current result 
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and those of Weidner et al. Firstly, the criteria used to measure function are 
slightly different. In the present study an eating success was counted if the rat 
lifted the paw from floor, the paw exited the slit, and the Cheerio fragment was 
grasped, withdrawn and transported to the mouth to eat. However, Weidner et 
al., (2001) did not include the transportation of the food to the mouth. Secondly, 
it may be that the injury in the rats of the present study was more extensive. Due 
to the nature of the dorsal corticospinal tract transection, rats may have had other 
areas of the spinal cord injured, such as the grey matter of the spinal cord or the 
lateral dorsal corticospinal tract. The extent of loss of directed forelimb reaching 
is indeed affected by the extent grey matter injury (Yamamoto et al., 2009). 
Yamamoto and colleagues found that rats that showed no return of function had 
extensive destruction through the medio-lateral extent of the grey matter, in 
addition to the dorsal corticospinal tract injury. However, further work analysing 
the extent of grey matter injury remains to be carried out to clarify this point. 
GM-CSF/eGFP-virus improves functional recovery 
Rats injected with GM-CSF-virus showed significantly more functional 
improvement in eating success, a trend towards more improvement in the paw 
opening and closing movements and a trend towards faster recovery of 
movements that required wrist flexion and extension, biceps flexion and shoulder 
abduction. Intact spinal interneurons that bypass the spinal lesion are capable of 
receiving new inputs from cut axons (Bareyre et al., 2004; Vavrek et al., 2006). 
Axons of the corticospinal tract (ventral CTS projections when dorsal CTS is 
damaged but ventral fibres are preserved) have been reported to sprout into 
spinal grey matter following spinal cord injury (Weidner et al., 2001). It could be 
that GM-CSF/eGFP-virus may be intensifying this sprouting effect, leading to the 
formation of new synapses, which in turn results in improved functional recovery. 
The current study found that rats injected with GM-CSF/eGFP-virus had more 
axons closer to the injury site than those injected with control virus. However, it 
failed to characterise the level of axonal sprouting into the grey matter of the 
spinal cord. Thus future studies need to analyse the extent of axonal sprouting to 
see if it could play a role in functional improvement. 
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Nonetheless, axonal sprouting may be mediated by GM-CSF-stimulated 
production of neurotrophic molecules. Researchers have shown improvement of 
function in spinal cord injured rodents injected with GM-CSF-protein (Bouhy et 
al., 2006; Ha et al., 2005; Hayashi et al., 2009). Bouhy et al., (2006) used open 
field Basso, Beattie, and Bresnahan (BBB) scores to record the extent of 
functional recovery of rats with a spinal cord injury at T8-T9 level, treated with 
intraperitoneal injections of GM-CSF. Rats treated with GM-CSF had more 
corticospinal axons regenerating past the injury site than those injected with PBS. 
In addition, more BDNF was expressed by microglia in the spinal cord of GM-
CSF injected rats than the rats injected with PBS control. It would be interesting 
to measure the levels of BDNF and other neurotrophins in the spinal cord and 
motor cortex of rats injected with the GM-CSF virus. 
Limitation 
In the current study, a histological assessment and behavioural assays were used 
to evaluate whether producing inflammation around injured corticospinal neurons 
enhances axonal regeneration and functional recovery. This revealed that cortical 
injections of medium and high concentrations of GM-CSF-virus were efficient at 
both promoting inflammation in the motor cortex and functional recovery. 
However, cortical injections of a lower concentration of GM-CSF-virus, namely 
GM4, resulted in better functional recovery, but failed to produce noticeable 
inflammation in the motor cortex. However, at least two factors can explain the 
lack of inflammation in GM4-injected rats: 1) the experimental set up and 2) the 
sensitivity/accuracy in measuring inflammation. In terms of the experimental set 
up, the histological assessments of the effects that GM4 on inflammation were 
carried out at different times after injection. In Chapter 4 a heightened 
inflammatory response to GM4-virus was found in the motor cortex of intact 
rats14 days after cortical injections. In the current chapter histological 
assessment of inflammation was carried out at 42 days after injection. This 
suggest that GM4 can produce inflammation at relatively early time-points, but 
this may have declined by 42 days after injection. It would be interesting to find 
out at which day inflammation peaks; the time points evaluated should be 
between 14 and 42 days after injecting GM4-virus into the motor cortex of rats 
with CST injury. Regarding the sensitivity/accuracy in measuring inflammation, 
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the histological assay presented in this chapter characterised inflammation by the 
increased density of microglial cells, irrespective of the activation states. A failure 
in evaluating the different activation states of microglia may mask the effect GM4 
has on inflammation. Microglial activation should be evaluated by also quantifying 
the number of activated microglia and phagocytic microglia, separately. It is 
possible that GM4-virus is promoting cortical inflammation by causing 
morphological changes in microglia.  
Conclusion 
In this study we have demonstrated that at high concentrations GM-CSF virus 
increases inflammation and astrogliosis in the motor cortex of rat, and produces 
axon protective effects following corticospinal tract injury. The cortical delivery of 
GM-CSF was associated with an improvement in reaching function. The 
anatomical and molecular mechanisms mediating functional improvement require 
further investigation. 
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CHAPTER SEVEN 
General Discussion 
This thesis has investigated the dual effects of inflammation on the central 
nervous system. Like peripheral macrophages, activated microglial cells – their 
CNS counterparts - express a number of potentially cytotoxic molecules which 
could impair neuronal survival (Raivich et al., 1999). However, there is 
accumulating evidence suggesting that microglia also produce signals which 
change neuronal gene expression to promote regeneration (Bouhy et al., 2006; 
Lalancette-Hebert et al., 2007; Makwana et al., 2007; Schroeter et al., 2006; Yin 
et al., 2006). 
The aim of the current project was to use perineuronal microglia as a tool to 
enhance corticospinal tract and facial nerve regeneration after axotomy. In 
addition, we explored the neurotoxic effect of microglial activation in the adult and 
neonate rodent brain. To provoke inflammation Poly I:C and viral GM-CSF were 
used. 
Perineuronal inflammation can be protective and enhance 
regeneration following central and peripheral axonal injury 
The difference in regenerative capacity between the central (CNS) and peripheral 
nervous system (PNS) has been primarily attributed to the non-supportive 
environment the injured CNS presents to regenerating axons, compared to the 
more permissive environment of the injured PNS (Filbin, 2003). However, the 
ability of neuronal cell bodies to mount an appropriate response to injury could 
also be a significant factor to create differences in PNS and CNS (Anderson et 
al., 1998; Raivich et al., 2004; Raivich and Makwana, 2007). The neuronal cell 
body response to axonal injury is accompanied by perineuronal inflammation 
around the cell body of the axotomised neurons. Interestingly, while axonal injury 
causes inflammation around PNS projecting neurons, axonal injury to CNS 
neurons does not cause perikaryal inflammation (Anderson et al., 1998). 
When inflammation is induced around the axotomised centrally projecting 
neurons by stimulating surrounding macrophages, neurons are able to extend 
their axons into the CNS (Lu and Richardson, 1991; Leon et al., 2000). The 
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improved axonal regeneration mediated by increased perineuronal inflammation 
is associated with increased upregulation of regeneration-related proteins (Leon 
et al., 2000; Lu and Richardson, 1991). 
This thesis demonstrates the effect of acute and chronic inflammation around the 
cell bodies of injures neurons on axonal regeneration and functional recovery. 
The inflammation produced by Poly I:C in the CNS appears to be short lived, 
peaking at day 3 after injection and decreasing thereafter. Injections of Poly I:C 
to the motor cortex are associated with a greater number of axons in the 
corticospinal tract after spinal cord injury. In addition, functional recovery 
following facial nerve transection is also improved by Poly I:C injections to the 
brainstem near the facial motor nucleus. Similarly, viral delivery of GM-CSF to 
the motor cortex promotes chronic inflammation which can be seen up to 42 days. 
Viral GM-CSF mediated inflammation in the motor cortex was associate with a 
greater number of corticospinal axons closer to the injury site after spinal cord 
injury, as well as functional recovery in reaching tasks.  
These results support previous evidence that perineuronal inflammation 
promotes axonal regeneration. Improvement in central axonal regeneration by 
mediating perineuronal inflammation has previously been demonstrated on 
central rhizotomy and optic nerve injury models. Like Hossain-Ibrahim et al. 
(2006), this thesis extends the application of this approach to spinal cord injury. 
In contrast to Hossain-Ibrahim and colleagues, who applied lipopolysaccharide 
(LPS) to the rat motor cortex and found no effect in the spinal cord, in this thesis 
a protective effects on injured axons and increased functional recovery were 
demonstrated.  
In addition, that Poly I:C has been shown to enhance functional recovery following 
facial nerve transection in rats. Previous studies using a number of different 
approaches have failed to demonstrate such robust functional recovery in the rat 
after peripheral nerve transection (Al-Majed et al., 2000b; Brushart et al., 2002; 
Hadlock et al., 2010; McQuarrie et al., 1977; Zhang et al., 2013). Peripheral nerve 
regeneration in the rat is robust with almost complete target reinnervation 
achieved within 8 weeks (Al-Majed et al., 2000b; Sinis et al., 2009). However, 
functional recovery is absent even up to 15 weeks following injury (Hadlock et al., 
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2010; Knox et al., 2013). The lack of functional recovery has been explained by 
polyinnervated non-functioning neuromuscular junctions (Zhang et al., 2013). 
The enhancement of functional recovery mediated by Poly I:C in this thesis 
appear to be independent of target reinnervation. Future work should concentrate 
on determining the effect perineuronal Poly I:C may have on neuromuscular 
junction reinnervation patterns and function. 
The effects observed on axonal regeneration in the spinal cord following 
perineuronal inflammation with Poly I:C and viral GMC-SF appear to be very mild. 
Despite their axon protective effects following spinal cord injury we failed to 
observe axonal regeneration into the injury site. Other experimental therapeutic 
approaches, which have mainly concentrated on the injury site, have shown avid 
growth into the glial scar and robust sprouting (Bradbury et al., 2002; Carter et 
al., 2008; Fabes et al., 2007; Goldshmit et al., 2011; Yick et al., 2003; Yick et al., 
2004). Targeting the inhibitory injury site which lacks neurotrophic support in 
combination with enhancing the neuronal cell body response may work in synergy 
to cause pronounced beneficial effects on axonal regeneration and recovery 
following spinal cord injury. 
How can inflammation promote axonal regeneration? 
The current study used GM-CSF and Poly I:C to produce inflammation around 
the soma of axotomised neurons, with the aim of producing or enhancing axonal 
regeneration. Inflammation may be affecting axonal regeneration by promoting 
mammalian target of rapamycin (mTOR)-mediated protein synthesis in the axon. 
mTOR is an atypical serine/threonine kinase, whose upstream regulators are 
PI3K and Akt, and PTEN (phosphatase and tensin homolog) and TCS 1/2 
(tuberous sclerosis), which act as inhibitors of PI3K and AKT, respectively (Hay 
and Sonenberg, 2004). There is indirect and direct evidence to show that mTOR 
is involved in axonal protein synthesis. Injured adult peripheral axons contain 
mTOR and its downstream targets, such as P-S6K, PS6, P-4E-BP1, ribosomal-
P0 and phospho-eIF-4E, which are components of the translational machinery 
responsible for ribosome-recruitment to mRNA (Jimenez-Diaz et al., 2008; Verma 
et al., 2005). Additionally, mTOR controls the axonal translation of the 
regeneration-associated protein GAP-43 (Abe et al., 2010) and the membrane 
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protein syntaxin-13 (Cho et al., 2014), which is involved in endosomal recycling 
of plasma membrane proteins (Prekeris et al., 1998). Functionally, the activation 
of mTOR results in robust axonal regeneration, after axonal injury of CNS 
neurons (Hu et al., 2010; Liu et al., 2010; Park et al., 2008).  
Proinflammatory cytokines can activate mTOR. The cytokine IL-6 has been 
shown to activate mTOR in the soma of spinal neurons of rats with CST injury 
and enhance spinal cord regeneration (Yang et al., 2012). Since both GM-CSF 
and Poly I:C can cause the production of IL-6 by microglia, it could be suggested 
that mTOR activation in neurons may be at least caused by IL-6 production. 
Currently, only GM-CSF has been shown to directly activate the upstream 
constituents of the mTOR pathway;  in cultured rat primary neurons challenged 
by NO the activation of this pathway was associated with increased neuronal 
survival (Schaebitz et al., 2008). Additionally, GM-CSF promotes neurite growth 
from postnatal RGCs mediated by mTOR (Legacy et al., 2013). It remains to be 
evaluated whether Poly I:C can also modulate the mTOR pathway. Nonetheless, 
it is possible that the regenerative effects associated with treating rats with GM-
CSF or Poly I:C may be mediated at least in part by the mTOR pathway.  
Enhanced axonal protein synthesis mediated by mTOR may lead to better axonal 
regeneration. Following injury, axonal processes of regeneration-competent 
neurons synthesize proteins from pre-existing mRNA (Merianda et al., 2009; 
Willis et al., 2005; Zheng et al., 2001). Locally synthesised proteins include 
endoplasmic reticulum chaperone proteins (Willis et al., 2005), the transcription 
factor STAT3 (Ben-Yaakov et al., 2012), and proteins important for retrograde 
signalling such as importin-β1 (Hanz et al., 2003) and vimentin (Perlson et al., 
2005). The ability of an injured axon to continue synthesising protein is correlated 
with its ability to regenerate (Verma et al., 2005). In addition, when protein 
synthesis is blocked in injured axons, a retraction of growth cones is evident 
(Zheng et al., 2001). Therefore, synthesis of proteins in the axons promotes 
axonal regeneration and the initiation of retrograde transport of injury signals. 
More protein production in the axons may lead to a stronger retrograde transport 
to the cell body, thereby increasing the cell body response and subsequently 
causing axonal regeneration. Retrograde transport of injury signals is important 
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for triggering a cell body response following injury. Signalling molecules (p38, 
JNKs, MAPKs, ERKs) can be transported from the axons to the neuronal cell 
body via macromolecular signalling complexes trafficked by dynein motors 
(Rishal and Fainzilber, 2010). Among the components of these macromolecular 
signalling complex is importin, which is a scaffolding protein that links the 
signalling molecules to the dynein motors. Importin has two isoforms, importin-α 
and importin-β. In adult sensory axons, importin-α is constitutively expressed in 
normal conditions and its expression remains the same after injury, while the 
expression of importin-β increases after injury, due to the local translation of 
mRNA (Hanz et al., 2003). The role of importin on axonal regeneration has been 
demonstrated in vitro and in vivo. In vitro, selective depletion of importin-β1 from 
axons attenuated the cell body response to injury in sensory neurons, with a 
reduction of over 60% of genes that are activated in the cell body after injury 
(Perry et al., 2012). In addition, lack of axonal importin-β1 delayed functional 
recovery from sciatic nerve injury (Perry et al., 2012). Additionally, importin on the 
dynein motors can also bind to vimentin, which itself can bind to phosphorylated 
ERK (Perlson et al., 2005) and to locally translated STAT3 (Ben-Yaakov et al., 
2012). These proteins are known to have an effect on gene regulation after 
axonal injury and are known to promote regeneration (Patodia and Raivich, 
2012a). Interestingly, intravitreal injection of GM-CSF upregulates STAT3 protein 
in the retina of rats with retinal degenerative disease; this was associated with 
increased photoreceptor survival (Schallenberg et al., 2012). In this thesis, the 
protective or regenerative effects of GM-CSF treatment in rats with spinal cord 
injury could be in part mediated by increased retrograde trafficking of STAT3, 
synthesised in injured axons. Future work should evaluate whether perineuronal 
inflammation produced by GM-CSF and Poly I:C increases regeneration of 
injured neurons by promoting a cell body response, which is mediated by the 
mTOR pathway, axonal protein production and retrograde signalling to the cell 
body.  
Inflammation is toxic in the CNS 
Injections of Poly I:C at high concentration and GM-CSF virus at high titres were 
associated with necrosis and cell death in the motor cortex. Inflammation 
mediated neural injury can be part of neurological disease processes (Raivich et 
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al., 1999). In this way, the toxic effects produced by Poly I:C and viral GM:CSF 
might help model inflammatory CNS disease. 
In this thesis has studied the inflammatory response to injections of GM-CSF-
virus into the striatum of different mouse strains. It was found that the 
inflammatory and glial response was low in the 129S2/Sv strain, widespread 
though moderate in BALB/c, and high in the FVB/N strain. Expanding the analysis 
of viral GM-CSF mediated inflammation to mice, opens an avenue of research 
using transgenics. This might permit the analysis of the molecular mechanisms 
through which GM-CSF may promote neuroprotective or neurotoxic effects. 
Work on producing a mouse model of inflammatory perinatal brain injury using 
the FVB/N strain has been presented in this thesis. Unlike, other models of 
inflammatory perinatal brain injury which rely on transient systemic effects (Bell 
and Hallenbeck, 2002), transuterine injections of GM-CSF-virus targeting the 
ventricles of the developing mouse brain, provides a prolonged inflammatory 
stimulus. Here it was shown that intraventricular viral GM-CSF causes microglia 
activation in various brain areas including the white matter. This response was 
transient disappearing as the mouse brain matures postnatally. Future work 
should concentrate in determining whether GM-CSF induced microglia activation 
causes white matter damage and behavioural deficits in adulthood, as observed 
in Cerebral Palsy. 
In the adult 129SV2 and BALB/c mice injected with GM-CSF virus into the 
striatum demonstrated mild to moderate responses. Microglia activation can 
result in two diverse phenotypes known as classical activation or alternative 
activation (Colton, 2009; Schwartz et al., 2006; Thored et al., 2009). Classical 
activation is associated with damage in the CNS and the production of pro-
inflammatory cytokines, while alternative activation may be supportive to the CNS 
by the expression of anti-inflammatory or neurotrophic factors (Giunti et al., 
2014). The absence of injury in the 129SV2 and BALB/c in the presence of 
microglia activation makes these strains suitable for the study of the effects of 
non-toxic inflammation on regeneration. 
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Limitations 
Chapter 3 
The conclusions that can be derived from the experiments on the effect of motor 
cortex injections of Poly I:C on corticospinal tract regeneration are limited. This is 
because of the absence of information on a number of parameters that have not 
yet been studied. 
First, no description of the effects of Poly I:C in the motor cortex of rats with spinal 
cord injury has been performed. Similarly no formal analysis has been carried out 
of the possible effects cortical Poly I:C might have on inflammation and 
regenerative gene expression at the level of the CST. Second, the description of 
Poly I:C effects on the neuronal response to injury was limited to the expression 
of two transcription factors. There is a large number of other regeneration 
associated genes and proteins that should also be studied to determine whether 
Poly I:C has an effect by promoting regeneration associated gene expression. 
Third, analysis was limited to the count of BDA labelled axons and retraction 
bulbs at the level of the spinal cord after injury. Data must be obtained on axonal 
sprouting from the CST, first to explain the observed increase in axonal number 
at the spinal cord and second to determine if there are any further effects that 
may represent an enhance regenerative effort. Finally, behavioural analysis could 
be carried out to determine whether the axon protective effect of Poly I:C promote 
recovery of motor function. 
There are also limitations on the study of perineuronal Poly I:C on facial nerve 
regeneration. The robust enhancement of functional recovery described in this 
thesis lacks neuroanatomical correlates. First, analysis of the effects of Poly I:C 
on inflammation and neuronal response at the level of the facial nucleus must be 
carried out. Second, the rate of axonal elongation at the level of the facial nerve 
must be determined. Third, effects of Poly I:C on collateral branching and 
neuromuscular innervation must be ascertained. These parameters would 
provide a possible mechanism by which increased functional recovery was 
achieved from perineuronal Poly I:C delivery. 
Chapter 4 
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A thorough description of the in vivo effects of viral GM-CSF injections to the 
motor cortex was carried out in this thesis. However, a number of questions 
remain to be answered. First, the cellular identity of cells transfected by the virus 
is unclear as morphology of eGFP positive cells in the GM-CSF/eGFP injected 
cortices is atypical of neurons. Double labelling with specific cellular markers for 
glia and neurons may be used to answer this question. Second, although 
microglia activation was demonstrated in a dose dependent manner with GM-
CSF virus in vivo, there is no direct evidence that GM-CSF protein or RNA was 
present following injections of the virus. This question can be addressed with the 
use of western blotting, ELISA, In-Situ Hybridization or RT-PCR for the virus 
encoded murine GM-CSF. Third, it is unclear whether the inflammatory effects of 
GM-CSF seen distally, in the pyramids and spinal cord, are due to global CNS 
inflammation or a diffusion effect of GM-CSF protein travelling down the CST from 
transfected corticospinal neurons. This can be assessed by determining levels of 
inflammation in areas not in close proximity to the CST or motor cortex and by 
determining whether there is murine GM-CSF protein or RNA at the pyramids 
and spinal cord. 
Chapter 5 
The study on the inflammatory effects of viral GM-CSF on different mouse strains 
is limited by a lack of information on gene expression on each of the strains. 
There is no direct evidence to demonstrate that the difference in response to viral 
GM-CSF injection between strains is not due to differences in GM-CSF 
expression. In addition, the strain dependent responses have not been 
characterised at the molecular levels. The importance of both of these factors 
may be effectively determined using comparative gene expression arrays to 
profile each strain response to viral GM-CSF injections. 
The work on the effects of intrauterine delivery of GM-CSF virus on the perinatal 
brain is limited by the use of scoring instead of formal quantification. In addition, 
no direct measurements of neuronal or axonal injury have been performed. These 
along with behavioural assessment of adult mice that have received GM-CSF in 
utero would help determine the value of this strategy as a model of cerebral palsy. 
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Chapter 6 
This thesis has demonstrated that viral delivery of GM-CSF to the rat motor cortex 
is associated with proregenerative effects following corticospinal tract injury. 
However, there remains a number of parameters that should be analysed to draw 
reliable conclusions from the presented data. First, no neuroanatomical evidence 
has yet been obtained from the animals from which the functionally recovery data 
was obtained. Second, no formal assessment of axonal sprouting and 
inflammation has been carried out at the level of the spinal cord. Third, the 
analysis of proregenerative gene expression was limited to immunofluorescence 
for c-Jun and ATF3 transcription factors in the motor cortex. Further work on 
these two areas would help elucidate the mechanism through which cortical 
delivery of viral GM-CSF is beneficial for functional recovery following spinal cord 
injury. 
General conclusion 
This thesis describes Poly I:C and lentiviral GM-CSF mediated inflammation in 
central nervous system. Inflammatory responses produced by these substances 
have been shown to be both protective and toxic. It has been demonstrated that 
perineuronal Poly I:C promotes axon protection following spinal cord injury and 
enhances functional recovery after facial nerve axotomy. Inflammatory response 
to lentiviral GM-CSF was found to be strain dependent in mice; being low in the 
129S2/Sv, widespread though moderate in BALB/c, and high in the FVB/N strain. 
Intrauterine injection of viral GM-CSF to the perinatal FVB/N mouse brain is 
associated with gliosis in periventricular brain areas. In the rat, GM-CSF induced 
perineuronal inflammation is associated with axon protective effects and 
improved functional recovery following spinal cord injury. The work presented 
here contributes to the understanding of the role of inflammation in 
neurodegeneration and axonal regeneration. It also promotes a new mouse 
model for perinatal white matter damage and a novel experimental therapeutic 
strategy for spinal cord injury.
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